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Biomineralisation is the biological control over precipitation of minerals, observed in a 
wide variety of organisms. In biomineralisation processes, proteins control both the 
nucleation and propagation steps in the precipitation of inorganic minerals, forming 
complex architectures with exceptional levels of control. Magnetotactic bacteria (MTB) 
use biomineralisation proteins encoded within their genome for the formation of 
extremely monodisperse biomineralised magnetite nanoparticles (MNPs) within an 
organelle (vesicle) termed the magnetosome. Precipitation of MNPs within this internal 
magnetosome vesicle with the aid of biomineralisation proteins allows such control 
over precipitation of high quality MNPs to be realised. 
Exploitation of the magnetosome formation process via biomimetic precipitation 
within a synthetic vesicle to form an artificial magnetosome is developed throughout 
this thesis. This is by optimisation of a vesicle nanoreactor for incorporation of a 
magnetite precipitation reaction within its core. This is by encapsulation of the alkaline 
reagent for the ensuing magnetite co-precipitation, which was found to be the most 
appropriate route to intra-vesicular precipitation. Various routes to transport iron ions 
into the core for completion of magnetite MNP precipitation are explored. Iron 
transport using biokleptic, biomimetic and entirely synthetic methods of 
transmembrane transport all have differing precipitation outcomes. Engineering co-
precipitation inside a vesicle to form a single magnetite crystal mimics the formation, 
and ideally the behaviour, of a magnetosome. 
Mimicking MTB precipitation magnetosome formation synthetically to achieve high 
quality homogenous and adaptable nanoparticles (NPs), as observed with naturally 
biomineralised magnetite. These particles should, have superior biomedical properties 
to synthetically made particles, currently used in nanomedicine, where MNPs hold 






1 TABLE OF CONTENTS 
Introduction 19 
1.1 Magnetism and Magnetite 2 
1.1.1 Magnetism 2 
1.1.2 Magnetite 7 
1.2 Magnetite formation routes 9 
1.3 Biomineralisation and Biomimetics 13 
1.3.1 Biomineralisation 13 
1.3.2 Magnetotactic Bacteria 15 
1.4 Vesicles 19 
1.4.1 Self-Assembly 20 
1.4.2 Lipids 24 
1.4.3 Polymers 26 
1.4.4 Formation Methods 29 
1.5 Biomimetics 34 
1.6 Applications of Biomimetics 36 
1.6.1 General Drug Delivery Applications 37 
1.6.2 Applications of Magnetic Nanoparticles 38 
1.6.3 MNP Properties Required for MHT 42 
1.6.4 Biomedical uses of Magnetosomes 43 
1.7 Artificial Magnetosomes 44 
1.7.1 Biomimetic Magnetosome System 45 
1.7.2 Aims and Objectives 48 
2 Methods and Materials 51 
2.1 Magnetite Synthesis 52 
2.1.1 Room Temperature Co-Precipitation (RTCP) 52 
IV 
 
2.1.2 Thermal Decomposition of Urea Co-precipitation 53 
2.1.3 Urea and Ammonia Co-precipitation 53 
2.2 Vesicle Synthesis 53 
2.2.1 Liposome Formation 54 
2.2.2 Polymersome Formation 54 
2.2.3 Vesicle size and polydispersity control methods 55 
2.2.4 Vesicle Clean up 57 
2.2 Iron transport methods 59 
2.2.5 Electrohydrodynamic Atomisation Vesicle Synthesis 59 
2.3 Iron Transport 60 
2.3.1 biological transporters 60 
2.3.2 A23187 divalent ionophore 61 
2.3.3 Electroporation 61 
2.3.4 In-situ incorporation 62 
2.4 Iron ion transports assays 62 
2.4.1 Carboxyfluorescein 62 
2.4.2 Ferene 63 
2.4.3 Prussian Blue 63 
2.4.1 Resazurin 65 
2.5 Control of particle formation 65 
2.6 Protein cloning and purification Methods 66 
2.6.1 Gene Cloning 66 
2.6.1 Protein Preparation 71 
2.7 Characterisation and Instrumentation 75 
2.7.1 Vesicle Characterisation 75 
2.7.2 Spectrographic Techniques 80 
2.7.3 Magnetic Measurements 84 
2.7.4 Protein Characterisation 85 
2.7.5 Magnetic Hyperthermia Measurements 88 
V 
 
3 Magnetite formation and quantification of iron ion transport 90 
3.1 Introduction 91 
3.2 Routes to magnetite Formation 92 
3.2.1 Thermal decomposition of Urea 95 
3.2.2 Combined Urea/Ammonia decomposition 96 
3.2.3 Room Temperature Co-precipitation of Magnetite 97 
3.3 Magnetite formation summary and further work 100 
3.4 Membrane transport assays 103 
3.4.1 Measurement of inter-vesicular redox potential 104 
3.4.2 Quantification of ferric/ferrous ion transport 106 
3.4.3 Vesicles Leakage assay 109 
3.5 Ways Forward and Conclusions 110 
4 Vesicle Formation: Optimisation of the Formation of Liposomes and 
Polymersomes 113 
4.1 Introduction to Vesicle Formation 114 
4.2 Liposomes 115 
4.2.1 Phospholipid selection 115 
4.2.2 liposome formation 122 
4.2.3 Liposome Formation Discussion 129 
4.3 Polymersomes 130 
4.3.1 Polymer Properties 130 
4.3.2 Polymersome formation 134 
4.3.3 Polymersome Formation Discussion 145 
5 Biomimetic transport systems 147 
5.1 Introduction to Biomimetic Transport Systems 148 
5.2 Bacterial Iron Transporters 149 
5.2.1 Cloning of Iron Transporters 152 
5.2.2 Expression of Iron Transporters 155 
5.2.3 Transporter Purification 158 
VI 
 
5.2.4 Incorporation into vesicles 160 
5.3 Ionophore iron transport 161 
5.3.1 A23187 incorporation into polymersomes 161 
5.4 Biomimetic Transport Systems Discussion 164 
6 Synthetic Transport Systems 167 
6.1 Introduction to Synthetic Reagent Transport 168 
6.2 Electroporation of Vesicle Membranes 169 
6.2.1 Electroporation of Liposomes 169 
6.3 Electroporation of Polymersomes 176 
6.3.1 Di-block Polymersomes 176 
6.3.2 Tri-block Polymersomes 186 
6.3.3 Carboxylic Acid Terminated RAFT Synthesised Polymersomes 192 
6.4 Optimisation of electroporation 193 
6.5 Room Temperature: Incorporation of Iron into 198 
RAFT Polymersomes 198 
6.6 Discussion of Synthetic Transport Systems 202 
7 High-throughput Synthesis and Electroporation of Vesicles 205 
7.1 Introduction to High-throughput Synthesis using Electrohydrodynamic 
Atomisation (EHDA) 206 
7.2 High throughput Vesicle Formation using EHDA 208 
7.2.1 Optimisation of EHDA 208 
7.3 Synthesis of Magneto-liposome ‘Artificial Magnetosomes’ 213 
7.4 Characterisation of Magneto-liposome ‘Artificial Magnetosomes’ 218 
7.4.1 Electron Microscopy of Magneto-liposome ‘Artificial 
Magnetosomes’ 218 
7.4.2 Raman Spectroscopy of Magneto-liposome ‘Artificial 
Magnetosomes’ 220 
7.4.3 Fluorescence of Magneto-liposome ‘Artificial Magnetosomes’ 221 
VII 
 
7.4.4 Bulk Magnetic Properties of Magneto-liposome ‘Artificial 
Magnetosomes’ 222 
7.5 Adaptability of EDHA for Artificial Magnetosome Synthesis 224 
7.5.1 DOPC Magneto-Liposomes via EHDA 224 
7.5.2 Microscopy of DOPC Magneto-liposomes via EDHA 225 
7.6 Discussion of EHDA Magneto-vesicle Synthesis 226 
8 Biomineralisation of iron oxides 227 
8.1 Introduction to the Biomineralisation of Iron Oxides 228 
8.2 Proteins Used in Synthetic Vesicles 229 
8.3 Magnetite Biomineralisation Protein Properties and Purification 230 
8.3.1 Proteins 230 
 Mms 231 8.3.1.2
8.4 Protein Effects on In Vitro Precipitation 237 
8.4.1 MmsF in Mineralisation Reactions 237 
8.4.2 Mms6 238 
8.4.3 Coiled-coils 239 
8.5 Vesicle Incorporation of Biomineralisation Proteins 241 
8.5.1 Lipids and Proteins 241 
8.5.2 Polymers and Coiled-coils 244 
8.6 Biomineralisation within Vesicles: Discussion 245 
9 Biomedical Application of Magneto-vesicles 248 
9.1 Introduction 249 
9.2 In vitro Magnetic Hyperthermia Tests 250 
9.2.1 Calibration of the Magnetherm 250 
9.2.2 Magneto-vesicle Heating Capability 252 
9.3 Magneto-vesicles as MRI Contrast Agents 259 
9.3.1 Calibration of measurements 259 
9.3.2 Magneto-vesicle MRI measurements 262 
9.3.3 Altering the Iron Concentration: Effects in MRI 264 
VIII 
 
9.4 Discussion of Biomedical Applications of Magneto-vesicles 267 
10 Future work and Conclusions 269 
10.1 Conclusions 270 
10.1.1 Vesicle Optimisation for Mineralisation 270 
10.1.2 Characterisation of Magneto-vesicles for use in Biomedical 
Applications 274 
10.2 Future Work 274 
11 Bibliography 277 
























Table 1.1 Physio-chemical properties of Magnetite 
Table 1.2 Chapter summary of project 
Table 2.1 Components of protein cloning and expression recipes 
Table 2.2 Buffers and solution in biology protocols 
Table 3.1 Summary of magnetite precipitation routes 
Table 4.1 Phospholipids investigated for liposome formation 
Table 4.2 Outcomes of high throughput phospholipid screening 
Table 4.3 Polymers investigated for polymersome formation 
Table 5.1 Properties of iron transporters investigated 
Table 7.1 Single axial experiments for EHDA vesicle synthesis  
Table 7.2 Optimisation of  EHDA parameters 
Table 7.3 
Optimisation of EHDA parameters for synthesis of  DSPC 
liposomes 
Table 9.1 ILP values of magneto-vesicle samples 




LIST OF FIGURES 
Figure 1.1 MH Curve schematic 
Figure 1.2 Schematic of MNP magnetic moment alignment 
Figure 1.3 Schematic of particle size versus coercivity 
Figure 1.4 Schematic of magnetite structure 
Figure 1.5 Iron oxide formation Pourbaix diagram 
Figure 1.6 Natural biomineralisation within organisms 
Figure 1.7 Formation of the MTB magnetosome 
Figure 1.8 
Schematic of critical micelle concentration as a function of monomer 
concentration 




Determination of packing factor in self-assembly 
Schematic of di-block and tri-block polymer structure 
Schematic of asymmetric vesicle preparation via inverted emulsion 
Figure 1.13 Schematic of cDICE formation of asymmetric vesicles 
Figure 1.14 Synthetic magnetosome formation by Mann et al 
Figure 1.15 Hypothesis of transmembrane transport of ions 
Figure 1.16 Schematic of overall objective of the thesis 
Figure 2.1 Schematic of extrusion of vesicles. 
Figure 2.2 Schematic of size exclusion chromatography (SEC) 
Figure 2.3 Schematic of EHDA synthesis of vesicles 
Figure 2.4 Schematic of Iron transport assays 
Figure 2.5 Schematic of Polymerase Chain Reaction 
Figure 2.6 Schematic of DNA Digestion and Ligation 
Figure 2.7 Schematic of Transmission Electron Microscopy 
Figure 2.8 Schematic of Gel Electrophoresis 
Figure 3.1 pH profiles of magnetite formation 
Figure 3.2 
TEM and grainsize analysis of particles produced by thermal 
decomposition co-precipitation with urea 
Figure 3.3 
TEM and grainsize analysis of particles produced by room temperature 
co-precipitation with NaOH 
Figure 3.4 Optimisation of hydroxide concentration 
Figure 3.5 Magnetic nanoparticle x-ray diffraction patterns 
Figure 3.6 Resazurin assay calibration data 
Figure 3.7 Ferene assay calibration data 
Figure 3.8 Prussian Blue assay calibration data 
Figure 3.9 Carboxyfluorescein assay calibration data 
Figure 4.1 Plot of average of vesicle size produced with each formation method 
Figure 4,.2 TEM and grainsizing of each liposome sample investigated 
XI 
 
Figure 4.3 Schematic of PEG-PHPMA/PMPC-PHPMA Mms6 mimic protein 
Figure 4.4 TEM and grainsizing of each di-block polymer investigated 
Figure 4.5 TEM micrograph of PBD-PEO polymersomes encapsulating NaOH 
Figure 4.6 TEM micrograph of PBD-PEO polymersomes encapsulating CO(NH2)2 
Figure 4.7 
TEM micrograph of PMOXA-PDMS-PMOXA polymersomes formed by 
alternative methods 
Figure 4.8 
Synthesis route for the reversible addition fragmentation chain transfer 
(RAFT) polymerisation of PMPC-PHPMA 
Figure 4.9 
Comparison of the effect of variation of PMPC block length in PEG113-
PHPMA400/30% PMPC28-PHPMA400 polymersomes 
Figure 4.10 
TEM micrographs of PEG113-PHPMA400/30% PMPC28-PHPMA400 
produced under different conditions. 
Figure 5.1 Hydropathy plot for each iron transporter 
Figure 5.2 Gel electrophoresis of magA PCR product 
Figure 5.3 Gel electrophoresis of mamMB PCR product 
Figure 5.4 Dot blot of expression trial with each iron transporter 
Figure 5.5 Western blot of MamMB 
Figure 5.6 TEM micrograph of MamMB incorporation into DPhPC liposomes 
Figure 5.7 TEM micrographs of ionophore incorporation into polymersomes 
Figure 6.1 TEM micrographs of electroporated liposomes containing NaOH 
Figure 6.2 TEM micrographs of electroporated liposomes containing CO(NH2)2 
Figure 6.3 
TEM micrographs of electroporated polymersomes containing 
CO(NH2)2 
Figure 6.4 TEM micrographs of electroporated polymersomes containing NaOH 
Figure 6.5 Schematic of hypothesised mechanism of electroporation 
Figure 6.6 EDX spectrum of PBD-PEO magnetopolymersomes 
Figure 6.7 SQUID analysis of magnetopolymersomes 
Figure 6.8 Assay of NaOH leakage during polymersome electroporation 
Figure 6.9 TEM micrograph of electroporated PMOXA-PDMS-PMOXA 
Figure 6.10 
TEM micrograph and grainsizing of electroporated and control PMOXA-
PDMS-PMOXA polymersomes 
Figure 6.11 
Schematic of hypothesised mechanism of electroporation of tri-block 
polymersomes 
Figure 6.12 
TEM micrographs of electroporated PEG113-PHPMA400/30% PMPC28-
PHPMA400 
Figure 6.13 
ICP-MS analysis of PBD-PEO magnetopolymersomes as a function of 
applied voltage 
Figure 6.14 
Fe content in PBD-PEO magnetopolymersomes as a function of pulse 
number 
Figure 6.15 
TEM micrographs of PBD-PEO magnetopolymersomes electroporated 
at different voltages/NaOH concentrations 
Figure 6.16 
ICP-MS analysis of PMOXA-PDMA-PMOXA magnetopolymersomes as a 
function of applied voltage 
Figure 6.17 
TEM micrographs of PEG113-PHPMA400/30% PMPC28-PHPMA400 
polymersome soaked in iron solution 
Figure 6.18 





TEM micrographs of room temperature precipitation incorporation 
into PEG113-PHPMA400/30% PMPC28-PHPMA400 polymersomes 
Figure 7.1 Schematic of EHDA synthesis of vesicles 
Figure 7.2 TEM micrographs of initial EHDA vesicle synthesis 
Figure 7.3 TEM micrographs of control EHDA synthesised DSPC liposomes 
Figure 7.4 TEM, SEM and EDX for EHDA synthesised DSPC liposomes 
Figure 7.5 
TEM micrographs of 750 V electroporated EHDA synthesised DSPC 
magneto-liposomes 
Figure 7.6 Raman spectrum of EHDA synthesised DSPC magneto-liposomes 
Figure 7.7 Fluorescence microscopy of Bodipy assay 
Figure 7.8 300 K SQUID MH curve of EHDA synthesised DSPC magneto-liposomes 
Figure 7.9 
Zero field cooled  SQUID MH curve of EHDA synthesised DSPC magneto-
liposomes 
Figure 7.10 
TEM micrographs of 750 V electroporated EHDA synthesised DOPC 
magneto-liposomes 
Figure 8.1 Sequence analysis of MmsF 
Figure 8.2 Sequence analysis of Mms6 
Figure 8.3 Schematic and sequence analysis coiled coil artificial scaffold 
Figure 8.4 Western blot and circular dichroism of purified MmsF 
Figure 8.5 TEM micrographs of MmsF proteinosome assembly 
Figure 8.6 TEM micrographs of MNPs with and without MmsF protein 
Figure 8.7 TEM micrographs of MNPs with and without Mms6 protein 
Figure 8.8 TEM micrographs of MNPs with and without coiled coil protein 
Figure 8.9 TEM micrographs of MmsF incorporated DPhPC liposomes 
Figure 8.10 TEM micrographs of Mms6 incorporated DPhPC liposomes 
Figure 8.11 TEM micrographs of coiled coil incorporated PBD-PEO polymersomes 
Figure 9.1 Hyperthermic heating ability of various magneto-vesicles 
Figure 9.2 
Hyperthermic heating ability of PBD-PEO magnetopolymersomes 
(2500 V) 
Figure 9.3 
Hyperthermic heating ability of PBD-PEO magnetopolymersomes 
(various electroporation voltages) 
Figure 9.4 Plot of relative ILP versus electroporation voltage 
Figure 9.5 Control MRI images of magneto-polymersomes 
Figure 9.6 R2 relaxation of magneto-polymersomes 
Figure 9.7 R2* relaxation of magneto-polymersomes 
Figure 9.8 MRI images of magneto-polymersomes/liposomes 
Figure 9.9 Optimised R2/R2* of PBD-PEO magneto-polymersomes 
Figure 9.10 R2 relaxation of serially diluted PBD-PEO magneto-polymersomes 







ABBREVIATIONS AND DEFINITIONS 
η Viscosity FieF 
Cation diffusion facilitator 
protein 
σ Standard deviation GPC Gel permeation chromatography 
µl Microlitre GUV Giant unilamellar vesicle 
°C Degrees Celsius HOMO 
Highest occupied molecular 
orbital 
ε Extinction coefficient ICP-MS 
Inductively coupled plasma mass 
spectroscopy 
A Absorbance IGP Ion getter pump 
b Block separation in copolymers ILP Intrinsic loss power 
BL21 
E. Coli cells for protein 
expression 
k Boltzmann’s constant 
c concentration K Kelvin 
CCP Close cubic packing kDa Kilo Dalton 




kHz Kilo Hertz 
cDICE 
Continuous droplet interface 
crossing encapsulation 
kT Absolute temperature 
CMC Critical micelle concentration kV Kilovolts 
D Diffusion coefficient l Incident light 
DH Hydrodynamic diameter l0 Transmitted light 
DLS Dynamic light scattering LB Lysogeny Broth 
DNA Deoxyribonucleic acid LUMO 










E. Coli Escherichia coli Mam 
Magnetosome associated 
membrane 
EDX Energy dispersive x-ray mg Milligram 
Eh 












Cation diffusion facilitator 
protein 
MLV Multi-lameallar vesicle 
MNP Magnetic nanoparticle SEC Size Exclusion Chromatography 
MRI Magnetic resonance imaging SQUID 
Super quantum interference 
conduction device 
MTB Magnetotactic bacteria SUV Small unilamellar vesicle 
mm Millimetre Tabs Absolute temperature 







nm Nanometres Tg Glass Transition Temperature 
OATZ Oxic-anoxic transition zone V Volts 
Oe Oersted x Ratio of ferric ion to total iron 
PA Phosphatidic acid XL10 E. Coli cells for gene cloning 
PBD Polybutadiene   
PBS Phosphate buffered saline   
PC  Phosphocholine   
PCR Polymerase chain reaction   
PdI Polydispersity Index   
PEG Polyethylene Glycol   
PDMS Polydimethyl Siloxane   
pH -log10[H+]   
PMOXA Poly (2-methyloxazoline)   
ppb Parts per billion   
ppm Parts per million 
R 
Ratio of total iron to hydroxyl 
ions 
rpm Revolution per minute 
SAR Specific absorption rate 
SB Super Broth 
SDS Sodium dodecyl sulphate 
XV 
 
AUTHOR DECLARATIONS AND 
CONTRIBUTIONS 
Except where specific references have been made to other sources the work in this 
thesis is the original work of the author and has not been submitted wholly or in part 
for any other degree. 
 
Chapter 3: pH traces (Figure 3.1) and XRD data (Figure 3.5) is unpublished work 
collected by Dr. Jonathan Bramble and Miss Lays Gierakowski respectively (previous 
members of the Staniland group). 
Chapter 4 and 6: Data in these chapters were collected with the help of Enrique 
Muñoz Albaladejo, (BSc (Hons)) and Miguel Perez Senent (BSc (Hons)) at the 
University of Leeds, who assisted with collection of phospholipid data in chapters 4 
and 6. Optimisation of polymersome formation was carried out with the help of Alan 
Lee Holmes (BSc (Hons)) (University of Leeds) in addition to Matthew E. Berry, 
(MChem) Catherine E Dirks (MChem) and Hugo Lynch (MSc) (University of Sheffield). 
All students carried out the work under my supervision and direction as part of their 
final year projects. Initial polymersome experiments were carried out in collaboration 
with the Dr. Lorena Ruiz-Perez (from the lab of Professor Giuseppe Battaglia, now at 
University college London). Cryogenic TEM and tomography was performed with the 
help of Dr Stephen Meunch and Miss Rebecca Thompson (BMS, University of Leeds)  
Chapter 5 and 8: Protein work was carried out under the supervision of Dr. Andrea 
Rawlings, who designed all vectors, primers and synthetic genes, who also advised on 
all methods and results. All iron transporters (with the exception of MagA and 
MamMB), biomineralisation protein and coiled coil scaffolds have also previously been 
cloned expressed and purified by Dr Rawlings.  
Chapter 7: Work in chapter 7 has been carried in close collaboration with Professor 
Mohan Edirisinghe, Dr. Poonam Bakshi and Mr. Meghdi Eltyab, (Department of 
Mechanical engineering, Univerity college London) with whom I optimised the EHDA 
system for artificial magnetosome synthesis with the help of their expertise. 
Chapter 9: MRI data was collected by Dr Annuerin Kennerley (Magnetic Resonance 
Physicist for fMRI facility, Department of Psychology, University of Sheffield) and MHT 
data in figures 9.2 and 9.3 was collected by Dr Paul Southern (UCL Nanomagetics Lab). 
SQUID data was collected by either Dr. Paul southern or Miss Wala Dizayee ( 





This project has been supported by funding from the Engineering and Physical Sciences 
Research Council (EPSRC). Firstly I would like to thank Sarah Staniland for not 
laughing me out of her office when I said I would like to take up her PhD project 
(following a recommendation from Professor Paul Millner). Sarah has been a great 
support over the last four years, keeping me busy with her off-the-wall ideas (all of 
which have worked!) Allowing me to cultivate my own collaborations, and visit far-
flung destinations (even if I do only get three days’ notice). Her drive, energy and 
guidance are the reason for the wide-ranging success of this project, and have spurred 
me on to make the most of the four years (and she let us move back to our natural 
environment of a Chemistry department, for which I’ll be forever grateful!!). A big 
thank also goes to Lays Gierakowski for imparting her wealth of knowledge on me  and 
ladened me with insider tip on vesicle making before running away to London.  
Secondly thank you to the rest of the Staniland group (past and present), Andrea, Jo, 
(proof-reading extraordinaire) Jon, Scott, Lori, Zainab and Pawel (you make every day 
entertaining), and in particular the undergraduate students which have contributed to 
this project (Alan, Enrique, Miguel, Catherine, Matt and Hugo) thank for doing as you 
were told (most of the time). A special thank you to Andrea Rawlings who kept 
everybody in check during our epic lab move, (and still keeps us in line on a daily 
basis), the best thing to come out of our move is that we now work in the same 
department (I would other have never known the importance of tea breaks), and 
having the patience of a saint when it comes to my incessant molecular biology 
questions.  
A big thank you to all of the people in the Molecular and Nanoscale Physics Group, you 
made the first two years of my PhD truly memorable and are still some of my close 
friends (particularly Jo, Meg and Spanish) which is surprising given the fact you are 
physicists.  
To all the people who have helped me hone my expertise in such a wide and varied 
field particularly all those people who have spent so long showing me the ropes in the 
world of microscopy (In Leeds,  Mike Ward, Martin Fuller, Stephen Meunch and 




Thank you Beppe and Lorena for introducing me to the world of polymer chemistry 
and Dave Adams (University of Liverpool) and Steve Armes, Joe Lovett and Christine 
Fernyhough (University of Sheffield) for kindly donating batches of polymer (so that I 
didn’t have to learn to make it!). Dr. Aneurin Kennerly has been invaluable to the 
biomedical success of this project and has been extremely patient in explaining MRI to 
a complete novice. 
To all of the collaborators in Mechanical Engineering at UCL (Mohan Poonam and 
Meghdi), I have thoroughly enjoyed my time in your lab and getting a taste of what it is 
like to be engineer, huge thanks to Mohan for all of your help in trying to cement the 
next stage of my career and of course your highly entertaining conversations. Also at 
UCL thank you to Quentin Pankhurst and Paul Southern for all of you help and guidance 
in getting to grips with magnetic hyperthermia treatment. 
Of course I should thank my mum, dad and KAB for humouring me when I said I was 
going back to “school” and offering nothing but encouragement and interest in my 
project, particular thank to my mum for her amazing dedication to proof-reading this 
thesis, and to KAB who has no hesitation in reminding me that no matter how much I 
know about vesicles I am still severely lacking in common sense. Thanks to all of “the 
girls” to providing a world away from Science (Particularly to Alex (Fat-arse) for her 
constant encouragement and volunteering to read this thing for me).  
And lastly the biggest thanks to Scott (Thanks lad!) for supporting my hair-brained 
scheme to move to Leeds and “do” science, you packed your bags with no questions 
asked and we started a new life in Yorkshire,  you “barely” batted an eyelid when two 
years later we were on the move again down to Sheffield. Not many people would have 
followed me round the country but I hope you’ve enjoyed our four year adventure as 







Bain and Staniland 
 Bioinspired nanoreactors for the biomineralisation of metallic-based nanoparticles for 
nanomedicine. Physical Chemistry Chemical Physics (2015). 
 
Bain et al.  
In situ formation of magnetopolymersomes via electroporation for MRI. Scientific 
Reports 5, 14311, (2015). 
 
Rawlings et al 
Self-assembled MmsF proteinosomes control magnetite nanoparticle formation in 
vitro. Proceedings of the National Academy of Sciences 111, 16094-16099 (2014). 
 
 
Bain et al  
 
Synthesis of ABA Tri-block co-polymer magnetopolymersomes via electroporation for 
potential medical application, Polymers (2015)  
 
Bakshi/Bain et al 
Manufacturing Man-made Magnetosomes: High-Throughput in situ synthesis of  














P a g e  | 2 
 
 
In this introduction chapter I will discuss background relevant to the biomimetic 
synthesis of magnetosomes for biomedical applications. This is a multi-disciplinary 
study inspired by nature, spanning physics, chemistry, biology, medicine, 
nanotechnology and nanomaterials synthesis. Magnetism and the magnetic material 
magnetite are discussed in section 1.1 and biomineralisation and magnetotactic 
bacteria in section 1.3. Artificial vesicles are described in section 1.4, biomimetics in 
section 1.5 and their application in 1.6. Finally, the introduction includes a description 
of the aims and objectives in the context of artificial magnetosome design in section 
1.7.  Aspects of this chapter are based on the review Bain et al1c 
 
1.1 MAGNETISM AND MAGNETITE 
 
The theory of magnetism as described in this section is from Blundell,11 Newey and 




The magnetic properties of a material are governed by its susceptibility to 
manipulation by an externally applied magnetic field. When a magnetic field is applied, 
electrons in an atom align with the direction of the applied field. The alignment of these 
electrons (parallel or antiparallel) determines whether a material is magnetic without 
the presence of an applied field. The measurement of a material’s magnetism is 
represented on a MH curve, (Figure 1.1). Figure 1.1 shows the magnetisation (M) of a 
material, in an applied magnetic field of strength H. The susceptibility (χ) of a material 
is determined by how magnetised (M) per unit volume it becomes in the presence of a 
magnetic field of strength (H), this relationship is shown in equation 1.1. The MH curve 
is generally sigmoidal as a result of increasing magnetisation of the material, with 
increasing H, until a point of magnetic saturation is reached.  
 
















As the field increases the material is magnetised in the same direction, the field is then 
returned back to zero and the field and the sample is magnetised in the opposite 
direction. This cycle is repeated with the material reaching it magnetisation saturation 
(a) in each direction (Figure 1.1). These parameters change the hysteresis of a material, 
defined as the field strength required to flip the moments and realign them in the 
opposite field direction, once magnetisation saturation is reached. When the particle is 
cycled between the positive (+) and negative (-) field, it gives rise to a hysteresis loop.  
The width of this hysteresis is determined by the field strength needed to flip all the 
spins; namely its coercivity. The coercivity of the magnetic material is the point at 
which an externally applied field reorders the material and hence the magnetic flux of 
the material returns to zero. 
 
 
Figure 1.1: Schematic of a magnetic hysteresis loop (MH curve), which measures the 
magnetisation of a material (M) as a function of the strength of the magnetic field (H) as the field 
increases the material is magnetised in the same direction, the field is then returned back to zero 
and the field and the sample is magnetised in the opposite direction. This cycle is repeated with the 
material reaching its magnetisation saturation (a) in each direction. Arrows indicate the direction 
of the magnetisation. The materials coercivity is shown by (b) the strength of the externally applied 
field required to reorder the material back to a zero.  
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The steepness of this curve describes how easily magnetised a material is (with more 
easily magnetised samples aligning at a lower H). It is also dependent on the type of 
magnetism a material displays, i.e. its size/spin alignment and the material’s atomic 
structure. 
 
𝑀 =  𝜒𝐻  (1.1) 
 
All materials possess magnetic characteristics due to the atoms containing electrons. In 
some materials there is no remnant magnetisation of the lattice in the absence of an 
external magnetic field. In these materials, magnetism still exists at an atomic level in 
the form of diamagnetism or paramagnetism. Diamagnetism occurs when all electrons 
in a material are paired, in this case the material’s spins align antiparallel to the field 
direction and therefore it is repelled in a magnetic field (Figure 1.2 b). This alignment 
means there is no net magnetic moment (due to no net motion of electrons, as all are 
paired) when a field is applied and therefore the material is weakly repelled by the 
field. The opposite is true in the case of paramagnetic materials, where unpaired 
electrons within the atomic structure show an attraction and align along the field 
(Figure 1.2 a). Both of these materials have a linear response in their MH curve, as the 
magnetism is lost when the field is removed. 
More ordered atomic structures give rise to paramagnetic materials with long range 
ordering, which can have remnant magnetism when the external field is removed. If 
this ordering is antiparallel across the entire lattice, then the atomic spins cancel. This 
leads to zero bulk magnetic moment in these materials. Materials which have this type 
of bulk alignment are called antiferromagnets (AFM) (Figure 1.2 c). If the opposite is 
the case, and all of the atomic magnetic moments are aligned parallel to one another, 
then this long-range ordering causes remnant magnetism when the field is removed, 
the material is ferromagnetic (FOM), (Figure 1.2 d). A third situation is also possible in 
which the atomic magnetic moments are aligned antiparallel as in AFM materials, but, 
due to a difference in the size of the atomic magnetic moments, (for example, caused by 
difference in atomic valences) the moments to not cancel. 
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 As a result these materials also have remnant magnetism in the absence of a field, 
these are known as Ferrimagnets (FIM) (Figure 1.2 e). In each case their magnetic 
properties are due to long range ordering of paramagnetic moments in the crystal 











Figure 1.2: Atomic alignment which occurs in each type of magnetism, arrows represent the spin 
alignment of magnetic moments which gives rise to the magnetic properties of the material. In the case of, 
a) diamagnetism, which is repelled in a magnetic field b) paramagnetism, where materials are attracted in 
an applied field. c)-e) show the long-range ordering of moments which occur in c) antiferromagnetism 
(anti-parallel spins), d) ferromagnetism (parallel spins), and e) ferrimagnetism (anti-parallel different size 
spins) respectively. 
 
AFM materials align in an antiparallel configuration, (Figure 1.2 c) and so the magnetic 
moments cancel, whereas in FOM materials electrons are aligned parallel to one 
another, and hence do not cancel giving an overall magnetisation (Figure 1.2 c). 
Similarly, moments do not cancel in the case of FIM materials, despite an antiparallel 
alignment of electrons. This is due to a size difference in the moments on adjacent 
atoms (e.g. due to a difference in valence) leading to remnant magnetism when the field 
is removed (Figure 1.1 e). 
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These effects are thermally dependent, with atomic ordering only occurring below a 
specific temperature, the blocking (TB) or Curie temperature. Above the TB, ordering is 
lost and materials behave as paramagnets. In the case of FOM, AFM and FIM materials, 
particle size and field strength (H) also affect the magnetic response, affecting the 
shape of the magnetic hysteresis loop (MH curve). This hysteresis is used to assess the 
magnetic hardness of a material, based on the point at which it saturates and its 
coercivity. These characteristics are dependent on the properties of the particle, i.e. the 
particles composition, size and shape (i.e. the size, orbital arrangement and electron 
pairing), therefore materials are classed as “soft magnets” and “hard magnets”, 
depending on the field strength (H) needed for the material to be magnetised.  
Nanoparticles can develop domains within their structure due to short range ordering 
of spins within a lattice, and the number of these domains increases as the particle size 
increases. These domains can build up in particles and affect their coercivity, for 
example a superparamagnetic nanoparticle (a single spin) will respond as a single 
domain (or whole particle) in a magnetic field (Figure 1.3 a). As the particle size 
increases and spins remain aligned in a single domain the coercivity increases (Figure 
1.3 b) as a higher magnetic field strength is required to return the magnetisation back 
to zero (due to the additive effect of all spins in the lattice). This coercivity then begins 
to decrease as the particle size further increases and domain walls begin to develop. 
These domain walls result in an inconsistent response in a magnetic field and therefore 








 Figure 1.3: Schematic of domain formation in magnetic nanoparticles and its 
effect on coercivity as particle size is increased from a) superparamagnetic 
nanoparticles to b) single domain and finally c) multi-domain magnetic 
nanoparticles.   
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Therefore bigger single domain magnets (all spins in alignment) are harder to flip than 
smaller particles. Particles larger than single domain contain domain walls (which 
separate regions of aligned spins) and will flip at lower values of H. If particles fall 
below a certain size, superparamagnetism is observed in which the particle has a single 
magnetic moment, and as a magnetic field is reversed the entire particle flips to realign, 
in this case any hysteresis in the MH curve is lost. Other factors which have a profound 
effect on a particles magnetic coercivity include its shape. The shape of the particle can 
affect how strong a field must be for the alignment of all moments. For example, in a 
needle shape particle the moments can more easily align in a head to tail formation; 
therefore needing a lesser magnetic field strength than a spherical particle. In a 
spherical particle repulsive forces between adjacent moments will have to be 




Magnetite (Fe3O4) (sometimes referred to as loadstone) is the most abundant naturally 
occurring ferrimagnetic material. Magnetite has an inverse spinel structure comprised 
of Fe2+ and Fe3+ centres in a 1:2 ratio with the overall structure of (Fe2+2Fe3+ O4).3, 14 
This ferrimagnetic structure gives magnetite the highest magnetic saturation of all the 
iron oxides, the properties of which are outlined in table 1.1. The cubic inverse spinel 
lattice arises as a result of opposite spins on successive iron atoms in the magnetite 
crystal lattice.3 The crystal structure arises from the arrangement of O2- counter ions in 
a face centred cubic packed (FCC) lattice, in which ferric ions occupy both octahedral 
and tetrahedral holes, and corresponding ferrous ions are found only in octahedral 
sites (Figure 1.4).15 Magnetite’s stoichiometry (([Fe]3+)2[Fe]2+O4) means that in 
isolation, the ferric ions behave as a paramagnet, being aligned in an applied magnetic 
field, due to their adoption of a high spin configuration.3 This leads to moving charges 
between the mixed valences, and a net magnetic moment within the lattice, giving rise 
to magnetite’s ferrimagnetic properties in the bulk crystal.  
 
 
















The spin moments associated with each atom in the magnetite lattice do not cancel out 
as they would in the case of antiferromagnetism. This is due to a difference in the 
number of electrons in the ferrous and ferric iron at the octahedral sites.3 The electrons 
associated with these ions are thermally delocalised, (which allows their movement) 
but when magnetite is cooled (below 118 K) these electrons become localised causing a 




Crystal lattice Inverse spinel/Close cubic packing 
Unit cell 0.839 nm 
Magnetism Ferrimagnetic 
Density 5.18 g cm-3 
Curie Temperature 850 K 
Melting Temperature 1583 °C 
ΔGf -1012.6 kJ mol-1 
Solubility 35.7 
Figure 1.4: Inverse spinel unit cell of Magnetite showing oxygen (Green) in an FCC lattice with Fe3+ (Pale 
blue) in both the octahedral and tetrahedral holes and Fe2+ (Purple) in half of the octahedral holes. 
(Diagram made with CrystalMaker version 9.2.2) 
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Net magnetisation is also lost at temperatures above the Curie temperature of 
magnetite (850 K),3, 17 as thermal energy causes the loss of long-range ordering and 
ferrimagnetism becomes paramagnetism. 
Particle size is important for magnetite. MNPs generally behave superparamagnetically 
below ≈30 nm in size.11, 13, 18 Above a certain size threshold (above ≈ 120 nm at ambient 
temperature) magnetite MNPs begin to exhibit multi-domain characteristics.11, 13, 18 
Domain walls (arising from multi-domain nanoparticles) in the crystal structure affect 
the particles magnetic response; as the spins need a higher magnetic field to overcome 
the energy in the domain walls and align. To achieve an efficient and consistent 
response in a magnetic field, single domain structure magnetite (between 30-120 nm) 
is required for complete homogeneity.11, 13, 18 
 
1.2 MAGNETITE FORMATION ROUTES 
 
A major consideration when studying magnetite (Fe3O4) is that it is prone to oxidation. 
This arises from the sensitivity of the ferrous ions, which can undergo slow room 
temperature oxidation to form the ferric iron oxide, maghemite (γ-Fe2O3).3, 19 
Distinguishing between these two iron oxides is difficult, as they share the same 
inverse spinel structure. When compared to magnetite (see section 1.1.2), maghemite 
has a ferrous ion deficiency at the tetrahedral sites. Characterisation techniques, such 
as XRD or Mössbauer spectroscopy, can be used to distinguish between maghemite and 
magnetite. However, this is non-trivial, as the differences between the two crystal 
structures are minor, meaning large amounts of material (in powder form) are 
required. Loss of absorption in the near IR-region can also indicate magnetite oxidation 
to maghemite, but again this is extremely difficult to pull out from the spectra.3 Figure 
1.5 a) shows the interchange between magnetite and the other iron oxides by 
processes such as dehydration, hydrolysis or oxidation, and the corresponding change 
in particle shape. These changes are generally related to the redox potential (Eh) and 
acidity (pH) of the reaction environment. Careful control of these parameters can allow 
for the exacting formation of a specific iron oxide, as shown in the Pourbaix diagram in 
figure 1.5 b).8  























Extensive research into magnetite formation has yielded methods for producing a 
range of magnetite particle sizes and morphologies.20 Crystallisation (nucleation and 
crystal growth) is governed by both thermodynamic and kinetic factors that render the 
process, and the resulting particle properties, extremely sensitive to reaction 
conditions. The mineralisation of magnetite occurs when insoluble nanoparticles are 
precipitated out of solution from soluble precursors. In an oxidative regime (i.e. 
increasing Eh), ferrous rich green rust intermediates (e.g. Fe(OH)2) form first.3, 8, 10 
Gradual oxidation of the ferrous iron to ferric iron leads to a mixture of ferrous and 
ferric rusts, which undergo dehydration to yield magnetite.10 
Precipitation can also occur by raising the pH, using a source of hydroxyl ions. For this 
route to successfully yield magnetite, a mixed valence iron solution must be used which 
has the appropriate stoichiometry for magnetite precipitation (1Fe2+ :2 Fe3+). It is 
important that this co-precipitation is carried out in an inert atmosphere, to prevent 
oxidation of the ferrous iron which will result in the formation of different iron oxides. 
20a, 20c  
Figure 1.5: Magnetite formation involves tight control of the redox conditions to ensure the correct iron 
oxide is formed. Evidence can be seen in a) a schematic of synthesis routes to the formation of magnetite 
adapted from Cornell & Schwertmann3 and b) an Eh-pH Pourbaix phase diagram from Takeno et al8 
showing how slight adjustments in pH or redox potential can result in the formation of different iron oxides 
(in this case at standard temperature 298.15K, and pressure 105 Pa).  
a) b) 
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This means that co-precipitation of magnetite must be carried out under an 
atmosphere of N2 or Ar. Maintaining an anoxic atmosphere makes synthesis of 
magnetite difficult. 
The oxidation of ferrous iron to its ferric counterpart leads to the likely formation of a 
range of competing iron oxides. Subtle changes to the reaction conditions can induce 
oxidation and alter the final product including changes in: temperature, precursor 
oxidation state, ionic ratio, cation concentration, anion type, redox of the reaction 
chamber atmosphere, etc.3 This delicate balance between pH and oxidation kinetics can 
introduce heterogeneity, causing changes in particle properties. For magnetite, this is 
particularly important for altering its magnetism, and also the size and shape of the 
resulting crystal. These properties are vital for the MNPs suitability for a particular 
application, where consistency and reproducibility in crystal properties is paramount. 
Larger, more uniform populations of pure magnetite MNPs can be produced, but 
generally via multistep processes involving increased temperature, pressure and/or 
toxic reagents, which more tightly control the nucleation, growth and oxidation kinetic 
in the reaction.20b, 20e-g There are many routes to magnetite formation such as, 
hydrothermal, sol-gel, flow injection and electrochemical synthesis routes.18 
This section covers various routes for magnetite synthesis including; high temperature 
reactions and partial oxidation of iron hydroxides. Whilst all methods offer acceptable 
levels of purity, they vary both in technical complexity of the techniques employed, and 
the overall reproducibility of the synthesis route. Studies show that synthesis of 
magnetite without some ferrous oxidation is highly unlikely.20f Perhaps the most 
comprehensive assessment of magnetite formation is by Regazzoni et al.20f They 
evaluate and draw comparisons between six different methods of magnetite synthesis. 
The study determines that high temperature methods and/or a nucleation burst by 
injection of a precursor into a hot reaction solution (hot injection) yields high quality 
particles of defined size and shape, but involves harsh chemical and physical 
conditions.20e, 20f, 21 The best method, in terms of particle quality, appears to be 
synthesis via hydrazine oxidation or the reduction of haematite. However, neither 
route is easily achievable in a standard chemistry laboratory, with both reactions 
requiring prolonged heating to 400 °C.20f Similarly, alkaline hydrolysis provides high 
quality magnetite, but again the reaction must be performed at a high temperature 
(500 °C).20f  
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Larger, more uniform octahedral particles with a relatively narrow size distribution 
can be achieved using oxidative routes at elevated temperatures (~ 90 °C) by way of 
partial oxidation in the presence of a base (which controls the reaction pH). A ferrous 
iron precursor is heated to form ferrous hydroxide, which is then partially oxidised 
(most commonly by potassium nitrate) to form a ferrous/ferric hydroxide mixture.1a, 22 
Dehydration of this mixture yields magnetite, however the reaction is extremely 
sensitive to alterations in the reagents used (iron salt type and OH- source), any change 
in the ratio of reagents, and changes in temperature.20f 
Although the conversion from 3(Fe(OH)2) to Fe3O4 (the Schikorr reaction)23 is possible 
at a lower (ambient) temperature, oxidation can mean the introduction of 
contaminants and by products, meaning sample purity is lost.20f Room temperature co-
precipitation is achieved by raising the pH of a mixture of ferrous and ferric ions in 
solution, which causes precipitation of magnetite MNPs.20f Unfortunately, this route 
produces small, ill-defined particles, often with broad size distributions, and is liable to 
produce a range of iron oxides.24 Particle size control can be improved by manipulating 
the reaction kinetics, particularly OH- addition rates, or to use phase transformation 
from iron oxyhydroxides.20c Thus co-precipitation at raised temperatures can improve 
particle quality. Methods, such as thermal decomposition of urea to ammonia, induce 
magnetite precipitation by way of a temperature triggered pH rise. Here, unwanted 
ferrous oxidation is minimised, as the precipitation of magnetite is controlled by the 
rate of urea hydrolysis. Although not as environmentally friendly as at co-precipitation 
at room temperature, (urea hydrolysis requires heating to 85°C), this heating method 
produces magnetite particles of a much higher standard (i.e. uniform size, shape and 
magnetic properties) than achieved with room temperature co-precipitation.21b, 25 
Perhaps the best ambient temperature route to magnetite synthesis was developed by 
Lenders et al.20a The group successfully achieved the in vitro precipitation of single 
domain ferrimagnetic magnetite at ambient temperature using co-precipitation; a 
synthesis route which normally yields ill-defined nanoparticles. By controlling the 
reaction kinetics, they first form a ferrihydrite precursor from ferrous ions, at low pH. 
The pH is then slowly increased by diffusion of NH3, which allows for a slow conversion 
of ferrihydrite to magnetite.20a  
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This achievement is mirrored by the work of Baumgartner et al, who also achieved co-
precipitation of magnetite yielding stable single domain magnetite MNPs at pH 9 and 
ambient temperature, by “ultraslow” addition of reagents and constant pH 
adjustments, to avoid precipitation of small superparamagnetic particles.26 
 




Biomineralisation is the crystallisation or precipitation of an inorganic material within 
or around a cell or organism,27 occurring in numerous organisms ranging from humans 
to algae.1b There are two distinct types of biomineralisation. The first is “biologically 
induced mineralisation” (BIM) in which the precipitation of a mineral is the by-product 
of a biochemical process.1b, 28 In these cases, there is often little to no control over the 
mineral formed. The second type is “biologically controlled mineralisation” (BCM) 
whereby the organism deliberately forms the mineral to fulfil a function (i.e. protective 
(shell), structural (skeleton), attack and defence (claws and teeth).1b In BCM, the 
minerals can be intricately designed to perform these functions, with the organism 
directing the materials to control requirements such as size, shape, toughness etc.  
Transmembrane metal ion transport proteins and/or crystal morphological control 
proteins are commonly used  by organisms to control the crystallisation of the 
resulting particles.1a, 29 These BCM minerals generally have superior properties when 
compared to equivalent artificially synthesised particles. Such architectures can be 
seen in multiple species of bivalves, molluscs and coral, which biomineralise a hard 
outer shell for protection.28 The coccolith is also an excellent example of this shell 
forming process. Coccolithophores form the coccolith plates in intracellular vesicles, 
and subsequently exorcise them to the exterior of the organism. The coccolith 
structures comprise individual biomineralised plates which then assemble into spheres 
to protect the organism (Figure 1.6).6, 27, 30  
 















Coccoliths have provided a model system for the study of biomineralisation 
mechanisms, and are indicative of the high levels of complexity that can be achieved by 
nature. Similarly, the diatom is a form of algae that is able to control the 
biomineralisation of silica using specific proteins called silaffins.28 Silaffins are 
polycationic peptides, which are able to exert control over the precipitation of silica 
nanosphere networks. A lysine-lysine section within this peptide structure has proven 
to be responsible for the formation of the network.31 When silaffins are added to an in 
vitro precipitation, there is a stark difference in the morphology of the silica formed 
when compared to the absence of protein.31  
The in vivo function of these negatively charged proteins is to induce crystal phase 
switching from aragonite to calcite during the formation of nucleating shell tissue 
sheets. In vitro use of these proteins initiates the same crystal phase shift observed in 
vivo.32  
 
Figure 1.6: Natural biomineralisation within organisms. Architectures observed in nature as the result 
of calcium carbonate biomineralisation in coccoliths, scale bars are 1 µm adapted from Young et al.6  
P a g e  | 15 
 
 
Whilst this is by no means an exhaustive list of bioadditives, it demonstrates the 
versatility that can be achieved when additives are “borrowed” from nature to improve 
chemical reactions. Understanding the mechanism by which these organisms 
biomineralise can be used to inform the generation of new biomimetic and bioinspired 
materials.33  
 
1.3.2 MAGNETOTACTIC BACTERIA 
 
Examples of biomineralised magnetite are found everywhere, from chiton teeth to 
MNPs within the brains of insects, birds and humans.1b, 34 Arguably, the most intricate 
and well-studied example of magnetite biomineralisation is the formation of 
magnetosomes in magnetotactic bacteria (MTB).35 MTB are a gram negative bacteria, of 
which there are evermore emerging diverse strains.36 They are found in sediments and 
saline, brackish and fresh water all over the world.35, 37 Each strain has a unique genetic 
make-up, but common to all MTB strains is the biomineralisation of magnetic iron 
based minerals, typically magnetite or gregite.35, 37 Since their discovery by Bellini in 
1963,38 and rediscovery by Blakemore in 1975,35 multiple research groups have 
emerged dedicated to understanding the mechanism of biomineralisation within these 
vesicles (termed magnetosomes) in magnetotactic bacteria.35, 39  
Magnetosomes are believed to be used as internal compasses, allowing the bacteria to 
passively align with a magnetic field, and navigate along the direction of the field, 
which is called magnetotaxis.40 Magnetotaxis allows the MTB to move in response to 
environmental cues (such as specific levels of O2 and CO2). The MTB orient themselves 
in their environment using the earth’s magnetic field lines, and move along them to 
seek out optimal redox conditions needed for their survival.40-41 Magnetotaxis is 
believed to be used in conjunction with both aero- and chemotaxis to orientate the 
magnetosome in the oxic-anoxic transition zone (OATZ). The OATZ is the border 
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Magnetotaxis is the most likely reason for MTB formation, however this is heavily 
debated.40, 42 Other alternative theories suggest that magneto-aerotaxis43 is a secondary 
advantage of biomineralising MNPs, and the magnetosomes are a primarily a product 
of respiration44 or detoxification.45 It is known for certain that a dipole moment is 
produced in the MNPs, allowing the magnetosomes, and therefore the MTB, to align 
with geomagnetic field lines. It has also been found that some MTB in the northern 
hemisphere are north seeking and vice versa in the southern hemisphere.46 Although 
these seeking species can live in the same environment,46 it has been observed that 
north seeking bacteria are repelled by the south pole of a magnet which raises 
questions regarding magnetotaxis.37 Whatever the reason for the formation of 
magnetosomes, it is clear that the MTB take advantage of the magnetic properties of 
the MNPs they form. They do this by exerting heavy biological control over the 
formation and alignment of magnetosome MNPs. 
 
 MAGNETOSOME FORMATION IN MTB 1.3.2.1
 
MTB are unique in the way in which they biomineralise exclusively magnetite or 
gregite nanoparticles within their magnetosomes (Figure 1.7 a).39f The mechanisms of 
magnetosome formation have been extensively studied, and it has been found that the 
proteins which control magnetosome formation are encoded by an area of the genome 
known as the “Magnetosome Island”.39c, 47 An accepted theory of MTB magnetosome 
formation in a well-studied species (Magnetospirillum magneticum AMB-1) starts with 
the invagination of the cytoplasmic membrane within the bacteria by the protein 
MamY.48 This creates a budding vesicle in the membrane, which is then broken off by 
the protein MamU47 (figure 1.7 b). These empty magnetosomes are arranged into 
chains by the protein MamJ anchoring them along an actin-like filament protein 
(MamK) inside the bacterium.49 Once aligned along MamK, the empty magnetosome 
vesicles then recruit Mam/Mms proteins into their membrane.49 This family of proteins 
allows for recruitment of iron to the lumen of the magnetosome through 
transmembrane iron-transporter proteins.39d, 50 
 
 




















Figure 1.7: The formation and biomineralisation of the magnetosome in within the magnetotactic 
bacterium M. magneticum AMB-1. a) Example of Magnetospirillum magnetotacticum AMB-1. Adapted from 
Schüler et al51 b) Schematic of formation of the magnetosome vesicle, recruitment of iron and 
morphological control exerted by bacterial proteins, redrawn by J. Galloway from Arakaki et al.39e  
 
Current research has not managed to definitively determine which protein(s) are 
responsible for iron transport into the magnetosome. This is despite thorough research 
into many promising candidates, in particularly the proteins MamMB52 and MagA.53 
These proteins have been assigned as antiporter systems through genomic, proteomic 
and re-crystallisation studies.53-54 They are believed to pump protons out of the 
magnetosome core, increasing the internal pH, and in turn pump ferrous iron ions back 
in. The pH rise within the iron (II) rich magnetosome leads to the precipitation of a 
single magnetite nanocrystal within the magnetosome core. The size, shape and 
crystallinity of the magnetosome bound MNP is controlled by specific 
biomineralisation proteins.29b, 51  
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Sufficient ferrous iron concentrations are only reached in MTB due to the 
compartmentalisation of the reaction.39b, 49 This hypothesis is supported by Stolz,55 
with the discovery that magnetosomes are only synthesised by MTB in cases where  
sufficiently high concentration of a ferrous ion source is available.39d This is supported 
by a study which suggests that magnetite mineralisation proceeds via the formation of 
an iron (II) precursor.56 Some suggest that this iron (II) can then be oxidised to iron 
(III) ferrihydrite by an iron oxidase protein (MamP),56 which is present in all MTB 
strains. This would then be followed by conversion to magnetite by continuous 
transport into the magnetosome of the ferrous iron.39d, 52, 53b Deletion of MamP has been 
shown to cause crystal defects in magnetosomes.56 Genomic, proteomic, lipidomic and 
electron microscopy analyses have confirmed the presence of a suite of magnetosome 
specific proteins within the magnetosome vesicles, and has helped to assign a function 
to many of them.39b Studies, focussed on further gene knockout mutagenesis,52, 57 
genomic studies,39c and proteomic studies;54, 58 are still trying to elucidate the role of 
these proteins. Numerous reviews24, 39c, 39e, 42, 59 detail what is already known about the 
formation of the magnetosomes and their potential for use in a range of applications. 
 
 BIOMINERALISATION PROTEINS 1.3.2.2
 
Biomineralisation proteins are pivotal to the formation and quality of MTB produced 
magnetite nanoparticles. Analysis of the magnetosomal magnetite crystals has led to 
the hypothesis that the initial nucleation of the particle is on the [111] face specifically. 
This is followed by non-specific growth, and selective suppression of specific axes to 
yield a cubo-octahedral particle in the case of Magnetospirillum magneticum AMB-1.60 
This control is provided by the biomineralisation proteins (Mms6, Mms13, MmsF) 
encoded for in the magnetosome island,47 which are believed to control the growth of 
the magnetite crystal by both promoting nucleation of Fe3O4 and blocking growth of 
specific crystal faces, to achieve precise crystal morphology.1a  
Perhaps the most well studied of these proteins is Mms6, which is a membrane protein 
with a single transmembrane region containing acidic iron binding sites on its C-
terminus.61 Mms6 is believed to play a key role as a nucleation site for iron minerals 
located on the magnetosome interior.1a, 61 Mms6 is the first of the few studied proteins 
from this system to be utilised in an in vitro magnetite precipitation.61  
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When this protein is added to a room temperature co-precipitation of magnetite there 
is a marked improvement in the monodispersity of the particles formed.1a, 29a, 62 
Another MTB biomineralisation protein whose function has been investigated is MmsF. 
MmsF is also believed to be the biomineralisation protein responsible for the formation 
of magnetite.57 The deletion of the MmsF gene in vivo leads to complete loss of 
magnetosome formation. Importantly, when the  cluster of genes responsible for 
biomineralisation is deleted and only MmsF restored, the formation of the entire 
magnetosome is restored, indicating that MmsF is the master regulator protein within 
the operon.29b This, along with the other key proteins,5 is believed to be responsible for 





A vesicle is a hollow spherical structure which encapsulates a body of aqueous or 
organic fluid, whose formation is governed by self-assembly. Vesicles are an integral 
part of nature, where they perform a wide variety of functions and have been widely 
researched since 1965.63 Vesicles are vital in multiple cellular processes, including 
transportation and compartmentalisation in cells. MTB vesicles are composed of a lipid 
bilayer membrane, in which it is difficult to introduce variations and functionalisation. 
Adaptation of a vesicles composition can be more pronounced and better controlled in 
a synthetic analogue. For example, it is possible to limit vesicle formation to certain 
morphologies by control of the composition of the components used to assemble the 
vesicle.64 Synthetic vesicle nanoreactors presented in the literature have facilitated the 
completion of numerous reactions.65 One key focus of this thesis is the utilisation of 
vesicles formed from both naturally occurring phospholipids and from synthetic 










For predictable vesicle formation, molecular level understanding of the self-assembly is 
key. Vesicles are generally formed from amphiphilic molecules which possess both 
polar and non-polar regions.66 This gives rise to both hydrophilic and hydrophobic 
properties simultaneously, and self–assembly occurs spontaneously upon addition of 
an amphiphile to aqueous solution,66 which arises from the hydrophobic effect.66a, 67 
This is because the hydrophobic portions of the molecule cannot form bonds with 
water either electrostatically (Van der Waals) or via hydrogen-bonding, due to lack of 
affinity between the non-polar chains and water according to Traube’s rule.68 This rule 
states that the surface tension of a system decreases threefold for each additional 
methylene group added to the non-polar region of an amphiphile.66a, 68 When a 
hydrophobic molecule of a certain size is added to water, an entropic effect dominates, 
forcing the water to arrange itself into a cage-like structure (clathrate) around the 
molecule to avoid contact, resulting in an increase in the order of the system. 66a, 68 
Despite energy being required to promote the rearrangement, this is more 
energetically favourable than hydrophobic/water contact, with higher numbers of 
hydrophobic residues increasing assembly efficiency.69 If a species is amphiphilic, each 
section of the amphiphile adopts the most energetically favourable conformation to 
satisfy their hydrophobic/hydrophilic requirements. Above a certain concentration of 
the amphiphile (the critical micelle concentration, or CMC), the formation of an 
amphiphile bilayer occurs to shield the hydrophobic portions of the molecules, and 
disassociation of the clathrate-like water cage.68 
The lowest energy conformation is adopted by the bilayer, causing spontaneous 
rearrangement into a stable vesicle conformation, to ensure all hydrophobic 
components are shielded. The formation of the vesicles must obey the Laplace 
equation, (Equation 1.2) which dictates that the inner pressure (pin) must be equal to 
the outer pressure (pout) plus the surface tension (γ) and radius (r) of the interface.66a 
 
𝑝𝑖𝑛 =  𝑝𝑜𝑢𝑡 + 2𝛾𝑟   (1.2) 
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The presence of hydrophobic interactions during the formation of a vesicle dictates 
that there must be a corresponding hydrophilic force present. This hydrophilic force 
adds disorder to a system, as they are able to form non-covalent bonds with water 
which on the macro scale forces assembly.69  
 
𝜇𝑁
0   =  𝜇∞ 





   (1.3) 
 
The assembly size is thermodynamically determined from the interaction of the free 
energy per molecule (µ0N), (Equation 1.3) given by the free energy per molecule (µ0∞) 
and the bond energy (∝kT) at a finite aggregate size (N). µN0 decreases as N increases, 
having a specific minimum which prevents infinite growth of an assembly. This 
relationship between µN0 and N gives rise to the critical micelle concentration (CMC) for 











Figure 1.8: a) Schematic showing the effect of monomer and/or aggregate concentration on the critical 
micelle concentration (CMC) (dotted red line) of an amphiphile assembly. b) Schematic of how surface 
tension decreases as a function of increasing amphiphile concentration again yielding an amphiphile 
critical micelle concentration (CMC) (dotted red line). 
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Application of this theory to an amphiphilic molecule directs that for the polar region, it 
is energetically more favourable for the polar head of the amphiphile to be in contact 
with water than with its neighbour.70  
 












  (1.4) 
 
These factors determine the aggregate geometry of an amphiphile. This is described in 
terms of the ratio between aggregate area (Aaggregate)/aggregate volume (Vaggregate) and 












Figure 1.9: a) Schematic of how the attractive and repulsive forces at an amphiphiles interface as the 
molecules surface area increases gives rise to an optimal headgroup area (a0) at a minimum interaction 
energy, b) The parameters which define the size and packing properties of an amphiphile, these being the 
volume (V) and length (l) of the non-polar tail, and the optimal area of the polar headgroup (a0) and c) 
how the hydrophilic repulsive (red arrows) and hydrophobic attractive (black arrows) act upon an 
amphiphile to promote assembly. 
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The balance between these attractive and repulsive forces (Figure 1.5), gives rise to an 
optimal headgroup area (a0), and a corresponding packing parameter (ρ) (Equation 
1.5)66a associated with each amphiphile.  
 
𝜌 =  
𝑉
𝑎0𝑙
  (1.5) 
 
This ratio between the hydrophobic tail volume and optimal headgroup area; described 
as the packing factor (p), determines the morphology adopted by the amphiphile on 
assembly.66a For packing factors less than 1, micelles are preferred, (Figure 1.10 a) with 
the length of this micelle increasing to form a cylinder (Figure 1.10 b)66a as the packing 
factor approaches ½. Between ½ and 1, a bilayer is formed, the most energy favourable 
configuration of which is a bilayer that closes to form a vesicle (Figure 1.10 c).66a Above 
a packing factor of 1, the system inverts, forming first an inverted cylindrical micelle 
(Figure 1.10 d) and then an inverted micelle at packing factors greater than 3/2 (Figure 
1.10 e).66a Knowledge of these mechanisms will allow for the exploitation of the process 









Figure 1.10: The packing parameters that can be achieved on assembly of an amphiphile as dictated by 
the ratio between tail volume and optimal headgroup surface area. Depending on this packing factor (p) 
number, amphiphiles can form a) micelles, b) cylindrical micelles, c) bilayers (vesicles), d) inverted 
cylindrical micelles and e) inverted micelles. Hydrophobic tails are shown in red and hydrophilic head 
groups in blue. 





Lipids (e.g. phospholipids) self-assemble to form biological membranes and vesicles. 
Lipid vesicles (liposomes) have been subjected to an extensive amount of research and 
characterisation, as well as their applicability to a wide range of applications, including, 
food science, cosmetics and medicine.71 Their encapsulation abilities have been widely 
explored, and are wide ranging, with liposomes being used to encapsulate a range of 
moieties, from single proteins to whole cells, via one preparation method.72 Monnard73 
and Tester74 previously outlined the properties of a liposome required for it to function 
as a nanoreactor, as requiring the reactor size to be in the nanometer range and 
designed to withstand changes in reaction conditions (such as temperature or pH). The 
composition should also allow for discriminatory diffusion as well as simultaneous and 
efficient encapsulation of all necessary reagents. Perhaps the most important property 
is inherent biocompatibility to have a chance of successful biomedical application.73 
There are many classes of “lipid” including, glycerolipids, sphingolipids and sterols.75 
The most significant for this study is the phospholipid, which makes up between 30-
80% of the molecules that self-assemble to form biological membranes.76 A 
phospholipid is an amphiphile that has a polar head containing a phosphate group and 
a non-polar hydrocarbon backbone.75 For liposome formation, the choice of 
phospholipid has a direct effect on vesicle properties. For example, a degree of fluidity 
must be maintained to control crucial vesicle properties including, phospholipid 
packing, melting temperature, and functionality, this is especially important for 
medical application.71a, 71b, 71d Fluidity is created by introduction of a double bond into 
the backbone of a phospholipid tail, which causes “kinks” in the chain; this introduces 
steric hindrance due to the geometry of the double bonds.69 Shorter chain lengths and a 
higher degree of unsaturation increases bilayer fluidity and thus the ease with which 
proteins can be incorporated. These variations can affect the outcome of self-assembly 
and are easily introduced into a synthetic lipid vesicle.71a, 71d 
Fluidity of a lipid bilayer can also be controlled by altering the temperature, osmotic 
pressure, bilayer composition, non-polar tail length and, in particular, the degree of 
unsaturation in the tail.77  
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Vesicle functionality can also be negatively affected by the presence of charge, which 
can create extra barriers to permeation, particularly to cations and anions.71a, 71c, 71d 
There are also several classifications of liposome from multivesicular and 
multilamellar structures to simple unilamellar vesicles, all of which can range in size 
from 10’s of nanometres (small unilamellar vesicles) up to the micron range forming 
giant unilamellar vesicles (GUVs), which are incredibly unstable disassembling upon 
agitation.71a, 78 Smaller than GUVs are multilamellar large vesicles (MLVs) and large 
unilamellar vesicle (LUVs), generally forming sizes around 500 nm.75 Below this size 
range are oligolamellar vesicles (OLVs), forming between 200-1000 nm, and finally 
small unilamellar vesicles (SUVs), which form within the target range of the vesicles in 
this thesis between 20-200 nm.75 These different structures and architectures arise 
from the preparation methods. More complex multilamellar and multivesicular 
structures, as well as nano-tubes, have previously been utilised in studies to mimic 
exocytosis.71d  
The liposomes in this thesis are synthesised from phospholipids alone, and although 
this is not an exact mimic of the MTB bacterial membrane, or even a naturally 
occurring membrane, the complex composition of these naturally occurring 
membranes would make it almost impossible to reproduce, as an unfeasible 
combination of compositions would need to be explored. Phospholipids seemed the 
obvious choice to focus on for formation of an artificial magnetosome vesicle, as they 
are the most prominent class of lipid in the magnetosome membrane, making up 62 % 
of the bilayer composition.39b 
Some manipulation of liposomes for application is possible, such as stabilisation for in 
vivo applications by the incorporation of cholesterol into the bilayer.71a, 71c, 71d, 79 This 
increases the membrane stability, particularly in the presence of biological fluids, 
although this also has the disadvantage of reducing membrane permeability.80 A 
bilayer can also be stabilised by polyethylene glycol (PEG), which causes interbilayer 
repulsion to overcome the Van der Waals forces present in the bilayer, thus preventing 
vesicle aggregation.71c The addition of PEG can also disguise the outer membrane, 
increasing the vesicles in vivo lifetime, delaying recognition by opsonins,81 which 
allows the vesicle to release its cargo at a specific target site.71c 
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This lifetime can be further lengthened by control of the size, with smaller liposomes 
(between 50 – 200 nm) exhibiting longer circulation lifetimes.82 Vesicle sizes outside of 
this range can have detrimental effects on the in vivo destination of vesicles, with 
smaller vesicles (<40 nm) being known to enter the liver, while those above 300 nm in 




Phospholipids can be restrictive and unstable with respect to functionalisation, which 
limits their use in nanomedicine.83 In comparison, polymers can offer increased 
stability, low permeability and increased molecular weights, and are also highly varied 
and tuneable.83-84 For this reason, amphiphilic copolymers have been utilised as lipid 
mimetics to self-assemble into polymersomes (polymer vesicles). In this case, polymer 
monomers with functional groups such as carboxylic acids, (to introduce polarity) 
mimic the phosphocholine head group of a lipid, while non-polar hydrocarbon based 
monomers, such poly-butadiene or poly-dimethyl siloxane, behave in the same way as 
a hydrophobic phospholipid tail.85 
Polymer vesicles offer a flexible and often more robust material, with greater scope for 
modification both pre and post assembly, to accommodate a wide range of chemical 
conditions. This, in combination with more robust mechanical properties, makes 
polymersomes ideal drug delivery and diagnostic agents.84, 86 One major advantage of 
using synthetic amphiphiles such as block copolymers is the wide range of 
architectures achievable by optimisation of both the polymer hydrophobicity and 
monomer block lengths (Figure 1.10).87 The architectures achieved by block 
copolymers can affect both the application they are suitable for and their effectiveness 
in those applications.88 In addition to this, it is entirely possible to engineer the 
monomer building blocks to closer suit the needs of the eventual application. 
Polymersomes’ particularly di-block architectures, are finding new applications across 
the entire field of biomedicine, offering superior properties as drug delivery vehicles 
when compared with lipid vesicles.83  
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The literature demonstrates how polymersomes can be engineered to incorporate a 
wide range of properties designed to meet the requirements of specific applications.83-
85, 89 For instance, di-block polymer drug delivery carriers have been engineered to 
respond to stimuli including; changes in temperature, ionic strength, pH and light.89e, 90  
Numerous reviews have outlined the various properties it is possible to incorporate 
into a vesicle, such as photosensitivity, pH sensitivity, specific melting temperatures 
and chemistry which can make the resulting vesicles show stealth in vivo.89b, 89d, 91 For 
example, pH can control polymer orientation during assembly, determining which of 
the monomer blocks make up the outer leaflet of the polymersome.89d, 92 It has also 
been shown that specific polymersomes disassemble upon irradiation with UV light, 
which has huge potential for the successful release of cargo in vivo. 89d, 92-93 In terms of 
targeted drug delivery, the variety of moieties already functionalised on to a 
polymersome bilayer is outlined in the review by Pawar et al,89b and encompasses 
antibodies, peptides, carbohydrates and small organic molecules. This functionalisation 
can be through both covalent and non-covalent methods, depending on the polymer 
chemistry.89b The literature highlights the high level of adaptability offered by 
polymersomes, in terms of their engineered properties, functionalisation and potential 
for use in applications.83-85, 89  
Much of this this is specific to use in biomedicine and drug delivery applications,89c, 90b, 
94 targeting specific biological sites, such as in the treatment of gliomas.95 The creation 
of pH sensitive biocompatible block copolymer polymersomes allows polymersomes to 
form or deform in response to changes in pH. Such as self-assembly above pH 6 as a 
result of deprotonation of an amine in the specific polymer material studied.96 The 
encapsulation efficiency of a polymersome can be improved by the use of microfluidics, 
as the laminar flow conditions within a microfluidic device result in a pH gradient at 
the flow interface.82, 97 These properties affect the in vivo response, solubility, 
permeability, surface topology and lifetime,91, 98  rendering polymers idea smart 
nanomedical vehicles. 
Most research into polymersomes has been carried out with di-block polymers.2a, 84, 86-
87, 99 However, ABA tri-block polymersomes which have a hydrophobic, hydrophilic, 
hydrophobic structure, thus forming a monolayer which mimic diblock polymer bilayer 
formation (Figure 1.11 a) and may offer alternative properties, particularly with 
respect to membrane transport and encapsulation.  
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This is due to the structure of ABA tri-block polymers, which consists of continuous 
hydrophilic, hydrophobic then hydrophilic sections, which assemble into a monolayer 
(Figure 1.11 b).  
 
 
Figure 1.11: Schematic of vesicle bilayer formation formed using a) a diblock (AB) polymer and b) a tri-
block (ABA) polymer. 
 
This monolayer has the same amphiphilic properties as a traditional polymer or lipid 
bilayer; therefore ABA tri-block polymers form the same architectures as liposomes 
and polymersomes in aqueous solution. The advantages of using an ABA tri-block for 
compartmentalisation of a reaction are the low permeability and end group reactivity. 
This could give rise to better encapsulation and maintenance of reactants, and as a 
consequence improve precipitation in the core. ABA polymers can be both stabilised 
and functionalised as with di-block polymers by adaptation of reactive end groups,9, 100 
this functionality is well placed for application in biomedicine. Conversely this may 
raise problems with regards to trans-membrane transport of reactants.  
The use of polymer medical vehicles, although a relatively new field, is having 
increasing success. For example Meier et al have successfully incorporated biological 
components into polymer membranes.100a This work has been further advanced by 
numerous other groups, by incorporation of both protein channels and enzymes.101  
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Much of this work is outlined in the review by Meier et al85 which demonstrates a 
framework of polymersome nanoreactors for the study of ion transporters, membrane 
proteins and as biomineralisation scaffolds. It also suggests that block co-polymer 
vesicles are now competing with liposomes in their use as vehicles for both the study of 
biological moieties and as successful nanoreactors.  
 
1.4.4 FORMATION METHODS 
 
 LIPOSOME FORMATION 1.4.4.1
 
There are a number of routes to form liposomes, including but not limited to; 
sonication, electroformation extrusion, coacervation (phase separation), inkjetting and 
microfluidics.71a, 71c, 78, 102 These preparation methods allow for multiple modes of 
encapsulation and, in some cases, encapsulation of multiple reagents. However, some 
methods are not suitable for the creation of an artificial magnetosome, due to low 
encapsulation efficiency.72 The preparation method is key to the eventual liposome 
size. For example, in their formation by sonication and extrusion,103 the radii tends to 
be less than 50 nm, producing SUVs.  
Whereas MLVs tend to form spontaneously, these can be converted to unilamellar 
vesicles by extrusion, which causes the rupture and reformation of the membrane. This 
technique can also be used as an effective method of encapsulation by the introduction 
of a new encapsulant upon reformation.103 
For the preparation of GUVs, lipid film hydration or electroformation are widely used.78 
Biological membranes are naturally asymmetric, this asymmetry is hard to achieve 
synthetically.104 However, more complicated preparation methods can allow for the 
independent design of the inner and outer leaflet of an asymmetric liposomal 
nanoreactor, such as the inverted emulsion method developed by Pautot et al.105 This 
allows for production of a vesicle capable of withstanding two contrasting external and 
internal environments, thus widening the scope of the reactions liposomal 
nanoreactors incorporate, and is ideal for the incorporation of immiscible solutions 
simultaneously (Figure 1.12).105  
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The drawbacks of using such a complicated method include: ensuring appropriate 
emulsion formation as this controls the final vesicle size, and the lipid concentration in 
the emulsion must be kept low when compared to other preparation routes, to prevent 
phase separation.  
 
 
Figure 1.12: Schematic of Pautot’s105 in which a) inverted water in oil micelles are formed using the inner 
leaflet lipid, before being centrifuged through b) a monolayer of the outer leaflet lipid to create the bilayer 
of the vesicle, before c) vesicles are collected in aqueous solution.  
 
It’s also difficult to avoid oil incorporating into the bilayer.105b Vesicles can also be 
formed using double emulsion methods, using water/oil combinations for separation 
of lipid and aqueous solutions.106 The vesicles can then be formed either by 
evaporation of a solvent layer106a or by using a droplet interface bilayer, in which two 
vesicles fuse at an interface bilayer, ideal for asymmetric vesicles and mixing of 
immiscible reagents.107  
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 POLYMERSOME FORMATION 1.4.4.2
 
A polymer molecular weight (of each block and also number of blocks) is fully 
controlled during its synthesis, and has a direct effect on the thickness of the resulting 
membrane, impacting polymersome stability, fluidity and diffusion properties.86, 89e, 91, 
94c, 98, 108 All of these properties can be tightly controlled by careful consideration of the 
block copolymer characteristics, paying particular attention to the molecular weight of 
the polymers. Polymersomes can be engineered to have superior mechanical 
properties when compared with liposomes. For instance, synthesis of polymersomes 
with increased tolerance to extreme environments, such as high pH and temperature, 
as a result of being a synthetic analogue.  
  The methodology chosen for polymer synthesis is key to the structure formed, the 
simplest of these routes being the addition of amphiphilic polymers to aqueous 
solution above the CMC (usually high concentrations) yielding micelle formation, 
although these easily disassemble upon dilution. Synthesis can occur via numerous 
methods such as, film rehydration, electroformation,84, 86 RAFT synthesis87, 108 layer by 
layer polyelectrolyte formation utilising charge to build up the polymer blocks in 
series.109 
Polymersomes form most easily through film rehydration, with polybutadiene-
polyethylene oxide (PBD-PEO) being one of the strongest and most commonly used 
polymers.110 In the case of polymer formed from PBD-PEO and polybutediene-
polybutylene oxide, several structures can be achieved from the same polymer 
depending on the required properties. For example, simple mixing forms large, multi-
lamellar polymersomes, ideal for the simultaneous encapsulation of multiple 
hydrophobic moieties. However the fluidity of the membrane allows for the application 
through various membrane pore sizes to control both the final diameter and 
lamellarity.99c  
 
This can be further adapted by control of the molecular weight during polymer 
synthesis, which in the case of PBD-PEO can increase the bilayer from ~5 nm up to a 
thickness of ~20 nm with increasing molecular weight and has been shown to have a 
direct effect on membrane elasticity and surface tension, which leads to increased 
stability and fluidity simultaneously.111 
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Furthermore, it is possible to prevent polymersome aggregation by controlling the 
thickness of the outer leaflet of the polymersome as a function of PEO concentration.112 
The diversity observed in formation methods of polymersomes is reflected in the 
almost endless combination of properties that can be incorporated into a polymersome 
by careful selection and design of the building-block polymer materials.99a  
 
 HIGH-THROUGHPUT VESICLE FORMATION 1.4.4.3
 
Microfluidics can offer control of vesicle formation on a large scale, by manipulation of 
the lipid solution flow in capillaries within the 10-100 µm range, with complete control 
over solution mixing.82 Microfluidic devices can be designed with multiple inlets for the 
introduction of solutions and mixing at specific points in the synthesis and by control of 
the capillary size and laminar flow rate the production of extremely monodisperse 
vesicle populations can be achieved.82  
Similar to microfluidic devices and offering the same level of control, but with the 
ability to produce smaller sized vesicles, is the high-throughput production of 
liposomes using electrohydrodynamic atomisation (EHDA).113 This is used for the 
synthesis of microbubbles, fibres and solid nanoparticles and for the first time in this 
thesis, vesicles. EHDA utilises a high electrical potential difference to induce focusing 
and break up of a liquid jet into small droplets113-114 and is well known for generating 
fine droplets from micro to nano scale, by elongation of a meniscus under electrical 
shear.115 It is a simple process involving formation, control and break up of a jet under 
the influence of a high electrical field. The equipment uses either a single needle or a 
co-axial series of needles in which, two immiscible liquids82 or suspensions are 
pumped through concentrically aligned needles, and subjected to an applied voltage. 
The application of a potential on the kilovolt (kV) scale results in various modes of 
atomisation, and the droplet frequency (yield).116 Among these, the cone jet is the most 
preferred jetting mode as it generates monodisperse, fine droplets of particles, in 
which the outer material solution encapsulates the inner. The EHDA method has many 
advantageous over conventional methods, generating micro to nano sized 
monodispersed droplets. It is a flexible process which can be modified for 
encapsulation efficiency. 
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Another high throughput method, based on the previously discussed inverted emulsion 
method (section 1.4.4.1), is the continuous droplet interface crossing encapsulation 
(cDICE) (Figure 1.13).117 This combines microfluidic capillary droplet with the 
emulsion/interface system developed by Pautot for asymmetric vesicle formation.105 
The cDICE method was developed by Abkarian et al.117-118 It is a vesicle synthesis 
method developed using similar methodology to that described in Pautot’s inverted 
emulsion method.105  
The cDICE method (Figure 1.13) is described as being high yield and tuneable in both 
end vesicle size and efficiency of encapsulated content. This is as a result of careful 
consideration of both the lipid adsorption time; for formation of the initial inverted 
micelles, and subsequent recruitment of the outer lipid leaflet, by optimisation of the 







Figure 1.13: Schematic diagrams showing experimental set-up for the continuous droplet interface 
crossing encapsulation (cDICE) method. The aqueous lipid solution is added to the rotating solution into 
by injection directly into the organic oil layer dropwise via capillary. These are then centrifuged through 
the lipid-oil solution (LOS), at which point inverted micelles are formed, and through the 2nd lipid interface 
to pick up the outer lipid leaflet, into the “dispersing aqueous solution (DAS). Successful vesicle formation 
is achieved by careful consideration of R (the droplet radius) and the flight time (τf) through the organic 
layers being sufficient to ensure effective coating of the aqueous droplets. Schematic adapted from 
Abkarian et al117.  
 
This has advantages over the Pautot method, in that it ensures clearance of the 
interface solution by the inverted micelles and successful coating of the outer layer 
lipid; as confirmed in the paper by real time fluorescence microscopy.117 The same 
method was used to test the Pautot method, and it was discovered that, in most cases, 
the centrifugation step did not give ample time for inverted micelle formation. 
Furthermore, in cases where the micelle was assembled, rather than pick up the outer 
lipid leaflet the micelles burst upon hitting the interface solution.  
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The improved synthesis route is achieved by incorporation of a microfluidic-like 
droplet addition to form the emulsion, and by use of a continually rotating system, to 
obtain an optimised centrifugal force; dependent on the phospholipid molecular 




Nature has developed some of the most complex but effective processes observed 
throughout science, so is an ideal place to seek inspiration for the design of new 
materials. Many of the complex mineral structures seen in nature, including naturally 
occurring magnetosomes, are biomineralised. Whilst being known for their superior 
magnetic and materials properties, the magnetosomes from MTB are difficult to 
produce due to the bacteria’s slow growth under fastidious conditions, which results in 
low magnetosome yields.119 For instance, certain species of MTB must be grown under 
1% oxygen conditions in order to produce magnetite nanoparticles. The magnetosomes 
harvested from MTB are also restricted to certain MNP sizes and shapes. Adapting and 
functionalising these particles for specific applications is therefore both limited and 
challenging. In addition, due to their bacterial origin, MTB derived magnetosomes have 
a high likelihood of generating an immune response if used for biomedical purposes in 
vivo. 
It is in situations such as these that research can turn to bioinspired synthetic 
alternatives for compartmentalisation to create nanoreactors. Synthetic analogues can 
be engineered to withstand the subsequent mineralisation conditions required to make 
artificial magnetosomes.89c, 90b Therefore a bottom-up approach, i.e. use of a synthetic 
vesicle, will allow the adaptation of this nanoreactor to form a MNP containing vesicle. 
For example the size and composition of a synthetic nanoreactor can easily be 
optimised with techniques such as extrusion.120 Furthermore, this means that reactions 
outside biological restrictions of temperature or toxicity can be accommodated by the 
synthetic host, in which significantly more chemical and physical adaptions are 
possible. This approach can be taken to creation of a synthetic magnetosome, using 
synthetic lipid/polymer vesicles to compartmentalise magnetite precipitation.  
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The incorporation of MTB biomineralisation proteins can be used to control the 
particle formation (if required), and to mimic the processes observed in MTB 
magnetosome formation. 
Vesicles offer the perfect vehicle for a biomimetic approach to synthetic 
biomineralisation. This is evident in the work of Mann and Hannington,121 and their 
work toward the creation of a biomimetic artificial magnetosome (Figure 1.14). 
 In this work vesicles were formed encapsulating ferrous iron ions, before raising the 
internal pH of the vesicle; via transmembrane diffusion of OH- resulting in iron oxide 
precipitation. However due to encapsulation of a finite concentration of iron during 
vesicle formation, a fully mineralised vesicle core was not achieved, as evidenced by 
TEM (Figure 1.12).  
Ongoing research has expanded this field further such as, the design of the 
“magnetonion,” a multilamellar vesicle, resembling an onion-like structure, in which 
MNPs sit within the layers of the “onion” by Faure et al122 and Sangregorio et al.123 Both 
of these systems build on Mann and Hannington’s biomimetic magnetosome system. 
Studies such as this and others124 are critical to the development of novel biomimetic 











Figure 1.14: Taken from Mann et al4 a) in which vesicles were used to encapsulate iron ions, the internal 
pH of which was increased by influx of hydroxyl ions. This diffusion leads to iron oxide formation in the 
core of the vesicle. b) Shows TEM of the resulting biomineralised vesicles, which are only inconsistently 
filled with iron oxide.   
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Compartmentalisation of a reaction constrains the environment to promote nucleation 
processes involved in crystallisation of magnetite MNPs. This approach has also been 
applied to the biomimetic biomineralisation of calcite, aragonite, hydroxyapatite and 
silica,1c, 125 demonstrating flexibility and diversity with regards to the reactions which 
can be incorporated into a biomimetic nanoreactor system. For biomedical application 
to be a reality it is necessary to obtain consistent and monodisperse mineralisation 
within a nanoreactor, to ensure a consistent response in a magnetic field, which 
remains a significant challenge.  
 
1.6 APPLICATIONS OF BIOMIMETICS 
 
Biomimetic studies have wide-ranging applications. Perhaps the most obvious 
application of a biomimetic system is its introduction back into a biological system to 
advance biomedicine. As a result of evolution, biological structures often offer superior 
properties for in vivo applications, achieving levels of control impossible to match with 
a purely synthetic system. Although impossible to match, we can get close to these 
levels of control using a biomimetic systems which have potential use for application in 
biomedicine. This section focusses on the biomedical applications that biomimetic 
systems are currently being used for and looks to potential uses in the future. Using a 
vesicle as the basis for a biomimetic system has the advantage of inherent multi-
functionality. This arises from its structure in which numerous reactions have been 
successfully compartmentalised.1c, 65, 126 Depending on the polarity of the molecule to be 
incorporated this could be on its outer leaflet, or within its hydrophobic membrane. 
Vesicles incorporating multiple elements with  therapeutic and diagonstic potential are 
termed theranostics. For example, attachment or encapsulation of a drug combined 
with incorporation of diagnostic tools such as fluorophores or magnetic nanoparticles 
(MNPs) can allow for simultaneous drug delivery and optical or magnetic resonance 
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1.6.1 GENERAL DRUG DELIVERY APPLICATIONS 
 
Many studies in the field of nanocarriers for biomedicine are now focused on 
development of theranostics.94b, 128 Theranostics are constructed from both therapeutic 
and diagnostic moieties.71b, 94b, 128-129 These multifunctional nanocarriers are designed 
to be effective, targeted vehicles that carry insoluble therapeutics, with longer lifetimes 
and narrower bio-distributions compared to delivery of the free drug.129 Theranostics 
aim to allow visualisation of a treatment site (diagnostic) whilst simultaneously 
targeting the area therapeutically and non-invasively. Theranostic nanocarriers are 
based on a wide variety of architectures including vesicles, dendrimers and carbon 
nanotubes. These nanocarriers contain functionalities such as; MNPs, quantum dots, 
fluorophores and/or antibodies. These nanocarriers take advantage of the leaky uptake 
and reduced drainage of tumour tissue (in the case of cancer treatment).128b  
A successful theranostic is defined as having four elements: 1) the carrier itself (the 
size of which is important for uptake), 2) a signal emitter, 3) payload (neither of which 
should affect the size, shape or surface chemistry of the carrier), and finally 4) a 
targeting ligand (for effective delivery).128b Theranostics can be engineered to release 
their cargo at a specific treatment site. This means that lower therapeutic doses are 
required than in non-targeted treatments, which significantly improves treatment 
efficiency and reduces side effects.71c  
Targeted delivery arises from either covalent binding or hydrophobic inclusion of a 
targeting moiety (such as antibodies) into the membrane of the nanocontainer. Most 
commonly this targeting molecule will consist of immunoglobulins, which are plasma 
proteins used to generate an immune response.81 Once at the target site, the vesicle can 
be engineered to become destabilised, which can cause them to fuse to cells and release 
their load at the target site.81  
As the pH of cancerous tissues is usually acidic, this can cause a destabilisation induced 
when the nanocarrier (which is designed to be stable at neutral physiological pH) enter 
the acidic environment. Small scale pH switches can also trigger the release of the 
cargo75 in the acidic tumour tissue. Other triggers can include fusion to cells, and 
targeted sequence recognition by attachment of specific antibodies on the nanocarriers 
to their corresponding antigens on the cancerous cells.129 
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The release of a drug can be engineered into the carrier. For example, Jia et al130 use an 
amphiphilic polymer with a disulphide bridge connecting the polymer blocks to build 
their vesicles. When this disulphide is reduced by intracellular concentrations of 
cysteine (at higher concentrations in the cancer tissue), the drug calcein is released.130 
Similarly, systems which are stable at physiological temperatures (<39 °C), can be 
designed to release liposome attached drugs on warming (for example by application 
of a magnetic field). Careful selection of lipids can introduce a vesicle melting 
temperature of, e.g. 42°C, by either engineering the thermal decomposition of the 
bonding chemistry within lipids, or thermal degradation of the whole liposome to 
provide a temperature switch.  
 
1.6.2 APPLICATIONS OF MAGNETIC NANOPARTICLES 
 
For use in biomedical applications MNPs need to be distinctly superparamagnetic iron 
oxide nanoparticles of uniformly sized single domain magnetite (between 30-120 nm) 
so that they have a consistent and predictable response in the application.13, 18, 131 This 
is because they are able to maintain their magnetic orientation in the absence of an 
applied field. If of a uniform size, the single domain MNPs are also able to produce an 
efficient and consistent response to an externally applied magnetic field.  
Magnetic nanoparticles are already used in biosensing, cell separation and 
immunoassay applications.13, 18, 131 MNP incorporation into a biomedical nanoreactor 
could introduce magnetic diagnostic and targeting functionalities, making these 
magnetic therapeutic moieties also a theranostic agent. Post formation loading of MNPs 
into a range of vesicles and nanoparticles (NPs) is of growing interest for use in 
targeted medical treatments.71b, 132 Following magnetic separation such as from patient 
blood for diagnostic assays by incorporation of MNPs.133 Targeted release of a drug 
(doxorubicin) from a magnetic nanocarrier has also been realised.134 Doxorubicin 
release is triggered by an externally applied alternating magnetic field, which heats the 
iron oxide nanoparticles within the bilayer, triggering drug release.134 Theranostics 
have huge potential in personalised medicine, as the therapeutic agent is ready to be 
administered at the potential treatment site, depending on a positive outcome from the 
diagnostic functionality of the nanocarriers.129 These applications will be discussed in 
more detail throughout this section. 
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 MAGNETIC RESONANCE IMAGING (MRI) 1.6.2.1
 
Magnetic resonance imaging (MRI) is a non-invasive technique which has been used 
internationally since the 1970’s.135 The technique makes use of hydrogen nuclei 
(supplied by protons from water) in the body. A magnetic field is used to align the 
protons (which are paramagnetic). When a magnetic field is applied to the body in an 
MRI scanner, the net magnetisation (M0) of protons from water in the body aligning 
with the direction of the field (B0) can be measured along the z axis (Mz).13, 136  
The magnetic moment of a proton is 3-dimensional, with a corresponding x and y 
moment, which precesses around B0 (z-axis) at a random orientation, known as the 
Larmor frequency.13, 136 When a radio frequency is applied, the protons absorb energy 
and move away from B0, creating Mxy. When this radio frequency is removed, the 
protons then relax back to their original alignment with the external magnetic field.13, 
136 This relaxation can be measured. T1 relaxation, the longitudinal or spin-lattice 
relaxation is due to the loss of heat to the surroundings, caused by the relaxation of Mz 
on the protons. 
 T2 relaxation, the transverse or spin-spin relaxation, is the rephrasing of the spins to 
align back with Mxy.13, 136 A third relaxation rate can be measured, and arises from the 
introduction of heterogeneity in the magnetic field; such as the presence of MNPs in the 
locality being imaged.13, 136 This is the T2* relaxation, and it is a combination of the 
transverse effects and dephasing caused by the presence of magnetic inhomogeneity. 
T2* is generally faster than T1 or T2. When scanning, the applied radio frequencies (~60 
mHz) flip protons by approximately 90°. The relaxation back to Mz is then measured.136 
Using electromagnetic fields applied at varying current which subsequently changes 
the field strength and allows the targeting of specific areas allowing imaging in all 3-
dimensions.136 
The MRI image is compiled using a combination of the resonance signals (the 
frequency and the phase) this outputs spatial information (known as K-space).137 The 
information is subsequently converted to image slices using Fourier transform 
techniques, with the difference in relaxation times creating contrast in the image.127d, 136 
Introduction of MNPs to a target site increases the T1 and T2* relaxation times of the 
surrounding protons, providing contrast to highlight specific areas in the body.137  
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Therefore, directing MNPs to tumour tissue using the attachment of targeting 
antibodies to the magnetic nanoparticles can “light up” the affected sites during 
scanning.13, 138 The effect on relaxation time can be controlled by altering the size of the 
contrast agent or composition of the material, which in turn also controls magnetic 
properties, as more magnetic material has increased relaxation rates providing greater 
contrast.139 
Iron oxide MNPs have great potential as replacements for the gadolinium contrast 
agents that are currently used. The interaction of protons with the local magnetic field 
of the iron oxide MNP can significantly enhance contrast in MRI scans in vivo, without 
the toxicity of the current gadolinium based agents. The presence of an MNP provides a 
local magnetic field, which dramatically increases the local atomic relaxation time, 
resulting in darkening of this area of the image. This is achieved by ensuring that the 
MNP has a shorter T2 (spin-spin) relaxation time than the surrounding tissue, 
improving contrast between cells containing MNPs and empty cells.127d, 139 MNP 
incorporation into drug loaded vesicles could also provide peripheral targeting of said 
drugs to a treatment site by localisation by applying large external magnetic field to 
direct the MNPs to the site of interest.127d,89c, 90a, 140 
 
 MAGNETIC HYPERTHERMIA TREATMENT (MHT) 1.6.2.2
 
MNP magnetism can also be exploited in magnetic hyperthermia therapies. 
Hyperthermic therapies are based on magnetically induced heating by oscillation of an 
externally applied alternating magnetic field.13, 141 This locally heats the area around 
the MNPs, and is used in the ablation of diseased tissue and/or release of heat activated 
drugs.127d, 142 Magnetic hyperthermia treatment (MHT) is an emerging non-invasive 
therapy, currently in clinical trials for remote tumour ablation. This is achieved by the 
targeting (either using antibodies via manipulation with a magnetic field depending on 
the tumour location) of MNPs to the affected site followed by the application of an 
alternating magnetic field at frequencies in the range of 100-150 kHz.143 The oscillating 
field switches the individual spins (for larger single-domain MNPs) or physically flips 
the whole particle (for smaller superparamagnetic MNPs). This switching or flipping 
can induce heating, as thermal energy is released as the spins and/or particles attempt 
to resist realignment with the alternating field.  
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This heat dissipates into the surrounding tissue, damaging or killing the diseased tissue 
if the temperature increase is high enough.13, 141a, 144 
Heating occurs via two different mechanisms, dependent on the particle size. The first 
is by Néel rotations, in which only the magnetic moment in the particle rotates. This 
mechanism occurs in larger ferri- and ferromagnetic nanoparticles, and thermal energy 
is generated by the switching dipole moments in the crystal lattice of the MNPs. This is 
shown in equation 1.6, where the amount of heat generated (PFM) is found from the 
field frequency (µ0f) multiplied by the area of the particles hysteresis loop (∮H dM).13 
 
𝑃𝐹𝑀 =  𝜇0 𝑓 ∮ 𝐻  𝑑𝑀       (1.6) 
 
The second mechanism involves Brownian rotation. Here, aligning of the magnetic 
moment causes the whole particle to rotate, and is the case for small 
superparamagnetic nanoparticles.13 The rotation causes shear stress as the particle 
flips, resulting in delivery of thermal energy to the surrounding medium.127d, 143 The 
heating power of a particle which undergoes these rotations (PSPM) is determined from 
equation 1.7, where heating power of the square of the field strength (H2), and the 
particles magnetic susceptibility (χ”) which is frequency dependent (µ0πf).13  
 
𝑃𝑆𝑃𝑀 =  𝜇0𝜋𝑓𝜒
"𝐻2      (1.7) 
 
Within each regime, the heating is largely dependent on the magnetic saturation and 
coercivity of the MNPs, as well as the frequency of the alternating field. In the case of 
smaller MNPs, which physically rotate, the interaction with the MNP’s surroundings is 
also important. The heating power of a particle is determined by calculation of its 
specific absorption rate (SAR) (equation 1.8), which calculates the heating power (P) of 
the particles based on the mass of the MNPs in the sample (mmnp). A different method 
involves the calculation of the intrinsic loss parameter (ILP). The ILP uses the SAR 
value, but also takes account of the alternating magnetic field parameters, namely the 
frequency (f) which scales linearly with P, and the field strength (H), which scales the 
heating power quadratically (Equation 1.9).  






  (1.8) 
 
𝐼𝐿𝑃 =  
𝑆𝐴𝑅
𝑓𝐻2
    (1.9) 
 
1.6.3 MNP PROPERTIES REQUIRED FOR MHT 
 
Accurate measurements of these parameters discussed above can be made difficult by 
contributions from loss of thermal energy into the system. Convection currents can 
develop in the heating solutions which are caused by the alternating field, which can be 
affected by the shape of the sample vessel and position of the temperature probe. It is 
also possible that the applied field is inhomogeneous, which also generates undesirable 
heterogeneity.145 These effects become more pronounced as research moves towards 
in vivo studies, as physiological fluids are also heterogeneous.145 Therefore, work is 
ongoing to obtain a standardised approach to accurate MHT measurements.145 The 
potential for MNPs to contribute to the efficacy of MHT is far reaching. Again, particle 
size and morphology are of great importance with regards to the outcomes of in vivo 
MHT. This can be seen in the study by Li et al146, where heating efficiencies at high and 
low fields with different size nanoparticles are presented. Li noted that, at a low 
applied field (9.6 kA m-1, 100 kHz), 8 nm particles (suspended in agar) gave the best 
heating (an increase of 9.3 °C), whereas at higher fields (23.9 kA m-1, 100 kHz) particles 
of 24 nm in diameter proved more efficient (giving an increase of 55 °C).146 This 
demonstrates the sensitivity of MHT to subtle changes in the magnetic properties of the 
MNPs used, and the need for extensive optimisation and standardisation with regards 
to all parameters. This drive for the use of MNPs in biomedical applications requires an 
extremely high degree of homogeneity in both particle size and shape. 
Compartmentalisation of the MNP formation reaction, as is the case with formation of 
many biominerals, offers the levels of control and reproducibility required. Effective 
use of MNP is heavily dependent on the particle characteristics, size and 
concentration.18, 127d 
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1.6.4 BIOMEDICAL USES OF MAGNETOSOMES 
 
Work is ongoing to understand the extent to which bacterial magnetosomes can be 
modified and functionalised for biomedical application.24 Their biomedical potential 
arises from stabilisation of the crystal within the bacterial magnetosome, which both 
prevents oxidation, and renders the MNP inherently biocompatible. Magnetosomes 
magnetic properties have proven to be superior in several applications (MRI and MHT) 
when compared with synthetic analogues24 due to the high level of homogeneity with 
respect to size, shape and magnetic response. There is a concerted effort to 
functionalise magnetosomes for a range of extensive applications,147 such as targeted 
therapeutics, DNA extraction, immunoassays and bio-sensing of toxic substances, as 
outlined by Lang et al24 and Matsunaga et al,147 demonstrates the potential of using 
magnetosomes ex vivo in nanomedicine.  
Magnetosomes have great potential as imaging contrast agents in MRI, having an 
increased T2 relaxivity rate of 146 mmol-1s-1 compared to 62 mmol-1s-1, for comparable 
dextran coated synthetic iron oxide nanoparticles. 148 In vitro work performed by Hergt 
et al141b, 149 was the first to discover the magnetosomes hyperthermic potential. By 
immobilisation of magnetosomes in gel to test their heating capability, they found that 
magnetosome heating gave a SAR of 140 with a heating power of 960 W g-1 compared 
to values recorded between 10-100 W g-1 for synthetic MNPs.141b  
In vivo hyperthermic heating efficiency assays of magnetosomes have also been tested 
by Alphandery et al, for the destruction of breast cancer tumour cells in a mouse 
model.150 In this study, complete destruction of a tumour was observed following three 
20 minute rounds of hyperthermia at 183 kHz and 40 mT, in the presence of 1 mg of 
magnetosome chains. A control sample of PEG/citrate coated iron oxide nanoparticles 
had no effect under the same conditions.150 Furthermore, very little difference is 
observed in the heating efficiency between magnetosomes when in their intact chains 
and when disrupted from the chains. It was found that chains of bacterial magnetsomes 
display increased uptake into cancer cells, when compared to those disrupted from 
their chain assembly. This is most likely to be due to aggregation of the disrupted 
magnetosomes, which TEM confirms was occurring in solutions of un-linked 
magnetosomes.144 
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1.7 ARTIFICIAL MAGNETOSOMES 
 
Despite their potential, MTB magnetosomes are low yield and inflexible with regards to 
engineering. This means that extraction from bacteria is not a feasible option for 
industrial scale-up. If magnetosome formation can be fully understood from first 
principles; particularly the role of each protein involved and how they work in concert 
to form the resulting MNPs, this knowledge can be used to attempt the bottom-up 
creation of an artificial magnetosome and thus enable superior biomimetic 
biomineralisation within nanoreactors. Mann et al4, 121a have previously achieved 
partial precipitation of inorganic minerals inside a vesicle by encapsulation of metal 
ion solutions in vesicle followed by influx of reagents to yield the precipitation.4, 121 
Unfortunately, it was found that encapsulation of a finite volume of iron ions limited 
the amount of material that could be precipitated inside the vesicle.  
Similarly, high quality particles from low temperature syntheses can be vastly 
improved by performing precipitation within a reversed micelle (phospholipid 
encapsulated aqueous solution).151 The Reverse micelle precipitation routes at room 
temperature typically tend to cause agglomeration, poor crystallinity and poor yields, 
and also require vast amounts of solvent (to maintain the micelle structure).  
However, Lee et al have found that by performing reverse micelle synthesis at slightly 
elevated temperatures (90°C), grams of monodisperse MNPs  can be obtained (without 
the addition of more solvent). The size of these MNPs can be adjusted by altering the 
iron salt concentrations.151 This is a good indication of how precipitation within a 
vesicle could make low temperature co-precipitation routes viable for the synthesis of 
high quality MNPs. It is unlikely that in an artificial magnetosome system the organic 
components and natural materials will withstand high temperature methods. Such 
mineralisation conditions are most likely lead to destabilisation of the vesicle 
membrane. Therefore, a compromise between reaction temperature and particle 
quality is required. A reaction route such as the urea method,20b, 20e may be appropriate, 
as high temperature is required but the reduction in reaction time makes the method 
applicable to a wider variety of vesicle materials. However, it remains to be seen 
whether compartmentalisation of these precipitation routes within a vesicle affects the 
end product, meaning that lower temperature routes could yield more homogenous 
particles. 
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1.7.1 BIOMIMETIC MAGNETOSOME SYSTEM 
 
Creation of a biomimetic magnetosome system will allow the simultaneous high-
throughput creation of an adaptable, magnetised nanocarrier, whilst also serving to 
better understand the formation of the MTB magnetosome and function of its 
associated proteins. For this process to be a success, an appropriate vesicle system 
must be developed. This will require an optimised composition, to allow effective 
permeation of the membrane,152 therefore consideration will need to be given to both 
the bilayer thickness and its fluidity.153 
 
For the synthetic magnetosome to be successful in compartmentalisation of magnetite 
precipitation; a balance is required between integration of an iron transport system, 
while simultaneously avoiding OH- leakage. Membrane permeability is determined by a 
permeability coefficient (Equation 1.10)76 as given by a diffusion constant (D), derived 
from the Nernst equation. Here the gas constant (R) and Temperature (T) is divided by 
Avogadro’s number (N) and f which is the frictional coefficient which accounts for the 
viscosity (η) and radius of the molecule (r) (Equation 1.11).76 This diffusion constant, 
as well as the concentration gradient dictates the rate of transport across a membrane 
as a function of the membrane surface area.76  
 
𝑃 =  
𝐷
𝑥
  (1.10) 
 
𝐷 =  
𝑅𝑇
𝑁𝑓
    where  𝑓 = 6𝜋𝜂𝑟  (1.11) 
 
Transport across a membrane can be initiated by careful control of both the inner and 
outer pHs. Osmotic effects can be used to aid transmembrane diffusion. Increase or 
decrease of the outer vesicular pH can force iron ions to move across the membrane to 
re-establish an equilibrium by promoting diffusion across the membrane.154 Ongoing 
studies are working towards better quantifying the effect of pH on membrane 
transport.124, 155 
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 There are two general hypotheses for the mechanisms of ion transport through a 
vesicle bilayer membrane, as determined by molecular dynamics (Figure 1.1),156 the 
first being the presence of a water defect in the hydrophobic region of the membrane, 
causing the rearrangement of the polar headgroups of the amphiphile, (Figure 1.15 a) 
this allows the leakage of ions through the pore. A second hypothesis, (Figure 1.15 b) is 
caused by the permeation of ions to the interfacial region of the membrane, which is 
then carried across the hydrophobic region by a “water finger”.156 Which of these 
mechanisms facilitates this ion transport is determined by the length of the 
hydrocarbon chain and the ionic strength of the solute.157 As well as natural diffusion, 
most biological transport is driven by proteins, ion channels and ionophores. Weak 
acids can be incorporated into a basic interior vesicle by making use of pH gradients.63 
Ion channels are generally driven by catalysed reactions, i.e. energy supplied by 















Figure 1.15: Transmembrane transport of ions is believed to be via one of two routes the first a) being 
penetration of water discrete water molecules into the hydrophobic region of the bilayer (i), this forces the 
rearrangement of the polar headgroups rearrange to shield the hydrophobic tails from water causing the 
formation of a pore (ii) when ions (yellow) can travel through.  Alternative hypothesis  b) (i) is that ions 
(yellow) accumulate at the interfacial region of the bilayer (ii) water then penetrates the membrane 
creating a “water finger” to carry the ions across the hydrophobic region of the membrane. 
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It is believed that ion channels in MTB are driven by the latter.52, 53b The use of 
membrane permeable ionophores, is one biomimetic approach to the creation of a 
nanoreactor. These molecules work by chelation of the ion to be transported to the 
ionophore, which then can move through a membrane to deliver the ion into a vesicle. 
This has been explored by Chakrabati et al158, by the addition of a divalent specific ion 
channel to a vesicle system. Their study has shown how biological components can be 
incorporated into synthetic vesicles to mimic the ion transport processes observed in 
nature. This was proven by the loading both Fe2+ and Ba2+ into preformed liposomes 
via liposomal incorporation of Ca2+ ionophore A23187.158  
This ionophore has been further explored for Fe2+ transport in chapter 5. Incorporation 
of these membrane proteins into a membrane depends on the headgroup chemistry, 
bilayer thickness, surface tension, curvature and stabilisation by the surrounding 
lipids.153 The activity of ion channels, such as those used in magnetotactic bacteria, can 
be monitored using a tethered bilayer,64 by measurement of changes in concentration, 
pH or ion conductance,153 on either side of the membrane. However, this is not as 
trivial in the case of vesicles, where the core solution is extremely difficult to measure. 
Vesicle membrane transport can be monitored by electric potential and pH gradients as 
measured by lipophilic fluorescent ion probes.63, 124 
Entirely synthetic membrane transport can be achieved by electroporation. This is a 
widely used technique in molecular biology for the introduction of DNA into a host 
cell.159 The application of an electric potential across a cell membrane can lead to its 
temporary poration by the increasing electric field inducing a transmembrane 
potential differnce, which eventually causes local defects that form pores.160  
Electroporation has been previously applied to synthetic di-block polymer vesicles for 
the introduction of biological moeities, and is believed to undergo similar poration to 
that observed in natural lipid cell membranes.161 The mechanism of electroporation is 
largely unknown; mainly due to the short time scale of pore formation, the complexity 
in probing the membrane, and the numbers of parameters involved. Studies of changes 
in phospholipid head group configuration using phosphate-nuclear magnetic 
reasonance spectroscopy (P-NMR) and observed changes in the vesicles structure 
following electroporation has suggested possible mechanisms include headgroup 
rearrangment.162 
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 Molecular dynamics has offered multiple hypotheses, similar to those discussed above, 
regarding electroporation mechanisms,160a, 163 however to date it has not been possible 
to prove which hypothesis applies experimentally.  
These studies have led to two distinct theories on what is believed to happen when an 
electric potential is applied to a membrane. As with natural ion leakage across a 
membrane, both mechanisms propose that, as a result of the generated pores, 
distortions in the membrane result in water penatration through a spontaeously 
formed hydrophobic pore.160b The lipids then rearrange to form a stable more long-
lived hydrophilic pore, which grows in size and is stabilised by a drop in potential.160b 
This causes a decrease in the conductance. The pore formation is reversible and pores 
reseal over time, with the pore size, stability/lifetime depending on the surrounding 
pressure, the field strength and pulse time, as well as the membrane material.160b 
The difference between the two mechanisms is how the distortions occur in the 
membrane. The most widely accepted hypothesis is the transient aqueous pore 
formation mechanism, were by the electric field causes local distortion and the 
rearrangment of the lipids due to conduction by the polar head groups.160 However, 
this has been questioned, as the same effect is observed in the absence of polar head 
groups. Thus an alternative hypothesis; the water wire mechanism, has been 
suggested, in which the water/membrane interface aligns and undulates with the 
current resulting in disortion, allowing water to pentatrate.160 There are multiple 
parameters which can affect the outcome of electroporation most notably the voltage 
applied across the membrane, but the outcome can also be affected by factors including 
path length of the cuvette, sample volume, temperature, pulse length and number of 
pulses.164  
 
1.7.2 AIMS AND OBJECTIVES 
 
Magnetotactic bacteria (MTB) produce single domain magnetic nanoparticles (MNPs) 
of a monodisperse size and shape within lipid vesicle structures termed 
magnetosomes. 
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 The creation of a synthetic magnetosome inspired by the mechanisms observed within 
MTB can address the problems involved in producing bacterial magnetosomes in 
sufficient quantity and adapting them for use in in vivo biomedical applications. The 
idea of a synthetic magnetosome has been previously suggested by Mann et al.4, 121a, 125 
This thesis builds on their work4, 121a in order to mimic a filled magnetosome at the 
nanoscale.  
Reversing Mann’s system, by encapsulating base in the core of nanoscale vesicles, 
followed by transport of iron ions, is unique to this project. Furthermore, purification 
and incorporation of magnetosome specific proteins believed to be responsible for the 
controlled formation of both the internal vesicle and subsequent precipitation of the 
particle in MTB is also unique. This creates a synthetic model of a magnetosome which 
can then be altered and functionalised depending on application.  
Synthetic magnetosomes produced as part of this project have been trialled in vitro for 
their potential as both contrast agents for magnetic resonance imaging (MRI) and 
therapeutics in magnetic hyperthermia treatment (MHT) of tumours (Figure 1.16). 
Each aspect of the synthetic magnetosome will require exploration an optimisation of 
the materials and synthesis routes before it can be brought together to create the final 
magnetosome. Table 1.2 outlines the plans for creating the synthetic magnetosome 
nanoreactor, and the chapter in which this is undertaken. 
 
Figure 1.16: a) Inspiration is taken from Magnetotactic bacteria (species shown is M. magneticum AMB-1), 
which biomineralises chains of magnetite within magnetosome vesicles. b) The aim of this thesis is to copy 
this process synthetically by (i) creating a synthetic vesicle with a basic core (ii) followed by transport of 
iron ions to yield (iii) the precipitation of a single magnetite nanoparticle. c) This synthetic magnetosome 
can then be used for the study of MTB biomineralisation proteins and incorporation of biomedical moieties 
for nanomedical application.  
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Aspect of synthetic magnetosome 
creation to be optimised 
Chapter in which optimised 
Magnetite synthesis route Chapter 3 
Vesicle composition Chapter 4 
Biological transporters Chapter 5 
Synthetic iron transport Chapter 6 
Scale up of synthetic magnetosome 
production 
Chapter 7 
Control of particle formation Chapter 8 
Biomedical potential of artificial 
magnetosomes 
Chapter 9 










CHAPTER 2:  
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All solutions used in all methods were degassed and sparged with N2 prior to use and 
all experiments were carried out under an inert atmosphere where possible. This was 
to prevent oxidation of the iron species used to ensure the precipitation of magnetite as 
opposed to other iron oxides. Lipids used were purchased from Avanti Polar Lipids Inc., 
and polymers used were purchased from Polymer Source. Other chemicals were 
purchased from Sigma Aldrich, unless otherwise stated. 
 
2.1  MAGNETITE SYNTHESIS 
 
There are many synthetic routes for the precipitation of magnetite, (as discussed in 
section 1.3.3) with each method resulting in different nanoparticle sizes and 
morphologies. Altering any one of a number of parameters within a specific synthesis 
route can result in unwanted contaminants, such as precipitation of undesirable iron 
oxide mineral phases, i.e. those other than magnetite (Section 1.3.2, Figure 1.3). 
 
2.1.1 ROOM TEMPERATURE CO-PRECIPITATION (RTCP) 
 
Room temperature co-precipitation20f is the precipitation of magnetite, in this instance 
from iron chloride salt sources. FeCl2∙4H2O (10 or 100 mM, 10 ml) and FeCl3∙6H2O (10 
or 100 mM, 10 ml) are combined respectively in a 1:2 ratio. This reflects the 
stoichiometry of the final magnetite crystal structure. The reaction uses NaOH (10/100 
mM, 10ml) to slowly increase the pH of the overall solution and initiate precipitation. 
The alkali is added drop-wise via a syringe driver (Harvard Instruments) at a rate of 20 
µl min-1 under N2 bubbling to ensure homogenous mixing of reagents. This rate of 
addition ensures slow formation of the correct intermediates, facilitating the desired 
stoichiometry for the precipitation of magnetite. The resulting black precipitate tends 
to contain relatively small magnetic nanoparticles (after ageing) which are 
subsequently washed by separation with a magnet and re-suspension in water, five 
times to remove any non-magnetic oxides from the final product. 
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2.1.2 THERMAL DECOMPOSITION OF UREA CO-PRECIPITATION 
 
FeCl2∙4H2O (10 mM, 10 ml) and FeCl3∙6H2O (10 mM, 10 ml) are combined in a 1:2 ratio. 
CO(NH2)2 (10 mM, 10 ml) is added to the mixed valence Fe solution, before being 
heated to 85°C and held at this temperature for four hours under N2. This allows for 
decomposition of CO(NH2)2 into NH3. The NH3 acts as the base to drive the co- 
precipitation of the iron salts, resulting in the formation of a black magnetic solid. The 
resulting solid was washed using separation with a magnet and re-suspension in water 
five times.20b 
 
2.1.3 UREA AND AMMONIA CO-PRECIPITATION 
 
The method of combined urea/ammonia co-precipitation was adapted from the 
previously published method by Mürbe et al.165 10 mM iron stock solutions of FeCl2 and 
FeCl3 are combined at a ratio 1:2 ferrous to ferric iron salt respectively (10 mM FeSO4 
can also be used as a ferrous iron source). A combination of chloride and sulphate iron 
salt were also used (2(FeCl3):1(FeSO4) 10 mM). The iron salt at a volume of 8 ml is 
added to a urea/ammonia mix solution with urea: ammonia ratio varying from 0-100 
% urea. The solution was then heated on a hotplate to 80°C and held at this 
temperature for four hours, under N2. The precipitated solid was washed as described 
above, using magnetic separation and re-suspension in water five times. 
 
2.2 VESICLE SYNTHESIS 
 
Various methods used to synthesise vesicles using both phospholipids and block co-
polymers are detailed below. The methods for magnetite precipitation outlined in 
section 2.1 were incorporated as closely as possible into each vesicle synthesis route. 
Once vesicles were formed using the methods outlined below, size exclusion 
chromatography was used to remove the supernatant to prevent magnetite 
precipitation external to the vesicles (Section 2.2.4).  
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FeCl2∙4H2O (10 mM, 10 ml) and FeCl3∙6H2O (10 mM, 10 ml) were combined in a 1:2 
ratio and added to the vesicle solution before being electroporated (5 × 2500 V). 
Centrifugation removed excess precipitate, and tip sonication, water bath sonication 
and extrusion (Section 2.2.3.3) were employed to control vesicle size. 
 
2.2.1 LIPOSOME FORMATION  
 
 BASIC FORMATION 2.2.1.1
 
Phospholipids (0.5 – 1 mg) are dissolved in 1 ml of chloroform and methanol (in a 1:1 
ratio). The solvent is then removed under vacuum to form a thin lipid film. The 
resulting film is rehydrated with the basic solution to be encapsulated, corresponding 
to the desired magnetite synthesis route e.g. NaOH, CO(NH2)2 or NH3 (Section 2.1).75 
The size distribution of the resulting liposomes is controlled by either bath sonication 
(Ultrasonic cleaner, VWR) for 30 minutes following film rehydration, tip sonication 
(Vibracell, Sonics) at 70 % amplitude for 15 minutes or, for a narrower size 
distribution, extrusion by 15 passes through a 100 nm membrane (Section 2.2.3.3). 
 
2.2.2 POLYMERSOME FORMATION  
 
 DI-BLOCK POLYMERSOMES 2.2.2.1
 
Encapsulation within polymersomes is essentially an extension of the film hydration 
method used in liposome synthesis (Section 2.2.1). An A-b-B amphiphilic block-
copolymer film (1-10 mg ml-1) is swelled overnight in a vacuum desiccator/oven 
(40°C). This is then rehydrated with 1 ml base whilst stirring for 12-16 hours, before 
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 TRI-BLOCK POLYMERSOMES 2.2.2.2
 
Poly (2-methyloxzoline)-b-poly(dimethylsiloxane)-b- poly(2-methyloxzoline) (PMOXA-
PDMS-PMOXA) was dissolved in 1 ml of CHCl3 in a round bottom flask. NaOH (10 mM) 
was added to the polymer/solvent at a rate of 50 µl min-1 to give a final concentration 
of 1 mg ml-1. The resulting mixture was then centrifuged (10 minutes at 9,800 g, Progen 
Genfuge, 24D microcentrifuge ) to remove any residual solvent (bottom layer) from the 
polymersome solution (top layer). This method was adapted by myself and Matthew 
Berry (MChem student) from the published method by Nardin et al.9b 
 
2.2.3 VESICLE SIZE AND POLYDISPERSITY CONTROL METHODS 
 
Vesicle size dispersity was controlled using a number of techniques. Each method, 
applied to the formation of both liposomes and polymersomes, narrowed the 
polydispersity of the overall vesicle population. 
 
 BATH SONICATION 2.2.3.1
 
The application of sonic energy to a lipid or polymer solution agitates the solution, 
causing any vesicles formed to collapse and re-assemble. This also encourages the self-
assembly of free lipids and instigates the simultaneous formation of small vesicle sizes 
with a narrower size distribution. Vesicle samples are subjected to bath sonication for 
30 minutes at the standard frequency of the bath (Ultrasonic cleaner, VWR (45 kHz). 
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  TIP SONICATION 2.2.3.2
 
Tip sonication is expected to exert greater control over the size distribution of the 
vesicles than bath sonication. This is due to the higher frequencies and more localised 
sonication that can be applied to the sample. Thus the effects of tip sonication on a 
vesicle sample have also been investigated. Samples are heated to above their phase 
transition temperature if necessary (Table 4.1). Sonication (Vibracell, Sonics) is applied 
to the sample in a glass vial for between 15-30 minutes at amplitude of 75 % using a 
narrow sonication tip (3 mm). Tip sonication applies sonic energy to a sample. This in 
turn breaks down vesicles in the solution, but with more precision than with bath 
sonication. This is due to greater control of the energy supplied to the sample by 




Perhaps exerting the tightest control over vesicle polydispersity, extrusion is the 
process of forcing vesicles through a membrane of a known pore size. This causes 
larger vesicles to break up and re-assemble into smaller ones. The size at which they 
reassemble is dictated by the pore size of the membrane used. The extrusion kit is 
assembled according to Figure 2.1 a). All filters and the membrane are soaked in the 
same buffer as the vesicle solution and placed in the centre of the extruder. Using gas 
tight syringes, the vesicle solution is passed from one syringe to the other through a 
100 nm pore membrane 15 times, as shown in Figure 2.1 b). These conditions have 
previously been optimised by the Battaglia group (Unpublished method) to obtain 
monodisperse vesicles of < 100 nm. In some cases samples were first passed through a 
400 nm membrane to initially decrease their size to avoid rupturing or obstructing the 



















Figure 2.1: Extrusion is the process of passing vesicle solution through a membrane containing pores of a 
known size to achieve a narrows size distribution. a) Shows the assembly of the extrusion kit, in which the 
extrusion membrane is placed between two filter papers held in place by two O-rings to prevent solution 
leakage. These are screwed into place by an outer metal casing. Syringes are inserted into each end of the 
extruder and the solution is passed from one to the other through the membrane. b) On passing through 
the membrane the lipid or polymer polydisperse vesicles are forced to reassemble into a monodisperse 
population of a size determined by the membrane pore sizes. 
 
 
2.2.4 VESICLE CLEAN UP 
 
To remove excess base following vesicle formation, vesicles are passed through a size 
exclusion chromatography (SEC) column.166 The presence of external base solution can 
cause precipitation of mixed oxides on addition of the ferrous/ferric ion solution. With 
some of the base solutions (NaOH) this precipitation is instantaneous; inhibiting iron 
transport and creating undesired complex mixtures of MNP both inside and outside of 
vesicles. To prevent this, all vesicle solutions were separated on an SEC column to 
isolate vesicles and exchange the outer solution for buffer or water. SEC columns are 
filled with sepharose beads of a designated size and porosity.  
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SEC is based on size separation (Figure 2.3). As NaOH in solution is much smaller than 
the vesicles, the base molecules take a longer path through the column. This is because 
Na+ and OH- can enter more spaces between the sepharose beads, and even the pores 
within the beads. This means that bigger assemblies (i.e. the vesicles) move through 
the column much faster. This separates them from the NaOH solution outside the 
vesicles, and exchanges the vesicles into the column equilibration buffer. Vesicle 
solutions are cleaned using GE Healthcare PD10 columns, or self-packed sepharose 4B 
in a 20 cm3 column. In each case, the column is filled with PBS buffer; the polymer 
solution is then added to the column and allowed to enter the sepharose. This is then 
topped up with PBS buffer to push the sample through the column. The eluent from the 
column is collected once the solution becomes cloudy; indicating the presence of 
vesicles. The pH of the collection solution confirms that vesicles are exchanged into 
neutral pH buffer. Smaller samples of vesicles (approximately 1 ml) were cleaned up 
using dialysis. For dialysis, the sample is encased in snakeskin dialysis tubing 
(molecular weight cut off 3,500 Dalton) and placed into 2 L of PBS for 12-16 hours to 













Figure 2.2: Size exclusion chromatography (SEC): SEC is used to clean up vesicles by addition of the vesicle 
solution to a sepharose column, which then moves down the column by way of gravity. The column separates 
suspensions by size, as bigger molecules/assemblies take a shorter path, limited by the ability to fit into the gaps 
between the sepharose beads (Red path). Smaller molecules, i.e. the eluent, can diffusively enter more of the 
spaces between beads, and so takes longer to leave the column (Blue path). 
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2.2 IRON TRANSPORT METHODS 
 
2.2.5 ELECTROHYDRODYNAMIC ATOMISATION VESICLE SYNTHESIS 
 
Technology used by the Edirisinghe group based at UCL113b, 114 has been utilised as part 
of this project. This has been used to both automate and optimise the synthesis of both 
liposome and polymersomes for the production of monodisperse vesicles as vessels for 
the production of a synthetic magnetosome. The equipment uses a capillary tube of 
specific size determined by the required size of the droplets produced. A potential 
difference (of the order kV) is applied between the capillary and ground electrode 
(Figure 2.3). The applied voltage is used to control the meniscus shape on exit from the 
capillary, (Table 7.1) for the formation of what is known as a “Taylor cone”.115 This 
creates a high charge density giving rise to the formation of nano-sized droplets as 
small as 30 nm in diameter. For the formation of base encapsulated vesicles, lipid 
solution and base are loaded into separate syringes that are fed into separate ports of a 














Figure 2.3: Electrohydrodynamic atomisation (EHDA) synthesis of vesicles: Shows a schematic of the 
single axial EHDA a) encapsulation of NaOH within lipid via EHDA jetting b) shows the composition of the 
resulting vesicles, c) vesicles are introduced to mixed valence iron solution and electroporated at 750 V, to 
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The solutions then combine in the capillary, at which point self-assembly into vesicles 
should begin. As the solutions leave the capillary, a voltage is applied (15-20 kV) and 
the solution is broken down into monodisperse droplets which assemble into vesicles. 
The vesicles are collected in water and mixed valence iron solution (Fe2+ 1:2 Fe3+, 10 
mM, 1 ml) is introduced to the vesicle solution and electroporated (Section 2.3.2.1) at 
750 V to aid iron transport into the core of the vesicle. 
 
2.3 IRON TRANSPORT 
 
Magnetite precipitation in the core of the vesicle is only possible if there is iron 
transport through the vesicle membrane. Four routes of iron transport have been 
explored to obtain an artificial magnetosome, starting with biological based 
transporters then moving to completely synthetic methods of cross-membrane 
transport. 
 
2.3.1 BIOLOGICAL TRANSPORTERS 
 
Biological transporters are incorporated into vesicles during vesicle formation (Section 
2.2). During polymer/lipid film rehydration, the biological transporter protein is added 
to the stirring solution at a concentration of 0.1 µg ml-1. The vesicles are then cleaned 
up using SEC (Section 2.4.2). After clean up, mixed valence iron salt (1 (FeCl2):2 (FeCl3) 
solution is added to the vesicles. The protein transporters should allow iron transport 
through the vesicle membrane. After incubation for 12-16 hours vesicles are again 
cleaned up via SEC (Section 2.4.2) to remove excess iron, before analysis. The success 
of the transporter was assessed using TEM (Section 2.6.1.1) and elemental analysis 
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2.3.2 A23187 DIVALENT IONOPHORE 
 
A23187,167 an ionophore, chelates divalent iron and transports this by subsequently 
passing across a membrane. Polymersomes (1 ml, 10 mg ml-1) with NaOH (10 mM) 
encapsulated and previously cleaned up via SEC (Section 2.4.2) were added to FeCl2 (5 
ml, 10 mM) which contained the A23187 ionophore, (1 µl, 1.90×10-6 M). The alkali 
containing polymersomes are incubated in the iron/ionophore for five days to facilitate 
cross-membrane transport of iron. The success of the transporter was assessed using 
TEM (section 2.6.1.1) and elemental analysis (2.6.2.4) to see if iron oxide was able to 




Electroporation is a technique widely used in biology for the transformation of DNA 
into cells. Electroporation electrically permeablises a cell membrane by application of a 
pre-determined voltage.159-160, 161 The mechanism by which the membrane is 
permeated has been widely explored, but as yet has not been confirmed (Section 1.6.3). 
Electroporation is used as a method of synthetic iron transport across the vesicle 
membrane by increasing membrane permeability. Vesicles absent of both protein 
transporters and/or ionophore were subjected to electroporation. Following clean up 
as above in section 2.2.3, iron solution (Fe2+ 1:2 Fe3+, 10 or 100 mM) is added to the 
vesicle solution in a ratio of 1:1 vesicle:iron solution. The combined solutions are then 
transferred to an electroporation cuvette, which has electrode plates on either side, 
and chilled for approximately five minutes on ice. The solution filled cuvette is then 
placed into the electroporator, ensuring that the cuvette plates make contact with the 
electrodes. A voltage is then applied to the sample (200 – 2500 V, manually varied to 
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2.3.4 IN-SITU INCORPORATION 
 
Fe2SO4∙H2O (16.6 mM) and Fe2(SO4)3∙H2O (15.6 mM) are combined in a volume of 10 ml 
of degassed water in a round bottomed flask. 1 ml of purified PEG113-
PHPMA400/PMPC28-PHPMA400 polymersomes (approximately 10 mg/ml) is added to 
the iron solution. This solution is then sealed and sparged with N2. A total volume of 4 
ml of NaOH (10 mM) is added dropwise, at a rate of 20 µl min-1 by syringe driver 
(Harvard Instruments). On addition of NaOH, a room temperature precipitation of 
magnetite occurs in the presence of the polymersomes. Once complete, the particles 
are removed from the solution by magnetic separation. The magneto-polymersome 
solution was heated to 80 °C for 0.5-1 hour, at which point it flocculated and the white 
opaque top layer of the solution was removed by pipette. 
 
2.4 IRON ION TRANSPORTS ASSAYS 
 
To quantify iron transport, membrane permeability, and therefore the success of the 
various methods reported (Section 2.3); several indicators of pH, redox potential, as 
well as fluorescence and iron chelators have been encapsulated in vesicles. All 
solutions are cleaned up using SEC (Section 2.4.2) following encapsulation of the 
relevant indicator. UV-vis (Section 2.6.2.1) or fluorescence (Section 2.6.2.2) spectra are 
recorded before membrane disruption or iron transport to generate a background 
spectrum. Vesicles are electroporated (Section 2.3.2.1) to permeate the membrane, and 
spectra are re-recorded. The specific method used with each indicator explored is 




Carboxyfluorescein168 is a fluorescent dye which self-quenches at high concentration, 
(≥100 mM). Upon leakage (via permeation or electroporation) the dye is diluted and 
the fluorescence signal should increase. Vesicles are rehydrated with 
carboxyfluorescein (100 mM) at a 10 % v/v carboxyfluorescein:lipid/polymer ratio 
and stirred for 12-16 hours.  
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Vesicles are then cleaned up by SEC (Section 2.4.2) and fluorescence measurements are 
taken using both a fluorimeter (Section 2.6.2.2) and using fluorescence microscopy 
(Section 2.6.1.5). Leakage from the vesicles is monitored using fluorimetry. 





Ferene is an iron chelator which undergoes a colour change from yellow to blue on 
chelation of Fe2+.169 FeCl2∙4H2O solution is prepared at various concentrations (100 
mM, 50 mM, 25 mM and 10 mM). 5 ml aliquots were combined with Ferene (10 µl at 15 
µM) and UV-vis spectra are recorded. 1 ml of the ferrous chelated Ferene (10 mM) is 
added to 3ml of NaOH (10 mM) and H2O separately, and incorporated into 
polymersomes. This is used to test compatibility with NaOH, chelation affinity and 
detection of the solution in the vesicle core. 
 
2.4.3 PRUSSIAN BLUE 
 
A 0.1 mM solution (prepared by serial dilution) of Prussian Blue (potassium 
ferrocyanide (K4[Fe(CN)6]∙3H2O) is prepared. 10 µl of the 0.1 mM K4[Fe(CN)6]∙3H2O is 
then added to FeCl2∙4H2O solution prepared at a range of concentrations appropriate to 
prepare a standard curve from the UV-vis spectrum, the UV-vis spectrum at each 
concentration is then recorded to obtain a standard curve. 1 ml of K4[Fe(CN)6]∙3H2O 
(10 mM) is added to NaOH (10 mM) during polymersome formation. This is again to 
detect compatibility with NaOH, chelation affinity and visibility of the solution in the 
vesicle core Vesicles are then cleaned up via SEC (Section 2.4.2) and recording of the 
UV-vis spectrum is repeated.170 
 





















































































































































































































































































































































































































































































































































































































































































































Resazurin is a redox sensing dye which changes colour from pink to clear upon 
oxidation.171 Solutions of H₃COONa (0.2 M) and CH₃COOH (0.2 M) are used to obtain 
pHs between 3.8 and 6.8, the solutions were prepared at pH intervals of 0.2. The pH 
was then measured using a Mettler Toledo PHE1204 pH meter. Resazurin solution (10 
mM) is prepared. 10 µL of Resazurin is added to 10 ml of each pH solution, and the UV-
vis spectra are recorded. For incorporation into vesicles, 1 ml of Resazurin solution (10 
mM) is also added to FeCl2∙4H2O (10 mM), which is then used to rehydrate a polymer 
film. The resulting polymersomes were cleaned up using SEC (Section 2.4.2) and UV-vis 
spectra are recorded. 
 
2.5 CONTROL OF PARTICLE FORMATION 
 
Polymer films are rehydrated according to the method described in Section 2.2.2.1, 
with 10 mM NaOH to a concentration of 10 mg ml-1. During rehydration, the relevant 
biological transporter (protein or scaffold) is added to the rehydration solution at a 
concentration of 10 µg ml-1. This is then left to stir for 12-16 hours. The vesicles are 
then exchanged into PBS buffer using SEC (Section 2.2.4), and electroporated according 
to the method described in section 2.3.2.1 to facilitate iron transport. The resulting 
biomineralisation reaction is analysed using TEM (Section 2.6.1.1) and elemental 
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2.6 PROTEIN CLONING AND PURIFICATION METHODS 
 
2.6.1 GENE CLONING 
 
 POLYMERASE CHAIN REACTION (PCR) 2.6.1.1
 
A Polymerase chain reaction (PCR) is used to efficiently select and exponentially 
replicate a chosen nucleotide sequence from template DNA (Figure 2.5).172 During this 
process DNA is heated, which causes its denaturation and the formation of 2 single 
strands of DNA. To carry out the replication, the DNA template (0.5 µl, 50 ng µl-1) is 
combined with DNA polymerase (1 µg µl-1 ,1µl) and a supply of deoxynucleotide 
triphophates (dNTP’s) along with pre-designed forwards and reverse primers (1 µl, 10 
µm). These primers attach to the DNA template on different strands at the beginning 
and end of the sequence to be amplified, and importantly at a temperature below the 
melting temperature of the primer sequences. The temperature of the reaction is 
increased to the optimum for the activity of the polymerase (70-72°C). The polymerase 
then extends the primers for a specific amount of time determined by the number of 








Figure 2.5: Polymerase Chain Reaction: To amplify a specific sequence of DNA, the DNA product is first 
denatured by heating. Pre-designed primers then attach to the DNA strands and read along the strand, 
replicating the sequence by sequential addition of dNTPs. This process is repeated multiple times with the 
accuracy of the replicate strand increasing with each round. 
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During this time the polymerase (1 µl) attaches to the template DNA and reads along 
the sequence. The polymerase constructs a complimentary copy from dNTP building 
blocks during a second heating step to duplicate the template DNA. These steps are 
repeated during the extension period to exponentially amplify the required gene, with 
the precision of the replication improving in each round due to the position at which 
the primers reattach (Figure 2.5). Accuracy can then be further increased by running 
the final product through a PCR clean-up kit. 
 
 RESTRICTION DIGEST 2.6.1.2
 
The gene required for cloning is “cut out” of the PCR DNA product (Section 2.6.1.1) 
using restriction enzymes to isolate the specific sequence which codes for the eventual 
protein target (Figure 2.6).173 The PCR product (approx. 10 µl) is added to an enzyme 
compatible buffer (Table 2.1) and adjusted to the correct concentration by dilution 
with sterile water. The appropriate restriction enzyme (1 µl), dependent on the 
restriction sites designed into the gene sequence, is added to the reaction mixture and 









Figure 2.6: DNA Digestion a) The required DNA sequence is isolated using digestion enzymes which 
recognise the beginning and end codon in the required gene b) During incubation with the enzymes, the 
desired sequence is cut out of the DNA product. Ligation: c) This section of DNA is then ligated into a 
circular DNA vector by covalently “zipping up” the ends of the DNA fragment with the vector. d) This forms 
a circular piece of DNA which is now suitable for cloning.  
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During this incubation period, the enzymes digest; or cut the PCR DNA at specific 
recognition sites. These sites are generally at the beginning and end of the DNA 
sequence required for cloning, and are incorporated in the primer sequences used in 
the PCR. During this time the polymerase (1 µl) attaches to the template DNA and reads 
along the sequence. The polymerase constructs a complimentary copy from dNTP 
building blocks during a second heating step to duplicate the template DNA. The 
reaction is then cleaned up via a PCR clean up kit or gel extraction (Section 2.5.1.6) to 
improve the purity of the digested sequence for ligation. 
 
 DNA LIGATION 2.6.1.3
 
The insert; or gene sequence required for cloning,173 isolated during the restriction 
digest process, (Section 2.6.1.2) is now ligated; or covalently linked into linearised 
plasmid DNA (pPR-IBA1). The insert (approximately 10 ng) and the corresponding 
vector (pPR-IBA1, 50 ng) are combined along with “instant sticky end ligase” (New 
England Biolabs) (5 µl 400 units per µl). The mixture is subsequently incubated at 
ambient temperature for 5-10 minutes. During this time the overhang sequences on 
the vector are “zipped up” via covalent linkage to the complimentary overhang 
sequence designed into the insert DNA (Figure 2.6). This creates a complete circular 
DNA plasmid suitable for cloning. 
 
 VECTOR TRANSFORMATION (XL10 GOLD) 2.6.1.4
 
DNA ligated into the appropriate vector to form circular DNA is subsequently 
introduced into XL10 Gold E. Coli cells (Agilent).173 Ligated plasmid DNA (5 µl) is added 
to 100 µl of cells on ice. These are then heat shocked at 42°C for 30 seconds, which 
causes the formation of pores in the cell membrane allowing for uptake of the DNA 
vector by the cells for amplification.  
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 After further chilling on ice for 5 minutes, the cells are combined with 300 µl of LB 
growth media and agitated at 37°C for approximately 1 hour to allow the cells to 
recover from the heat-shock. After this time, the cells are deposited on to an LB Agar 
plate containing the antibiotic carbenicillin (100 µg ml-1). The addition of the antibiotic 
ensures that only cells containing the pPR-IBA1 DNA are able to grow on the plates due 
to the presence of an ampicillin resistance gene. Plates are incubated at 37°C for up to 
16 hours to allow colonies of cells to form. 
 
 COLONY PCR 2.6.1.5
 
Individual cell colonies can be picked and amplified via a PCR reaction to confirm the 
presence of the inserted vector, and more importantly the gene of interest. In this case, 
specific individual colonies are picked and re-suspended in 100 µl of water. PCR 
reactions are prepared according to the method outlined in section 2.4.1.1, but with the 
addition of 1 µl of the colony solution in place of the genomic DNA. The resulting PCR 
products are analysed using gel electrophoresis (see section 2.6.4.1) to determine if the 
target gene has been successfully incorporated into the plasmid. The remaining colony 
suspension is added to LB and carbenicillin for culturing at 37oC with shaking before 
extraction of the plasmid via mini prep kit (Qiagen). 
 
 DNA SEQUENCING 2.6.1.6
 
In DNA products which appear to be of the expected size (kDa) in gel electrophoresis 
analysis (Section 2.6.4.1) the plasmid is extracted from E. Coli by with a mini prep kit 
(Qiagen). The extract is sequenced by Beckman Genomics. A 15 µl sample of the 








Table 2.1: Components of protein cloning and expression recipes, buffers were made to pH 7.4, and 




Method Buffer/Solution Component Volume 
General Use 
Phosphate buffered 
Saline (1L) (PBS) 
Sodium Chloride 80g 







Distilled water Make up to 1L 
Cell grow up LB Media 
Yeast extract 5 g 
Sodium Chloride 10 g 
Plate grow up 
LB Agar 
Yeast extract 5 g 
Sodium Chloride 10 g 
Agar 15 g 




10 x blocking buffer 
(Sigma) 
4 ml 
PBS Tween 16 ml 
Total Volume 20 ml 
Dot and 
Western blots 
Towbin transfer buffer 
Tris buffer 1.5g 
Glycine 7.2g 
Methanol 100 ml 
MilliQ Water 500 ml 
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2.6.1 PROTEIN PREPARATION 
 
 VECTOR TRANSFORMATION (BL21) 2.6.1.1
 
As outlined in section 2.4.1.4, a DNA vector (1 µl) is transformed into E. Coli BL21 
(DE3) RP (Stratagene) cells (100 µl) using heat-shock (42 °C for 30 seconds).173 LB 
growth media (300 µl) is added to the transformed cells and incubated at 37°C for one 
hour to allow the cells to recover. Recovered cells are spread on to an LB agar plate 
containing the antibiotics, carbenicillin (100 µg ml-1) and chloramphenicol (35 µg ml-1), 
and incubated at 37°C for about 16 hours to allow colonies of cells to form. 
 
 EXPRESSIONS TRIALS 2.6.1.2
 
To ensure maximum efficiency in protein production, a number of auto-induction 
growth media were trialled to determine the optimum expression conditions for a 
maximum yield for each protein under analysis. For the expression trial, four media of 
increasing nutrient content (LB, 2YT (2 x), TB (4 x), and SB (8 x) in 400 ml volumes are 
inoculated with a starter culture (containing the appropriate antibiotics) of the colony 
of interest and incubated at 37 °C. Expression occurs spontaneously at a specific cell 
density. Protein expression levels are checked at three time points (24, 40 and 48 
hours). At harvested time points, the protein cell pellets are re-suspended in lysis 
buffer (Table 2.2, 500 µl of culture is lysed in 125 µl lysis buffer). The lysate is then 
analysed using a dot blot to assess protein expression levels (Section 2.6.4.3). 
 
 CELL CULTURING 2.6.1.3
 
Transformed BL21 (DE3) RP cells are grown up over a period of 4-6 hours in 5 ml of LB 
supplemented with carbenicillin and chloramphenicol as before. After this time, an 
aliquot is taken (1 ml) and added to 400 ml of the appropriate media containing both 
Carbenicillin (100 µg ml-1) and Chloronphenecol (35 µg ml-1); (Section 2.2.5.2).  
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Cultures are grown under the optimised conditions (time and temperature) using auto-





The 400 ml cultures are harvested by centrifugation (3000 rpm for 20 minutes in a 
Megafuge 40R (Thermo Scientific) using a swinging bucket rotor (75003607) to pellet 
cells. The pellet is re-suspended in 3 ml of PBS (0.1 M phosphate) and tip sonicated (70 
% amplitude, 6 x 20 second sonication (Vibracell Sonicator, Sonics) to lyse cells; and 
the solution is centrifuged again (12,000 rpm for 45 minutes) to pellet cell debris. The 
soluble protein in the supernatant can then be isolated by affinity chromatography. 
This works by passing the solution through a column containing a resin which will bind 
protein depending on its fusion tag; Streptactin resin (IBA) for a strep tag and Nickel 
resin (Expedeon) for a His tag. The bound protein is then eluted using the appropriate 
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Method Component Volume 




4 x stacking buffer^ 
 
1.25 ml 
Acrylamide (30 % w/v)* 0.7 ml 
10 % Ammonium Persulphate (APS) 
 
25 µl 
Tetramethylethylenediamine(TEMED) 20 µl 
SDS-Page Resolving Gel 
Deionised water 3.4 ml 
Acrylamide (30 % w/v)* 4 ml 
4 x Conc Resolving Gel Buffer^ 2.5 ml 
10 % APS 60 µl 
TEMED 12 µl 
Milli Q (autoclaved) 33.5 µl 
  
PCR reaction 
10 x KOD Buffer (Merck) 5 µl 
MgSO4 (25 mM) 3 µl 
Template DNA (50 ng µl-1)** 0.5 µl 
Forward Primer (10 µmµl-1) 1 µl 
Reverse Primer (10 µm µl-1) 1 µl 





















Table 2.2: Buffers and solution in biology protocols *Acrylamide composition is equal to 
37.5:1Acrylamide to bis-acrylamide** Typical concentration #Used as per manufacturer’s 









KOD Hot Start Polymerase (1 µg µl-1) 1 µl 
Restriction digest 
10 x Enzyme Reaction Buffer (NEB) 5 µl 
Restriction Enzyme (NEB) 1 µl 
Sterile Water 
Make up to 20 
µl 
Vector Ligation 
Vector (50 ng µl-1)** 2.5 µl 
DNA Insert (50 ng µl-1)** 2.5 µl 
Instant Ligase# (NEB) 5 µl 
Colony PCR 
GoTaq green DNA polymerase# 
(Promega) 
10 µl 
Cell suspension 1 µl 
Forwards primer (10 µmµl-1) 1 µl 
Reverse primer (10 µm µl-1) 1  µl 
MillQ water 7  µl 
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2.7 CHARACTERISATION AND INSTRUMENTATION 
 
2.7.1 VESICLE CHARACTERISATION 
 
 TRANSMISSION ELECTRON MICROSCOPY (ROOM TEMPERATURE) 2.7.1.1
 
This section is based on the textbook Transmission electron microscopy: a textbook 
for materials science. Williams, (1996)
177 
Transmission electron microscopy (TEM) was used to visually assess iron oxide, 
protein and vesicle samples; high resolution (as low as 0.2 nm) state allows for 
visualisation of objects in the nanoscale size range (Figure 2.7). The higher resolution 
achieved by using electron microscopy is the result of using an electron beam at 100-
200 keV. This provides wavelengths able to observe and image samples that are 
smaller than the diffraction limit of light. This beam is generated from an electron gun 
at the top of the microscope column, with the electron source usually being in the form 
of either a tungsten filament or a lanthanum hexaboride (LaB6) crystal. Condenser 
lenses, which consist of magnetic coils, are used to concentrate and focus the beam 
onto the sample. A high level of detail is resolved by the interactions of the electrons as 
they are transmitted through the specimen, interacting with electrons in the sample, 
hence offering information about the internal structure. Imaging is carried out under 
very high vacuum. This removes the propensity for the beam to interact with anything 
other than the sample. The ion getter pump (IGP) further improves the vacuum by 
ionisation of the gas in the vessel and application of an electric potential. This causes 
acceleration of ions into an electrode which are then consequently immobilised, 
thereby creating a very high vacuum.177 Both continuous film and holey carbon coated 
TEM grids (Agar Scientific) were used to visualise samples. The sample (5 μl) is applied 
to a grid and left to stand for approximately 1 minute, after which time the excess 
liquid is blotted off. Grids are then dried, either slowly at ambient temperature or by 
vacuum. Samples assumed not to contain dense iron minerals are also stained prior to 
TEM imaging. This is a common procedure in electron microscopy for many samples; 
particularly biological specimens.  
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This is because low electron density elements (e.g. hydrogen, carbon, and oxygen) have 
poor contrast in the electron beam as they are less able to interact with the transmitted 
electron beam. The stain is made up of a heavy metal salt. The electrons in the heavy 
metal interact and deflect the beam to a much greater extent than the sample. Hence 
the stain provides a better contrast between the stained sample and the background. 
The sample is added to a grid as described above. This is then followed by the heavy 
metal stain (2 % uranyl acetate or 0.75 % uranyl formate), which is blotted off after a 
12 second staining period. The instruments used included a Phillips CM200 and CM100 
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 CRYOGENIC TRANSMISSION ELECTRON MICROSCOPY 2.7.1.2
 
Greater detail and accuracy with regards to vesicle structure can be achieved by 
cryogenically freezing the sample before electron microscopic analysis. Freezing the 
sample conserves its structure which is often lost when dried on to a conventional TEM 
grid. For a vesicle, this is analogous to popping a balloon or deflating a beach ball, and 
then attempting to analyse it structure. Samples are prepared for cryo TEM by freezing 
in liquid ethane. Essential to cryo TEM is the absence of cubic water ice, for this reason 
instrumentation involved in grid preparation must be kept under liquid N2, cooled and 
dried before introducing the grid.177 
Cubic ice can absorb the electron beam leaving the grid obsolete as the beam can no 
longer penetrate the sample. Liquid ethane is used for sample freezing due to it having 
a higher boiling point at -188°C when compared to -195°C of liquid nitrogen. Liquid 
ethane is cold enough to freeze the aqueous solution on the grid without the formation 
of cubic ice and without being so cold that it will boil upon the introduction of the grid; 
as in the case of liquid nitrogen. Samples are prepared for cryo EM using a Vitrobot 
(Series 2 and 3). The sample is loaded on to a holey carbon grid (~5 µl), unlike 
conventional TEM there is no need for dilution. The Vitrobot automatically blots the 
sample (3-6 seconds at blot force 3) to remove excess sample and achieve an optimum 
thickness of ice for imaging. The grid is then plunged into the liquid ethane and stored 
under liquid nitrogen until use. Grids are loaded into the microscope (in this case a 
Phillips CM200 or a Tecnai F20) and imaged in low dose mode, to avoid damaging the 
solvent ice. In addition to this, there are three separate modes which must be used to 
obtain the final image: 1) search mode is used at low magnification to move around the 
grid and identify areas of interest. The microscope is then switched into 2) focus mode, 
these are two areas on either side of the region of interest, each area is adjusted to 
absolute focus, which in turn should bring in to focus the area to be imaged, an element 
of defocus is then applied ( ~ -1 µm) to enhance contrast. Finally the microscope is 
switched to 3) exposure mode and the image is taken, this can be taken only once as 
the effect of exposing an area essentially melts it. 
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 DYNAMIC LIGHT SCATTERING 2.7.1.3
 
Dynamic light scattering (DLS) was utilised to explore vesicle size distribution and 
aggregation properties.178 DLS is the measurement of fluctuations observed in light 
scattered from a vesicle or particle sample. These fluctuations are related to diffusion 
within the sample, and used to calculate particle size, the intensity of light scattered is 
measured with respect to time.178 Due to Brownian motion occurring within the 
sample, there is constructive and destructive interference which has an effect on the 
light intensity and scattering over time; called the translational diffusion coefficient (D) 
(Equation 2.1). This takes into account solution viscosity (η), Boltzmann’s constant at 
absolute temperature (kT), and the hydrodynamic diameter (DH) of the particle; which 
assumes that all of the particles are solid spheres:178 
 
 
𝐷 =  
𝑘𝑇
3𝜋𝜂𝐷𝐻
     (2.1) 
 
 
Smaller particles diffuse faster through the solution causing more fluctuations than 
bigger particles that have slower diffusion. The technique works by way of a polarised 
beam which is scattered by density and concentration fluctuations in the sample. A 
detector picks up speckling caused by scattered light interfering with the sample. The 
time dependence of this scattering at a specified angle is used to form an 
autocorrelation function, which describes the spot intensity over time. For 
monodisperse samples, this comes from the exponential decay arising from the 
diffusion within the sample. This in turn is related to the hydrodynamic diameter of the 
particle. If a sample is polydispersed, the correlation function is based upon a 
distribution of decay rates, due to the variation in particle motion in the sample. 
 
For vesicle samples, a dilution of 400 µl in 1 ml was analysed in a disposable DLS 
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Samples were scanned three times at a standard temperature of 25°C, with each scan 
having 10-14 runs, the sample is scanned using the refractive index and viscosity 
settings for a sample of liposomes in water, as these most closely match the sample 
properties. Data is analysed using Malvern Zetasizer software, and replotted using 
GraphPad Prism. It is also possible to estimate the polydispersity index (PdI) (Equation 
2.2) of the sample which relates to the standard deviation (σ) of a Gaussian distribution 
applied to the data (ZD2). 
 
𝑃𝑑𝐼 =  
𝜎2
𝑍𝐷
2                  (2.2) 
 
 
 GEL PERMEATION CHROMATOGRAPHY 2.7.1.4
 
To determine polymer concentration following dilution during clean up, gel 
permeation chromatography (GPC) is employed. GPC separates compounds in a 
solution by size An aqueous column is used to analyse the polymer molecular weight, 
size and concentration. The system is first pumped with PBS buffer; which also acts as 
a baseline for polymer samples. Samples of polymer (1ml) at known concentrations, in 
PBS buffer are then injected into the column. A constant supply of fresh buffer is 
pumped along the column. As the polymer sample moves along the column it interacts 
with porous beads in the column akin to SEC (section 2.2.4), the samples retention time 
in the column is dependent on its size and molecular weight, as bigger/heavier particle 
move down the column faster resulting in a shorter retention time. For this reason 
different polymer sizes and weights have different retention times. A detector analyses 
the solution leaving the column, giving rise to a chromatogram, displaying the species 
present at a given retention time. In the case of the polymer, two peaks were observed 
(one peak representing each polymer block). The peak areas can be integrated give an 
approximate polymer concentration, therefore each peak is integrated to create a 
standard curve for polymer concentration (from samples with a known concentration). 
Polymer samples of unknown concentration are then injected, and the peak area is 
again integrated. These values are then extrapolated against the standard curve to 
estimate polymer concentration. 
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 FLUORESCENCE MICROSCOPY 2.7.1.5
 
Vesicles with the addition of fluorescently tagged lipids are analysed using a 
fluorescence microscope.179 Excitation of electrons in the fluorescently tagged lipids by 
radiation of light at a specific wavelength causes emission of light by the fluorophore 
upon electron relaxation. Vesicles are labelled with the fluorescent lipophilic dye 
Bodipy (Life technologies, λem 503 nm λex 512 nm). This allows for initial analysis on the 
formation of vesicles, and measurement of the approximate size (to a resolution of 
approximately 500 nm).  
 
2.7.2 SPECTROGRAPHIC TECHNIQUES 
 
 UV-VISIBLE SPECTROSCOPY 2.7.2.1
 
An electrons transition from the highest occupied molecular orbital (HOMO) to the 
lowest unoccupied molecular orbital (LUMO) can have an energy which corresponds to 
the UV/visible region of the electromagnetic spectrum (200-900 nm) depending on the 
orbital structure of the molecule. This HOMO/LUMO transition occurs when light 
energy (ΔE) is absorbed by the molecule. A broad absorption is observed due to a range 
of ΔE values, which correspond to the multiple vibration and rotation states within the 
molecule.179 The expected absorbance of a material is given by the Beer-Lambert law 
(Equation 2.8). This relates the absorbance of a molecule (A) to either the relationship 
between the incident light (I0) and transmitted light (I), or its molar extinction 
coefficient (ε), given by the molecules attenuation of light at a specific wavelength, the 





=  𝜀𝑐𝑙    (2.3) 
 
A sample is exposed to a light source of known wavelength in a spectroscope (Cary 
50 probe).  
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Before hitting the sample, wavelengths in the light are then separated by either a 
monochromator, which uses diffraction grating for the separation, or splitting with a 
prism. The absorbance by the sample is the detected. Standard curves of each sample 
analysed by UV-Vis spectroscopy are first compiled by serial dilution of a sample of 
known concentration. Spectra of samples are then recorded at a concentration below 
the saturation concentration, as determined by calibration. The UV-Vis spectra of 
relevant vesicle samples were collected using a Lambda 35 (Perkin Elmer) or a 50 
probe (Cary) UV-Vis Spectrometer. Samples concentrations were optimised by serial 
dilution of the initial vesicle concentration (generally unknown), 1 ml of sample at the 
appropriate dilution were measured in disposable UV-Vis cuvettes with a path length 
of 0.45 cm.  Spectra were run between 200 and 900 nm initially for detection of an 
absorbance peak and analysis of the overall sample. Secondary measurements were 
then taken to obtain spectra of the specific absorbance of the UV active material 
present, which were as follows; Ferene λ = 593 nm, Prussian blue with ferrous iron λ = 
740 nm and ferric iron λ =492 nm, Resazurin at pH 2 λ = 530 nm and at pH 10 λ = 610 




A fluorimeter can offer quantitative analysis on the fluorescence emitted from a 
sample. Two electron beams pass through two monochromators, one each for 
excitation and emission.179 The signal then hits a detector and is outputted graphically. 
Fluorimetry was used to confirm encapsulation of a fluorescent dye within a vesicle, 
which subsequently confirmed the presence of the vesicles following clean up via SEC 
(Section 2.2.4) to remove background fluorescence. A LS55 Fluorescence 
spectrometer (Perkin Elmer MA, USA) for the detection of fluorescently labelled 
vesicles. A maximum sample volume of 1 ml was added to a disposable fluorimetry 
cuvette. Spectra were collected for both excitation and emission of the fluorescent 
dye carboxyfluorescein appropriate scanning wavelengths were chosen to ensure that 
λem of 492 nm and λex  of 517 nm were collected. Samples were diluted 10 fold (for a 
1 mg/m vesicle sample) to avoid saturation.  
 
P a g e  | 82 
 
 
 ENERGY DISPERSIVE X-RAY SPECTROSCOPY 2.7.2.3
 
Energy Dispersive X-ray (EDX) elemental analysis is carried out on vesicle samples 
which appear to have a dark crystalline encapsulant during TEM imaging, in order to 
determine the elemental composition of the vesicle contents. In EDX, the incident 
electron beam focussed on the sample ejects electrons from the core of the elements 
encountered. A higher energy electron fills this vacancy, emitting an X-ray of a 
characteristic wavelength to allow it to fill this lower energy level. Therefore, the 
energy of the emitted X-ray can be used to identify the element it came from. Every 
element has unique X-ray emission pattern, the intensities of which are detected by a 
spectrometer. Plotting the spectrum allows peaks to be identified that correlate to the 
element(s) that emitted the X-rays. Fitting of the peaks in the spectrum includes a 
correction factor based on the intensity of the X-ray from that element. In general, 
heavier elements are easier to detect. Thus, fitting of the spectrum allows the user to 
quantitatively confirm the relative elemental composition of the specimen.180 EDX 
analysis is performed on the whole samples (i.e. the vesicle containing nanoparticles) 
in addition to individual particles within the vesicle. The spectra are recorded using a 
UWT Oxford Instruments EDXS detector and processed using the ISIS software during 
TEM analysis (Section 2.6.1.1) by focusing of the beam on to a sample after insertion of 
an X-ray emission detector mounted on to the side of the microscope. 
 
 INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY 2.7.2.4
 
Inductively coupled plasma mass spectrometry, (ICP-MS) is used to determine iron 
concentrations in magneto-vesicle samples. ICP uses ionisation of samples followed by 
mass spectrometry to detect the presence of specific elements down to a concentration 
of part per billion (PPB).179 The sample is nebulised into an argon gas phase to form 
electrically conductive plasma, by heating with an electromagnetic coil. Heating the 
plasma causes the formation of positive ions; by loss of an electron. The plasma is then 
introduced to a mass spectrometer and ions are separated based in their mass/charge 
ratio by acceleration in an electric or magnetic field. The mass/charge ratio causes a 
certain amount of deflection in the spectrometer, and it is this deflection that is 
detected. 
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 A quadrupole mass spectrometer scans the mass ranges present in the sample, and 
only allows samples with a specific mass/charge ratio to hit the detector. The detected 
intensity is then compared to a standard curve for that element, to determine the 
concentration of a specific element in the sample. ICP samples are prepared for 
detection of the iron concentration, by dissolving a known volume of magneto-vesicle 
sample into nitric acid (concentrated) to a total volume of 5 ml (4 parts water to 1 part 
acid). This was done to dissolve magneto-vesicles so that any iron ions present are in 
solution. Samples were analysed using a Specto-Ciros-Vision Inductively Coupled 
Plasma Optical Emission Spectrometer, in which the iron content was detected by 
measurement at optical emission lines (usually at least 2 per element) this is then 
compared to a previously measured calibration standards of known concentrations 
which the instrument uses to calculate a calibration graph for each line and 
subsequently displays the calculated element concentration in the sample.  
 
 RAMAN SPECTROSCOPY  2.7.2.5
 
Raman spectroscopy analyses the vibrational and rotational modes of a molecule 
which causes inelastic scattering and can be detected spectroscopically to determine 
the identity of a molecule, by analysis of its chemical fingerprint. Raman 
spectroscopy ware carried out on artificial magnetosome samples to identify a 
chemical fingerprint for both magnetite and the surround bilayer. Raman spectra 
were obtained with a confocal-Raman spectrometer (Jobin Yvon LABRAM) 
equipped with a Nd-YAG laser (100 mW, 532.2 nm) and diffraction gratings of 1800 
grooves mm
−1
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2.7.3 MAGNETIC MEASUREMENTS 
 
 SUPER QUANTUM INTERFERENCE CONDUCTION DEVICE (SQUID) SAMPLE 2.7.3.1
PREPARATION 
 
A SQUID is an extremely sensitive magnetometer, able to detect magnetisation 
between 1 x 10-17 and 5 Tesla. A SQUID measures the voltage from a sample when it is 
placed in a magnetic field.  
 
At a critical electric current, a voltage will be given out; this voltage is affected by the 
applied magnetic field. The SQUID consists of two superconductors separated by an 
insulator, which form a Josephson junction. When this is exposed a magnetic field, 
current flows through the superconductor loop. Any change in the magnetic field 
induced by the sample has a direct effect on the current and the overall flux in the coil. 
This change in flux is then translated into magnetisation of the sample.181 Hysteresis 
loops of the magneto-vesicle samples are recorded by applying and reversing a field 
between 1000 and -1000 Oe at 300 K to create an M/H curve (Section 1.3.1, Figure 1.2). 
These measurements were performed by either Miss Wala Dizayee (Department of 
Physics) or Dr Paul Southern (UCL Healthcare Biomagnetics Laboratory). Samples are 
prepared for analysis by drying a known volume or weight of solution into a small 
eppendorf under vacuum. Data are analysed by first plotting the paramagnetic 
contribution from the eppendorf. The paramagnetic signal is then subtracted from the 
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2.7.4 PROTEIN CHARACTERISATION 
 
 GEL ELECTROPHORESIS 2.7.4.1
 
The success of gene cloning can be assessed by gel electrophoresis.182 Running the 
purified DNA through gel separates the DNA by size. A 1 % agarose gel is made up by 
dissolving 0.5 g of agarose into 50 ml of TAE conducting buffer (Table 2.2). The 
dissolved gel is poured into a mould and 3 µl of SYBRsafe™ (Life Technologies) is added 
to the molten gel. SYBRsafe™ is an aromatic compound which interacts with the DNA 
product via π-π stacking, known as intercalation, which then makes the DNA visible 
under UV light.183 For this reason, the dye can be incorporated into the agarose gel, but 
is only visible after intercalation with DNA. The negative charges on the phosphate 
backbone of the DNA; due to the structure of the nucleotide building blocks (Figure 
2.8) are the basis of DNA gel electrophoresis.182 These negative charges cause the DNA 
products to move towards the positive electrode once a potential difference is applied.  
The distance the DNA migrates is dependent on its size; the larger the DNA product the 
less distance it will travel towards the positive electrode compared to a smaller DNA 
molecule. Each DNA sample is combined with loading dye (Mass Ruler) to a total 
volume of 6 µl (5 parts DNA to 1 part dye), a voltage of 200 V is applied and the sample 
is electrophoresed for 20 minutes. Once separated, the gel is visualised under UV Light 
and compared to a DNA ladder with bands of a known size (kDa) (Mass Ruler, Life 
Technologies). 
 
 SODIUM DODECYL SULPHATE-POLY-ACRYLAMIDE GEL ELECTROPHORESIS 2.7.4.2
(SDS-PAGE) 
 
Gels were prepared according to the recipes in table 2.2, with the resolving gel below 
the stacking gel and a comb to provide appropriately sized gels. The re-suspended cell 
pellet and/or the purified protein is combined with sodium dodecyl sulphate (SDS) 
loading dye in a 1:1 ratio (20 µl total volume) which is heated to 95°C.  
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This denatures the protein into a linear peptide chain so that movement through the 
gel is dependent on molecular weight alone. The protein is also coated in SDS 
detergent, which provides an SO42- charge. This negative charge allows the protein to 
travel through the poly-acrylamide gel matrix in response to an applied electric field. 5 
µl of the protein/loading dye solution is loaded into the gel along with a molecular 
weight ladder (Page Ruler, Life Technologies); the gel is then electrophoresed at 200 V 
for 40 minutes (Figure 2.8). The gel consists of a stacking gel on top of a resolving gel 
(Table 2.2). These gels are at different pH depending on whether the glycine is 
protonated or not. The stacking gel maintains the denatured protein as a tight band. 
This band then enters the resolving gel and each protein migrates depending on its 
molecular, with smaller molecular weight species travelling further (Figure 2.8). The 
proteins can be visualised by addition of Coomassie blue staining or subsequent 




Specific proteins analysed by SDS-PAGE can be visualised using a technique termed 
Western blotting.182 This involves electrophoretically transferring the protein contents 
of a gel to a nitrocellulose membrane. The membrane is then incubated with a protein 
which blocks nonspecific binding of antibodies to the membrane surface. The protein 
of interest is detected by incubation with a primary antibody which can bind 
specifically to the target protein (usually the antibody is for an affinity tag, such as the 
His tag or strepII tag used in this study). The antibody is also conjugated to a 
Horseradish peroxidase enzyme (HRP) which can break down hydrogen peroxide and 





















Figure 2.8: Gel Electrophoresis ai) DNA gels are run using the DNA product as a whole mixed with mass 
ruler loading dye to visualise the DNA bands. The PO3- on the backbone of the DNA drags the DNA through 
a 1 % agarose gel towards the positive electrode. ii) The products in the DNA separate by size as they 
move toward the positive electrode; with bigger products travelling slower and so producing bands higher 
up the gel. b) SDS-PAGE protein gels work in similar way, i) proteins are first denatured with SDS to 
produce long chain peptide so that proteins are compared by molecular weight alone. The SDS also coats 
the peptide with charge in the form of SO42- ions. ii) This charge then forces the peptide to move towards 
the positive electrode during the electrophoresis. iii) An SDS-PAGE gel is made of a stacking gel and a 
resolving gel. The protein first moves through the stacking gel as a tightly stacked band, a pH change in the 
resolving gel then separates bands by size in the same way as DNA gel electrophoresis (aii). 
 
The HRP oxidises the luminol, which emits light at 425 nm in this excited state. As the 
HRP is affixed to the antibody, which is attached to the protein of interest on the 
nitrocellulose membrane, the chemo-luminescence is localised to only those areas that 
contain the protein of interest. The gel, nitrocellulose membrane, and filter papers are 
soaked in transfer buffer (Table 2.2) for 5 minutes and then assembled into a stack 
before loading into a Transblot Turbo (Bio-rad). Semi-dry electroblotting for 30 
minutes transfers the protein bands from the gel onto the nitrocellulose membrane. 
The membrane is then blocked for one hour using 45 ml of PBST (Table 2.1) and 5 ml 
of 10 x concentrated blocking buffer (Sigma) to prevent nonspecific antibody binding.  
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The primary antibody (Strep-Mab classic HRP) is added at a ratio of 1:4000 and left to 
bind to StrepII tag containing protein sites for one hour. The membrane is then washed 
three times for ten minutes with PBST. Finally, a detection reagent (Clarity Western 
ECL, Bio-rad) is added to the membrane which was visualised using the Bio-rad Chemi-
doc. Dot blotting of expression trial time points are prepared using the same method, 
however protein samples are dotted directly on the nitrocellulose membrane before 
the blocking of non-specific binding sites. 
 
  CIRCULAR DICHROISM 2.7.4.4
 
Circular dichroism (CD) was used to analyse the secondary structure of protein 
samples to ensure successful protein folding upon purification. CD measures the 
difference between left and right circularly polarised light. In the case of optically 
active protein samples (due to the presence of chiral centres in the protein structure), 
the secondary structure can be analysed, as the presence of α-helices and β-sheets have 
distinctive CD spectrum traces. Purified protein samples were diluted with ultrapure 
water to give a concentration of 0.1 mg/mL based on the A at 280 nm. A Jasco J810 CD 
instrument was used to acquire spectra using a 2-mm path-length cuvette. Wavelength 
scans of 260 nm to 190 nm were collected using a 1-nm slit width and 1-s intervals. 
Each sample was analysed three times, and data were averaged before subtracting a 
blank water spectrum. For thermal stability, the A at 222 nm (a marker of helical 
content) was monitored as the temperature of the sample was ramped from 20–85 °C. 
Data analysis was performed using DichroWeb (20).5 
 
 
2.7.5 MAGNETIC HYPERTHERMIA MEASUREMENTS 
 
Magnetic nanoparticles can induce a temperature increase in an alternating magnetic 
field (Section 1.2.2). Magneto-vesicle samples were tested for their ability to induce 
similar effects. Samples are tested on a Magnetherm (Nanotherics). The heating ability 
of samples in a predefined alternating field was tested.  
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The magnetherm consists of a coil (with 9 or 17 turns) around which a specified 
current flows to generate a magnetic field. This coil is connected to a recirculating 
water bath set at 10 °C to prevent non-specific heating from the coil. The sample is 
placed in the centre of the coil to experience an even magnetic field, and a temperature 
probe is then placed into the sample (T-type thermocouple). Once the temperature of 
the sample has equilibrated, the voltage is turned up to the maximum resonant peak-
to-peak voltage for the coil/capacitor combination being used.  
This generates a magnetic field (of strength H) alternating at a specific frequency. The 
voltage must first be tuned to resonance for the coil/capacitor combination to prevent 
excess heating. Once the current is flowing and the sample is exposed to the alternating 
magnetic field, the temperature is recorded every one second over a 30 minute period. 
Control samples of the sample buffer solution are also measured over a 30 minute 
period. The control sample measurements are then subtracted from magneto-vesicle 
sample to obtain the heating from the vesicles alone. Data is plotted of the change in 
temperature over time, and an intrinsic loss parameter (ILP) (Equation 2.4) for the 
sample is extracted. The ILP is calculated from the specific absorption rate (SAR) 
(Equation 2.5) of the sample at a specific magnetic field (H2) and frequency (f), after 
normalisation, so the ILP value is independent of sample vessel, magnetic field and 
alternating frequency. The specific absorption rate of the system measures the initial 
heating of the sample (ΔT/Δt) with respect to the specific heat capacity of the material 
(c) and its concentration (MFe). 
 
𝐼𝐿𝑃 =  
𝑆𝐴𝑅
𝐻2𝑓
     (2.4) 
 





















CHAPTER 3:  
 
3 MAGNETITE FORMATION AND 













In order to use a vesicle as a nanoreactor as outlined in section 1, the reaction that the 
vesicle encapsulates must first be optimised. For this system, the intended purpose is 
the incorporation of a magnetite precipitation reaction into the core of the vesicle. The 
vesicle itself must of course be optimised; in terms of both size and chemical 
composition, before consideration of the vesicle optimisation, an appropriate 
magnetite precipitation route must be chosen and optimised. 
Many published routes for magnetite precipitation were disregarded due to the nature 
of methodology (see section 1.3.3). For example, if the method requires harsh chemical 
solvents20g or high temperatures20f, 20g such conditions could degrade the nanoreactor 
vesicles, either before or during mineralisation. Also, extremely tight control over the 
reaction conditions is required for the precipitation reaction to yield magnetite rather 
than other iron oxide or oxyhydroxide species. This is particularly crucial in the case of 
room temperature reaction routes, in which small changes in reaction condition can 
alter the product(s) formed. These changes can include altering the iron salt used, or 
variations in the strength of the alkali, and the rate of addition of the base used (Section 
1.2, figure 1.5). However, perhaps the most difficult to control is the potential for 
oxidation from external sources, which could significantly shift the redox potential of 
the system away from the formation of magnetite. A change in any one of these 
parameters could divert the course of the reaction away from the intended route to the 
precipitation of magnetite. These deviations, particularly in pH or Eh, would result in 
changes in the iron oxide formed. For this reason, all solutions used have been 
deoxygenated, and reactions were carried out under an inert atmosphere wherever 
possible. Three synthesis routes to magnetite precipitation were explored, as outlined 
below. These synthesis routes were chosen from a range of published methods20b, 20d-f 
based on their suitability for eventual incorporation into a vesicle nanoreactor for in 
situ magnetite precipitation reactions. Three routes were selected for vesicular 
incorporation (Section 3.2) due to their expected suitability for integration into a lipid 
or polymer vesicle. 
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It is important to be able to monitor and quantify intra and inter-vesicle activity, 
particularly with respect to mimicking iron transport across the vesicle membrane. In 
an attempt to extract more information from the process of magnetite precipitation, 
and the consequent iron ion cross-membrane transport, a number of assays were 
designed and tested on the bulk magnetite syntheses described in this chapter. These 
have later been adapted to assay the efficiency of iron transport across vesicle 
membranes. The success of the assays both as a general method and their effectiveness 
in the core of a vesicle are also outlined (Section 3.3). The three most appropriate 
routes to magnetite synthesis identified in the literature were explored for their 
effectiveness in producing good quality MNPs of a narrow polydispersity and the 
ability of the synthesis route to translate to a liposome or polymersome nanoreactor 
platform. The results were analysed with the pretext of being able to carry out the 
reaction in the core of a vesicle. 
 
3.2 ROUTES TO MAGNETITE FORMATION 
 
The general mechanism for the formation of magnetite is the combination of ferric and 
ferrous ions at the stoichiometric ratio for the formation of magnetite; namely 2 Fe3+: 1 
Fe2+. The pH of this solution is then raised by the addition of NaOH or thermal 
decomposition to create a hydroxyl ion source. This leads to the formation of iron oxy-
hydroxide intermediates.3, 20f A further increase of the pH by slow addition of the OH- 
ion source, or as the result of oxidation, results in precipitation of magnetite 
nanoparticles with a water by-product (Equation 3.1).20f 
 
Fe2+ +  2Fe3+ +  8OH− → Fe3O4 +  4H2O     (3.1) 
 
The mechanism by which the magnetite forms is by conversion of ferric iron salts into 
magnetite (and other iron oxides) by the introduction of hydroxyl ions (or oxidation). 
This in turn raises the reaction pH causing the precipitation of magnetite (or other iron 
oxides) (Figure 3.1).  
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There is a balance between the levels of ferric ions and the increasing pH, which is 
demonstrated in figure 3.1 a). The mass/balance diagram shows how the species in a 
magnetite reaction can be predicted as the reaction progresses. For example in the 
absence of ferric iron and at a OH/Fe ratio of 2 the reaction would contain 100 % 
ferrous hydroxide. As the ferric ion concentration in the reaction then begins to 
increase, the percentage of ferrous hydroxide present drops as it is converted, until 
100 % green rust (Fe6(OH)12SO4, XH2O) is obtained of a ratio 0.33 ferric to total iron in 


















Figure 3.1: a) Shows the relationship- between magnetite and its iron oxide species (FexOy) as formed at 
varying ferric to total iron ratios, with the increased addition of the hydroxyl ion source. b) A pH profile 
shows the relationship between magnetite formation and pH as a function of total iron: OH- (R). The point at 
which these intermediates are formed can be controlled as demonstrated in c) by variation of the ferric : 
total iron ratio (x).10 Figure adapted from unpublished data collected by J. Bramble. 
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Figure 3.1 a) shows that magnetite forms at an iron ratio of 0.66 ferric iron and an 
OH/Fe ratio of approximately 2.6:1. If either of these parameters then changes, i.e. the 
addition of excess hydroxyl and ferric iron (until the ratio is 1) magnetite is further 
converted to the entirely ferric iron oxide Goethite.10 
There are multiple routes that this reaction can take depending on the type of reaction 
and the iron salts used (Section 1.3.3). More generally the magnetite formation 
pathway first goes via formation of green rust intermediates, which form at a 1:1 ratio 
of OH/Fe (R). The pH profile then plateaus, (Figure 3.1 b) indicating that additional OH- 
can be added and these intermediates remain stable until a critical point (R ~ 2) at 
which point the green rusts are converted to magnetite.  
The formation of both the intermediate(s) and the eventual magnetite crystal can occur 
earlier by fine adjustment of the ferric to total iron ratio (Figure 3.1 c). The 
intermediates can form at a lower OH- to iron ratio. This means that they are essentially 
forming at a slightly lower pH when the amount of ferric iron to total iron is decreased. 
For example, figure 3.1 c) shows that at a ratio of 0.2 ferric iron to 0.8 total iron in 
solution, the green coloured magnetite precursor/intermediate is made at a much 
lower concentration of OH- compared to a ratio of 0.5 ferric iron to 0.5 total iron, due to 
the higher acidity of Fe3+. These slight changes can have a huge impact on the final 
species formed. While this makes conversion between iron oxides easy, this easy 
interconversion also results in mixed heterogeneous assemblies forming, when a single 
species (magnetite) is required. This interchange is the reason all magnetite 
precipitation must be performed under an inert atmosphere, with slow hydroxyl 
addition, as uncontrolled oxidation can result in the precipitation of mixed iron 
oxides.10 The optimum ratio of ferric and ferrous iron has been determined by previous 
group members,62 who used a 2:1 ratio of ferrous to ferric iron respectively, to account 
for uncontrolled oxidation during the reaction. This excess ferrous ratio was suitable 
for magnetite formation when using just chloride salts, and when using a combination 
of iron sulphate and chloride. Despite this, it was decided that the best ratio to use for 
intra-vesicular precipitation would be to use the stoichiometric ratio of ferrous to 
ferric iron for magnetite formation. It is unlikely that the same level of oxidation would 
be experienced upon precipitation within a vesicle, as the interior of the vesicle itself is 
a controlled environment.  
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Therefore; it would be more beneficial to begin with the stoichiometric ratio of iron for 
magnetite formation, thus increasing the probability of eventually forming magnetite 
within a vesicle nanoreactor. 
 
3.2.1 THERMAL DECOMPOSITION OF UREA 
 
Magnetite precipitation was carried out using the thermal decomposition of urea as the 
alkali source (method in section 2.1.2). Figure 3.2 shows a representative TEM image of 
the nanoparticles formed via this route. The TEM image shows that the particles have 
an aspect ratio of about 1, and the particles are euhedral (i.e. have sharp, well defined 
edges), and appear hexagonal in shape in these transmission images. The grainsize 
analysis (Figure 3.1 b) shows the particles have an average size of 83 nm ± 6 nm, which 
is a very uniform size distribution. A uniform size distribution is desirable because this 
should mean that the particles also have a uniform magnetic behaviour (see section 


















Figure 3.2: a) TEM micrograph of magnetite nanoparticles synthesised by thermal decomposition of urea b) 
Particle grainsizing from TEM micrographs confirmed that the method produced the biggest nanoparticles, 
with Gaussian distribution analysis giving an average particle size of 65 ± 11.17 nm with respect to the 
spherical particles only. 
b) 
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Co-precipitation using urea maintains a neutral pH until the decomposition of 
CO(NH2)2 to NH3 (Equation 3.2) at temperatures greater than 85°C. This release of 
ammonia to solution induces a pH rise (pH 2 up to 6 or 7) as aqueous ammonium 
hydroxide is formed. As a result minimal by-product oxidation occurs.  
 
 
(NH2 )2 CO →  NH3 +  HCNO  (3.2) 
 
 
Particles of this size are within the size range of ferrimagnetic nanoparticles as 
opposed to superparamagnetic for the room temperature co-precipitation route (see 
section 1.1.1 for theory on magnetism of MNPs). The experiments which utilised 
precipitation with urea (Figure 3.2 a) show higher purity with respect to particles size 
and morphology when compared to other magnetite precipitation reactions. This is 
likely to be because of the greater control over oxidation when using these 
precipitants, which consequently provides improved magnetite crystallisation. 
These ferrimagnetic particles are within the single domain size range, and they closely 
resemble the particles synthesised within magnetosomes of MTB. The main 
disadvantage of this method is that heating to 90°C for four hours is required. This 
limits the composition of the vesicle in which the reaction could be incorporated, due 
to most vesicle forming lipids and polymers being unlikely to be able to withstand 
these extreme temperature conditions. Therefore, whilst this method will be tested for 
incorporation into vesicles (Chapter4), it is likely that the disadvantages of using the 
method will outweigh the superior quality of the particles it produces. 
 
3.2.2 COMBINED UREA/AMMONIA DECOMPOSITION 
 
A second method of magnetite formation was explored with the intention of decreasing 
the heating period needed for magnetite precipitation. It was hoped that introduction 
of ammonia into the reaction may decrease the volume of urea needed to decompose to 
initiate magnetite precipitation. This should lead to the reaction reaching completion 
earlier (i.e. with less heating necessary as less decomposition of urea is needed).  
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In turn, this should make the method more appropriate for incorporation into a vesicle 
interior. This method was adapted from Jeong et al.,20e as they find that improved 
particles are as the result of tight pH control. To explore the effect of the addition of 
ammonia on particle formation, with the intention of creating superior particles using 
shorter heating times, the ratio of urea to ammonia was varied starting from 100 % v/v 
urea; needing four hours heating for thermal decomposition, up to 100 % ammonia 
which is closer in mechanism to a room temperature co-precipitation (i.e. no heating 
should be required). Multiple iron salts were tested using ferric and ferrous iron 
chloride (10 mM) and iron sulphate (10 mM) and a combination of both. The reaction 
volume (8 ml), heating temperature (80-100°C) and the iron to hydroxide ratio (2:1) 
were kept constant. Some of the precipitates showed signs of magnetism on separation 
with a magnet; this did not follow a particular trend. Furthermore all samples appeared 
much browner in colour than those produced by other methods, the brown colour of 
the majority of the samples produced suggests that the reaction was lacking ferrous 
ion, instead forming ferric oxyhydroxide FeO(OH). This is likely to be due to oxidation 
of the ferrous ion present in the sample, either due to oxidation by undesired influx of 
air, or fast addition of the high pH ammonia solution, based on the visual quality of the 
sample following clean-up, no further measurements were carried out. In conclusion it 
was determined that to incorporate this into a vesicle would be an over-complication 
of an already successful method (Section 3.2.1), and so was not taken forward for 
testing as a compartmentalised vesicle reaction.  
 
3.2.3 ROOM TEMPERATURE CO-PRECIPITATION OF MAGNETITE 
 
Magnetic nanoparticles were synthesised using room temperature co-precipitation 
from ferrous and ferric iron ions (in a 1:2 ratio respectively) as described in section 
2.1.1, using slow addition of NaOH via syringe driver (20 µl min-1) as shown by 
equation 3.3.  
 
 
Fe2+ +  2Fe3+ +  8OH−  → 2βFeOOH + Fe2+ + 2H2O + 2OH
−  → Fe3O4 + 4H2O   (3.3) 
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The resulting precipitate was washed 3-5 times before imaging using TEM. The TEM 
micrographs show relatively monodisperse nanoparticles of an average size of 10 ± 2 
nm (Figure 3.3) Particle morphology was extremely consistent, with the particles 
appearing pseudo-spherical. It is envisioned that the incorporation of this method 
within a vesicle will result in rapid nucleation of magnetite as iron ions cross the 
vesicle membrane. This could have both advantages and disadvantages. For example, 
faster nucleation may result in higher quality crystals without allowing time for a) 
oxidation or b) unwanted intermediates. Rapid nucleation may also lead to the 
formation of many small magnetite nanoparticles within the vesicle, rather than a 
magnetosome-mimetic single MNP. Conversely this fast nucleation may also have huge 
disadvantages, in that successful precipitation of magnetite would depend on the 
kinetics of the diffusion across the membrane, i.e. whether a high enough concentration 
of iron ions are able to cross the membrane fast enough for all the desired precipitation 














Figure 3.3: a) TEM micrographs of room temperature co-precipitated nanoparticles with 10 mM NaOH 
shows particles relatively spherical in shape, this is observed across the entire sample b) with the 
relatively monodisperse in size and shape. c) Particle grainsizing from TEM micrographs confirmed that 
particles had low polydispersity with Gaussian distribution analysis giving an average particle size of 
10.1 ± 2.8 nm. 
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The reaction was repeated at three different NaOH concentrations to determine the 
optimum concentration for the encapsulated nanoreactor precipitation reaction. Each 
sample was prepared from a single batch of ferrous and ferric iron chloride salt 
solution at the stoichiometric ratio for magnetite formation. NaOH was added at a rate 
of 50 µl min-1 in which the only variable was increasing NaOH concentration. It was 
found, that as the concentration was increased from 1 mM to 5 mM, 10 mM and finally 
50 mM a visible colour change from brown to black in the reaction solution was 
observed. After magnetic separation and washing with MilliQ water 3-5 times, each 
nanoparticle sample was analysed using TEM. The particulate samples with the lowest 
base concentration appeared dark orange to brown in colour indicative of the 
formation ferric-oxy-hydroxide. It is likely that the pH was not raised high enough to 
drive the reaction to completion, with the most likely product in this case being 
goethite.3 As the concentration of hydroxyl ions in solution increases to 50 mM, the 
solution becomes brown green in colour, suggesting the presence of green rusts in the 
solution. After aging for 12-16 hours, this sample turned brown suggesting 













Figure 3.4: Optimisation of hydroxide concentration: TEM micrographs of iron oxide formation at 
increasing NaOH concentrations added to a room temperature co-precipitation reaction (a-d). The iron 
oxide products produced changed from an amorphous to crystalline phase. The crossover point of this 
transition is at around 5 mM where more structure is observed in the images. Fully crystalline particle are 
observed at 10 mM and above. Adapted from Bain et al.7 
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At NaOH concentrations of 10 mM and above, the presence of magnetic nanoparticles is 
observed. The TEM analysis confirmed this; figure 3.4 (a-d) shows TEM micrographs of 
particles synthesised at the four different alkali concentrations. Figure 3.4 a) made at 1 
mM NaOH clearly shows the presence of amorphous material; most likely to be 
Fe(OH)2, based on the colour of the precipitate and correlation with the Eh/pH phase 
diagram for iron oxide precipitation (Figure 1.5). Figure 3.4 b) could be described as 
being in an intermediate phase,3, 20f whilst still largely amorphous there is a noted 
difference between 1mM and 5 mM, with the formation of some plate-like material; 
possibly “green rusts” or iron oxy-hydroxide.3 Between Figure 3.4 c) and d) there is a 
marked difference in the particle quality, with 50 mM NaOH producing larger more 
monodisperse nanoparticles than 10 mM NaOH. Although the 50 mM sample was 
clearly superior in the quality of the particles produced, in terms of eventual in vivo 
application, the lower the concentration of base that can be used the more 
biocompatible the end vesicle is likely to be. Therefore, there needs to be a trade-off 
between particle quality and minimising potential toxicity. With this in mind, the 
optimum concentration was chosen to be 10 mM, as it was deemed to be relatively low 
toxicity (as confirmed in section 6.2.2) but also resulted in the successful precipitation 
of MNPs. It is also hoped that any loss of quality with respect to the particle 
morphology due to this lower base concentration would be compensated for during 
compartmentalisation of the reaction and the eventual incorporation of MTB 
biomineralisation proteins. 
 
3.3 MAGNETITE FORMATION SUMMARY AND 
FURTHER WORK 
 
There were multiple syntheses that could have been explored in determining the best 
magnetite precipitation route (Table 3.1). Not all methods could be tested either for 
practical reasons (temperatures required too high) or lack of time. This means that 
only the most promising methods were picked to be carried out, the resulting 
precipitate was analysed with respect to particle size, morphology and polydispersity 
of the population.  
 























2:1 90 83 ±6 Yes 
Urea/Ammonia 
decomposition 
2:1 80-100 Not Measured Unsuitable 
Table 3.1 Summary of magnetite precipitation routes tested 
 
Three methods have been tested and the results presented above, (summarised in 
table 3.1) precipitation of magnetite. Summary of magnetite precipitation route via 
partial oxidation had been previously tested by Lays Gierakowski (previous student in 
the Staniland group) and the particles using this method were inferior to the particle 
produced using thermal decomposition of urea. Therefore the high temperatures and 
harsh conditions needed to make these particles did not justify its use and thus it was 
deemed unsuitable for incorporation into a vesicle. Similarly precipitation using a 
combination of urea and ammonia was judged to be an over-complication of the 
standard urea precipitation route. The samples produced were of poor quality visually, 
appearing brown in colour and with very little magnetism. Therefore no further 
experiments were performed using this method. For the two methods which produced 
suitable particles X-ray diffraction (XRD) was performed (again by L. Gierakowski).The 
diffraction pattern (Figure 3.5 ) for both thermal decomposition of urea and  room 
temperature NaOH co-precipitated particles confirmed the presence of magnetite 
nanoparticles, by the presence of peaks representative of the faces that are found in the 
magnetite crystal structure, particularly the 111, 311, 511 and 440 miller indices. The 
ease with which these particles are made is a huge advantage for this system.  













For incorporation into a vesicle, both co-precipitation routes could be considered 
superior to other routes explored, largely due to the ambient conditions (NaOH) and 
delayed pH increase (urea) make these interesting routes to explore when 
compartmentalised within a vesicle core. Thermal decomposition of urea is perhaps 
the most suitable route for iron ion encapsulation and crystallisation of magnetite 
inside a vesicle as it prevents magnetite formation prior to the encapsulation of 
reagents. This means that membrane transport of the iron ions can be completed 
before the heating stage to induce precipitation. Furthermore heating the sample to 
induce precipitation on the whole produced larger magnetite nanoparticles with an 
average diameter of 83 ± 6 nm compared to the room temperature co-precipitation 
which produced particles with an average size of 10 ± 2 nm. 
There is a wealth of further work which could be carried out on optimisation of an 
appropriate route if time permitted. This could include further variation of the ferric to 
ferrous ratio used, although this would then have to be translated to measurements on 
the intra-vesicular ratio to ensure that the ratio added to the extra-vesicular media is 
effectively transported into the vesicle core.  
 
Figure 3.5: X-ray diffraction patterns of magnetic nanoparticles produced via a) thermal decomposition 
of urea and b) room temperature co-precipitation by NaOH. Experimental data (traces in black) have been 
compared to a literature profile for pure magnetite (red trace). Noise in the trace decreases from a) to b) 
which corresponds with TEM micrographs of the samples (Data collected and plotted by L. Gierakowski, 
adapted for this thesis). 
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This is highly unlikely, and therefore fine tuning of the ratio (outside of the vesicle) 
would likely be required to achieve an optimum intra-vesicle ratio. Similarly, oxidation 
could be more closely monitored. The stoichiometric ratio of ferric to ferrous iron in 
magnetite has also been used in the solutions as it seems the logical place to begin for 
the compartmentalisation of the precipitation of magnetite on the assumption that 
oxidation will be negligible in the vesicle core. However, this has not yet been tested 
and should oxidation occur within the vesicle, it may be necessary for the ratios to be 
adjusted accordingly for optimisation of magnetite formation.  
 
3.4 MEMBRANE TRANSPORT ASSAYS 
 
The results of membrane transport for the formation of magnetite can qualitatively 
analysed visually (ideally the intra-vesicular precipitation of magnetite should yield a 
black/brown precipitate) and using electron microscopy. This is both time consuming 
and expensive. Furthermore, TEM alone cannot provide any quantitative analysis of, a) 
how much of the iron ion solution is crossing the membrane, b) whether one iron 
species is preferentially crossing the membrane over the other and c) what effect this is 
having on the internal pH. Therefore, the design of an assay is required to be able to 
quantify this transmembrane activity. This assay was designed so that encapsulation of 
a detection agent (for the detection of changes in pH, redox potential, iron ion chelation 
or vesicle leakage) was incorporated into the vesicle core.  
The transmembrane transport of iron ions can then be both detected and quantified by 
measurement of changes to the UV-vis absorption or fluorescence spectrum due to 
changes in the encapsulated indicator. In each case, the solutions of the detection 
agents were made up at varying concentrations and the absorption or fluorescence 
spectra of standard non-encapsulated solutions were recorded to create a calibration 
curve. This could then be used to quantify the concentration of the detection agent 
inside the vesicle. Background spectra of blank vesicles were also recorded so any 
contribution from the lipid or polymer can be subtracted. In each case, the solution at 
maximum concentration (i.e. 100 % iron chelation) was encapsulated.  
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3.4.1 MEASUREMENT OF INTER-VESICULAR 
REDOX POTENTIAL 
 
An assay was designed to detect changes in the redox potential of the system. As iron 
crosses the vesicle bilayer, there will be an increase in acidity which in turn will reduce 
the pH. This is because, as the reaction proceeds, the hydroxyl ions will be used up by 
reacting with the iron, further increasing the internal vesicular pH. This will change the 
redox potential of the solution in the vesicle interior. In an attempt to detect these 
changes, and consequently quantify iron ion membrane transport, a redox sensing dye 
was encapsulated along with the basic solution in the vesicle core. The dye used is the 
aromatic complex Resazurin (7-hydroxy-3H-phenoxazin-3-one 10-oxide). Due to its 
aromaticity, the dye is both UV-active and weakly fluorescent. A colour change is 
observed from blue to pink as the aromatic nitrogen in the complex is reduced (Figure 
2.5). In the vesicular system, this reduction will occur as a consequence of iron ions 
entering the vesicle core and reducing the internal pH. The colour change that 
corresponds to decreasing pH can be seen in figure 3.6 a), with solution changing from 
blue to pink as the pH decreases from six to three. The UV-Vis spectra for these 
solutions at decreasing pH are plotted in figure 3.6 b). This shows an overall shift from 
500 nm to 600 nm as the solution changes from pH 3.8 to 6.8. A calibration curve was 
constructed from the maximum absorbance in the UV-Vis spectrum of each sample 
(Figure 3.6 c). Measurements of the emission were taken at 5 nm intervals; and a 
biphasic calibration curve was obtained, which jumps between phases at 
approximately pH 5.4. This corresponds to the point at which the solution becomes 
distinctly blue; it is assumed that this switch corresponds with the reduction of the 
Resazurin complex.  
While this is useful in measuring the increase in pH from 4 to 5 or vice versa (which 
would indicate incorporation of iron ions), it cannot give an accurate measurement of 
the specific pH at a given point as iron ions cross the membrane. However, Resazurin 
can also be monitored visually by a change from pink to blue, therefore rendering these 
measurements obsolete. After obtaining the necessary control data, the assay was 
incorporated into polymer vesicles (as optimised in chapter 4) for determination of 
trans-membrane iron ion transport.  
















On incorporation into the vesicles, the absorption signal of the Resazurin was lost. This 
test was repeated multiple times at increasing concentrations of indicator before 
incorporation, and on each occasion the spectrum saturated. For the control sample, 
the signal was lost each time it was incorporated into the vesicle. There are a number 
of explanations as to why no absorbance was observed, such as the internal volume of 
the vesicles act to limit the ability to encapsulate volumes and concentrations of 
Resazurin that can be detected. Conversely, this may mean that the small molecule 
Resazurin; is able to leak out of the vesicle interior and be subsequently removed 
during clean-up. Furthermore, the vesicle interior is so small compared to the volume 
of the bulk solution that the amount of Resazurin remaining in the sample post-clean-
up may be too low to detect even if it were successfully encapsulated. Although highly 
unlikely, it cannot be ruled out that the Resazurin was never encapsulated to begin 
with. It is more likely that scattering from the surrounding polymer/lipid is preventing 
detection of the absorbance of Resazurin.  
Figure 3.6: a) Shows the colour change observed as the pH of the solution is decreased. b) UV-Vis 
spectrum of the corresponding absorbance’s at each pH, showing a shift from 500-600 nm. c) Calibration 
curve of Resazurin absorbance as a function of solution pH, experimental data is shown in black.  
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Scattering from the polymer; which is visible in solution, is likely to impede the ability 
to measure the absorbance of the encapsulated indicator. 
 
3.4.2 QUANTIFICATION OF FERRIC/FERROUS ION TRANSPORT 
 
Two further approaches to quantify of trans-membrane iron ion transport were 
explored. These routes focussed not on change in internal vesicle condition (i.e. redox 
and pH), but instead on measurement of the ferrous iron concentration within the 
vesicle core. Again, calibration curves for each assay were obtained, to aid intra-vesicle 




Focussing on the ferrous ion concentration within the vesicle, control of ferrous iron 
ions chelated to the ferene complex (5,5′-[3-(2-Pyridyl)-1,2,4-triazine-5,6-diyl]difuran-
2-sulfonic acid disodium salt), upon chelation of the ferrous ions a colour change from 
clear to deep blue is observed. Samples were measured by UV-vis spectroscopy, and 
again these control samples showed a maximum absorbance at around 520 nm, the 
intensity of which decreased as a function of concentration (Figure 3.7 a). 
These data were plotted (Figure 3.7 b) for the determination of the internal vesicle iron 
concentration; with a darker blue solution and higher intensity of absorbance being 
related to increased trans-membrane movement of ferrous iron. This plot revealed a 
step-wise change when ferrous ion became chelated to the ferene molecule, which as 
with Resazurin is detectable by eye. It did not reveal any information with regard to the 
concentration of the ferene, from which the ferrous ion concentration could then be 
determined. Moreover, as in section 3.3.1, the absorption of the ferene species could 
not be detected following incorporation into a vesicle (Figure 3.7 c).  
 
 



















UV-Vis spectra taken of vesicles which should have the chelated ferene encapsulated 
showed no characteristic absorbance profile as observed in control, uencapsulated 
samples. The possible reasons for this are multiple, and relate to encapsulated 
volume/concentration of indicator and scattering from the polymer shielding 




Figure 3.7: a) UV-Vis absorption of ferrous chelated ferene as a function of ferrous iron concentration, 
showing a maximum absorbance at 520 nm. b) Calibration curve of absorption vs. ferrous iron 
concentration. c) UV-Vis spectrum of ferrous chelated ferene after encapsulation in vesicles showing no 
absorption.  
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 PRUSSIAN BLUE 3.4.2.2
 
To determine whether leakage caused the failure of the ferene assay, a larger complex 
that can indicate the presence of iron in solution was investigated. Potassium 
ferrocynaide (Prussian blue) was deemed to be more suitable; particularly due to its 
wide-spread use as a detection agent of cell viability and cell death. On this basis, the 
same experiments (unencapsulated calibration curve determination and detection post 
encapsulation of known concentrations) were performed using the Prussian blue 
ligand complex. As before, Prussian blue was chelated to iron ions, although in this case 
ferric ions were used for the chelation. On introduction to a ferric ion solution, an 
extremely deep blue colour is observed due to the chelation of the ferric ions by 
Prussian blue, which after serially diluting multiple times still resulted in saturation 














Figure 3.8: a) UV-Vis absorption of ferrous chelated potassium ferrocyanide as a function of ferrous iron 
concentration showing a maximum absorbance at 730 nm. b) Calibration curve of absorption vs. ferrous 
iron concentration. c) UV-Vis spectrum of ferrous chelated potassium ferrocyanide after encapsulation in 
vesicles showing no absorption. 
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To alleviate these issues, the control experiments were repeated with a ferrous ion 
solution, which formed a less intense red solution upon chelation. Each solution gave a 
maximum absorbance at 730 nm, with the intensity changing as a function of 
concentration; (Figure 3.8 a). When the absorption with ferrous iron chelated was 
plotted as a function of iron concentration, it is again not possible to estimate iron 
concentration as required. Instead, a step-wise change is observed upon chelation of 
iron ions, which can be detected by eye. However, on encapsulation of both the ferrous 
and ferric chelated solutions within a vesicle core, it was not possible to detect the 
absorbance of either species. It is unlikely that the Prussian blue chelated complex 
could leak across the vesicle bilayer, based on the complex size; therefore it is more 
likely that issues with scattering are responsible for the failure of this colourimetric 
assay.  
 
3.4.3 VESICLES LEAKAGE ASSAY 
 
Carboxyfluorescein is a fluorescent dye which is self-quenching at concentrations of 
100 µM and above.168 Therefore, it can be used to monitor leakage from vesicles, by 
encapsulation at high (quenched) concentrations. Upon poration of a membrane 
(leakage) the dye will be diluted, and the fluorescence will be “switched on”. This 
fluorescence intensity can then be quantified, and related to the concentration that has 
leaked from the vesicle. PBD-PEO polymersomes were prepared that encapsulated 
carboxyfluorescein (10 % w/v at 100 µM), with the excess dye outside the vesicles 
being removed by SEC. Encapsulation of the dye in the core of the vesicles was 
confirmed by fluorescence microscopy (Figure 3.9 a). The resolution of this microscope 
is not high enough to allow us to see individual vesicles directly, but the discrete 
fluorescence observed can be attributed to the presence of the vesicles. Fluorescence 
spectroscopy was performed before and after electroporation. It was anticipated that 
electroporation would aid leakage and correspond to an increase in the fluorescent 
signal. The polymersomes were electroporated at increasing applied voltages (in 
parallel) to porate the membrane and aid leakage. It is expected that increased voltage 
will yield increase leakage, and therefore an increase in the fluorescence intensity 
(Figure 3.9 b). 



















On poration of the polymer membrane, no change in the fluorescence signal intensity 
was observed. This is likely to be because the fluorescence signal was saturated before 
electroporation, and therefore any change was undetectable. Serial dilutions of the 
sample were unsuccessful. It is probable that there was a problem with the 
carboxyfluorescein concentration, as the microscopy image shows relatively strong 
fluorescence when the fluorophore should have been at a self-quenching 
concentration. The experiment was repeated at both lower (1 µm) and higher 
concentrations (100 µm) of carboxyfluorescein with the same result. Therefore it was 
not possible to optimise the method to obtain useable data.  
 
3.5 WAYS FORWARD AND CONCLUSIONS 
 
It was found that, in choosing an appropriate route to magnetite precipitation, there is 
a trade-off. This is between achieving high quality nanoparticles, while avoiding harsh 
reaction conditions and complicated synthesis routes which cannot be easily 
incorporated into a vesicle.  
 
Figure 3.9: a) Fluorescence microscopy image of PBD-PEO polymersomes containing 10 % w/v 100 µm 
Carboxyfluorescein. Scale bar is equal to 1 µm b) Fluorimetery data on the carboxyfluorescein 
encapsulated polymersomes, electroporated at different voltages to detect fluorescence “switch on” 
following poration. 
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This is demonstrated by direct comparison between the room temperature co-
precipitation and co-precipitation from the thermal decomposition of urea. While the 
particles produced by oxidation as a result of decomposition of urea appear to be of a 
better quality; as they show increased monodispersity and producing particles of a size 
which are comfortably in the region of a single domain ferrimagnetic nanoparticle. It 
can be argued that the urea based method is less suitable than co-precipitation at room 
temperature with NaOH method. This is because the urea method requires a long 
period of heating, which the vesicle may not withstand. Therefore, it may not be 
prudent to use the method which produces the most monodisperse nanoparticles, as 
the synthesis process may destroy the nanoreactor. Instead, it seems logical to choose a 
method which, although it produces nanoparticles of a lower size, distribution and 
quality, is more amenable for vesicular incorporation. It may also be that 
compartmentalisation of the room temperature reaction is able to control the size and 
morphology of the encapsulated precipitate. The urea/ammonia decomposition 
(Section 3.2.4) method was not selected for further study either. This is because many 
of the reaction attempts were unsuccessful, and the combined encapsulation of both 
urea and ammonia was overcomplicating the precipitation. Unfortunately, if only urea 
was encapsulated as the reactive base inferior particles were also produced.  
Two methods were used for incorporation into a vesicle (Section 4.4); these are the 
decomposition of urea (Section 3.2.1) room temperature co-precipitation, (Section 
3.2.3). Room temperature co-precipitation was chosen for encapsulation due to both 
the simplicity of the method and the ambient temperature at which the reaction occurs. 
The thermal decomposition of urea appeals mainly due to the delayed introduction of 
the high pH environment. This allows external control over the point at which 
precipitation occurs by altering the temperature. This means that the pH increase can 
be induced at an optimum time in the reaction, either during or post trans-membrane 
transport of iron ions (Section 3.2.1). The factor determining the quality of the particles 
in each case appears to be control of the rate of the pH increase, which induces 
precipitation. In the cases where high quality particles were produced, the introduction 
of the OH- was done in a gradual and controlled manner.  
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This control was exerted either by using a steady rate of addition controlled by syringe 
driver (NaOH), or by controlling the point at which precipitation can occur induced by 
heating the sample (CO(NH2)2). In the cases were magnetite was not formed (combined 
urea/ammonia route), the high pH solution was added en masse at the beginning of the 
reaction. This rapid addition results in the formation of brown, non-magnetic 
nanoparticles (presumed to be FeO(OH)). Each of these routes to magnetite synthesis 
was tested for its effectiveness in both the lipid and polymer vesicles, and the 
optimisation is discussed in chapter 4.  
Unfortunately, efforts to quantify the iron ion transport across both a lipid and polymer 
membrane were unsuccessful. Each iron and redox potential quantification assay was 
only able to indicate the point at which there was colour/pH switch, causing a change 
in the absorption spectra. This is ineffective, as each of these changes can be detected 
by visual inspection of the sample. Confirmation of successful encapsulation within a 
vesicle was also not achieved. As discussed above, this could be due to a number of 
reasons (Section 3.3). One reason being the low volume/concentration of the 
encapsulated assay reagent, this is unlikely as the concentration in each case was 
increased and the sample concentrated with no improvement in the ability to detect 
the encapsulated solution. The encapsulated volume is extremely small, but the 
absorption should still be detectable; as it saturated the spectrum in each case when 
measuring the control solution.  Therefore the most likely reason for the undetectable 
emission/absorption from the vesicle contents is scattering from the polymer/lipid 
shielding the solution. This scattering would therefore make any change undiscernible, 
both by eye and in UV-Vis absorption analysis. Across all assays explored, it was not 
possible to determine whether scattering was the reason for failure in vesicles. In all 
cases the vesicle solution was cloudy before UV-Vis detection due to the scattering of 
light. It is therefore likely that this scattering effect, due to the vesicle bilayer, masks 
any absorbance from the dye, rendering encapsulated assay solution undetectable. The 
outcomes of this chapter have formed the basis for all other experiments throughout 
this work. The now optimised precipitation reactions were applied throughout all of 
the proceeding chapters to create a vesicle nanoreactor and eventually a fully artificial 
magnetosome. The failure to establish an effective assay has resulted in the iron 
transport in all subsequent experiments being estimated from TEM, elemental and 
magnetic measurements. 









CHAPTER 4:  
 
 
4 VESICLE FORMATION: 
OPTIMISATION OF THE 
FORMATION OF LIPOSOMES AND 
POLYMERSOMES  
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4.1 INTRODUCTION TO VESICLE FORMATION 
 
The simultaneous iron uptake and pH increase for magnetite formation inside an 
artificial magnetosome requires an optimised composition of the nanoreactor vesicle. A 
pH gradient is required for successful magnetite precipitation, and this must be 
established and maintained across the membrane. The lipid or polymer system must 
therefore be able to remain assembled in the presence of this pH gradient. The 
magnetite precipitation route must also be considered, due to the possibility of 
sustained periods at high temperatures, as this is required as part of some magnetite 
precipitation reactions.20e, 20f Precipitation routes of this nature are known to make 
more homogeneous nanoparticles when compared to room temperature 
precipitation,2b, 3, 20f but are not necessarily suitable to be carried out within a vesicle 
core. Therefore, following the results presented in chapter 3, it was decided, that only 
two magnetite precipitation routes would be incorporated into vesicles. The room 
temperature co-precipitation route with NaOH, due to the mild synthesis conditions 
used, and the thermal decomposition of CO(NH2)2. Although thermal decomposition 
does require high temperatures (90 °C), the advantage of being able to remotely induce 
precipitation (using heating) may outweigh the drawback of needing to use elevated 
temperatures. This is providing a suitable vesicle can be found to withstand the 
temperature and pH conditions. With this in mind, the vesicle itself must of course be 
optimised; in terms of both size and chemical composition. The vesicle must be an 
appropriate size to contain the formation of an MNP of an appropriate size for 
application. The internal environment of the vesicle must also have suitable conditions 
for the reaction to be able to occur successfully. It is not feasible to develop a working 
vesicle nanoreactor without first knowing the reaction requirements; such as the pH 
and temperature range that the vesicle will have to withstand.  
 
This chapter documents the formation of vesicles, trialling both phospholipids and 
amphiphilic di- and tri-block copolymers, as artificial magnetosome nanoreactors. 
Multiple formation routes, such as simple film rehydration, sonication techniques, 
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 These techniques were assessed with reference to their ability to encapsulate a 
solution of high pH, and the vesicle monodispersity, to ensure uniform particle 
precipitation within the core. Monodisperse vesicle samples were taken forward for 
further study as the candidate nanoreactor vesicle for incorporation of magnetite co-
precipitation optimised in chapter 3. Throughout this chapter, TEM of negatively 
stained vesicles shows the morphology, degree of aggregation, and sample 
homogeneity. However, staining and drying artefacts can result in distortions and an 
apparent shrinkage of the vesicles. Dynamic light scattering (DLS) was used to 
characterize both the vesicle size and the sample size distribution. While DLS offers 
analysis of the sample population, the measurement is based on the particles 
hydrodynamic size, which presumes a spherical, solid material. This can contribute to 
vesicles appearing larger than their true size, as they are not solid, may also not be 
perfectly spherical, and will also have a shell of water/solution around the exterior, all 
contributing to increasing the size measured in DLS. Therefore, it should be noted that 
there is a discrepancy (approximately two-fold) between the DLS and TEM sizing, but 
importantly the population distribution is in agreement. 
 
This chapter is a summary of optimisation of vesicles formation therefore sections 
4.2.1 and 4.3.1 are a discussion of the different properties of the lipids and polymers 
studied with respect to their applicability to use in a vesicle nanoreactor, and sections 




4.2.1 PHOSPHOLIPID SELECTION 
 
Naturally occurring phospholipids are an integral component of cell membranes; 
therefore making them well suited for use in in vivo biomedical applications. The 
properties of the phospholipids need particular consideration for functionality when 
designing a nanoreactor. Withstanding the pH gradient needed for magnetite 
precipitation is essential, but this has to be balanced with a capability for incorporation 
of biological components (e.g. transporter proteins) or for synthetic poration, to 
facilitate iron transport across the bilayer, and thus enable the magnetite precipitation 
reaction to proceed within the core.  
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The lipid properties that have been varied include; variations in charge (+/-) (which 
can affect vesicle formation), various hydrocarbon chain lengths, and degrees of 
hydrocarbon chain saturation, which dictates the flexibility, permeability and melting 
temperature (Tg) of the lipids within a bilayer. The properties of the phospholipids 
selected are outlined in Table 4.1. 
 
 SATURATED PHOSPHOCHOLINE (PC) BASED LIPIDS 4.2.1.1
 
Phosphocholine (PC) based phospholipids are zwitterionic molecules with an overall 
neutral charge. They are found in both the MTB bilayer39b and in the membranes of 
many mammalian cells, making them inherently biocompatible. PC lipids are also found 
in a wide variety of other organisms, including Escherichia coli. This should increase 
the likelihood of successful MTB membrane protein incorporation into synthetic 
liposomes, as they share similar properties to the native environment of the protein. 
Phospholipids with mid-range Tg’s may represent materials that are ideal for magnetite 
nanoreactor formation. This is because they should be able to form a stable vesicle, 
which can also withstand the conditions needed for magnetite precipitation (pH 12 and 
possibly heating). As the Tg should not be too high, they should also not be too robust 
which would hinder membrane transport with respect to iron ion permeation of the 
vesicle membrane. For this reason, two lipids with Tg’s around 50°C were studied, as 
they may offer the ideal balance between stability and permeability required for 
magnetite nanoreactor formation. These are 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) and Dipalmitoylphosphatidylcholine (DPPC) (Table 4.1). Both 
are phosphocholine lipids with entirely saturated hydrocarbon tails, which means 
there will be little fluidity in the bilayer. DSPC and DPPC will be in the gel phase at 
ambient temperatures, due to their relative Tg’s (55 and 41°C respectively), and so they 
should form relatively impermeable bilayers (to avoid OH- leakage) at room 
temperature. The only significant difference between these two lipids is the length of 
the stearic acid and palmitic acid non-polar chains. The stearic acid in DSPC is slightly 
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The mid-range melting temperatures of DSPC and DPPC are above ambient 
temperature but below the temperature of co-precipitation using urea (90°C). This 
means that permeability to iron ions could be increased as the lipids are raised above 
the Tg as part of the precipitation reaction. 
 
 UNSATURATED PHOSPHOCHOLINE (PC) LIPID 4.2.1.2
 
Egg-PC, is as the name suggests, isolated from chicken egg yolk, and is the most cost 
effective and widely studied of the PC lipids to be tested. The lipid has a comparable 
molecular weight to all of the other lipids investigated (770.12 g mol-1) (Table 4.1). The 
structure of the lipid is a simple phosphocholine, with a single unsaturated bond on 
one of the hydrocarbon. This means that egg-PC bilayers are relatively fluidic, which 
gives rise to its low Tg (-10 °C) (Table 4.1). If this is effective in encapsulating the 
necessary base for magnetite precipitation, it is likely that this lipid will provide a 
cheap ($200 per gram, Avanti polar lipids) and easy method for formation of an 
artificial magnetosome. In terms of forming easily adapted liposomes, the chemistry of 
which does not interfere with its nanoreactor functionality, egg-PC may not be a good 
candidate. 
Offering increased fluidity in a bilayer is, 2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), ⁸ with a transition temperature of -20 °C⁷ (Table 4.1). This was investigated 
due to its easy handling as a result of being in the liquid phase at ambient 
temperatures, when compared to other lipids used with much higher Tg (DSPC and 
DPPC discussed above) which are in the gel phase at low temperatures and therefore 
can precipitate easily. The low transition temperature of DOPC is the result of 
unsaturation in the hydrocarbon tail. The double bonds cause kinks in the backbone, 
which generates disorder in the bilayer upon self-assembly, resulting in space between 
adjacent phospholipids. This has a direct effect on both phase behaviour and bilayer 
elasticity.63 Therefore, permeation of the bilayer with iron ions may be easier with 
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 THERMALLY STABLE LIPID 4.2.1.3
 
With liposome stability in mind, the more robust phospholipid 1,2-Diphytanoyl-sn-
glycero-3-phosphocholine (DPhPC) was also investigated. It is the other extreme in 
properties when compared to DOPC, offering heightened thermal stability due to a Tg of 
200°C. The lipid is known to be extremely robust in high pH environments, which 
arises from the methyl groups on the hydrocarbon backbone causing an interlocking 
effect when packed into a bilayer, stabilising the vesicle. This means that a higher 
temperature is required for DPhPC to transition to a fluid phase, making this lipid ideal 
for encapsulating high pH solution and withstanding the high temperatures involved in 
the thermal decomposition co-precipitation discussed in chapter 3. Conversely, it must 
not be ignored that the high Tg, and thus its rigidity, may hinder the transport of iron 
across the membrane. It should be noted that this study is novel, with such high 
temperature reactions never being compartmentalised within a vesicle, therefore it is 
now known yet known which lipids will react in what way during mineralisation. 
Furthermore, the high stability also dictates high cost ($1,100 per gram, Avanti polar 
lipids), therefore DPhPC may not be a viable option for widespread testing and scale-up 
of artificial magnetosome synthesis. 
 
 PHOSPHATIDIC (PA) LIPID 4.2.1.4
 
All phospholipids mentioned so far have phosphocholine head groups. There are other 
types of phospholipid that are also available and present in cell membranes, therefore 
present viable options for exploration as potential vesicle membranes as part on this 
thesis. The   effect of changing the lipids polar headgroup was tested with vesicle 
formation using, 1,2-dipalmitoyl-sn-glycero-3-phosphate Na+, (DPPA). DPPA (Table 
4.1) has the same dipalmitoyl hydrocarbon backbone as DPPC, but with a smaller PA 
headgroup when compared to PC. The PA head group size means that it is much closer 
to the backbone than PC lipids, which is likely to affect the packing of a PA bilayer. It 
has been shown that the presence of PA lipids in a membrane has an effect on the 
curvature of the membrane,106b, 153 presumably as result of the smaller head group 
leading to closer packing in the bilayer.  
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The closer packing may impact the overall vesicle size and it permeability as bilayer 
lipids move closer to one another. It is not yet known whether or not this will be 
advantageous in this nanoreactor system. 
 
 PHOSPHATIDYLETHANOLAMINE (PE) LIPID 4.2.1.5
 
On the other hand, a larger head group may serve to increase fluidity and permeability 
across the lipid vesicle. Dipalmitoylphosphatidylethanolamine-polyethyleneglycol 
5000 (DPPE-PEG 5000) has a larger phosphatidylethanolamine (PE) head group than 
phosphocholine, due to an extra ethyl group between the phosphorous and nitrogen. 
Again, this is likely to affect bilayer packing by increasing space between lipids in the 
membrane.104, 153, 184 The increased membrane fluidity may affect both vesicle size and 
membrane permeability. The DPPE lipid investigated also has a large polyethylene 
glycol (PEG) chain attached to the polar head group, with a molecular weight of 5000 g 
mol-1. The presence of this PEG group may have both advantages and disadvantages, on 
the properties of the resulting vesicle. The PEG could add potentially useful properties 
for in vivo application, such as prolonging the vesicles in vivo lifetime.71c On the other 
hand, the size of the PEG molecule on the inner leaflet will significantly reduce the 
inner diameter of the vesicle. On the outer leaflet; the size of the PEG molecule could 
sterically hinder the transport of ions across the membrane. 
 
 CHARGED LIPIDS 4.2.1.6
 
Using a charged lipid for bilayer formation may help to prevent aggregation, essential 
for in vivo application, and possibly increase stability through entropic effects.185 
Charged lipids include the cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane 
(chloride salt) (DOTAP) or the anionic lipid 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol) Na+ (DOPG), (Table 4.1). These lipids may also improve drug lifetimes 
through electrostatic bonding of the drug to the lipid,186 although charged lipids can 
also increase vesicle toxicity.71c A charge on the outer leaflet of the vesicle may also 
affect ion uptake.71c Cationic lipids will likely lead to the repulsion of iron ions, whereas 
with anionic DOPG, uptake of the cationic iron could be improved.152, 187 
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 Although one potential problem of using anionic lipids is electrostatic binding of the 
positively charged iron ions to the anionic polar heads. 
 
4.2.2 LIPOSOME FORMATION 
 
The nine phospholipids outlined in table 4.1 were previously investigated as part of 
undergraduate projects in the Staniland group. They were screened using DLS for a 
high throughput approach to analyse the ability of each lipid to encapsulate basic 
solution (both NaOH and CO(NH2)2 were tested), vesicle size and sample polydispersity 
following formation via bath sonication. The bath sonicated liposomes were then 
sequentially subjected to either tip sonication or extrusion to investigate their effect on 
sample polydispersity (again using DLS). The high throughput nature of the 
experiments meant that lipids which did not show a suitable peak in the DLS spectrum 
(i.e. a relatively monodisperse population in the region of 1 µm) were not taken 
forward. The results of this screening are shown in table 4.2. Here, lipid(s) egg-PC, 
DPPA, DOTAP and DOPG are shown to be the least suitable for further study, as a 
vesicle population could not be detected in DLS analysis. Lipid(s) DSPC, DPPC, DPhPC, 
DOPC and DPPE-PEG 5000 were found to have a vesicle population in the nanometer 
range (as measured by DLS), so were deemed suitable for further investigation. 
 
The lipids revealed to be the most suitable in the screening were then optimised with 
respect to vesicle formation for the creation of a synthetic magnetosome nanoreactor. 
As NaOH represents the highest pH solution that would need to be encapsulated, it was 
assumed with respect to pH that if the vesicle was capable of encapsulating NaOH (pH 
12) then encapsulation of CO(NH2)2  would also be possible. For each of the three 
formation methods (bath sonication, tip sonication and extrusion) bath sonication was 
used to rehydrate the lipid film followed by parallel studies of either tip sonication or 















Egg PC No N/A 
DSPC Yes Tip sonication 
DPPC Yes Tip sonication 
DPhPC Yes Bath sonication 
DOPC Yes Extrusion 
DPPA No N/A 
DPPE-PEG 5000 Yes Tip sonication 
DOTAP No N/A 
DOPG No N/A 
Table 4.2: Outcomes of high-throughput screening of phospholipids, which identifies the best vesicle 
formation method for each lipid tested. 
 
The methods offer differing degrees of size and population control, with control 
increasing from bath sonication, to tip sonication, and the most control exerted by 
extrusion. TEM imaging was performed on the sample for each lipid which gave the 
best results in DLS screening to check vesicle morphology. Bath sonication was 
performed for approximately 30 minutes from a lipid film rehydrated with NaOH (10 
mM). Tip sonication was then applied for 30 minutes at 70 % amplitude. This was 
carried out at 4°C during the high throughput test, however in cases where the Tg was 
above 4°C, the lipid precipitated. Thus, to avoid this, all subsequent tip sonication was 
performed at temperatures above the lipid Tg (Table 4.1). Using this combination of 
bath and tip sonication successively should give a higher propensity to produce 
unilamellar vesicles, when compared to film rehydration or bath sonication alone.⁶ 
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In parallel to this samples were also extruded through a polycarbonate membrane with 
100 nm pores, which should exert extremely tight control over the vesicle population 
size. Sizing was obtained from DLS measurements, which was compared to TEM 
grainsizing distributions. All concentrations used were determined from the high 
throughput screening which were based on literature values for successful vesicle 




For DSPC, the high throughput screening suggested that the most suitable vesicles 
were prepared by bath sonication followed by tip sonication. When this test was 
repeated, the results were again promising producing an average vesicle size of 192 ± 
39 nm (Figure 4.1). This is a huge improvement in the sample vesicle size distribution 
when compared to the two other vesicle formation methods which were applied. The 
samples produced by bath sonication were entirely unsuitable, with bath sonication 
generating species in the µm range (1.28 ± 325 µm). Extrusion does not appear to 
produce vesicles, due to the absence of a peak in the DLS spectrum (Figure 4.1). 
 
The reason for the success of the tip sonication in comparison to the other two 
methods is likely to be due to the Tg of the lipid. Bath sonication may have a limited 
effect on the vesicle size, as the lipid will be in the gel phase. Therefore, the low 
frequency sonication of the water bath isn’t likely to affect the DSPC assembly. This 
suggests relatively low stability of the DSPC lipid with which bath sonication is 
sufficient. However, when a more localised higher frequency is applied (in the case of 
tip sonication), a large change is observed in the DLS spectrum, which confirms a large 
decrease in vesicle size to 192 ± 39 nm (Figure 4.1). 
 
 This higher frequency is expected to be more detrimental to the vesicles, and therefore 
the lipid Tg will not be an issue in the same way. The DSPC vesicles are presumed to be 
lost when extruded through a 100 nm membrane (after bath sonication), as no peak 
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Figure 4.1: a) Plot of the average vesicle size (from DLS analysis) for the vesicle sample produced with 
each formation method (bath sonication, tip sonication and extrusion).  
 
Again, due to the lipid being in the gel state, forcing 1.28 µm liposomes through a 100 
nm polycarbonate membrane in the gel state is unlikely to be effective. The reason for 
the loss of the peak in the DLS spectrum is probably due to precipitation of the lipid 
which then sediments in the cuvette during DLS scanning. This precipitation is visible 
when the lipid is below the transition temperature. 
 
TEM imaging of DSPC vesicles produced using tip sonication at 60 °C with 
encapsulation of NaOH revealed a dual population (Figure 4.2 c). The images show 
vesicles at 309 ± 187 nm. The bigger vesicles are not required, and the two populations 
can be separated using SEC, due to the large difference in size. The vesicles do show a 
consistently spherical morphology, with no sign of aggregation. However, this lipid was 
difficult to work with. For example, precipitation of the lipid below the Tg raised 
particular problems with extrusion and DLS analysis. 
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 Therefore DSPC may not be a suitable for nanoreactor functionality, particularly with 
the room temperature co-precipitation. But the lipid does have greater potential with 





DPPC gave very similar results to DSPC (Figure 4.1), with bath sonication producing 
vesicles in the micrometre range (3 µm) and extruded samples showing no apparent 
vesicle structures in the DLS spectrum. Again, this is likely due to the Tg of the lipid 
hindering the effectiveness of these methods. The application of the higher frequency 
tip sonication produced vesicles with an average hydrodynamic radius 59 ± 17 nm. 
This suggests that, as with DSPC, the localised higher frequency is enough to reduce the 
average vesicle size considerably. Subsequent TEM analysis (Figure 4.2 b) confirmed 
that vesicles formed in the presence NaOH were had a good average size of 83 ± 18 nm, 
but also revealed a large amount of lipid residue in the sample. It is possible that this is 
the result of degradation of the lipid during the tip sonication, which could be 
optimised (in terms of applied amplitude and sonication time) to avoid the destruction 




DPhPC produced the most monodisperse liposomes by bath sonication alone. The DLS 
of the bath sonicated sample showed the average vesicle size to be 124 ± 12 nm. This 
corresponds well to the TEM micrograph shown in figure 4.2 d), in which liposomes 
are had an average size of 77 ± 35 nm. TEM also reveals consistent vesicle morphology 
throughout the sample, with all vesicles appearing highly spherical with a constant 
bilayer thickness of 3-4 nm. No further size control measures were performed on the 
DPhPC liposomes, as the sample produced by bath sonication was of a good enough 
standard. The major disadvantage of using this lipid for large scale artificial 
magnetosome synthesis is the high cost ($1,100 per gram, Avanti polar lipids). 
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Whilst the liposomes produced were of a suitable size and morphology when 
compared to the other lipids tested, more of the cost effective lipids screened produced 
suitable vesicles than was expected (although perhaps with the addition of tip 
sonication/extrusion). Therefore the good monodispersity of DPhPC samples did not 
justify the high cost of using the lipid for large scale testing and synthesis.  
 
Therefore this particular lipid was only used when the requirement for extremely 
stable vesicles with minimal processing is the case. This is the case when vesicles were 
required to incorporate proteins, where high quality vesicles are required with 
minimal post-formation modification to avoid displacing the bilayer proteins, or if 

























Figure 4.2: TEM micrograph of each liposome sample following formation with the best method as 
determined via the high throughput screening and the corresponding TEM grainsize analysis. a) DOPC 
liposomes via extrusion, b) DPPC liposomes via tip sonication c) DSPC d) DPhPC liposomes via bath 
sonication e) DPPE-PEG 5000 liposomes via tip sonication. 





DLS analysis of DOPC vesicles formed using extrusion showed an average size of 90 ± 
13 nm, which is the most suitable vesicle size of all of the lipids tested. DOPC showed 
consistency in size of the species formed across all three formation methods: bath and 
tip sonication producing vesicle sizes of 68 ± 6 nm and 38 ± 7 nm respectively (Figure 
4.1). DOPC may form vesicles more easily with all three methods, due to the high 
fluidity of the lipid bilayer. DOPCs low Tg proved much easier to work with overall, and 
it likely that this amenability made modification of the vesicle size with each technique 
easier. Whereas the higher Tg lipids, such as DSPC, were less responsive at ambient 
temperature, with a noticeable precipitate developing. TEM of the DOPC vesicles after 
extrusion showed a relatively monodisperse population with most vesicles between 39 
± 17 nm (Figure 4.2 a). The vesicle morphology was highly consistent across the 
samples imaged, showing consistently spherical vesicles, particularly when compared 
to other lipids screened such as DPPC (Figure 4.2 b). 
 
 DPPE-PEG 5000 4.2.2.5
 
DPPE-PEG 5000 vesicles formed via tip sonication gave the largest average vesicle size 
(as measured by DLS) to be 252 ± 27 nm. This is not surprising, due to the attached 
PEG molecule which will affect bilayer packing and increase the overall vesicle 
diameter. As with DPPC and DSPC, bath sonication and extrusion had a detrimental 
effect on the vesicle size, with both showing much larger vesicle species, as 2.7 ± 0.9 
μm and 5 ± 0.5 μm respectively. The PEG moiety is expected to be responsible for this, 
with bath sonication again not being a high enough frequency to affect the natural 
assembly size of the decorated lipid. Extrusion with a 100 nm membrane was probably 
not appropriate for such large vesicles, and appears to have had a detrimental effect on 
the vesicle size, with DLS analysis suggesting vesicles have increased in size. This peak 
in DLS spectrum is likely to be caused by large aggregations of lipid, as extrusion would 
not increase the overall vesicle size. TEM imaging of DPPE-PEG 5000 liposomes, 
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The formation of this network is possibly the result of DPPE’s high Tg. In order to verify 
if the sonication temperature could affect the formation of this network, DPPE was tip 
sonicated at a temperature of 65˚C. TEM and DLS analyses indicate that vesicles were 
formed, suggesting that creation of vesicles at temperatures above the Tg is sufficient to 
prevent network formation.  
 
4.2.3 LIPOSOME FORMATION DISCUSSION 
 
All the lipids on which the formation and size control tests were repeated with NaOH as 
the encapsulant following the high throughput screen were successful to a relative 
degree. Each size control method defined as the most appropriate in these data 
presented in this section correlates with previous data obtained in the undergraduate 
project (see contributions page XV). Vesicles of a relatively monodisperse size 
distribution were obtained with all lipids, except for DPPE-PEG 5000. It was 
unexpected that TEM imaging would reveal such a high number of useable vesicle 
materials, therefore the DPhPC, which was predicted to be the most appropriate 
material was not cost effective enough to be used in in high throughput testing and 
high yield production of artificial magnetosomes. For the phospholipids, the majority of 
the DLS spectra indicated the presence of species at around the desired 100 nm size. 
There were a number of more cost effective materials to take forward, particularly 
with respect to high throughput synthesis. All lipids with the exception of DPhPC were 
further explored (in chapter 6) for their appropriateness as a nanoreactor for the 

















Work in this section is taken from the publication Bain et al7 
 
4.3.1 POLYMER PROPERTIES 
 
Section 1.4.3 describes how the use of polymers for vesicle engineering allows the 
incorporation of a wider range of properties appropriate for use in diverse 
applications. To address some of the issues encountered with lipids in section 4.2, such 
as robustness and stability, particularly with the DPPC and DSPC lipids which proved 
difficult to work with, a variety of polymers with a range of molecular weights, 
structures and functional groups were investigated.  
These polymers are outlined in Table 4.3, with their selection explained throughout 
this section. Further reasoning includes the point that most of the polymers have their 
own distinct functionality to explore such as di-block versus tri-block structure, 
carboxylic acid end groups, and large variations in the polymer molecular weight. 
The first polymer to be investigated was the amphiphilic A-B block copolymer, 
synthesised by the polymerization of ethylene oxide (PEO) and butadiene (PBD) 
monomers in separate block length of 2500 g mol-1 and 1300 g mol-1  respectively (low 
molecular weight) or 35,000 (PBD) and 15,000 (PEO) at high molecular weight. PBD-
PEO was chosen as previous studies had shown the production of monodisperse 
unilamellar vesicles within the desired size range (50-200 nm) for this polymer 
system.99b, 108, 188 PBD-PEO is a relatively simple polymer, with an unreactive non-polar 
block, which is unlikely to interfere with the transport of iron ions.  
The polar block in the polymer is ideally suited for use in biomedical applications, 
where it could double up as a stealth coating, as it is already widely used in liposome 
engineering, delaying recognition in vivo71c without the need for functionalisation post 
formation. Two versions of this polymer were tested, each with varying block lengths. 
Block lengths has a direct effect on the overall packing factor of the polymer and the 
subsequent vesicle architecture (Section 1.4.3). Therefore, two extremes of both high 
(35,000-b-15,000) and low (2500-b-1300) molecular weight were investigated.
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The packing factor of the low molecular weight polymer is on the theoretical boundary 
between the formation of vesicles and tubes (Figure 1.10). Therefore, by lengthening 
the hydrophobic block in particular, it is predicted that self-assembly will be driven 
towards the exclusive formation of vesicles. Another factor affecting the packing of the 
amphiphilic block co-polymers in the head group size (Section 1.4.1), therefore 
increasing the polar block of polyethylene oxide to polybutylene oxide (PBO) should 
affect polymersome size and possibly morphology. Thus, a PBD-PBO polymer was also 
selected for comparison. The PBD polymers tested were chosen following the work of 
Professors Antony Ryan, Stephen Armes and Giuseppe Battaglia who have extensively 
studied the chemistry, assembly and morphological behaviours of these polymers.20c, 
119 
The other polymers were chosen because of their differing structures and specific 
functionalities, particularly the A-b-B-b-A tri-block polymer poly(2-methyloxazoline)-
poly(dimethylsiloxane)-poly(2-methyloxazoline) (PMOXA-PDMS-PMOXA). This 
polymer has been extensively studied, largely by the group of Wolfgang Meier,9, 89a, 100 
due to its tri-block (A-b-B-b-A) composition. They have assessed polymersome 
formation, the polymer’s permeability and polymerization properties. Several studies 
have provided proof of concept data for the use of the PMOXA-PDMS-PMOXA 
polymersomes as nanoreactors.9, 89a, 100, 189 The discrete PMOXA-PDMS-PMOXA 
polymersomes has proven to be biocompatible and are thus the focus of research for 
exploitation in biomedical applications,98 making them excellent vehicles for future 
theranostic applications.  
70% PEG113-PHPMA400/30% PMPC28-PHPMA400 polymersomes offers a different 
polymer assembly system for investigation. This polymer is produced through 
reversible addition fragmentation chain transfer (RAFT) synthesis, which is 
polymerisation induced by self-assembly (PISA). This work was performed in 
collaboration with Prof. Steven Armes group (University of Sheffield). The polymer 
system has been chosen to incorporate carboxylic acid groups exclusively on the inside 
of polymersomes (Figure 4.3). This acts as a mimic for the carboxylic acid rich 
magnetosome membrane protein Mms6 from magnetotactic bacteria,61 which is 
believed to biotemplate magnetite nucleation and/or growth. 
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 This system was designed so that the carboxylic acids would be preferentially 
displayed on the inside of the vesicle by control of the polymer lengths, with the 
smaller length acidic PMPC-PHPMA chains favouring the inner bilayer leaflet (Figure 
4.3). 
Again, two variations of the polymersomes were investigated, with and without the 
addition of an ethylene glycol dimethylacrylate (EGDMA) cross-linker. Cross-linking 
should prevent trans-bilayer rearrangement (“flip-flop”); essentially ‘locking’ the 
chains in place to keep COOH groups on the inner leaflet of the polymersome. 
 
 
Figure 4.3: Schematic of the 70% PEG113-PHPMA400/30% PMPC28-PHPMA400 system designed to mimic 
the nucleation of iron ions by Mms6 in the MTB magnetosome. The 70% PEG113-PHPMA400/30% PMPC28-
PHPMA400 polymersomes have been cross-linked with ethylene glycol dimethylacrylate (EGDMA) to 
promote the assembly of carboxylic acid terminated PMPC-PHPMA exclusively on the inside of the 
polymersome. This assembly should then act as a mimic for acidic amino acids in Mms6, which are 
believed to bind ferrous iron and nucleate the controlled precipitation of magnetite. 
 
4.3.2 POLYMERSOME FORMATION 
 
A similar methodology to the lipid vesicle formation was applied (as described in 
section 4.2.2). Here generation of polymersomes encapsulating first neutral PBS and 
then secondly NaOH was used to test the formation method and then subsequently the 
ability to encapsulate high pH solution. 
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NaOH represents the highest pH that would need to be initially encapsulated, and 
therefore the most extreme conditions vesicle formation would have to withstand. As 
with the phospholipids, each of these polymer samples were formed using extrusion, 
bath and tip sonication. The outcome of this screening is outlined below (Figure 4.4). 
 
 DI-BLOCK POLYMERSOMES 4.3.2.1
 
The di-block polymersomes were produced by rehydration and swelling of a polymer 
film. Although likely to have already formed, the polymersomes were then subjected to 
tip sonication to explore vesicle size control. For the three polymersomes; PBD2500-
PEO1300, PBD35,000-PEO15,000, and PBD16-PBO22, polymer films were rehydrated with 10 

















Figure 4.4: TEM micrographs for a) PBD2500-PEO1300, b) PBD35,000-PEO15,000 and c) PBD16-PBO22 
polymersomes formed by tip sonication and the corresponding DLS population analysis taken before (red) 
and after (black) modification by tip sonication. 
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Following stirring, the polymersome samples were tip sonicated at 70 % amplitude for 
30 minutes. The DLS analysis before and after sonication, and TEM images of the tip 
sonicated polymersomes are shown in figure 4.4. The low molecular weight PBD-PEO, 
produced the most discrete, monodisperse polymersomes with an average size of 203 
± 55 nm (Figure 4.4 a). The sonication of the polymer sample had very little effect on 
the size of the polymersomes, with the only difference being a slight decrease in 
polydispersity, with an average size of 203 ± 45 nm. This was not the case with the high 
molecular weight PBD-PEO, in which the tip sonication failed to produce discrete 
vesicles, instead forming a mixture of tubes and conjoined vesicles/micelles (Figure 4.4 
b) These mixed morphologies are reflected in the DLS spectrum, with multiple species 
being detected giving an average size 1.3 ± 0.6 µm. The effect of tip sonication on the 
population was a general decrease in the size of the assemblies, but little improvement; 
or perhaps an increase of the population dispersity (Figure 4.3 b) but giving an average 
size of 1.7 ± 0.9 µm. Similarly, the third and final di-block polymer showed little 
improvement, although the TEM confirms the presence of only vesicle morphology 
(Figure 4.4 c). The DLS also showed multiple species are present with high 
polydispersity. The general populations in both the TEM and DLS analysis are much 
larger than desired, with an average size of 893 ± 353 nm. Due to the poor quality of 
the high molecular weight PBD-PEO and PBD-PBO vesicles (Figure 4.3 b) and c), no 
further investigation was carried out on these polymers. Instead PBD2500-PEO1300 was 
taken forward, due to its ability to form uniform, monodisperse vesicles, within the 
desired size-range produced by the simple film swelling and tip sonication techniques. 
PBD2500-PEO1300 polymersomes formed by film rehydration/swelling were compared to 
samples which had been further modified by extrusion through a 100 nm 
polycarbonate membrane. It was found that while extrusion produced a close to 
homogeneous population of 41 ± 6 nm shown by TEM figure 4.5 a), and 123 ± 26 nm by 
DLS (Figure 4.4. b). However, as this does require an extra processing step, which may 
not be necessary as simple stirring yields two populations of polymersomes. This first 
population is of 100 ± 9 nm by TEM (Figure 4.5 a) and 203 ± 55 nm by DLS, with the 
second population around 43 ± 4 nm by TEM and 58 ± 6 nm by DLS (Figure 4.5 b).  














Figure 4.5: a) TEM micrograph of PBD2500-PEO1300 polymersomes after extrusion b) the corresponding 
DLS size analysis comparing the polymersome population difference between the stirred and extruded 
samples c) Polymersome bilayer measurement. Greyscale measurement of polymersome bilayer showing 
a thickness of 4-5nm, as measured on a cryo-EM image of the stirred polymersome sample. 
 
The similar vesicle distribution achieved by stirring alone is indicative of the ease of 
processing possible with PBD2500-PEO1300. To fully confirm the PBD-PEO polymersome 
size, cryo-EM was also performed (Figure 4.5 c). This analysis doesn’t generate the 
same deformations from staining and drying, showing a preserved membrane bilayer 
and a true size slightly larger than the corresponding stained TEM. However, cryo-EM 
is not a routine analysis, due to the time consuming and expensive nature required to 
prepare samples for this method. Therefore, cryo-EM cannot be performed on a large 
number of samples to produce accurate size distributions. Importantly, this analysis 
also revealed a polymer bilayer thickness of 4-5 nm (Figure 4.5 c) comparable to a 
naturally occurring lipid bilayers (approximately 5 nm).84 Encapsulation of CO(NH2)2 
was also tested, which also produced polymersomes of an appropriate size distribution 
in the 100-200 nm range as shown in figure 4.6.  
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As PBD2500-PEO1300 performed the best in the above experiments, all further tests on di-
block polymersomes throughout this thesis were performed on PBD2500-PEO1300, and 
this polymer was the di-block example taken forward for further study and the main 












 TRI-BLOCK POLYMERSOMES 4.3.2.2
 
Initially, PMOXA-PDMS-PMOXA polymersome formation was devised from the 
published method by Meier et al.9b, 89a In this method, the polymer is dissolved in 
ethanol at a concentration of 17 % by weight, followed by dilution to the critical 
aggregation concentration (CAC). Low solubility of the polymer and low volumes of the 
solvent made this method difficult to replicate. Therefore, the published method was 
adapted by dissolving the polymer in chloroform at a final concentration above the CAC 
of 0.15 x 10-3 g ml-1 in water.9b Addition of aqueous solution at a rate of 5 µl min-1 
yielded phase separation between the aqueous solution and original solvent.  
 
Figure 4.6: Negative stained TEM image of PBD2500-PEO1300 polymersomes following 
encapsulation of CO(NH2)2. 
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Isolation of the aqueous layer via centrifugation yielded a polymersome solution with 
an average size of 45 ± 6 nm as imaged by TEM, (Figure 4.7 a) with the presence of 
some tubular structures (not included in the TEM grainsizing). The corresponding DLS 
data shows an average size of 33 ± 8 nm and a polydispersity index of 0.5 (Figure 4.7 b) 
in agreement with the TEM data, and yielded a narrower dispersity than those 














When polymersomes were produced using method published by Nardin,9b (in which 17 
% w/v polymer was dissolved in ethanol and which is the added dropwise to water 
whilst stirring) TEM analysis reveals large networks of interconnected polymer of 
approximately 1800 nm in length (Figure 4.7 b) or 800 nm as measured by DLS (Figure 
4.7 d). 
 
Figure 4.7: a) TEM of PMOXA-PDMS-PMOXA polymersomes sample produced via the adapted slow 
aqueous addition method. b) TEM of PMOXA-PDMS-PMOXA polymersomes produced via the previously 
published method9 shows the presence of polymer networks c) Comparison of TEM (Grey bars) 
grainsizing and DLS (Red bars) sizing data show an average size of 45 nm compared to 32 nm 
respectively and a polydispersity index of 0.5. d) the corresponding TEM (Grey bars) and DLS (Red 
Bars) grainsizing showing an average size of  1.8 µm and 800nm respectively. 
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It is possible that the narrower dispersity obtained by the adapted formation route 
presented in this work, is a result of the slow addition of the aqueous solution. It is 
evident from figure 4.7 b) that the original synthesis route shows an extensive 
polymerisation of the polymer into a network. 
This network formation is not observed with my novel method of PMOXA-PDMS-
PMOXA polymersome formation, as the TEM images clearly show the presence of 
discrete vesicles (Figure 4.7 a). The biggest difference between the two synthesis 
routes was: firstly, the choice and volume of solvent used, and secondly the rate of 
addition of the aqueous solution. With a rate as slow as 5 µl min-1 it is possible that 
vesicles are forming and being stabilised in dilute solutions, and so avoiding the further 
polymerisation or aggregation effects. Variation of the rate of addition from 5 to 50 µl 
min-1 made very little difference to the overall quality of polymersomes. However, 
when the aqueous solution is added as one volume to rapidly dilute the sample, the 
large scale networks observed with Nardin’s published method are again present. 
(Figure 4.7 c) 87 The PMOXA-PDMS-PMOXA concentration was varied from 5 mg to 10 
mg but this did not appear to affect polymersome assembly.  
 
 RAFT SYNTHESISED POLYMERSOMES 4.3.2.3
 
70% PEG113-PHPMA400/30% PMPC28-PHPMA400 polymersomes were produced using 
RAFT polymerisation (reaction scheme in figure 4.8). This is the polymerisation of 2-
hydroxypropyl methacrylate (HPMA) using a 4,4’-azobis (4-cyanopentanoic acid) (V-
501) initiator and a 4-cyanopentanoic acid dithiobenzanoate (CADB) chain transfer 
agent.2 The synthesis was carried out in water at 70 °C, with the HPMA block further 
polymerised by 2-(methacryloyloxy) ethylphosphorylcholine (PMPC). PMPC acts as 
both a macro chain transfer agent in the second polymerisation step and the 

















It is this chain extension with PMPC that drives the self-assembly of the polymer, with 
PHPMA’s degree of polymerisation dictating the eventual morphology. The nature of 
this synthesis, in which polymersomes are formed directly in the reaction, means the 
scheme is not open to modification, making it overall less flexible than other 
approaches. Therefore, polymersome size and quality is controlled by adaptation of the 
polymer synthesis conditions. To explore changes in morphology, two different PMPC 
polymers with varying degrees of polymerisation with respect to the PMPC blocks, 
were investigated. After formation both PMPC28 and PMPC32 polymersomes were 
soaked in NaOH to account for any shrinkage/swelling that may occur, so that the size 
can be accurately assessed.  
 
The overall appearance of the vesicles with the PMPC32 displays a more monodisperse 
size and consistent morphology (Figure 4.9 a). Whilst PMPC28 still forms vesicles, there 
is a mixed population with the obvious presence of both vesicles and tubes of varying 
size (Figure 4.9 a). This is reflected in grainsize analysis of the polymersomes, giving 
high polydispersity with sizes ranging from 246 ± 137 nm, compared to a narrow size 
distribution of 79 ± 24 nm observed with PMPC32 polymersomes (Figure 4.9 b).  
 
 
Figure 4.8: Synthesis route for the reversible addition fragmentation chain transfer (RAFT) 
polymerisation of PMPC28-PHPMA400 in water at 70°C using a 4,4’-azobis (4-cyanopentanoic acid) (V-
501) initiator and 4-cyanopentanoic acid dithiobenzanoate (CADB) chain transfer agent.2 

























However, when the structure of the polymersomes formed with both block lengths are 
more closely analysed with respect to bilayer thickness, the PMPC32 block appears less 
suitable. Measurement of the thickness of the polymersome bilayer membrane reveals 
PMPC28 is approximately 10 nm, two times thicker than a traditional lipid bilayer. 
Nevertheless, it is still comparative, having a similar hydrophobic/hydrophilic 
composition (Figure 4.9 c). The boundary layer of the PMPC32 is a much wider, at 25 
nm (Figure 4.9 c). This is likely to have a profound effect on iron ion transmembrane 
transport, decreasing the likelihood of full bilayer penetration by the iron ions. It is 
likely that the thicker the boundary layer, the less successful full penetration is likely to 
be. Furthermore, the increased thickness of the bilayer has the direct effect of reducing 
the inner core diameter.  
 
Figure 4.9: a) Comparison of the effect of variation of PMPC block length in PEG113-PHPMA400/30% 
PMPC28-PHPMA400 polymersomes between PMPC28 and PMPC32. b) The corresponding TEM grainsize 
analysis of polymersomes at the different block lengths. c) Highlight of the difference in bilayer thickness 
as a result of changing the PMPC block length.  
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This smaller core would result in a smaller MNP forming, even if the core is filled in the 
case of PMPC32. Therefore, although the appearance of the PMPC32 block appears to 
make vesicles with the desired size and morphological characteristics, its bilayer 
thickness could hinder membrane transport, which is a major limitation for the 
creation of the nanoreactor. All subsequent investigations were carried out exclusively 
on polymersomes with a PMPC28 block length, particularly as modification of the 
vesicle size and morphology is easier to control than bilayer thickness. 
Synthesis of PEG113-PHPMA400/30% PMPC28-PHPMA400 polymersomes is generally 
carried out at a pH of 3.5. As encapsulation of NaOH (pH 12) is required, polymersome 
synthesis was also carried out at pH 6.5, to minimise the impact of a pH switch by 
uptake of NaOH. Another alteration to the polymer synthesis was the introduction of an 
ethylene glycol dimethylacrylate (EGDMA) crosslinker, with the aim of locking the 
COOH end groups on the inner leaflet of the polymersome, to aid magnetite 
mineralisation. Finally, the samples prepared under each condition were tip sonicated, 
with the aim of further narrowing the dispersity of the sample population. The TEM 
micrographs of vesicles formed under each condition are shown in figure 4.10, 
negatively stained TEM images were analysed qualitatively to establish which methods 
are likely to produce vesicles with the most promising vesicle size and size 
distributions. Under the usual pH 3.5 polymersome formation conditions, tip 
sonication has a detrimental effect on the polymersomes, both with and without cross-
linker. In this case, a network is formed, or polymerisation with the loss of discrete 
vesicles. On addition of the cross-linker at pH 3.5, the vesicle population is marginally 
improved with a decrease in the presence of tubes. Negatively stained TEM images 
were analysed qualitatively to establish which methods are likely to produce vesicles 
with the most promising vesicle size and size distributions (see figure 4.10). 
  






















In the absence of cross-linker, tip sonication significantly reduces the vesicle size; and 
again the presence of the EGDMA cross-linker changes the vesicle size, seemingly 
producing larger vesicles. This suggests that the cross-linker has a stabilising effect on 
the vesicles, allowing it to withstand the high frequency applied during tip sonication.  
Figure 4.10: TEM micrographs of PEG113-PHPMA400/30% PMPC28-PHPMA400 produced under different 
conditions. Top; pH 3.5 and bottom; pH 6.5. Under each pH condition polymersome morphology was 
compared between tip sonicated (Top row) and non-tip sonicated (Bottom row) samples. The 
polymersomes at each pH without (left column) and with (right column) the addition of a cross-linker are 
also compared. 
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When the cross-linker is not present, the vesicles appear to be more easily broken up. 
This leads to a reduction in size upon re-assembly after sonication due the high 
frequency applied. Interestingly, the tip sonication does not seem to affect the presence 
of polymeric worms in the sample, as their formation arises from the hydrophobic/ 
hydrophilic ratio in the polymer composition. Therefore, avoidance of tube formation 
would require further optimisation of the block lengths, rather than the formation 
method. Overall, the vesicles produced at pH 6.5 were much higher quality, particularly 
with the presence of the cross-linker. 
At pH 6.5, discrete vesicles are observed in the TEM micrographs under each set of 
conditions (Figure 4.10). This was not the case for polymersomes synthesised at pH 
3.5. Although, discrete vesicles can be seen in the unmodified polymer when tip 
sonication is applied, polymerisation or aggregation of the vesicles occurs. At low pH, 
the carboxylic acid groups on the end of the polymer will be protonated. This lack of 
charge repulsion may now promote polymer aggregation, which is further encouraged 
by the dis-assembly and re-assembly of polymersomes during tip sonication. Whereas, 
in the polymersome sample produced at pH 6.5, the carboxylic acids will be 
deprotonated, and so electrostatic repulsion between polymers occurs. Therefore all 
future experiments with respect to exploring membrane transport were carried out 
with polymersomes synthesised at pH 6.5, both with and without the EGDMA cross-
linker.  
 
4.3.3 POLYMERSOME FORMATION DISCUSSION 
 
A wide variety of potential phospholipids and polymers are available. Thus, a 
systematic approach was taken to trial a range of polymer and lipid materials to assess 
their suitability for use as magnetite nanoreactors. Vesicle size, polydispersity and 
morphology were assessed at each stage, and materials were disregarded based on 
their results at each stage. The challenging nature of the magnetite precipitation 
reaction in addition to an ability to encapsulate basic solution and permit 
transmembrane transport of iron ions, either synthetically or via incorporation of MTB 
transporter proteins into its membrane is essential.  
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This means that a wide range of materials with varying composition, chemical 
properties (i.e. pH tolerance, Tg) and molecular weight were investigated to obtain a 
suitable composition for design of a synthetic magnetosome. 
All polymers tested were successful in that they are able to form polymersomes, 
although certain samples simultaneously formed worm-like tubular structures. The 
three di-block polymers tested formed polymersomes by basic film rehydration and 
further modification by tip sonication, to obtain low vesicle dispersion, without too 
much modification. Of the three di-block polymers tested, the low molecular weight 
PBD-PEO formed superior vesicles, of a much more appropriate size and polydispersity 
range 101 ± 9 nm (TEM) and 203 ± 55 nm (DLS), with the second population around 43 
± 4 nm by TEM and 58 ± 6 nm by DLS (Figure 4.5 b). The other two di-block polymers 
formed mixed morphologies and vesicles in the µm range, (1.7 ± 0.9 µm for high Mw 
PBD-PEO and 893 ± 353 nm for PBD-PBO) which are too large for the artificial 
magnetosome system.  
The tri-block polymersome synthesis initially proved much more difficult to use to 
make appropriate polymersomes for nanoreactor formation. However, adaptation of 
the method produced appropriately sized vesicles with promising properties for use as 
a nanoreactor, particularly with respect to the mechanisms of transmembrane 
transport. The PEG113-PHPMA400/30% PMPC28-PHPMA400 system proved extremely 
promising, particularly when synthesised at the higher pH of 6.5. This synthesis also 
provides less of a pH jump during the subsequent encapsulation of a basic solution. 
Therefore, only certain polymers were selected for further investigation, these being 
the low molecular weight PBD-PEO di-block polymer, as it formed robust 
monodisperse vesicles, with inherent biocompatibility (for the PEG molecule). The tri-
block polymer also has potential following the development of an adapted formation 
method. It will be of particular interest to see how this polymer transports soluble iron, 
when compared to the more typical di-block bilayer compositions. Finally PEG113-
PHPMA400/30% PMPC28-PHPMA400 polymers, form well defined discrete vesicles of a 
good size and morphology under optimised conditions (formation at pH 6.5). These are 
also of particular interest due to their carboxylic acid functionality which should mimic 
the nucleation properties of biomineralisation proteins found within the MTB 
magnetosomes.  
 











CHAPTER 5:  
 
5 BIOMIMETIC TRANSPORT SYSTEMS 
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5.1 INTRODUCTION TO BIOMIMETIC TRANSPORT SYSTEMS 
 
The proteins encoded in the Magnetosome Island (MAI) are pivotal to the successful 
formation of the MTB magnetosome (Section 1.3.2.1).42, 47, 190 These proteins control 
each step of magnetosome formation: their size, shape, arrangement, the recruitment 
of iron, and the subsequent controlled precipitation of magnetite.47 This chapter 
focuses on the proteins whose function is believed to be to the transport of iron across 
the magnetosome membrane and into the magnetosome lumen. The nucleation of the 
particle is controlled by proteins encoded within a specific gene cluster.42, 190 These 
proteins are responsible for the high levels of homogeneity and distinct morphology of 
the particles, these proteins and their effects will be investigated in chapter 8.42, 47, 190 
The transport proteins outlined in table 5.1 are believed to act as antiporters, 
transporting ferrous ions into the core of the magnetosome, while pumping protons 
back out. As the protons are transported out of the core, the internal pH slowly 
increases. This increase facilitates the precipitation of a single magnetite crystal, which 
is mimicked in the artificial system by the encapsulation of solution at pH 10. 
The functions of these proteins have been investigated by gene deletion experiments. 
Uebe et al52 discovered, by gene deletion of mamB and mamM genes, that cross-
membrane transport of iron is by way of a complex dimer. They believe that the 
transport protein MamB can only function in the presence of another protein, MamM. 
Deletion of both these genes together caused the ΔmamB-ΔmamM double mutant to 
exhibit a phenotypic loss of the magnetosome vesicle. This study is an excellent 
example of the control exerted by the proteins genetically encoded in the MAI. The 
structures of many of these proteins have been predicted from sequence analysis,47 or 
the structure of soluble portions of the proteins have been determined by X-ray 
crystallography.47  
As yet, the purification of these intact membrane proteins has not been achieved, which 
is probably due to their hydrophobic and water insoluble nature making the synthesis 
and purification of these membrane proteins extremely challenging. Membrane 
proteins require purification into detergent micelles, before reconstitution into a 
synthetic membrane, i.e. a vesicle.  
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The success rate of membrane protein purification in general is relatively low, due to 
the difficulty isolating the proteins from their native membranes and problems relating 
to protein mis-folding and low yields.173 The successful cloning and expression of these 
genes will be invaluable for both the experimental confirmation of their predicted 
function and the formation of a fully mimetic artificial magnetosome. Incorporation of 
these proteins into the bilayers of the vesicles optimised in chapter 4 will confirm their 
function and allow for the selective and continuous transport of iron ions into the 
vesicle core. Due to the difficulty of their purification, it was decided that to investigate 
proteins exclusively from the magnetosome would further limit the experiments 
success. Therefore, this chapter looks at both MTB proteins believed to act as 
transporters in the magnetosome, but also homologues of these proteins from 
elsewhere in the MTB genome believed to have iron transporting function (Table 5.1). 
 
5.2 BACTERIAL IRON TRANSPORTERS 
 
Seven membrane proteins were chosen for investigation, (table 5.1) as previous 
studies have identified these proteins as potential iron transporters.47, 52, 53b Antiporters 
are a group of proteins which generally span a membrane; allowing movement of ions 
and protons across the membrane to maintain the osmotic pressure and dissolved ion 
concentration. In the case of MTB transporters, they are believed to take up iron ion 
from the magnetosome exterior and carry them across the membrane, subsequently 
collecting a proton and transporting it out of the magnetosome.39d 
In the case of MTB transporters they are believed to take up iron ions from the 
magnetosome exterior and carry them across the membrane, while simultaneously 
transporting a proton out of the magnetosome. Mutagenesis studies have been carried 
out on some of these genes to determine their function. Mutagenesis experiments have 
suggested that the proteins act as antiporters, and in the case of MamMB and FeOA/B 
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Table 5: Transporters investigated in this chapter and the associated properties of each protein47 
 
With the exception of FeOA and FeOB (which are found in the cell membrane), all other 
transporters investigated here are believed to sit in the magnetosome membrane.47, 53 
In all cases however, they show high hydrophobic content and the presence of multiple 
transmembrane helices (as shown in the hydropathy plots in figure 5.1). The presence 
of a high number of transmembrane helices (with proteins MamN, MagA and FeOB 
having 11-15 helices);47 will likely make them highly insoluble and a challenge to 
successfully purify. It is likely that the high number of transmembrane helices will 
mean correct insertion into a synthetic bilayer extremely difficult, relying on both 
correct folding of all helices and simultaneous insertion of up to 11 transmembrane 










Effect of gene 
deletion 
FeOA 106 9.68 2 No Iron transport 
MamB 296 5.35 3 No Magnetosome 
MamM 318 5.88 3 No Crystal formed 
MamO 637 6.50 8 Empty 
magnetosome 
MagA 434 9.86 11 Empty 
magnetosome 
MamN 437 6.59 11 Empty 
magnetosome 
FeOB 706 5.12 15 No Iron transport 

















Also, the proteins investigated that have been shown to function as heterodimers will 
likely need both partners present to be stable and active. MamMB and FeOAB form 
dimer complexes47, 52, 191 and so must be co-expressed. This means that the genes 
(which will be cloned in separate PCR reactions) must then be ligated into the same 






Figure 5.1: Hydropathy plots for each of the seven MTB transporters investigated throughout this 
chapter indicating the number of transmembrane helices and associated insolubility in each membrane 
protein structure.  
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5.2.1 CLONING OF IRON TRANSPORTERS 
 
Genes encoding the various iron transporters were amplified from Magnetospirillum 
magneticum AMB-1 DNA by PCR using site specific primers (see section 2.6.1.1) into 
XL10 gold E. Coli cells. Cells colonies were harvested and incorporation of the desired 




MagA has previously been characterised by Nakamura et al53 and was found to have 
iron transport functionality in the formation of the MTB magnetosome. The found that 
MagA possesses a sequence homologous to a potassium transporter (KefC) found in E. 
Coli.53 The magA gene was amplified by PCR and subsequently digested using 
restriction enzymes NheI and PstI (N terminal) or AvrII and SbfI (C-terminal) 
depending on the required destination vector (encoding either an N or C terminal His8 
tag). 
Analysis by gel electrophoresis (section 2.7.4.1) revealed that AvrII was unsuccessful in 
digesting the DNA (Figure 5,2). Therefore, sequential digestions with the enzymes were 
performed. This product (and the NheI/PstI digested product) was ligated into 
pBRNHT or pBRCHT vectors previously cut with the same restriction enzymes. These 
ligated plasmids were introduced into XL10 E. coli cells and colonies were allowed to 
develop overnight on LB-Agar in the presence of carbenicillin. When colonies were 
subject to DNA sequencing, the magA gene was not present. This result suggested that 
the colonies comprised empty vector only. The molecular cloning process was then 
repeated with alternative primers encoding BSaI restriction enzyme sites for insertion 
into pPRIBA1 vector. The outcome of this optimised PCR is shown in figure 5.2 a), and 
shows a DNA product of approximately 2000 base pairs when compared to the 
molecular weight marker (Massruler (Life Technologies) believed to be the MagA gene 
(as shown by the band in the right hand lane of the gel electrophoresis). After digestion 
with BsaI, the magA gene was ligated into the pPRIBA1 vector (previously cut with 
BsaI) and transformed into XL10 gold cells. 
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Ten colonies were selected and their plasmid DNA extracted. Colony PCR with the 
magA specific primers was used to confirm to presence of the magA gene. DNA gel 
electrophoresis analysis of these products showed that six of the ten colonies 
contained the desired gene. (figure 5.2 b). Colony ten (figure 5.2 b) which gave the 
most intense band was subsequently transformed into BL21 (DE3) E. coli cells for 














The magnetosome proteins MamM and MamB have been shown to form a heterodimer, 
present and highly conserved in all MTB.52 MamB facilitates iron transport and 
magnetite mineralisation, and is stabilised by the presence of MamM.52 MamB has been 
shown to play a pivotal role in MTB biomineralisation, functioning as an iron 
transporter, but also interacting with other magnetosome proteins.52 Uebe et al. have 
reported the unusual interplay in this dimer complex, particularly how the deletion of 
MamB results in the complete loss of the magnetosome.52  
Figure 5.2: a) Gel electrophoresis of magA PCR product showing a single band at approximately 2000 
base pairs. b) Colony PCR results of the same DNA product with 6 of the 10 colonies showing DNA 
present, again at 2000 base pairs; the colonies have varying concentrations (indicated by band 
intensity), with colony 10 being the highest, and therefore used in protein expression trials. 
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Whereas the deletion of MamM results in only loss of the magnetosome crystals 
homogenous crystallinity, instead forming polycrystalline particles.52 Two hypotheses 
are presented for the role of MamM in the dimer; the first being to protect it from 
proteolytic degradation, while the second suggests a role in MamB folding to ensure 
functionality.52 
A different approach to that described in section 5.2.1.1 was taken to the production of 
the MamMB complex. In this instance, a synthetic gene sequence was used based on the 
combined sequences of MamM and MamB. It was thought that expressing a single gene 
product, which allows co-translation of the two proteins simultaneously, would be 
more likely to lead to a successful protein complex. The synthetic gene was designed so 
as to read the sequence of MamM followed by the MamB sequence, with production of 
each indicated by the usual start and stop codons found in the natural genes. Between 
the two open reading frames is a ribosome binding site to allow efficient translation of 
the second sequence. The mamM sequence also encodes a C-terminal His6 tag, and the 
mamB sequence encodes a C-terminal StrepII tag. This differential tagging allows for 
separate detection of each protein of the complex individually. The synthetic gene was 
amplified by PCR. The PCR product was then digested with BsaI, the sites for which had 
been previously engineered into the synthetic gene. The cut PCR product was then 
ligated into a similarly cut pPRIBA1 vector and then introduced into XL10-Gold cells.  
Digestions and ligation were repeated several times and, despite optimisation of the 
various steps, introducing a heat inactivating step into the ligation process and using 
different preparations of vector, no colonies formed following transformation into 
XL10 Gold cells. To circumvent these issues, blunt end ligation was used to insert the 
PCR product into pCR Blunt vector (Life technologies, in which the lack of insert yields 
a toxic gene preventing cell growth). This generated colonies containing the DNA 
product represented by the bands in figure 5.3 a), confirming the presence of a DNA 



















A colony PCR of the MamMB product gave limited success, with only one of the four 
colonies collected giving a protein band which by the size (given by the band position 
on the gel) is deemed to be MamMB, following characterisation of the DNA by gel 
electrophoresis (Figure 5.3 b). Two bands at approximately 2000-3000 base pairs and 
3000-4000 base pairs were observed, the exact size of the bands are hard to 
distinguish due to poor separation of the mass ruler bands. The presence of two bands 
confirms that that both pieces of DNA have been successfully cloned, with mamB at a 
much higher concentration (bottom band) than mamM. Again, sequencing of the colony 
PCR given by the band in lane I of Figure 5.3 b) confirmed that the plasmids did in fact 
contain the mamMB construct.  
 
5.2.2 EXPRESSION OF IRON TRANSPORTERS 
 
The seven transporters in table 5.1 were included in an expression trial to obtain 
optimised conditions for maximum expression of the membrane proteins. In the case of 
MagA, MamM and MamB, the DNA plasmids obtained in section 5.2.1 were used. 
Figure 5.3: a) Gel electrophoresis of MamB cloning PCR product from a synthetic gene showing two bands 
at approximately 2000 and 3000 base pairs, believed to be mamB and mamM respectively. b) Shows the 
consequent colony PCR results of the same DNA product for the two colonies chosen with DNA products 
present again at 2000 and 3000 base pairs; the bands have varying intensities indicating that MamB is in 
relative excess.  
P a g e  | 156 
 
 
 The other targets were provided already cloned into expression vectors by Dr. Andrea 
Rawlings (Staniland group). MamN was not included in the expression trial as several 
attempts to generate colonies in BL21 (DE3) cells were unsuccessful, with no colonies 
being present after 18 hour plate incubation at 37oC. This could be due to degradation 
of the DNA stock, or potential toxicity to E. coli from the encoded gene The success of 
the other six did not warrant repeating the cloning of MamN from bacterial DNA. In the 
case of each of the other proteins, the plasmid DNA was extracted from XL10 Gold cells 
and introduced into BL21 (DE3) E. coli cells following clean-up. Colonies were grown 
on agar plates and added to starter cultures which were grown for 6-8 hours. These 
starter cultures were used to inoculate LB, 2YT, TB (Terrific broth) and SB (super 
broth) media cultures and grown for 24, 40 and 48 hours at 37 °C. Following 
incubation, cells were chemically lysed to degrade the cell wall and the proteins 
denatured using guanidine.  
Protein detection using dot blot analysis was used to determine the presence of the 
correct protein (by antibody/tag recognition) and qualitative determination of the 
relative protein concentration produced under each condition. Each target protein was 
detected using HRP labelled anti-Strep tag antibodies as described in section 2.7.4.2. 
The results of expression for each target under each condition are shown in the dot 
blot in figure 5.4. a). All six proteins expressed under at least one of the conditions 
tested, although the concentration of the proteins (given by the intensity of each spot) 































Figure 5.4: a) A dot blot for optimisation of each the growth condition of each of the six transporters 
(MamN was omitted) expression levels were analysed from growth in four different media ( LB, 2YT, TB 
and SB ) with protein concentration analysed after 24, 40 and 48 hour growth periods, detection of the 
proteins was using a strep tag specific antibody. b) Both MagA and MamMB both have His6 tags, therefore 
detection was carried out for these two samples using a His6 tag specific antibody.  
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While FeOA produced relatively high protein concentrations in LB auto inducing 
medium after 48 hours its counterpart FeOB did not give the same levels of expression. 
As the literature demonstrates these proteins need to be used in conjunction with one 
another191 as FeOB is believed to be the transporter in the FeOA/FeOB complex 
analogous to MamMB, therefore it can be deemed inadequate to express and purify 
FeOA if the same levels of production cannot be reached by FeOB. On this basis, neither 
protein was carried further. The highest expressing targets in figure 5,4 b) are MamM 
and MamMB (synthetic gene), with MamM the highest in LB after 40-48 hours 
incubation and MamMB in TB after a 48 hour growth period. Although it was 
interesting to confirm that MamM can be produced without its partner MamB, it was 
not possible to singularly clone MamB to fully confirm the findings presented in Uebe 
et al.52 MamMB produced extremely high intensity spots in multiple conditions 
(possible due to its codon optimisation) and therefore was the priority target for 
purification. 
The least abundant protein was MagA, which (section 5.2.1.1) had low or undetectable 
expression levels with each growth medium, even after the maximum time point of 48 
hours. In 2YT medium after 40 hours, there was a detectable signal; however it was not 
high enough compared to the other targets to warrant further investigation. MagA also 
has an octa-histidine tag sequence, modified sequence which can then be detected 
using an antibody which recognises a His5 sequence. Protein expression using His5-tag 
detection are shown in figure 5.4 b). The dot blots showed the presence of protein but 
at extremely low levels, therefore it was decided not to try and purify MagA. This was 
also the case for MamO, again protein was detected at extremely low concentrations, 
although grown in super broth this concentration was higher, it was determined to be 
too low compared to the expression levels of other proteins tested. 
 
5.2.3 TRANSPORTER PURIFICATION 
 
MamMB was produced in TB for 48 hours in a larger volume (2.4 L) to ensure a 
sufficient yield for membrane harvesting. Cells were harvested by centrifugation at 
4,000 x g. Membranes were isolated from the cell pellet by first disrupting the cells 
(using a cell disrupter to lyse the E. coli).  
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The cells were subjected to centrifugation to pellet the cell debris. The supernatant was 
collected and the cell membranes isolated by ultra-centrifugation (100,000 x g, for 1 
hour). The membranes were then suspended in resuspension buffer (PBS + 20 % 
glycerol) and frozen at -80˚C. The isolated membranes were then thawed and dissolved 
in PBS supplemented with 1% DDM detergent, before insoluble material was removed 
by ultracentrifugation as before. The solubilised membranes were mixed with 
streptactin resin and purified via the StrepII tag on MamM. Following competitive 
elution by desthiobiotin, the protein was applied to a nickel resin and purified via the 
His8 tag on MamB. The presence of the complex in the eluent following both 
purification steps was confirmed by detection on a Western blot using both streptactin-
HRP (for MamM) and anti His5 antibody (for MamB) in parallel (Figure 5.5). The blot 
shows that MamB (figure 5.5, left) and MamM (figure 5.5, right) are both present 














Figure 5.5: MamMB protein after affinity purification was analysed using a Western blot. The presence 
of protein was detected using a histidine specific antibody for detection of MamB (left) and a streptactin 
specific antibody for detection of MamM (right). This individual tagging made detection of both proteins 
possible from a single column fraction.  
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5.2.4 INCORPORATION INTO VESICLES 
 
The detergent micelles containing MamMB were combined with pre-formed DPhPC 
lipid vesicles with the addition of Bio-beads. The presence of the Bio-bead in the 
solution should disrupt the detergent micelles, causing their dissolution and 
subsequent incorporation of MamMB into the DPhPC lipid membrane. To aid 
incorporation, the system was incubated for 12 hours at 4˚C. Following removal of the 
Bio-beads (by centrifugation) the DPhPC liposomes were mixed with a ferrous and 
ferric iron solution combined at the stoichiometric ratio to investigate iron transport 
into the vesicle. This would serve to both confirm incorporation of the protein into the 
lipid membrane and its activity as a transporter. Unstained TEM micrographs of the 
liposomes after the incubation period (Figure 5.6) did suggest the presence of iron 
oxide in and around what is presumed to be the DPhPC liposomes (due to their highly 













Figure 5.6: TEM micrographs of DPhPC/MamMB liposomes mixtures after incubation in a ferrous and 
ferric ion mix solution (At the stoichiometric ratio for magnetite precipitation). 
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A unique feature on many of the liposomes looks to be iron ion accumulation, 
suggesting the localisation of the transporter on or in the liposomes. However it is clear 
that this accumulation is not in the core of each vesicle, looking to be located in or on 
the bilayer (which cannot be seen due to poor contrast). This is common between all 
species in the sample, appearing to all have a single accumulation (presumed to be of 
iron) on one side of the vesicle. This suggests that the transporter is accumulating 
soluble iron but is failing to transport it into the vesicle. Other micrographs (not 
shown) suggested disruption of the DPhPC liposomes by the detergent, suggesting that 
both the type of detergent and the detergent removal process needs to be better 
optimised. From the analysis conducted so far it is difficult to ascertain if the MamMB 
complex has been incorporated in a functional state within the vesicle membrane. 
Some of the vesicle species within the micrographs do suggest some localisation of the 
protein to the liposome bilayer, as shown by the accumulation of metal ions. However, 
further confirmation is required. An ideal method would be to introduce a fluorescent 
label onto the protein to visualise any potential co-localisation of the protein to the 
vesicle.  
 
5.3 IONOPHORE IRON TRANSPORT 
 
Ionophores are lipid-soluble molecules synthesised by microorganisms for the 
transport of ions across a cell membrane. These come under two classifications: 
compounds that bind to a particular ion, shielding its charge and facilitating its 
crossing of the lipid membrane, and ionophores which form channels or hydrophillic 
pores in the membrane, to allow ion transport. Ionophores can increase membrane 
permeability to certain ions.  
 
5.3.1 A23187 INCORPORATION INTO POLYMERSOMES 
 
The divalent cation ionophore, A23187, is a carboxylic acid known to carry ferrous ions 
across a bilayer membrane.167a This was used to test polymer membrane permeability 
to biological moieties and transport of iron ions in to the polymersome core.  
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The ionophore can carry various divalent ions, having been shown to transport both 
calcium and magnesium from an aqueous to an organic phase.167 In vivo this is used to 
maintain divalent concentration across membranes in rat liver mitochondria. A23187 
works via exchanging carboxylic acid protons for cations, by dissociation of the proton 
associated to the molecules carboxylic acid groups. Two ionophore molecules are 
required for the complexing of a single divalent cation, (i.e. a carboxylic acid group for 
each charge on the cation).167b 
Three polymers were screened which had previously been shown to be effective as a 
nanoreactor (Chapter 4). These were the di-block polymers PBD-PEO and PEG113-
PHPMA400 / PMPC28-PHPMA400, and the tri-block polymer PMOXA-PDMA-PMOXA. 1 % 
(v/v) of A23187 was added to each of the polymersome solutions and left for 24 hours 
in the presence of a ferrous ion solution. This should cause the transport of the ions 
across the membrane. Each polymer had a basic interior by encapsulation of NaOH ions 
prior to incubation with A23187. Incorporation of A23187 into a PBD-PEO membrane 
resulted in the production of amorphous polymer with no discrete polymersomes 
present under TEM analysis. Entrapped within the polymer appears to be iron oxide 
nanoparticles, which suggests that the ionophore is chelating iron but has disrupted 
the polymer membrane.  
Unstained TEM micrographs (Figure 5.7) of the PMOXA-PDMA-PMOXA samples show 
beam damage to the polymersome, but also the presence of electron dense material in 
the vesicle core, suggesting precipitation of iron oxide. However this electron dense 
material looks to be both amorphous and limited. This could be due to the low 
concentration of the ionophore in the solution, resulting in a finite concentration of 
ferrous ion to be transported across the membrane. This is akin to the problems 
experienced by Mann et al.4 in their earlier artificial magnetosome study. This could be 
due to the increased thickness of the polymer membrane (~10 nm) when compared to 
a biological membrane of 4-5 nm, hindering the penetration of the full membrane by of 
the ionophore. 
Finally, the A23187 was used with polymersomes prepared from PEG113-PHPMA400 / 
PMPC28-PHPMA400 without cross-linker. As with other polymers tested, after addition 
of the ionophore, the polymer was soaked in ferrous ion solution. 
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 TEM and cryo-TEM micrographs analysis (figure 5.7) shows that an electron dense 
species has accumulated within the core of the polymersomes. This is likely to be due 
to the formation of an iron oxide. The polymersomes appear distorted in the TEM 
micrographs, which could be attributed to the presence of the ionophore in the 
membrane. To confirm this, the vesicles were further analysed by cryo-TEM, which 
showed the presence of spherical polymersomes (Figure 5.7 inset), which shows the 
distortion of the membrane in the room temperature TEM images is likely to be a 














The cores of PEG113-PHPMA400 / PMPC28-PHPMA400 polymersomes appear to have 
the highest electron density of all the other polymers investigated (figure 5.7 inset). 
Despite having the thickest membrane, it is possible that the difference in the polymer 
chain lengths adds to the fluidity of the membrane, making the transport of iron across 
the membrane by the ionophores easier.  
Figure 5.7: Clockwise from top left: TEM micrographs of PBD-PEO, PEG113-PHPMA400 / PMPC28-
PHPMA400 and PMOXA-PDMS-PMOXA polymersomes after incubation with 10 mM ferrous chloride 
solution containing 1 % (v/v) A23187 to facilitate ferrous ion transport into the polymersome cores. 
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Increased iron oxide precipitation could also be improved by the chemistry of the 
polymersome membrane, namely the presence of carboxylic acids lining the vesicle 
core which could aid precipitation once A23187 has successfully transported the 
ferrous ion across the membrane. It has not yet been possible to detect the presence of 
A23187 in the membrane, for this a marker such as a fluorescent tag would be needed 
for direct visualisation of the molecule in the membrane. However, control samples 
(shown in chapter 6) have proven that ferrous and ferric ions cannot cross any of these 
polymer membranes unaided. Therefore the presence of iron oxide in the vesicle core 
can be confidently attributed to ionophore activity.  
 
5.4 BIOMIMETIC TRANSPORT SYSTEMS DISCUSSION 
 
Membrane proteins are notoriously difficult to work with, with their cloning, 
expression, purification and incorporate into artificial vesicles extremely difficult to 
perform. Furthermore, confirmation of the proteins’ orientation is also extremely 
difficult to determine. The orientation is under thermodynamic control, and is 
dependent on the hydrophobic interactions in the bilayer.76 Minimal control of this can 
be achieved during addition of the protein to the vesicle.107b Only one of the six 
transporter targets was successfully cloned, expressed and purified, which was the 
MamMB complex. Previous work had shown MamMB is extremely difficult to work 
with, due to the need for co-expression to make a stable complex of the two proteins.52 
Therefore, the decision was taken to clone the two genes mamM and mamB from a 
synthetic gene which encodes the expression of both proteins in series from a single 
piece of DNA. This had surprising success, with both proteins being co-expressed with 
less optimisation than expected. This was confirmed by the identification of the two 
different tags on each protein. A major issue with the production of membrane proteins 
is that, due to their function, they sit in a membrane, making them largely hydrophobic 
and highly insoluble. Therefore, extracting the proteins from their native membrane is 
extremely difficult. For this reason, multiple MTB transporter targets where chosen, 
and a large scale expression trial was carried out to determine optimum production 
condition for each protein. Despite the majority of the transporter targets expressing 
protein in expression trials at detectable concentrations, it was not feasible to attempt 
to purify all targets within the timeframe of this PhD. 
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 Therefore, targets that were expressing at low levels were dismissed. Only MamMB 
was successfully purified within the time constraints after solubilisation of the proteins 
with detergent micelles. Co-purification of both proteins was confirmed by Western 
blotting, showing two bands of varying sizes detected by their respective tags in the 
same column fractions. Unfortunately, testing of the protein complex for iron transport 
in a vesicle system was largely inconclusive, mainly due to limited characterisation and 
a lack of time for thorough optimisation. The TEM analysis revealed localised 
precipitation to DPhPC liposomes; it was not possible to detect the presence of the 
protein, so at this stage analysis was restricted to detection of morphological changes 
only. 
It would also be of advantage to fluorescently label the proteins to determine 
localisation to differentially labelled liposomes (either spectroscopically or using 
fluorescence microscopy). However, to perform this efficiently it would require 
mutagenesis of the protein sequence to incorporate a cysteine residue for the specific 
addition of a fluorescent tag. 
Transmembrane transport of iron ions by ionophore proved successful. Positive results 
were not seen across the board for all polymers tested, for example, A23187 was 
unsuccessful in incorporation into PBD-PEO. Limited incorporation was observed with 
PMOXA-PDMS-PMOXA, but the ionophore did appear to transport ferrous iron into the 
membrane. However, this transport was limited, meaning optimisation of the 
ionophore concentration, which would have to be increased four-fold to double the 
iron ion concentration transported, this would likely yield increased precipitation. 
PEG113-PHPMA400 / PMPC28-PHPMA400 yielded much better results, appearing to 
have electron dense material filling the vesicle cores. Although TEM analysis indicates 
that the ionophore has produced a change in the contents of the vesicle core, specific 
detection of the ionophore within the vesicle has not been confirmed. Similar to the 
future approach set out above for the MamMB complex this would ideally be via 
addition of a fluorophore.  
Although at this point analysis has been limited to TEM characterisation and 
observation of morphological changes to the vesicle structure and core. Results have 
been positive and indicated some successful incorporation and functionality of A23187 
and possible ferrous localisation to the MTB transporters. 
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 Detailed studies of the other transporter targets investigated would not only help 
characterise multiple MTB proteins, but may yield formation of fully functioning 
artificial magnetosomes. However, in its present state, biological transporters cannot 
be considered a feasible route to iron transporter in a synthetic magnetosome, due to 
difficulty of the proteins production and the low yields expressed. From an academic 
point of view further work will be carried out on this protein to fully confirm 
incorporation and functionality as a transport, but from the context of scale-up for 
biomedical application it does not represent a practical option, therefore through the 

























CHAPTER 6:  
6 SYNTHETIC TRANSPORT SYSTEMS 
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6.1 INTRODUCTION TO SYNTHETIC REAGENT TRANSPORT 
 
The natural transport system used in MTB uses protein antiporters, which both 
transport ferrous iron into the magnetosomes whilst also slowly increasing the 
internal pH by removal of H+. However, expression and purification of the antiporters 
has proven difficult; as demonstrated in chapter 5. Their inherent hydrophobic nature 
means that isolation of E. Coli membranes and later reconstitution in synthetic vesicles 
has proven challenging, and therefore impractical. Whilst their incorporation would 
have created a fully artificial magnetosome, other artificial and more practical synthetic 
methods of membrane permeation are possible, and so are investigated throughout 
this chapter. The primary method of transmembrane iron transport explored here is 
the use of electroporation. As discussed in chapter 1, electroporation is the use of an 
electric field to open temporary hydrophilic nanoscopic pores in a membrane to allow 
reagents to cross that membrane.159a, 161, 164, 192 The potential generated across the 
membrane is dependent on: the membrane composition, the vesicle size, and the 
extracellular medium; and is widely used in the field of molecular biology to deliver 
DNA into cells.164 In this chapter, electroporation is used as a completely synthetic 
method of membrane permeation. During electroporation, the reagents should be able 
to cross the vesicle membrane to precipitate magnetite within the vesicles, which is a 
novel use of this technique. In each case, the vesicles have a high pH aqueous core. 
These are suspended in an iron solution (low pH) with the membrane providing a 
barrier to mixing, and therefore to reacting. Control of the electroporation parameters 
can control the pore size, and thus the reactant flow. This should allow control over the 
size of the nanoreactor bounded MNP, as in situ electroporation could offer a magnetic 
response remotely activated by the application of an electric field. In these 
experiments, vesicles encapsulating an OH- source (optimised in chapter 3) are 
electroporated in the presence of mixed valence iron salts. This technique has been 
applied to all lipid and polymer vesicles which have produced high quality vesicles in 
the presence of basic solution in chapter 4. As with other studies in this project, many 
lipids/polymers were trialled initially, due to the large number of potentially suitable 
materials. Of those materials, those that appeared promising were then investigated 
more thoroughly to determine the type of iron oxide present. 
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6.2 ELECTROPORATION OF VESICLE MEMBRANES 
 
6.2.1 ELECTROPORATION OF LIPOSOMES 
 
The two different routes to magnetite precipitation discussed in chapter 3, were 
incorporated into the most promising liposomes, from the results presented in chapter 
4. In each case, iron chloride salt solutions were used, made up of iron (II) chloride 
tetrahydrate (FeCl₂・4H₂O, 10mM) and iron (III) chloride hexahydrate (FeCl₃ 6H₂O, 10 
mM) in a 1:2 ratio. For DOPC samples, 3ml of the 1:2 FeCl₂/FeCl₃ solutions were added 
to vesicles encapsulating either NaOH (10 mM) or urea (10 mM). Electroporation was 
used to porate the lipid membrane and allow iron ions to enter the vesicle core. These 
short lived and reversible pores, allow the non-specific exchange of solution across the 
vesicle membrane.⁸ Transport across the membrane is the result of a difference in 
chemical potential as the result of a concentration and pH gradient between the inner 
and outer solution. 
 
 ELECTROPORATION FOR ROOM TEMPERATURE CO-PRECIPITATION. 6.2.1.1
 
Following electroporation, room temperature co-precipitation vesicle samples 
(encapsulating NaOH) were kept at 4 °C. This is because the co-precipitation reaction 
using sodium hydroxide and iron salts is virtually instantaneous, precipitating 
magnetite at room temperature. TEM analysis of electroporated 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) encapsulating NaOH, shows vesicles with an average 
size of 396 ± 77 nm, (Figure 6.1 a). Vesicles appear to be filled with electron dense 
material, presumed to be iron oxide, but this needs to be confirmed using a technique 
such as singe-are electron diffraction as part of further work. The TEM analysis 
suggests that DOPC vesicles containing NaOH do produce iron oxide, possibly in the 
vesicle core. Overall, there are very few distinguishing factors with regards to the 
nature of the iron oxide precipitated such as a distinct crystal facets or the obvious 
presence of the bilayer (which should be visible at low contrast). 
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Generally, the DOPC vesicles are homogenously electron dense, and it is apparent that 
the entire vesicle structure (core and bilayer) contain the same electron dense species 





















Figure 6.3: TEM micrographs of liposomes made from a) DOPC lipid, Inset highlights electron density 
difference between what is believed to be the vesicle bilayer and the darker core b) DSPC lipid c) DPPE-PEG 
5000 lipid and d) DPPC lipid after electroporation. In each case the liposomes containing NaOH, were 
electroporated in the presence of iron ion solution for the room temperature co-precipitation of magnetite.  
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This was not what was expected, as soluble iron should have passed through the 
membrane into the vesicle core during electroporation, leaving the bilayer free of 
electron dense material. This suggests that the vesicle membrane has been flooded 
with the soluble iron, which may be in an amorphous phase. It is possible that this is 
due to the concentration of NaOH in the core being too low (either through leakage or 
too low concentration at encapsulation).  
There is some heterogeneity with respect to the electron density in some of the vesicles 
imaged, as distinct particles can be seen. These vesicles still have the homogenous dark 
core as seen in other examples, which is distinct from the smaller darker areas. This 
suggests that these darker spots are made of a different, denser material, with the 
smaller particles perhaps being in the membrane or stuck to the outer surface. Overall, 
it is clear that electroporation has been successful, as unstained DOPC vesicles now 
have dark (electron dense) material within them, which is presumed to consist of iron 
oxide species. This homogeneity with respect to the presumed vesicles encapsulation 
of iron oxide is possibly due to the high fluidity of the DOPC bilayer. However, it can 
also be seen in the sample shown in figure 6.1 a), that the applied voltage does not have 
a uniform effect, with the outcome of the precipitation differing both within and 
between vesicles. 
When the vesicle material is changed to 1,2-distearoyl-sn-glycero-3-phosphocholine 
(DSPC) but still incorporating NaOH, more definition can be observed in the TEM 
micrographs, with a visible bilayer surrounding the electron dense cores (Figure 6.1 b). 
There is a distinct difference in the sizes and shapes of the vesicles following 
electroporation. Before electroporation, vesicles are 192 ± 39 nm in size. After, there is 
a mixture of morphologies: spherical vesicles with an average size of 188 ± 49 nm but 
also elongated vesicles 597 ± 237 nm occurring after electroporation. It is possible that 
these larger structures are the result of vesicle fusion during electroporation, 
especially as some of the samples appear to have budding vesicles on the end of the 
elongated structures. Both the larger and smaller vesicles appear to have a distinct, 
electron dense core, and look to be partially fused. These larger structures were also 
present in the DSPC vesicles pre-electroporation (Figure 4.2), and so can be assumed to 
be a product of the formation method as opposed to an effect of the electroporation. 
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All of the vesicles in the DSPC sample have an electron dense core, which look to be 
particulate As these particulates have a rounded morphology rather than a facetted 
one, it is unlikely that they are salt crystals from the PBS buffer. Their spherical nature 
suggests the presence of a smaller vesicle population on which electroporation has 
been unsuccessful at generating an electron dense mineralised core. More analysis 
would need to be performed on this sample to determine if this is in fact a smaller 
vesicle population.  
For example, dilution of the sample would solubilise the structures if they are salt 
crystals and they would no longer be visible in TEM. In vesicles where the 
electroporation appears to have been successful, evident by the dark, electron dense 
vesicle core, the contents of the interior appear to be much more heterogeneous than 
within the DOPC vesicles. Furthermore, in most cases, this precipitate does not fill the 
vesicle core. Instead, the precipitate exhibits varying density, with distinct smaller 
particles in the core again having higher density when compared to the rest of the 
vesicle core. This suggests the presence of mixed species in the core, and is likely due to 
heterogeneous nucleation with in the vesicle. 
In the case of NaOH filled Dipalmitoylphosphatidylethanolamine-poly(ethylene glycol) 
(DPPE-PEG 5000) vesicles, the TEM images show a lipid network rather than vesicles 
after electroporation (figure 6.1 c). Whilst individual spherical structures could be 
vesicles of <50 nm, they are entirely embedded in the network and. Also, no distinct 
features of a vesicle (i.e. a bilayer) can be identified. Despite this, there is a clear 
difference in density between these structures and smaller darker particles. These 
particles are presumed to be iron oxide nanoparticles, and are associated with or 
embedded in larger and paler formations (presumed to be liposomes) (Figure 6.1 c). 
Unfortunately, as with the other liposome examples, while nanoparticles may be 
present they are not filling the interior of a vesicle. It is possible that this is again due to 
a shortage of iron ions that are able to penetrate the liposomes and the network, or loss 
of the basic solution due to the network formation. On the whole, the DPPE-PEG 5000 
sample is highly unsuitable for further investigation, and more exploration of the 
formation method to obtain discrete vesicles would have to be carried out. In this 
project, this is unjustified due to a large number of more successful combinations of 
materials, with the only advantage to this lipid being the PEG functionalisation.  
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However, this lipid could be re-visited in future work, if PEG attachment for biomedical 
application proves difficult with other materials.  
Liposomes prepared with Dipalmitoylphosphatidylcholine (DPPC) prepared above the 
lipid Tg. Figure 6.1 d) shows what appears to be a vesicle with a diameter of 230 nm, 
although no typical vesicular features are observed. The presence of only one vesicle in 
the TEM micrograph (Figure 6.1 d) is reflective of the poor quality of the sample. 
Although the size of the vesicle before and after electroporation is comparable, there is 
a distinct difference in the shape. Before electroporation (figure 4.2 c), vesicles appear 
extremely spherical, the vesicle in figure 6.1 d) is highly distorted (although too round 
to be a salt crystal). There is the presence of sparse electron dense material inside the 
possible vesicle; however this is much less dense than in the other electroporated lipid 
samples (Figure 6.1). It is unlikely that this electron dense material is magnetic, 
crystalline iron oxide, but is more likely to be an amorphous iron intermediate species. 
It is not clear whether this poor precipitation is the result of poor iron uptake, as DPPC 
has a Tg above the ambient temperature at which the mineralisation reaction is 
performed. Therefore, the DPPC lipid will be in the gel state, which could result in poor 
permeability even when using electroporation. However, this is unlikely as the same 
effects are not observed in DSPC (which has a similar Tg to DPPC), so it may be another 
property of this system that is responsible for the differences observed. 
The limited mineral precipitation may also be due to loss of the basic encapsulant, 
which will limit the precipitation reaction, meaning the reaction is likely to stall at an 
amorphous intermediate phase. There is no clear reason, from analysis of the DPPCs 
composition, as to why it should be more “leaky” to NaOH than the other lipids tested. 
However, in the absence of an effective leakage assay, it is impossible to say 
conclusively. Despite beam damage to the sample, it is still clear that DPPC does not 
respond well to electroporation. Only limited transport into the vesicle core has been 
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 ELECTROPORATION FOR THERMAL DECOMPOSITION CO-PRECIPITATION 6.2.1.2
 
Samples encapsulating urea were electroporated and then subsequently heated to 90°C 
in an oil bath for four hours. During this time, the decomposition of urea occurs, 
yielding ammonium hydroxide (an aqueous solution of ammonia). This increases pH 
and is able to induce the co-precipitation reaction, and should yield a single magnetite 
particle within the vesicle core. Electroporated DOPC vesicles containing urea show a 
large amount of lipid residue, and the presence of electron dense material (presumed 
to be iron oxide) (Figure 6.2 a). The presence of an electron dense precipitate confirms 
that all of the reagents of the precipitation reaction were present during the heating 
step after electroporation, and the thermal decomposition of urea was successful to 
yield a mineral precipitate. However this precipitate is not nanoparticles as expected, 
but looked to be large aggregates of electron dense material of mixed morphologies. 
Furthermore, this precipitation has not occurred within vesicles, evident by a large 











Figure 6.4: TEM micrographs of liposomes made from a) DOPC lipid b) DSPC lipid c) DPPE-PEG 5000 lipid 
and d) DPPC lipid. In each case the liposomes containing urea, were electroporated in the presence of an 
iron ion solution for the room temperature co-precipitation of magnetite. 
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As the DOPC vesicle in the room temperature experiments (section 6.2.1.1) were of a 
much higher quality, this degradation of the lipids cannot be attributed to the lipid. 
Instead, this suggests that DOPC is unable to withstand the heating step required to 
decompose CO(NH2)2.. 
When the DOPC lipid is changed to DSPC and encapsulating urea (Figure 6.2 b), only 
the presence of electron dense material (likely to be iron oxide) can be determined. 
Again, this is coupled with a large amount of lipid residue. DSPC lipid again appears 
unable to withstand the sustained period of heating, as the electron dense material 
appears to be suspended in a lipid agglomeration, rather than precipitated within 
vesicles. It is of note that the particles are extremely well defined; possibly suggesting 
that DSPC has incorporated and better retained the precipitation reactants when 
compared to the DOPC lipid, possibly due to the reduced flexibility of DSPC. 
DPPE-PEG 5000, (Figure 6.2 c) appears to be equally poor when using the urea 
magnetite precipitation route. DPPE-PEG 5000 samples still have a large amount of 
agglomeration. Contrast is greater than with unstained lipid, the liposome core is of a 
much lower electron density than with the other samples, suggesting poor 
encapsulation or permeation of reactants. This may be due to steric hindrance from the 
PEG groups on the outer leaflet of the DPPE-PEG 5000 vesicles. The heat looks to have 
disrupted the vesicle membrane, causing fusion and aggregation of the lipid, again 
likely promoted by the presence of the large outer PEG groups. When this experiment 
was repeated but with liposomes prepared above the Tg of DPPE-PEG 5000, there is 
better formation of vesicles but still no presence of iron oxide after electroporation and 
heating. These data show that vesicles cannot form when the lipid is in the gel state. 
Furthermore, the apparent agglomeration of the below Tg formed liposomes during 
heating, suggests that the liposomes are unstable upon heating. However, when 
liposome formation was repeated above the lipid Tg, liposomes are successfully 
formed. Presumably, as these liposomes drop below the Tg they return to the gel state, 
they are presumed to be stabilised, essentially “locked” in this conformation. It is likely 
that this gel state is responsible for the unsuccessful electroporation as the “locked” 
lipids are not likely to rearrange as easily upon electroporation. 
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As in the case of the NaOH sample, and to avoid the same pitfalls observed with DPPE-
PEG 5000, liposomes made with DPPC lipid were formed above the lipid Tg. When 
incorporating urea into these liposomes, very round vesicles with a distinctive electron 
density formed after electroporation and heating. These were found in small 
aggregates ((Figure 6.2 d), and their size and shape indicates that all vesicles in this 
sample have similar characteristics. The contrast that can be seen between the vesicles 
and the unstained TEM grid suggests permeation of the membrane with the iron ion 
solutions.  
 
6.3 ELECTROPORATION OF POLYMERSOMES 
 
Work in this section is taken from the publication Bain et al7 
 
6.3.1 DI-BLOCK POLYMERSOMES 
 
The di-block copolymer PBD-PEO, formed vesicles of an appropriate size, with the 
narrowest size distribution from the results presented in chapter 4. Therefore, PBD-
PEO was chosen for trial experiments on the electroporation of polymersomes. An 
initial electroporation voltage of 2500 V was chosen due to a recommendation from 
collaborators (Battaglia group, UCL) who had previously optimised these conditions for 
PBD-PEO polymersomes. Furthermore, due to the increased robustness of the 
polymersomes, it was thought that a larger voltage would be required than for the 
liposomes. This is because increasing the voltage applied to the vesicle should form 
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 TEM OF PBD-PEO POLYMERSOMES 6.3.1.1
 
When the PBD-PEO polymersomes were subjected to electroporation (2500 V, 5 
pulses), reagents were able to diffuse through the resulting membrane pores. This was 
first carried out on polymersomes pre-loaded with the iron ion solution and incubated 
in the presence of the either NaOH or CO(NH2)2 (both 10 mM) and heated if required as 
per the conditions outlined in section 2.1.3. These polymersomes appear to be filled 
with an electron dense material that is presumed to be iron oxide. In each case, a 
bilayer of approximately 5 nm can be observed around the electron dense core (Figure 
6.3). This experiment was performed initially to ensure that the polymer could behave 
in the way that was hypothesised. This is also how Mann et al4 tried to mineralise their 
phospholipid artificial magnetosomes (i.e. encapsulation of iron and base to yield the 
precipitation of iron oxide). However, the iron oxide is not homogenous across the core 
of the vesicle, presumably due to the same issues encountered in the original Mann 
work.4, 121a The finite concentration of iron encapsulated within the polymersomes core 
during formation is not sufficient to crystallise a single homogenous nanoparticle. 
Therefore the system was switched back to that used within section 6.2.1, i.e. the 
encapsulation of base and the transport of iron into the core which should continually 









 Figure 6.3: a) Shows TEM micrographs of iron solution loaded PBD-PEO polymersomes which have then 
been electroporated in the presence of NaOH. Typical vesicular features, such as the bilayer is visible in 
addition to a heterogeneous electron dense core. There is also evidence of some membrane breakage. B) 
Similarly shows the same system but electroporated in the presence of CO(NH2)2 and heated at 90°C for 
four hours. The polymersomes have remained intact throughout this period and appear again to be filled 
with heterogeneous but electron dense material.  
P a g e  | 178 
 
 
The system was reversed (base on the inside) and electroporated under identical 
conditions. The PBD-PEO polymersomes now appear as membranes decorated with 
much smaller discreet particles (Figure 6.4 b) and c). A control sample of base (NaOH) 
filled polymersomes were suspended in an iron solution, and left to incubate for 48 
hours. After this time, MNPs did not form, showing that the natural permeability of the 
PBD-PEO membrane was not sufficient to allow the reagents to penetrate the 
membrane (i.e. the base cannot leak out and the iron ions cannot leak in) (Figure 6.4 a). 
Figure 6.4 b) shows some MNPs associated with the external vesicle membrane; this is 
likely due to some degradation of the sample. The charged and magnetic nature of the 
mineralised PBD-PEO polymersomes appears to result in free iron oxide MNPs 

















Figure 6.4: Cryo-EM images of extruded PBD-PEO polymersomes before a) and after b) electroporation, 
with the latter displaying a high density of electron dense particles around the membrane (presumed to be 
iron oxide). c) Shows the same sample as in b) but imaged after drying down by regular TEM. d) Grainsize 
distributions from TEM images of a control sample (unelectroporated PBD-PEO polymersomes incubated 
in an identical iron solution) and an electroporated sample after SEC clean-up. This shows a narrower size 
distribution in the electroporated sample as a result of size separation during column clean-up e) Magnetic 
nanoparticle grainsizing taken from TEM images shows the particles to have an average diameter of 2.5 
nm (SD ± 0.5 nm). 
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In order to determine how the MNPs are associated with the membrane, Cryo-EM was 
employed (Figure 6.4 b) to ensure far fewer sample preparation artefacts.193 Cryo-EM 
images of unelectroporated polymersomes (Figure 6.4 a) and electroporated PBD-PEO 
magneto-polymersomes (Figure 6.4 b) showed particles present within and associated 
with the membrane only in cases where electroporation had been applied with 
negligible free particles in the background. This is because any unbound external 
precipitate is removed, due to difference in size when run down the SEC column. Size 
analysis of the PBD-PEO magneto-polymersomes based on the room temperature TEM 
data showed them to be 47 ± 9 nm (Figure 6.4 d). To further characterize the vesicles 
and their associated MNPs, a tomographic tilt series of the polymersome sample was 
generated. This allows for a clearer analysis of both the polymersome membrane and 
its interior (see video in the appendix). A few PBD-PEO magneto-polymersomes can be 
seen to have smaller polymersomes encapsulated within them. From analysis of the 
entire sample, it is clear that precipitation of MNPs is localised to within the outer 
membrane of the PBD-PEO magneto-polymersomes. This is evident by the lack of 
MNPs within the membrane of the inner polymersomes (see appendix video). The MNP 
size analysis shows that they have a small size and a tight size distribution of 2.5 ± 0.5 
nm in diameter (Figure 6.4 e) when electroporated at this voltage. The extremely small 
size of the particles is likely to be controlled by the elasticity of the polymer limiting 
particle growth. The nanoparticle size could be limited by the stretching range of the 
polymer membrane. Also, because of the position of the nanoparticles within in the 
membrane, it is likely that they can only propagate within the confines of the pore in 
the membrane. 
It is of particular interest that the Cryo-EM images (Figure 6.4 a and b) were obtained 
10 months after the sample was prepared, as opposed to the regular TEM image in 
Figure 6.4 c) which was obtained two months after preparation. This confirms the 
stability of the magneto-polymersomes against degradation over a long time period, 
which is promising for their potential future use in biomedical applications. It can be 
confirmed that the particles appear to be coming out of the polymersome membrane 
are still tightly bound, to either the MNPs within the membrane or the membrane itself, 
as they were not removed during SEC clean-up. 
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 Although this was an unexpected result (as precipitation was expected to occur in the 
polymersome core), it is highly advantageous as it leaves the core of the vesicle 
completely free for further functionalization, such as the encapsulation of therapeutics 
during formation or post formation. 
 
 PORE FORMATION IN DI-BLOCK POLYMERS 6.3.1.2
 
A hypothesis for the mechanism of MNP formation within the membrane during 
electroporation is that pores open allowing ion-transport across the polymer 
membrane upon application of a voltage. This would result in an iron ion / base 
interface within the poration channels. The membrane acts as a nucleation site, and the 
pore acts as a template to restrict the size of the growing MNPs within the membrane 
(Figure 6.5). Upon poration, the interface between the two reagents within the 
membrane is the point at which precipitation is likely to occur. The size of these 
particles is controlled by the pore width, i.e. the particle cannot grow outside of the 
dimensions of the membrane core. Furthermore, according to current literature,160, 164 
the pores created during electroporation are presumed to be reversible. It is unlikely 
that these pores will be able to re-close with the newly precipitated particle now sat 
inside it. Therefore, it is likely that the pore remains partially open (although filled with 
the MNP) and this gives rise to the “feathering” effect observed around the 
polymersomes (Figure 6.4 b). This hypothesis also supports that, because the pores are 
not entirely closed, continued nucleation and precipitation can occur in the pore which 
effectively then spills out.  
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Figure 6.5: Schematic of the proposed mechanism for nanoparticle synthesis within polymersomes using 
electroporation. (a) Electroporation opens pores within the membrane at which point influx of iron ions 
occurs in parallel with efflux of NaOH (encapsulated) (b). (c) Shows the in situ room temperature co-
precipitation that then occurs at the interface between the reactant solutions within the membrane. To the 
right of this is a diagram and a Cryo-EM image of a PDB-PEO magneto-polymersome.7 
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 ELEMENTAL ANALYSIS OF PBD-PEO POLYMERSOMES 6.3.1.1
 
Energy dispersive X-ray (EDX) elemental analysis showed the particles within the 
polymersome membrane were an iron-oxide species by the presence of characteristic 
peaks for Fe and O (although of course oxygen will always be present) (Figure 6.6). 
Other peaks in the spectrum arise from polymersomes (e.g. C, O), the buffer (e.g. P, Na, 
Cl & K in PBS) or the instrument itself and the formvar-carbon coated copper grid on 
which the sample has been dried down (e.g. C & Cu). Unfortunately, EDX cannot give 
any information about the redox species or amount of iron oxide present. Therefore, to 
determine the amount of iron oxide present, induced coupled plasma emission 






Figure 6.6: Energy dispersive X-ray spectrum of an MNP within the bilayer of a PDB-PEO magneto-
polymersome. Spectra show peaks for copper (CuKα at 8.05 keV, CuKβ at 8.90 keV and CuLα at 0.93 keV) as a 
result of the copper mesh TEM grids. Presence of iron oxide is indicated by peaks for both iron (FeKα at 6.40 
keV and FeKβ at 7.06 keV, and FeLα at 0.71 keV) and oxygen (OKα at 0.53 keV). Other peaks are likely to be 
due to the buffer used in the reaction and the carbon coating on the TEM grid. 
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ICP-MS revealed that iron compounds make up approximately 1.40-1.42% of the 
sample (dependent on oxide type) of the PDB-PEO magneto-polymersome (iron 
concentration: polymer concentration ratio (as measured by ICP-MS and gas 
chromatography), (Appendix calculation 1). This value was calculated using the 
approximate polymer concentration, as estimated from gas chromatography (see 
Appendix for GC polymer weight calibration) and the polymersome size (from TEM 
micrographs). This was used to calculate the internal volume of the polymer and the 
total volume occupied. Weighing the PDB-PEO polymersome used to form the 
magneto-polymersome film was done by drying a known volume of polymer solution 
at a known concentration under vacuum into a pre-weight Eppendorf. This was 
compared to the polymer theoretical weight (as measured by GC, see appendix), a ratio 
of polymer to iron oxide (by mass and ICP-MS ppm values) was established; in ppm.  
 
 MAGNETIC MEASUREMENTS OF PBD-PEO POLYMERSOMES 6.3.1.2
 
Magnetic hysteresis measurements (Figure 6.7) reveal that the particles behave 
superparamagnetically. This corresponds to the expected magnetic behaviour of the 
2.5 ± 0.5 nm sized magnetite MNPs, as they should be smaller than the single domain 
size for magnetite (which is about 30 nm)3. Magnetic measurements have been quoted 
as ranges to accommodate for the formation of either magnetite or maghemite, which 
have different molecular weights. It is not possible to tell from the magnetic 
measurements alone which of the two magnetic iron oxides have formed. To confirm 
this, further analysis would be required in the form of Mössbauer spectroscopy or 
powder X-ray diffraction (XRD). However, these techniques require large amounts of 
particles as a powder, which it has not been possible to synthesise at this time. It may 
be possible to do these measurements once scale-up of the magneto-polymersome 
process is begun. 
Magnetic analysis combined with the established ratio for polymer to iron oxide also 
reveals that MNP magnetic material makes up approximately 0.20-0.23 % of the 
magneto-polymersome mass. There is a significant difference between the percentage 
of MNP and the total amount of iron present in the sample (1 to 1.4 %).  
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This means that not all of the particles (or all of each particle) observed in the TEM 
images is magnetic. It may be that other iron oxides, such as ferrihydrite, FeO(OH)2, 
goethite (α-FeO(OH)), or other iron containing species that are not magnetic may have 













Figure 6.7: A superconducting quantum interference device (SQUID) was used to analyse the magnetic 
response of the magneto-polymersomes at 300 K. The hysteresis indicates the presence of 
superparamagnetic nanoparticles in the magneto-polymersomes. There is little to no coercivity in the 
hysteresis, which corresponds to the magnetic behaviour that is expected for magnetite particles that are 
likely to be present from the sizing analysis. 
 
 PH OF PBD-PEO POLYMERSOMES 6.3.1.3
 
pH was measured at each stage of the magneto-polymersome formation process. This 
shows minimal change in pH to the extravesicular solution before and after 
electroporation (Figure 6.8). Polymersomes were also sonicated to disrupt the 
membranes before and after electroporation.  
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Disruption of base filled polymersomes that had not undergone MNP precipitation 
showed an increase in pH as the NaOH was released. This is contrary to the disruption 
of the magneto-polymersomes, which showed a small lowering of the pH. This is 
evidence that no NaOH remains on the interior of the magneto-polymersomes after 
electroporation. It also supports that the insertion of MNPs within the polymer 
membrane does not alter the integrity of the membranes. Importantly, the small pH 
changes seen are not significant enough to raise toxicity concerns for eventual in vivo 
applications, as this indicates that all NaOH is reacted and neutralised during the MNP 

















Figure 6.8: Assay of leakage of NaOH during polymersome preparation. The pH of a polymersome solution 
(10 mg ml-1) was taken before (blue column) and after (red column) SEC clean up. The sample was then 
sonicated to break open the polymersome. The pH was then taken again to determine the effect of 
encapsulant (orange column). Finally a magneto-polymersome sample was sonicated to break them open 
and to release any unreacted NaOH and the pH taken a final time (purple column). Minimal and a lower 
change in pH after the magnetopolymersomes and cleaned up post electroporation, with a further minimal 
lowering of the pH post sonication indicating no NaOH remains post MNP production. 
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6.3.2 TRI-BLOCK POLYMERSOMES 
 
Tri-block polymer membranes differ from conventional bilayer membranes in that the 
hydrophilic-hydrophobic-hydrophilic composition of a conventional membrane is now 
all part of one molecule. This forms a monolayer with the same 
hydrophilic/hydrophobic characteristics as a traditional bilayer. Therefore, it cannot 
be assumed that a tri-block membrane (essentially a monolayer) will react to the 
application of an electric field in an identical way to a di-block polymer membrane. 
Previous studies have shown that pores can form in a PMOXA-PDMS-PMOXA 2D 
suspended membrane by application of an electric field.100b Pores are able to form in 
the PMOXA-PDMS-PMOXA membrane behaving in a manner analogous to a 
phospholipid membrane. The difference in geometry and stability between a 
suspended membrane and a polymersome monolayer means that the two systems may 
not be directly comparable. However, the extended hydrophobic region of the polymer, 
as a consequence of its ABA type composition, results in reduced permeability due to 
an increased thickness of 10 nm,100b which is about double that of a lipid bilayer. This 
means that the incorporation of biological processes and biomembrane species into 
these polymersomes is unlikely, due to its synthetic nature and low permeability. 
 
 TEM OF PMOXA-PDMS-PMOXA POLYMERSOMES 6.3.2.1
 
As with the other materials in this chapter PMOXA-PDMS-PMOXA polymersomes have 
been investigated as a nanoreactor for room temperature co-precipitation of 
magnetite. Again, an optimum concentration of NaOH (10 mM) was used as the 
aqueous solution for polymersome formation to create the high pH core environment 
needed for the precipitation. Similarly, electroporation was again used to facilitate 
synthetic iron ion transport across the PMOXA-PDMS-PMOXA membrane. The 
application of the electric potential across the membrane leads to poration. The 
presumed influx of the iron ion solution and efflux of NaOH induced precipitation, as 
with the other polymers investigated. 
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On meeting (presumably in the membrane as with PBD-PEO)7 the precipitation of 
electron dense nanoparticles is observed (Figure 6.9). The electroporated magneto-
polymersomes produced a paramagnetic response when placed in a magnetic field, 
which when combined with other data suggests a magnetic iron oxide has been 
precipitated within the polymersome, and that electroporation of tri-block 
polymersomes allows the permeation of reagents, resulting in MNP crystallisation in 











Close inspection of the polymersomes (Figure 6.9) confirms the formation of electron 
dense nanoparticles within the polymersome membrane, almost analogous to the 
raisins in a plum pudding. The particles are presumed to be iron oxide, and are tightly 
associated to the membrane as they remain bound during the column clean-up process, 
as seen with PBD-PEO discussed above. The nanoparticles have an average size of 2.7 ± 
0.9 nm, (Figure 6.10 a) and show improved monodispersity with regards to particle 
size and shape when compared to a typical room temperature co-precipitation of 
magnetite (Figure 6.10 b) & c). This particle distribution is comparable with the NPs 
formed within the bilayer of the PBD-PEO discussed above. 
 
Figure 6.9: PMOXA-PDMS-PMOXA polymersome following electroporation at 5 x pulses at 750 V shows 
electron dense material presumed to be iron oxide MNPs within the polymersome, with higher density in 
the core when compared to the extremities. 




















 In stark contrast to the di-block polymersomes (section 6.3.1.1), precipitation also 
appears to occur in the vesicle core. The core appears considerably more electron 
dense than previously seen in the TEM micrographs (Figure 6.4 c). This can be 
attributed to a higher particle yield in the membrane following electroporation, and 
greater influx of iron ions into the core of the polymersome. This would result in a 
proportion of NP precipitation within the core that is not seen the PBD-PEO magneto-
polymersomes. This is most likely due to the difference in polymer composition and 
the effect this has on the electroporation mechanism. 
Figure 6.10: (a) Shows the change in polymersome size before and after electroporation. Unelectroporated 
control polymersomes (striped bars) have an average size of 45 ± 8 nm, whereas after electroporation a dual 
polymersome population at 20 and 60 nm is observed giving an average polymersome size of 43 ± 2 nm. (b) 
Shows the formation of iron oxide nanoparticles within tri-block PMOXA-PDMS-PMOXA polymersomes as the 
result of electroporation. Inset: an example of a magneto-polymersome, showing the distribution of 
nanoparticles within the polymersomes. On the right is the corresponding grainsizing from TEM, showing the 
average nanoparticle formed after electroporation to be 3 ± 1nm in diameter. This is in comparison to (c) a 
standard room temperature co-precipitation of magnetite, grainsizing from TEM images shows an average 
nanoparticle size of 9 ± 2 nm. 
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It is possible that the tri-block polymer pores are more stable, due to polymerisation of 
the methacrylate groups, which can have a stabilising effect.9 This stabilisation would 
allow increased iron influx to the vesicle core. It is also a possibility that the increased 
length of the hydrophobic region of the polymer (4000 when compared to 1300 of the 
PDB-PEO system) would lead to decreased permeability prior to electroporation. This 
would significantly reduce leakage of NaOH out of the polymersome. Leading to a 
higher concentration of reactant being present in the vesicle core during 
electroporation. This would support the observation of a slight increase in both vesicle 
size and polydispersity after electroporation.  
Furthermore, the voltage the polymersomes are able to withstand is orders of 
magnitude higher than previously reported values for suspended membranes of 
PMOXA-PDMS-PMOXA. A voltage of 750 V was applied to the polymersomes five times, 
and this did not cause breakdown of the polymer membrane. This can be compared to 
a previously reported breakdown voltage 1 ± 0.2 V and 1.5 ± 0.2 V following 
polymerisation for a suspended membrane.100b Although there is not complete 
breakdown of the polymersomes following electroporation, there is a distinct change in 
their size distribution and morphology (figure 6.10 a & b). The polymersomes appear 
much more robust than previous membrane studies have demonstrated,100b with 
significant changes in the size and shape of the polymersomes. Post electroporation, 
polymersomes form a dual population at 20 and 60 nm, which give an average 
polymersome size of 43 ± 12 nm. 
 
 PORE FORMATION IN TRI-BLOCK POLYMERS 6.3.2.2
 
Polymersomes also appear to be misshapen when compared to the non-electroporated 
control sample, (Figure 6.10 a) and to other di-block polymersomes. Di-block 
polymersomes are able to maintain their shape following the application of voltages up 
to 2500 V.7 For these reasons, it is believed that the electroporation pore formation and 
molecular rearrangement of the membrane in a tri-block co-polymer differs 
substantially from bilayer arrangements previously reported.161  
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It is reasonable to believe that the generally accepted theories of electroporation, both 
the transient aqueous pore mechanism159a, 160b, 194 and the water wire mechanism195 
could both cause membrane pore formation, as there is currently insufficient evidence 
to draw a firm conclusion. However, these mechanisms are based on bilayer membrane 
arrangements composed of molecules with a single hydrophobic and single 
hydrophillic region. The new single-layer membrane ABA tri-block polymersome 
differs from this model, and as such will likely yield significantly different results upon 
electroporation. This should be able to contribute to electroporation theory and the 
establishment of a conclusive mechanism. 
It has previously been proposed by both Lomora196 and Itel197 that the tri-block 
polymers could completely double over on itself, in a configuration analogous to a 
“hairpin”, which would render them equivalent to a di-block or lipid, thus assembling 
to form a bilayer equivalent to a lipid bilayer (as shown by Figure 6.11 b). However 
further analysis would be required to investigate whether this is possible for a polymer 
with a molar mass as large as 4000 g/mol; such as the polymer used here, this could 
include more detailed studies on the polymersomes mechanical properties (such as the 
elasticity and bending modulus) or more involved and accurate techniques such as 
neutron scattering. More achievable measurements could come from Cryo-EM analysis, 
which should allow for more accurate bilayer thickness measurements, which may give 
an indication as to how the polymer is assembling. 
While this may be the case, the tri-block magneto-polymersomes are distinctly different 
to those formed with lipids and di-block co-polymers, in that there is electron dense 
material also within the core of the vesicle which gradually lessens towards the vesicle 
extremities. Therefore, it is possible that a different mechanism is in play. One 
hypothesis is that because the membrane is one unit (a single polymer as opposed to 2 
polymers forming a bilayer), this would mean that head group rearrangement to form a 
pore is restricted (Figure 6.11). A mechanism for the polymers rearrangement during 
electroporation may be due to the mechanical properties arising from the tri-block 
composition of PMOXA-PDMS-PMOXA. Flexibility within the tri-block polymer 
membrane could mean that the introduction of polar water molecules into the 
membrane by electroporation could cause the polymer to bend over on itself to shield 
the hydrophobic region of it structure (Figure 6.11 c). 
 








This is possible due to both the length of the membrane and its high flexibility. The 
driving force of this rearrangement is that adopting a bent configuration would likely 
be more entropically favourable than interactions between the PDMS and water. 
Furthermore, the distortion observed post electroporation (which has not been the 
case with other materials explored) suggests that electroporation and mineralisation is 
more destructive to the integrity of the polymersome morphology than for the di-block 
and phospholipid bilayer vesicles. It may be that, for the tri-block polymersomes, the 
electroporation process is not as reversible as with polar head rearrangement seen for 
di-block and lipid membranes. This may be due to interactions between the reactive 
PMOXA end groups on the polymer (Figure 6.11 c) maintaining the pores, or the 
extreme bending of the polymer damaging its structure. In each case this is likely to be 
the cause of both the change in polymersome morphology and increase in particles 
observed, as well as more MNP density in the core as the pore are retained.  
Figure 6.11: Schematic of our hypothesis of the formation of pores by electroporation. a) Shows the 
case for a lipid or di-block polymers. The PMOXA-PDMA-PMOXA tri-block membrane could self-
assemble in one of two ways: b) shows a schematic of the completely fold over hairpin-like membrane 
form analogous to a more traditional bilayer, which can then follow the same mechanisms for 
electroporation as a), and c) shows the tri-block assembly as a monolayer and on electroporation bend 
over on it-self to shield the hydrophobic region of it structure. 
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This theory could be proven by applying the same method to tri-block polymer 
possessing a smaller hydrophobic region. Decreasing the hydrophobic region would 
reduce flexibility and ability to shield the hydrophobic region, possibly resulting in less 
poration or no poration, with high fields resulting in membrane breakdown. 
 
6.3.3 CARBOXYLIC ACID TERMINATED RAFT SYNTHESISED 
POLYMERSOMES 
 
PEG-PHPMA / PMPC-PHPMA polymersomes, have been designed by the group of 
Professor Stephen Armes, (University of Sheffield) to assemble so that the carboxylic 
acid groups of the PHPMA monomer are displayed on the inner membrane of the 
polymersome. This can be used to mimic the nucleation properties of the MTB 
biomineralisation proteins, which are rich in carboxylic acids. These polymersomes 
were electroporated with the same iron ion solution as used with other polymers 
tested. Unstained TEM images (Figure 6.12) suggests electroporation was successful 
for the PGMA polymersomes. This is the case for both those with the unprocessed 
polymer (Figure 6.12 a) and with the presence of an ethylene glycol dimethylacrylate 
(EGDMA) cross-linker (Figure 6.12 b), as all have dark, electron dense cores, which is 














Figure 6.12: TEM micrographs of PEG-PHPMA / PMPC-PHPMA polymersomes encapsulating NaOH (10 
mM) a) without and b) addition of EGDMA cross-linker. Polymersomes were electroporated (750 V, 5 times) 
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However these results differed from electroporation of the other polymersomes. In this 
case, electron dense material seems to fill the entire core of the polymersomes. TEM 
shows vesicle membranes which are much wider, at 50 nm, than those seen before 
(Figure 6.12). It has been shown by Warren et al2a that as the PHPMA molecular weight 
increases the polymersome membrane grows exclusively inwards, eventually leading 
to vesicle death.2a This increase in membrane width is likely to affect the polymersome 
properties, particularly under electroporation (to look more like the PMPC32 sample 
(chapter 4). More notably, there is a dark ring around the outside of each 
polymersome, which also seems to have caused aggregation of the vesicles. There is a 
dark vesicle core which is equally electron dense to the outer layer of the 
polymersomes (Figure 6.12 b), suggesting that incorporation  of the carboxylic acids 
groups into the polymer are on both leaflets of the bilayer causing the additional 
nucleation of iron oxide around the outer rim of the polymersomes. 
 
6.4 OPTIMISATION OF ELECTROPORATION 
 
In an effort to optimise the electroporation process and understand the mechanisms of 
membrane rearrangement on application of the electric field, a varied voltage, reagent 
concentration and number of pulse were applied to the polymersome sample. These 
experiments were carried out on three examples of different types of membranes, a di-
block polymer membrane (PBD-PEO), a tri-block membrane (PMOXA-PDMS-PMOXA), 
and a lipid membrane (DSPC). The amount of electron dense material present in the 
vesicles was analysed after the samples were cleaned using SEC, to remove any 
unreacted soluble iron precipitate or iron oxide that had not been successfully 
incorporated into or on the polymer. Vesicles were dissolved in nitric acid (5 ml total 
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When PBD-PEO polymersomes were electroporated between 250 and 2500 V, a 
general trend of increasing incorporation of iron is observed with increasing voltage, 
(measurement obtained from iron content in ICP-MS) (Figure 6.13). This is presumed 
to be due to a higher voltage being able to open larger pores in the membrane. It may 
also be that the higher voltage resulted in deeper penetration of the membrane, with 




FIGURE 6.13: ICP-MS iron of PBD-PEO magneto-polymersomes content measured as a function of the 
voltage applied to the polymersomes during electroporation showing increasing iron incorporation with 
increased electroporation voltage. 
 
It can be presumed that the iron in the ICP-MS sample (within error) is tightly 
associated with polymersomes, as they have been passed through the SEC column after 
electroporation. This means that any external iron precipitate in the sample should 
have been removed by a combination of SEC and centrifugation. When, at a low voltage 
of 200 V, the number of pulses applied to the sample is increased from 2 to 50 pulses, 
iron content as measured by ICP-MS also increases (Figure 6.14 a).  
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It is perhaps surprising that the polymersomes are able to withstand the application of 
50 pulses. By applying a low voltage multiple times, it is expected that fewer, smaller 
pores will be opened each time. As more pulses are applied, this will slowly build up 
the number and/or size of particles precipitated in the membrane. This will depend on 
whether each pulse opens new pores in the membrane (more NPs) or if previous NP 
containing pores are re-opened (larger NPs). In either case, this will allow an increased 
mass of iron to precipitate within the membrane, with each pulse applied to the 







Figure 6.14: Iron content (ppm) in magnetopolymersome samples as a function of the number of pulses 
applied to the sample at a) 200 V and b) 1000 V. 
 
This same trend is not observed when the pulse number is varied at higher voltages 
(1000 V) (Figure 6.14). In all cases, the Fe content is lower for these samples 
electroporated at higher applied voltages. A huge (4 fold) increase of iron content is 
observed when the number of pulses is increased from 2 to 10 pulses (the same pulse 
increase at 200 V for the same range is only 2 fold). However, the iron content at 50 
pulses returns to a much lower level, similar to iron content seen at 2 pulses when the 
applied voltage is 1000 V. Whereas at 200 V a further increase occurs, at the higher 
voltage of 1000 V, a dramatic decrease in the polymersome iron content ensues, back 
down to a ppm level which is comparable to that obtained with just 2 pulses (Figure 
6.14 b). The reason for this decrease is unclear, but one possible explanation could be 
that the vesicle structure is compromised after the large high number of voltage pulses.  
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Further analysis is required to confirm if vesicles are still present following 
electroporation under these most extreme conditions. It is likely that there are 
optimum critical values between 10 and 50 pulses, at which point maximum iron oxide 




















Figure 6.15: a) TEM micrographs of polymersomes after electroporation at different voltages 
and increasing NaOH concentration (as labelled). b) Shows the corresponding MNP grainsize 
analysis for each sample.  
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By exploration of this matrix, and by fine tuning of the number of pulses at each 
voltage, an optimum pulse number for maximum precipitation could be extrapolated 
for each applied voltage, by further work.  The most telling results for the mechanisms 
of electroporation come from TEM micrographs electroporated at the two extreme 
voltages (200 V and 1000 V). As the voltage is increased five-fold, and NaOH 
concentration kept constant, the number of nanoparticles in each polymersome 
increases approximately three-fold (as determined by visual inspection), (Figure 6.15 
a), but the particle size decreases dramatically (Figure 6.15 b).  
Furthermore, applying a fixed voltage to samples containing increasing concentrations 
of NaOH and mixed valence iron solution increases the number of particles present but 
has less effect on the particle size. This suggests a mechanism where once the pore has 
been opened the more reagent there is present, the more the particle can grow; 
perhaps even sustaining the lifetime of the pore by continued precipitation. It is also 
possible that, at a lower voltage, the pores are wider or open for longer, either of which 
would also lead to increased particle size. Increasing voltage seems to also have an 
effect on cross-membrane transport and subsequent precipitation, by increasing the 
number of pores in the membrane per pulse applied. This therefore increases the 
number of opportunities for precipitation, hence increasing the number of particles per 
polymersome. 
Electroporation of the PMOXA-PDMS-PMOXA membrane was also carried out at three 
different voltages: 200, 750 and 1500 V. ICP-MS was used to assess the iron content in 








 Figure 6.16: ICP-MS iron content (ppm) of magneto-polymersomes as a function of the voltage applied to 
tri-block polymersomes during electroporation with varied electroporation applied voltage. 
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The largest amount of iron was observed for 750 V (6.5 ppm), suggesting this is the 
optimal voltage to carry out electroporation at; this value is in agreement with studies 
presented in chapter 7.  
The use of significantly lower voltages (200 V) may lead to poration which does not 
fully penetrate through the entire membrane, or fewer pores opening, limiting iron ion 
permeation into the vesicle. Conversely, larger voltages may lead to ions or base 
leaking through the pores before they are able to react. This forms the basis or working 
hypothesis that pores formed at lower electroporation voltages are either larger or 
more stable, allowing increased precipitation within the membrane. Whereas at higher 
voltage, pores may be smaller and/or close more quickly and therefore the resulting 
particles are much smaller. As with other studies in this chapter, more in depth 
investigation is required to confirm these results and further optimisation is required 
(e.g. temperature, ratio of iron ions in solution, type of polymersomes electroporated) 
which will likely affect the outcome of electroporation. 
 
6.5 ROOM TEMPERATURE: INCORPORATION OF IRON INTO  
RAFT POLYMERSOMES 
 
PEG-PHMPA/PMPCA-PHPMA was of particular interest, due to the COOH group on the 
PHMPA monomer. It is hypothesised that the addition of these groups will mimic the 
ferrous ion binding sites of the Mms6 protein as a possible nucleation site on the inner 
leaflet of the polymersome for precipitation of magnetite in natural magnetsomes. 
Should it be possible to preferentially place all of these groups on the inner leaflet of 
the vesicle, this should create a synthetic mimic of the proteins incorporated into the 
MTB membrane. To attempt to achieve this, the EGDMA cross-linker was incorporated 
into some samples in an attempt to lock all of the COOH groups on the inside of the 
vesicle and avoid bilayer “flip-flop” turning these acidic moieties to the external surface 
of the vesicles. 
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These polymersomes assemble as part of the polymer synthesis process, and in some 
cases are pre-cross-linked. Therefore, the same method of encapsulation during 
rehydration could not be employed as was used with the other liposomes and 
polymersomes. Instead, these pre-formed polymersomes were left in solution with 10 
mM Fe2+ solution for 4 days to ensure diffusion of iron into polymersomes. 
 This differs from the usual stoichiometric ratio of ferrous to ferric iron (1:2), as the 
carboxylic acid groups on the PHPMA polymer are expected to bind only ferrous iron 
(mimicking the biomineralisation proteins in MTB). These iron soaked samples were 
then cleaned using SEC before NaOH was added to mineralise these RAFT 
polymersomes. TEM images (Figure 6.17 a) obtained from the non-cross-linked PEG-
PHPMA/PMPC-PHPMA polymersomes show a monodisperse vesicle population, with 
dark rings on the inner and outer leaflet of the polymersomes. This suggests chelation 
of electron dense material to the carboxylic acids on the polymersome membrane 
surfaces, but limited nucleation within the vesicle core. This is likely to be due to the 
concentration of iron ions being too low. There are multiple reasons for this low 
concentration such as: nucleation on the outer polymersome leaflet which could 
prevent permeation of the ferrous ions to the core, or low permeability of the ferrous 
ions through the membrane, independent of the concentration. However when this 
experiment was repeated on multiple occasions, unstained TEM images (Figure 6.17 b) 
showed polymersomes that do not have a dark core, indicating the membrane may be 
impermeable to ferrous ions, as suggested by the earlier experiment. Therefore 
mineralisation of these pre-formed polymersomes is unreliable and not reproducible, 
























To assess the success of the iron oxide precipitation TEM images on cross linked and 
non-cross-linked polymer after clean up via SEC were taken (Figure 6.17). These dark 
areas remain attached, even after samples were cleaned up using SEC, and so should 
still be functional for ferrous ion binding. It appears overall that nanoparticles have 
formed both inside and outside these structures. This suggests that carboxylic acid 
groups are displayed on both sides of the polymersomes, in spite of efforts to orientate 
them exclusively on the inside. More investigation is required to understand exactly 
why there is intermittent uptake of iron (Figure 6.17 a) and b). Perhaps, more 
importantly, these groups do seem to be involved in coordinating the growing 
nanocrystal by mimicking the Mms6 nucleation site. This is certainly at least a proof of 
concept for the use of polymers and synthetic amino acid mimics such as these to carry 
out biomineralisation reactions inside vesicles. 
A second and unique method to precipitate iron oxide inside the PGMA polymersomes 
was developed, in which polymersomes encapsulating NaOH were added to a room 
temperature co-precipitation (RTCP) magnetite synthesis (Figure 6.18). The reaction 
uses stoichiometric amounts of base and iron ions (outside of the polymersomes) to 
produce magnetite.  
 
Figure 5.17: PEG-PHPMA / PMPC-PHPMA polymersomes, after being soaked in iron ion solution for 4 days. As can 
be seen in a) electron dense material is chelated to both the inner and outer leaflet, whereas compared to b) in 
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It was hypothesised that, by addition of the polymersomes to the reaction, some of the 
mineralisation reaction would occur within the polymersome by diffusion of the 
reactants. To allow full conversion to magnetite from other iron oxides, the reaction 









After magnetic separation, two layers were observed: a bottom layer of black particles, 
and a top white layer of polymersomes. The polymersomes were speckled with orange 
and black, suggesting incorporation of iron oxide. To separate polymersomes from any 
external precipitate, samples were heating to 80°, the heating step causes the polymer 
to flocculate to the top of the reaction vessel. A dirty white layer, which is thought to 
contain polymersomes with encapsulated nanoparticles was subsequently removed 
from the rest of the solution.. TEM images of this layer (Figure 6.19) suggest 
incorporation of iron oxide was successful in all samples, as a dark electron dense core 
can be seen in the polymersomes, although further characterisation and optimisation is 






Figure 6.18: Schematic of room temperature precipitation incorporation into polymersomes a) pre-
formed polymersomes are added to the mixed valence iron solution of a room temperature co-
precipitation (section 2.1.1). b) As the precipitation reaction proceeds, it is anticipated that permeation of 
the reagents (iron and hydroxyl ions) through the vesicle membrane will result in c) pecipitation of 
magnetite within the polymersomes core, d) polymersomes are the collected by heating the solution to 80 
°C, at which point the polymer flocculates to the top of the solution and can be collected. 












6.6 DISCUSSION OF SYNTHETIC TRANSPORT SYSTEMS 
 
This chapter documents the first time electroporation has been used to permeate 
synthetic vesicle biomineralisation nanoreactors. The advantage of this method is that 
it a simple process (far less complex than incorporating biological trans-membrane 
transporters). With optimisation, electroporation may also offer greater templated 
control of the inorganic metal oxide precipitation reaction being encapsulated. This 
should allow the development of magnetically tuneable vesicles. The hypothesis for the 
mechanism of electroporation (Figure 6.5) is that it induces pore formation. In these 
vesicles, this should enable the simultaneous efflux of base and influx of iron through 
the pores to mix the reagents and equilibrate the pH gradient. It appears that this 
occurs at a mixing boundary within the membrane, yielding the crystallisation of 
multiple membrane embedded MNPs templated within the electroporated pores.  
In the case of the lipids tested, the room temperature co-precipitation route appeared 
more amenable for use in conjunction with electroporation, although none of the lipid 
samples gave high amounts of monodispersed nanoparticles or a single nanoparticle in 
the vesicle core. All liposome samples appear to contain aggregated non-liposomally 
associated lipid residue. 
a) b) 
Figure 6.19: Incorporation of iron oxide by incubation of PEG-PHPMA / PMPC-PHPMA polymersomes, in a 
room temperature co-precipitation reaction a) without and b) with cross-linker. The mineralisation in this 
case was carried out with both iron salts and base on the exterior of the pre-made polymersomes. 
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 Overall, the liposomes are able to maintain their structural integrity following 
electroporation for the room temperature route to precipitation, with the vesicles for 
the most part remaining intact and almost identical in size and morphology to those 
imaged before the voltage was applied. For DPPE-PEG 5000 and DPPC, precipitation 
was finite with limited precipitation in the core. It is unclear (due to lack of an 
appropriate assay) whether this is due to low base encapsulation or limited 
electroporation success. The resulting precipitate was relatively heterogeneous where 
encapsulation and uptake of iron ions appeared much more successful (DOPC/DSPC). 
There appears to be a homogenous amorphous species which fills the core, in addition 
there is also a suite of smaller more electron dense heterogeneous NPs. For DSPC, the 
amount of this precipitate also varies considerably between vesicles in the same 
sample. In the case of the CO(NH2)2, most lipids did not appear to withstand the four 
hour heating step necessary for the decomposition of urea to ammonium hydroxide, 
except in the case of DPPC liposomes. The DPPC liposomes were formed at 
temperatures above the Tg of the lipid, which appears to yield more stable liposomes. 
On the whole, liposomes do not fare well under the harsh heating conditions necessary 
to thermally decompose urea. For this reason, polymersomes were deemed to be 
possibly a more robust route to the formation of vesicle templated magnetic 
nanoparticles. As such, polymersomes were trialled in identical experiments. 
Polymersomes were formed that encapsulate either NaOH or urea to be used in the two 
different magnetite precipitation routes. Once electroporated, they were then left to 
age (NaOH) or heated (urea) depending on the encapsulate, to induce magnetite 
precipitation. In the case of the PBD-PEO and PMOXA-PDMA-PMOXA polymersomes 
they were tested for the in situ formation of MNPs within a vesicle. The diameter of 
magneto-polymersomes was shown to be uniform by DLS and TEM, with no signs of 
aggregation. The mineralised polymersomes are embedded with electron dense NPs, 
presumed to be iron oxide. These NPs vary in size depending on the electroporation 
conditions used (Figure 6.15). Further optimisation of the reactant concentrations can 
alter the rate of influx and efflux of substances across the membrane, due to the basic 
principles of osmosis and diffusion. Figure 6.16 demonstrates the first steps towards a 
tuneable method of nanoreactor encapsulated magnetite synthesis, and offers 
flexibility with respect to designing the number and size of the MNPs within the 
membrane simply by altering the reagent concentration and/or the electroporation 
parameters. 
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 Whilst these results are by no means conclusive with regards to explaining the 
mechanism of electroporation as applied to polymersomes, it does shed light on some 
of the theories in the literature. However, to truly understand the mechanism of 
electroporation and to obtain full control over the nanoreactor bounded mineralisation 
process is likely to be the subject of another full thesis. 
Interesting results were gathered with the carboxylic acid terminated polymers PEG-
PHPMA / PMPC-PHPMA. The addition of the carboxylic acid groups appeared to be 
effective in the nucleation of iron ions and precipitation of iron oxide. However, the 
electron dense material seems to be precipitating on both the inner and outer leaflet of 
the polymersomes, with the internal precipitation appearing more limited. Further 
investigation is required to determine whether this limited precipitation is due to an 
issue with reactant concentration, or if it is due to the location of a proportion of the 
carboxylic acid groups on the outer leaflet of the polymersomes. Despite this double 
edged mineralisation, these data are extremely promising, as the mineralisation 
method appears to have been effective. However, as with all of these methods, further 
optimisation is required with respect to maximising trans-membrane iron ion 
transport. Control over the arrangement of the carboxylic acids groups to exclusively 
display on the inner leaflet of the polymersomes (by modification of the polymer chain 
lengths), could well solve this issue and ensure that internal polymersome 





















CHAPTER 7:  
 
7 HIGH-THROUGHPUT SYNTHESIS 
AND ELECTROPORATION OF 
VESICLES  
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7.1 INTRODUCTION TO HIGH-THROUGHPUT SYNTHESIS USING 
ELECTROHYDRODYNAMIC ATOMISATION (EHDA) 
 
Although monodisperse vesicle populations can be achieved using conventional 
processes such as tip sonication and extrusion (Section 4.2.2), for large-scale 
production of vesicles, they do not constitute feasible methods as they are time-
consuming and difficult to scale above microgram quantities (particularly with regards 
to extrusion). To achieve commercially viable yields of monodisperse vesicles, other 
more high-throughput methods of production have been explored. 
Taking an engineering approach to high-throughput synthesis of vesicle formation led 
to collaboration with the Edirisinghe group, at the Department of Mechanical 
Engineering University College London (UCL). The Edirisinghe group have designed 
multiple ways to synthesise vesicles based on a method termed Electrohydrodynamic 
Atomisation (EHDA). In EHDA, fluid is delivered through a needle under an electric 
field.113-114 The technique has traditionally been used for the high-throughput 
production of microbubbles, solid nanoparticles and some forms of electrospinning.113-
114 
Briefly, EHDA comprises the lipid or polymer solution delivery at an optimised rate, via 
a syringe driver. The solution is then fed through a capillary needle of a specific length; 
this length depends on both the material used and the desired end morphology (Figure 
7.1). The capillary can be single (EHDA), co-axial (CEHDA) or also multi-junction (for 
example, T-junctions). Each of which allow various methods of delivery to be explored 
with multiple solutions incorporated at varying points in the synthesis. The electric 
potential delivered across the end of the capillary causes the breakdown of the solution 
into monodisperse droplets; in the case of bubbles or droplets (Figure 7.1). This 
droplet size determines the size of the end particle, and is regulated by the voltage 
applied to the capillary; in the order of kV. The polydispersity of the population 
achieved via EHDA/CEHDA is controlled by the jetting mode used; which is again 
determined by the applied voltage. The various jetting modes achievable include, a 
single conejet; producing the most monodisperse populations. Bi-jet and multi-jetting 
is also possible, with the polydispersity of the sample gradually increasing as the jets 
multiply.  













Figure 7.1: Schematic diagram showing experimental set-up for the electrohydrodynamic production of 
artificial magnetosomes. a) Encapsulation of NaOH within DSPC liposomes via the EHDA jetting system, b) 
showing the composition of the EHDA formed vesicles, c) before being introduced to mixed valence iron 
solution which is consequently electroporated at 750 V, d) to yield a magnetic nanoparticle within the 
vesicle core (artificial magnetosome). 
 
The synthesis of vesicles via EHDA is a novel process jointly developed the 
Staniland/Edirisinghe groups, specifically between myself and Dr Poonam Kaushik 
Bakhshi from the Edirisinghe group, for the high-throughput synthesis of artificial 
magnetosomes. Throughout the optimisation of the EHDA magneto-vesicle synthesis, 
parameters such as needle length, flow rate and applied voltage were both explored 
and optimised, using both EHDA and CEHDA, for lipid and polymer systems. The 
successful synthesis of an artificial magnetosome lipid system was the aim of this work, 
but at a higher yield than other methods explored thus far. As with all other studies 
throughout this project, the system is designed to mimic the invagination of the 
cytoplasmic membrane in MTB to form an empty magnetosome. In this case with the 
DSPC assembly process, this occurs as the lipid is delivered to the end of the capillary, 
at the point where the lipid flow is broken down into monodisperse droplets, giving 
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The results and discussion throughout this chapter is based on the joint first author 
publication Bakshi/Bain et al.198 
 
7.2 HIGH THROUGHPUT VESICLE FORMATION USING EHDA 
 
The size and morphology of the MTB magnetosomes is a key advantage when 
compared to conventionally synthesised, non-biogenic MNPs. Therefore, an essential 
property of an artificial magnetosome system must be tight control.39b, 58a, 199 Making 
artificial magnetosomes using EHDA offers a high-yield route to more adaptable 
functional MNPs, and represents an excellent model system for biomineralisation. 
Throughout the chapter this goal is achieved by the formation of lipid vesicles using the 
high-throughput electrohydrodynamic atomisation (EHDA) methodology. EHDA 
vesicles were porated by way of electroporation (as described in chapter 6), to 
transport iron into the vesicle core, to encourage magnetite crystallisation. A single-
crystal iron oxide nanoparticle was precipitated within each liposome, forming a near-
monodisperse population. The particles were assessed by TEM, Cryo-EM, fluorescence 
microscopy, DLS, Raman spectroscopy and magnetic susceptibility measurements. The 
results indicate the potential for a commercially viable route of producing very high-
yields of artificial magnetosomes. 
 
7.2.1 OPTIMISATION OF EHDA 
 
Several of the materials discussed throughout chapter 4 were used to determine the 
ideal lipid or polymer material combinations in the optimisation of artificial 
magnetosome synthesis via EHDA. The results of previous vesicle formation 
experiments using these materials (chapter 4) differed considerably to the results 
presented throughout this chapter. This is presumably due to the introduction of the 
applied voltage during EHDA altering the assembly process.  
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Specifically, the synthesis of DSPC vesicle using the EHDA technique produces a much 
more monodisperse population when compared to synthesis via methods such as tip 
sonication and extrusion. Due to the large volumes of lipid and/or polymer needed to 
run the EHDA experiment, not all materials investigated in Chapter 4 were suitable for 
EHDA vesicle synthesis. For example, the expensive DPhPC produced possibly the best 
vesicles in chapter 4, however the large amount of lipid that would be required to 
repeat this experiment make the cost of using this lipid unfeasible. Initial experiments 
have been carried out using the EHDA equipment at the Erdisinghe lab (UCL) by Dr 
Poonam Bakshi, who optimised the needle length to be used. Experiments were 
performed on both the single and co-axial capillary systems using a wide variety of 
materials and material combinations. For the observation of the slurry during EHDA 
jetting, a high speed camera (Weinberger AG, Dietikon, Switzerland) was connected to 
a computer and a fibre optic light source was used for illumination. Data were recorded 
at 138 frame s-1 and shutter control was 1/140 s. Samples were then analysed using 
both DLS sizing and conventional TEM images (performed by Dr. Bakshi)  
 
 
 SINGLE-AXIAL EXPERIMENTS 7.2.1.1
 
The conventional polymersome synthesis method requires up to 24 hours of stirring to 
fully rehydrate a polymer film, with regards to the polymer-base solutions tested. In 
the case of an EHDA polymer sample, the polymer film rehydration was not used. 
Instead, for single axial experiments, a 17% (w/v) polymer in ethanol solution was 
added to the appropriate base. It is possible that some polymersome self-assembly may 
occur prior to EHDA in the syringe pump, before being passed through the EHDA 
capillary. However, it is thought that any assembly that had occurred would 
disassemble and subsequently re-assemble, in a similar manner to that seen during 
extrusion (Section 4.2.2), or at the very least modified by the effects of passing the 
solution through the EHDA. In each case, the solution produced by the EHDA in various 
jetting modes115 were collected in an iron solution (Fe2+/Fe3+ 2:1) and subsequently 
electroporated. The distance between the needle tip and the iron solution bath was 
120-150 mm.  
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Table 7.1: Single axial experiments performed on various lipid and polymer material. 
 
DSPC liposome formation was tested using the single axial EHDA system. The resulting 
TEM images (Figure 7.2 a) (i)) show much improved liposomes of a relatively 
monodisperse size of 106 ± 22 nm when compared to liposomes synthesised via tip 
sonication (192 ± 39 nm). Experiments were also carried out using an A-B-A tri-block 
copolymer (PMOXA−PDMS−PMOXA, 17% w/v solution in ethanol) (Table 7.1). 
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Optical microscopy images (Figure 7.2 b) (i)) suggests that nanoscale vesicles were not 
present in solution, but more likely to be polymer micro-particles, produced by the 
EHDA system. The most likely composition of these particles is as a mixture of polymer 
and base that, due to variation in solute and solution, have remained stable.  
TEM carried out on the PMOXA−PDMS−PMOXA EDHA produced particles showed only 
a small number of dark spots on the grid. As there is no distinct structure to the 
particles, they are unlikely to be vesicles. Also tested was an amphiphilic commercially 
available polymer (PEO-Stearate 40 5% w/v solution) purchased from Sigma Aldrich. 
Again, optical microscopy images suggested the presence of polymer particles on the 
microscale.  
TEM imaging of the PEO-Stearate sample (Figure 7.2 c) (i)) show an electron dense 
material, which is likely to be crystalline iron oxide. This has precipitated due to the 
presence of un-encapsulated base during the atomisation process, which has led to 
uncontrolled precipitation in the iron solution.  
The TEM micrographs also show what appears to be residual polymer in the solution, 
meaning assembly was largely unsuccessful. Although there seems to be vesicle-like 
species, it is more likely, when combined with the optical imaging, that these are 
polymer particles produced by the cone-jet of EHDA.  
 
 CO-AXIAL EXPERIMENTS 7.2.1.2
 
The experimental set-up for the coaxial needle EHDA jetting consists of a needle within 
a needle stainless steel coaxial device coupled to the high power voltage supply. In each 
case, the basic solution intended for the interior of the vesicle is delivered through the 
inner capillary. Simultaneously, the lipid or polymer encapsulating solution is delivered 
via the outer capillary. This method was developed based on the theory that the co-
axial flow will induce vesicle formation as a droplet forms at the end of the capillary. 
The droplet then forms with the NaOH solution on the inside of the lipid or polymer 
solution, forming a droplet within a droplet. Optimisation of flow rate and voltage was 
conducted with a view to obtaining a stable cone jet.  
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Co-axial experiments in which polymers or lipids are dissolved in organic solvent was 
driven through the outer capillary, and a solution of aqueous NaOH through the inner 
capillary, creating “a-droplet-within-a-droplet” encapsulation system. These 
experiments proved to be unsuccessful in establishing a cone-jet. This is most likely 
because of a mismatch between the two solution spray rates, which meant they failed 
to establish a stable jetting mode. For this reason, there were fewer material 
combinations suitable for this methodology, with most failing to form a stable jet. 
For the synthesis of artificial magnetosomes, the inner needle was fed with aqueous 0.1 
M NaOH, and the outer needle was supplied with polymer or lipid vesicle solution (10 
mM in ethanol). These solutions were subjected to EHDA jetting at different voltages. 
The flow rate of the vesicle solution and NaOH were varied between 10-50 μl min-1 in a 
1:1 ratio. The resultant jet spray was collected in doubled distilled water, which was 
deoxygenated by bubbling with nitrogen gas. The distance between the needle tip and 










Figure 7.2: Shows TEM micrographs (stained with 2 % Uranyl acetate) representative results from the 
structures produced using the parameters outlined in table 7.1. For single axial experiments (upper), 
a)DSPC (10 mg ml-1), 15 µl min-1, 15 kV, b) PMOXA-PDMS-PMOXA, 15 µl min-1, 16.8 kV and c) PEO-40 
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Three materials were tested under these conditions, these being DSPC lipid, PMOXA-
PDMS –PMOXA tri-block polymer and the stearyl acetate/ethyl cellulose (20%:5% v/v 
respectively). In each case, the polymer or lipid material (in ethanol) was run through 
the capillary at a flow rate of 15 µl min-1.  
The DSPC and the stearyl acetate/ethyl cellulose mixture produced a conejet, whereas 
the tri-block polymer formed a multijet. All three samples were analysed using DLS. 
These DLS data established that the only successful sample produced on the coaxial 
capillary system is the DSPC lipid, which shows a peak at 79 nm. However, this size 
information did not correspond well with the subsequent TEM analysis. TEM 
micrographs (Figure 7.2) show the presence of much larger structures (about 2-4 µm 
in diameter). Therefore, further optimisation of the voltage and flow rate was needed 
to achieve smaller droplets upon atomisation. In the case of the stearyl acetate/ethyl 
cellulose system, no peak was observed in the DLS analysis. A broad peak at between 
about 2-3 µm for the tri-block polymers suggests that the synthesis of vesicles in the 
nanometre range was unsuccessful. 
Therefore no further tests were carried out on either of these materials. It is likely that 
the poor results achieved with the co-axial system when compared to the single axial 
system are largely due to imbalance in both the surface tensions and conductivities of 
the two different solutions. The concentration of the basic solution was increased by 
multiple orders of magnitude (from 100 mM to 1 M) in an attempt to bring the base 
solution conductivity in line with that of the polymer solution. Unfortunately, this 
resulted in the formation of a mutijet, which makes encapsulation impossible. Based on 
these data, it was decided that DSPC formed the best, most cost effective EHDA 
synthesised vesicles and this was the focus of the remaining studies in this chapter.  
 
7.3 SYNTHESIS OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
 
 The best lipid for the system was determined to be 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) which was then further optimised to determine the optimum 
flow rate and applied voltage combination; as outlined in table 7.2.  
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The optimised conditions (Table 7.2) for the formation of the artificial magnetosome 
were found to be a combination using a single axial, bi-port needle (Schematic figure 
7.1).  
Flow rate (µl/min) 
DSPC/NaOH 
Applied Voltage(kV) Spray and jetting mode 
10/10 0-20 Too slow drop formation 
20/20 
0-3 No-effect 
4 Drop elongation 
5-9 Micro-dripping 
9-13 
Unstable Cone-jet (fine 
particles) 
14 Occasional double- jet 
15 Unstable mode 
16-18 Multi jet 
19-20 Unstable mode 
30/30 





Unstable cone jet with 
thinning 
40/40 





Unstable cone jet with 
thinning 
50/50 





Unstable cone jet with 
thinning 
 
Table 7.2: Table of EHDA optimisation all experiments were carried out at a concentration of 
10 mM DSPC and 100 mM NaOH: Variation of flow-rate and applied voltage specific for 
generating DSPC nanovesicles using EHDA technology. For effective vesicle production a stable 
jetting mode must be achieved, the optimum conditions are highlighted in the table.  
 
This is a single capillary featuring two separate inlets, meaning the solutions (DSPC and 
NaOH) remain separated until they enter the capillary, at an optimised rate of 20 µl 
min-1. This generates a steady flow of mixed lipid and base (NaOH 10 mM) solution, and 
it should be noted that DSPC lipid was delivered below its Tg (55°C). An optimised 
electrical potential difference of 16.8 -17.5 kV was delivered to the capillary as at this 
voltage the vesicle solution generated a continuous stable jet as it left the capillary. 
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Unlike the studies discussed in chapter 4 using DSPC, in which synthesis was difficult 
due to the Tg making polydisperse vesicles, the lipid self-assembles into a high quantity 
of near-monodisperse liposomes when accelerated by jetting though the EHDA needle 











Figure 7.3: a) A stained TEM image of the NaOH encapsulated vesicles formed under optimised conditions 
(200 µm diameter, 96 mm needle length, 20 l min-1 flow rate, 16.8-17.5 kV voltage). b) The size 
distribution of non-electroporated liposomes obtained by DLS. c) Compared to the size distribution 
obtained via grainsizing from TEM images. 
 
The size and size-distribution of the resulting liposomes were measured as 22 ± 4.8 nm 
by both electron microscopy (TEM) and 22 ± 0.2 nm using dynamic light scattering 
(DLS) analysis (Figure 7.3). The application of a localised high electric field during 
electroporation induces the reversible poration of the DSPC membrane. In the case of 
EHDA synthesised liposomes, this leads to the transport of iron ions across the 
membrane through these pores into the liposome core, hence mimicking the role of the 
transmembrane ion-transport proteins found in the MTB magnetosome. On this basis, 
DSPC was further investigated for the best conditions for incorporation of the 
magnetite synthesis routes optimised in chapter 3, particularly with respect to the 
voltage applied during electroporation. The findings of this investigation are 
summarised in table 7.3.  
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Table 7.3: Optimisation of the EHDA DSPC liposomes. All Samples were made with DSPC at a 
concentration of 10 mM (unless otherwise stated) encapsulating NaOH at 100 mM, under single axial and 
co-axial conditions (as indicated). These EHDA generated vesicles were electroporated in the presence of 
mixed iron ion solution (in the stoichiometric ratio for magnetite formation). 
 
Many of the samples looked to contain vesicles when investigated using TEM but 
confirmation of vesicles on the micrographs was inconclusive as to whether the 
electroporation step was successful; therefore DSPC liposomes samples were 
dismissed. Also, the majority of the coaxial samples showed only lipid residue in the 
TEM imaging. In terms of the electroporation, differing to the results presented in 
chapter 6, mid-range voltages around 200-300 V appear to be the most successful at 
inducing mineralisation. TEM images show some electron dense material in the vesicle 
core (Figure 7.4). The most promising conditions screened are shown in figure 7.4.  
Jet Voltage Electroporation 
TEM 
analysis 
Single Axial (200 µm needle) 
Multijet 
 
17-18kV 4 x 500-1000v Polymer residue 
17.1kV 
 
5 x 160V No vesicles 
5 x 310V Monodisperse vesicles 
 5 x 460V 
5 x 600V No vesicles 








5 x 170V 
5 x 320V 
5 x 480V 
5 x 630V Large vesicles 
5 x 750V Monodisperse vesicles 





5 x 140V No vesicles 
5 x 280V Monodisperse vesicles 
5 x 420V No vesicles 
5 x 570V 
Lipid residue 
 
5 x 680V 
17kV 5 x 860V 
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These were produced by both single and coaxial capillary systems, forming a multijet 
and a conejet respectively, and electroporated five times at 310 V in the case of the 











Figure 7.4: TEM, SEM and EDX data for the DSPC liposomes made via EHDA using the single axial 
(electroporated 5 times at 310 V) and coaxial (electroporated 5 times at 280 V) outlined in table 7.3 Cu, Ca, 
Cl, C and Si are probably from the grid and/or the buffer used to prepare the samples. Also, the spectra 
indicate the presence of iron (FeKα 6.40 keV, FeKβ 7.06 keV, FeLα 0.71 keV) and oxygen (Okα 0.53 keV) 
indicating that the cores do contain iron oxide.. 
 
The samples were then analysed by TEM, SEM (performed at UCL) and EDX. These data 
show that the electron dense vesicle core contains iron and oxygen, suggesting the 
possible presence of iron oxide. This data was used as a basis for further analysis and 
fine tuning by Dr. Bakshi (UCL), in terms of needle length, flow rates and voltage 
applied to the capillary, to yield the optimised parameters outlined below (Section 
7.2.1). Optimised electroporation conditions for maximum transport of iron ions into 
the EHDA synthesised liposomes were applied to the DSPC liposomes. These conditions 
used a voltage of 750 V, (optimised by the UCL team) with a pulse length of 100 μs; a 
parameter determined automatically by the electroporator. This pulse was applied to 
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7.4 CHARACTERISATION OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
 
7.4.1 ELECTRON MICROSCOPY OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
 
Electroporation of EHDA synthesised DSPC liposomes results in the crystallisation of 
an electron dense material (presumed to be a magnetite MNP based on elemental and 
magnetic analyses) within the liposome core. This system comprises an artificial 
magnetosome, as shown in both standard (dried sample) and cryogenic TEM 
(figure 7.5). This TEM confirms that electroporation of EHDA synthesised DSPC 
liposomes according to these parameters, results in the successful formation of an 
electron dense material within the liposome core. TEM micrographs (figure 7.5) show 
clearly a dark material, around which membrane of approximately 8 nm is visible. 
Membranes were visualised using a 0.75 % uranyl formate stain. This negative stain 
pools around the objects, and is able to highlight electron sparse (organic) materials, 
such as the liposome bilayer.  
To confirm that the presence of the apparent lipid bilayer around the nanoparticle is 
not simply an artefact of drying the sample down on to the TEM grid, Cryo-EM was 
employed. Cryo-EM maintains the liquid content of the vesicle, which means its 
structural integrity, is preserved, making the detection of the bilayer much more 
conclusive. This can be seen in the Cryo-EM images (Figure 7.5b). The vesicles appear 
to have swelled during the electroporation process, resulting in an increased average 
size when compared to the non-electroporated liposomes (Figure 7.5 c). The is likely 
due to the high fluidity of the lipid membrane; especially when compared to the 
polymer system (Chapter 6) which may account for this swelling. This, when combined 
with the voltage applied during electroporation, likely means that the lipid is still in the 
gel phase, which would give rise to movement of the phospholipids during the 
electroporation process.  
 
 













Figure 7.5. TEM images of unstained nano-liposomes subjected to optimised (100 s pulse duration, 9 
pulses, 750 V) electroporation conditions show electron dense material in their core, assumed to be an 
MNP crystal. a) (i) and (ii) standard TEM micrographs b) (i) and (ii) Cryogenic-TEM images. c) Grainsizing 
from the TEM of the artificial magnetosomes, showing an average size of 58 ± 8 nm. 
 
If this is the case it is probable that, once the liposomes are within the iron solution and 
the ions cross the bilayer, the resulting formation iron-oxide within the interior can 
swell the vesicles, within the range of the phospholipids elasticity. 
This gives rise to artificial magnetosomes closer in size to the native MTB structures. 
This is a particular point of interest, i.e. that the artificial magnetosomes are of 
comparable size (58 ± 8 nm) to natural magnetosomes. These are significantly larger 
than the average size of the non-electroporated liposomes (Figure 7.3). TEM analysis 
(performed by the UCL team) also confirms that EHDA formed electroporated 
magneto-liposomes remain stable for a minimum of 120 days, confirmed by TEM 
(performed at UCL). This stability could be due to stabilisation by the presence of the 
magnetite crystal within their core, and the likelihood that the lipid is now in a solid 
phase (below its Tg).  
 
P a g e  | 220 
 
 
7.4.2 RAMAN SPECTROSCOPY OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
 
As discussed earlier, TEM alone cannot confirm the elemental and material 
composition of the observed structures within the magneto-vesicles. Therefore Raman 
spectroscopy (performed at UCL) was used to analyse the artificial magnetosome 
sample, to confirm which materials are present. The spectrum contained significant 
peaks at 180-240 and 579 cm-1 (T2g shifts)  300-400 cm-1 (Eg shift) and 668 cm-1 (A1g 













Figure 7.6: Raman spectrum of artificial magnetosomes (shows DSPC lipid encapsulating 
magnetite). Spectrum shows the presence of peaks representative of magnetite (at 180-240 and 
579 cm-1 (T2g shifts) 300-400 cm-1 (Eg shift) and 668 cm-1 (A1g shift)76) and a phosphatidylcholine lipid 
bilayer (peaks highlighted at 750 cm-1 (Phosphocholine), 1000-1100 cm-1 (Hydrocarbon tail) 
and 1200-1600 cm-1  (CH2)).76, 185, 200 
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This is assumed to come from the only electron dense material observed in the 
samples, i.e. from the dark vesicle core. As magnetite is a crystalline iron oxide, it can be 
extrapolated that the electron dense cores of the magneto-vesicles do consist of 
magnetite. Similarly, peaks at 750 cm-1, 1000-1100 cm-1 and 1200-1600cm-1 
correspond to the presence of both a lipid bilayer, and more specifically a 
phosphocholine head group. This is assumed to be due to the DSPC lipid (Figure 
7.6).185, 200 It cannot be ruled out that these peaks are the result of segregated magnetite 
nanoparticles and vesicles. Similarly, it is possible that the lipid peaks are due to free 
lipid not incorporated into the vesicles. SEC clean up should have removed both free 
lipid and external iron oxide precipitate. However, as what appear to be co-assembled 
structures are consistently observed in standard and cryogenic TEM (see above), it is 
most likely that the lipid bilayer does surround a magnetite core. Therefore, it is 
assumed that the Raman spectra, TEM micrographs and more specifically the increase 
in the vesicle size before and after electroporation are extremely indicative of 
magnetite filled DSPC lipid vesicles, i.e. artificial magnetosomes. 
 
7.4.3 FLUORESCENCE OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
A fluorescence assay was employed to confirm that the MNPs are surrounded by DSPC 
liposomes. This was carried out by incorporation of the lipophilic dye BODIPY FL (C5-
ceramide(N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-Iidacene-3-
pentanoyl)sphingosine, Life Technologies) which was simply mixed with the artificial 
magnetosome sample, with the excess dye subsequently being removed by SEC. The 
dye should only be visible if a lipid bilayer is present, and should be localised to the 
bilayer or lipid structure(s).201 Analysis by fluorescence microscopy showed the 
presence of discrete fluorescent vesicles following magnetic separation and washing of 
the artificial magnetosome sample (Figure 7.7 a). These fluorescent vesicles were 
subjected to a magnetic field; by application of a magnet at the edge of the microscope 
slide. When the magnetic field is applied, movement of the discrete fluorescent vesicles 
was observed in the direction of the magnetic field (Figure 7.7 b). This was not the case 
for suspensions of uncoated MNPs, which were used as a control. 
 









Figure 7.7 a) Lipophilic fluorescent dye incorporation (Bodipy), showing the presence 
fluorescently labelled DSPC liposomes. b) On application of a magnetic field (applied in the 
direction of the magnet) show the movement of the fluorescently tagged liposomes (circled). 
 
7.4.4 BULK MAGNETIC PROPERTIES OF MAGNETO-LIPOSOME ‘ARTIFICIAL 
MAGNETOSOMES’ 
Evidence so far has established that the system has been successfully optimised for the 
precipitation of a single magnetic iron oxide crystal within the core of a DSPC lipid 
vesicle. To confirm the composition of the magnetic material, magnetic hysteresis and 
field-cooled/zero-field-cooled magnetic susceptibility measurements as a function of 
temperature were performed using a SQUID (by the team at UCL). Particular attention 
was applied to the identification of the characteristic Verwey transition16 of magnetite; 
and thus rule out the precipitation of significant amounts of maghemite. In the case of 
the room temperature magnetic analysis, a characteristic hysteresis of a soft magnetic 
material was observed (Figure 7.8). The magnetic particles within the DSPC liposomes 
align with the magnetic field as it was switched between 3000 and -3000 Oe. The 
magnetic particle switched easily, showing little or no coercivity. As magnetite is a soft 
















Figure 7.8 Magnetisation vs Field hysteresis plot performed at 300 K using a SQUID. The plot shows 
typical hysteresis of soft magnetic material, and is characteristic of magnetite. 
 
With respect to the zero-field cooled magnetic data, (Figure 7.9) despite the small 
sample size (maximum of 1 x 10-2 emu g-1), these data clearly show the presence of a 
magnetic material. More specifically, there is a change in magnetic behaviour at 118 K, 
where there is a change of slope in the zero filed cooled (ZFC) plot. This is due to the 
Verwey transition, a structural re-ordering that is characteristic of bulk magnetite.16 
The re-ordering leads to a magnetic phase transition, i.e. the Verwey transition, as 
indicated by the slight plateau at 118 K.17 This characteristic change along the cubic 
magnetocrystalline axis switching from the body diagonal to the cube edge results in a 
magnitude loss of magnetic remanence and provides a fingerprint for the presence of a 
magnetite nanoparticle. This is highly indicative of the presence of a pure magnetite 
nanoparticle, which in combination with both the Raman and fluorescence studies, can 
confidently be assumed to be precipitated within the core of the EHDA synthesised 


















Figure 7.9. Zero field cooled and field cooled magnetisation vs temperature plots (applied field 
of 100 Oe). Inset shows remanence of the field cooled data. The Verwey transition is shown a 
dotted line (∙∙∙∙∙) marked on the plot to highlight the temperature it occurs at (118 K). 
 
7.5 ADAPTABILITY OF EDHA FOR ARTIFICIAL MAGNETOSOME 
SYNTHESIS 
 
7.5.1 DOPC MAGNETO-LIPOSOMES VIA EHDA 
 
To determine the adaptability and robustness of the system, a methodology using the 
same synthesis route was applied to an alternative lipid material. In this case the 
phospholipid used was 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). When 
compared to DSPC, this lipid has increased fluidity, due to unsaturation in the 
hydrocarbon tail. DOPC has proven successful both in initial liposome formation tests 
(Chapter 4) and with the conventional electroporation method (Chapter 6). 
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As with the DSPC liposomes; at an initial lipid concentration of 0.5 mg ml-1, single axial 
EHDA was used. This was run through the single axial capillary at a rate of 15 µl min-1 
under 16.7 kV. During delivery of the lipid solution a stable conejet was achieved and 
maintained which resulted in the formation of monodisperse liposomes. 
 
7.5.2 MICROSCOPY OF DOPC MAGNETO-LIPOSOMES VIA EDHA 
 
Although not characterised to the same extent, the DOPC magneto-liposomes 
synthesised by EHDA appear to produce a mono-disperse population compared to 
formation by tip sonication or extrusion. A dark, electron dense core and a bilayer (as 
observed by negative stain) are both visible in TEM. This can be seen in the TEM 
micrographs (Figure 7.10 a), although not as clear as in the DSPC lipid micrographs, a 
distinct difference in the density between the vesicle core and respective bilayer can be 
seen in figure 7.10 a) inset. Grainsizing of several TEM micrographs gave an average 
vesicle size of 207 ± 42nm (Figure 7.10 b). The increased size of the DOPC artificial 
magnetosomes demonstrates the adaptability of the methodology to produce 









Figure 7.10 a) TEM micrographs of DOPC lipid artificial magnetosomes showing both an electron dense 
core and lipid bilayer; as indicated by the red arrows (inset). b) Shows the corresponding TEM grainsizing 
which gives an average liposome size of 207 ± 42 nm. 
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7.6 DISCUSSION OF EHDA MAGNETO-VESICLE SYNTHESIS 
 
Many lipids, particularly DSPC, can be difficult to work with in more traditional 
liposome synthesis methods, such as sonication or extrusion71a owing to high glass 
transition temperature (Tg) (Section 4.2.3). TEM analysis of liposomes prepared by 
both traditional and electrohydrodynamic methods show a distinct difference. Those 
prepared by EHDA show clear vesicles of a near monodisperse distribution, which are 
not observed in the DSPC control sample. (Chapter 4, section 4.2.3). It can be surmised 
that the negative effects of the DSPC lipid Tg are not observed in the EHDA prepared 
sample. This may be due to the application of substantially high voltages during the 
continuous flow and rapid formation process circumnavigating the fluidity issues seen 
below Tg in the non-electrically mediated syntheses. This ensures that the DSPC 
remains in the amorphous/gel phase throughout the self-assembly. During 
conventional liposome synthesis, the temperature must be kept above 55°C to maintain 
lipid fluidity, making processes like extrusion difficult. This is in stark contrast to the 
wet-chemistry formed DSPC liposome control sample in which vesicles appeared to be 
severely damage by the preparation method (tip sonication), (Chapter 4, Section 4.2.3). 
The application of the electrical potential difference is not only responsible for the 
rapid formation of nano-vesicles, but also appears to assist in the formation of a 
vesicular structure, hugely increasing their stability, when compared with liposomes 
formed by e.g. tip sonication.  
Room temperature magnetic analysis showed only little coercivity. As magnetite is a 
magnetically soft material, it was expected that the coercivity would be relatively low, 
and this is not the case in naturally biomineralised magnetosomes in MTB.144, 202 
Despite this the temperature versus moment magnetic measurements performed on 
the DSPC magneto-liposomes undoubtedly shows the characteristics of magnetite. 
Most convincingly, the Verwey transition was observed during ZFC measurements, 
which is a characteristic, feature of stoichiometric magnetite. This is supported by EDX 
elemental analysis of the electron dense cores shown in TEM, which contain iron and 
oxygen, and Raman spectra that show peaks for magnetite. Thus, a simple, high-
throughput method to producing precise single-domain sized magnetite nanoparticles 
in situ within liposomes has been demonstrated to create these magneto-liposome 
‘artificial magnetosomes’. 









CHAPTER 8:  
 
8 BIOMINERALISATION OF IRON 
OXIDES 
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8.1 INTRODUCTION TO THE BIOMINERALISATION OF IRON 
OXIDES 
 
Biomineralisation reactions in organisms are controlled by dedicated proteins.1b, 1c, 47 It 
was briefly discussed in section 1.3.2.2 that precipitation of the magnetite crystal 
within the magnetosome is tightly controlled by specific proteins present in the 
magnetosome membrane.1a, 5, 29 The transmembrane helices which span the 
magnetosome membrane can present the protein termini and/or hydrophilic loop 
regions to the magnetosome interior. These sequences displayed within the 
magnetosome core are believed to act as nucleation sites for precipitation of the 
magnetite crystal, or to direct the crystal growth and particle properties. Many of these 
proteins have previously been investigated in vivo (for instance phenotypes resulting 
from gene deletions, localisation of the protein within the cell).1a Studies in vitro have 
analysed their effects on synthetic magnetite formation in one pot precipitation 
reactions, as well as when anchored on to synthetic surfaces.1a, 62, 203 There are believed 
to be a minimum of nine biomineralisation proteins essential for magnetosome 
synthesis, the details of which have been collated and reviewed by Nudelman et al.47 
Gene deletion experiments performed by various groups have found that this group of 
proteins has control over the number of crystals (MamR),47 magnetic properties 
(MamS)47 and crystal size and shape (MamD, MamG, Mms6, Mms13 and MmsF).47 In 
general, all of these proteins are of low molecular weight, and comprise a high number 
of exposed charged residues, which are believed to give these proteins their nucleation 
properties in the magnetosome.1a, 5, 29a Large proportions of their sequences are made 
up of hydrophobic residues arranged into transmembrane helices, which allow them to 
insert into the magnetosome membrane. This chapter presents the first incorporation 
of MmsF proteins into a synthetic vesicle, and the first test of intra-vesicular function 
for the creation of an artificial magnetosome (for MmsF and Mms6). These proteins 
were produced and purified by Dr. A. Rawlings within the Staniland group. In addition, 
an artificial antiparallel coiled coil protein scaffold was used to display the loops 
connecting the transmembrane helices of these proteins in a stable and water soluble 
form in a conformation similar to that thought to be present in the native protein. The 
loops selected were the regions considered responsible for interacting with the in vivo 
MTB magnetite crystal. These proteins have also been incorporated into vesicles, as 
they offer a much more feasible alternative for future large scale production.  
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8.2 PROTEINS USED IN SYNTHETIC VESICLES 
 
Three MTB biomineralisation proteins have been explored in the Staniland laboratory. 
These have been designated as biomineralisation proteins by way of genetic mutations, 
deletions and proteomic analyses in vivo. These proteins are Mms6,61 MmsF5, 29b and 
Mms13.61 Within the Staniland group, previous work has focussed on cloning, 
expressing and purifying each of these proteins to confirm their function and assess 
their effect on synthetic magnetite precipitation. Both Mms61a, 29a and MmsF5 (as part of 
this thesis) have been successfully expressed by Dr. A. Rawlings (Staniland group). It 
was found that, when these proteins were added to room temperature co-precipitation 
reactions to produce magnetite nanoparticles, significant differences in the 
morphology of the resulting nanoparticles were observed.1a, 5 For this reason, this 
chapter explores their incorporation into synthetic magnetosomes to investigate their 
effect on intra-vesicular magnetite precipitation. In the case of Mms13, attempts to 
produce the protein in a soluble form (due to its highly hydrophobic content) were 
unsuccessful. Therefore tests on its biomineralisation functionality have thus far been 
limited to genetic analysis within MTB.204  
Vesicular incorporation of artificial scaffolds has also been explored, as part of this 
chapter. Within the Staniland laboratory, coiled coil artificial scaffolds have been 
developed which display what is believed to be the active, magnetite interacting loop of 
the magnetite biomineralisation protein. The in vitro effect of these proteins on MNP 
precipitation has been investigated in room temperature co-precipitation reactions, 
(by other members of the Staniland group) and this chapter presents the first results of 
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MmsF is a small 20 kDa protein described in the literature as the master regulator 
protein of magnetite biomineralisation in the MTB magnetosome.29b The presence of 
MmsF in the magnetosome has been confirmed by the addition of a green fluorescent 
protein tag.29b This tag has indicated that the C terminal region of the protein is located 
on the inside of the magnetosome. Structural predictions and sequence analysis have 
suggested that there are three transmembrane regions, the sequences of which are 
highly conserved.5 The helices sit in the magnetosome membrane (Figure 8.1), causing 
the formation of a loop between helices I and II, which is present in the magnetosome 
interior. This loop is highly conserved in MmsF, and various homologues; it’s believed 
that this conservation is due to its function as the active site.5 
Within this loop region there are a large number of acidic residues, believed to act as a 
nucleation site(s) for magnetite precipitation.5 Mutagenesis studies in vivo have 
discovered that deletion of the mmsF gene causes defects in the magnetite 
biomineralisation process, resulting in smaller, misshapen particles, the effects of 
which are reversed when the mmsF gene is reintroduced.29b In fact, deletion of the 
entire gene cluster (containing mmsF) yields the same results as the single mmsF 
deletion, but morphological control is restored when just mmsF alone is reinstated.29b 
This provides an excellent indication that MmsF is the magnetite regulating protein in 
























Mms6 is a small acidic protein which has previously been found to be bound to the 
magnetosome crystal on extraction from MTB.1a, 29a Deletion of the operon containing 
the mms6 gene causes a decrease in the size and change in the geometry of the 
magnetite crystal.29a It is believed that Mms6 is functional in biomineralisation of 
magnetite due to its localisation on or near the magnetite crystal surface.  
 
 
Figure 8.1: Sequence analysis of MmsF (top) reveals three transmembrane helices shown by the blue red 
and yellow regions in the sequence. These correspond to the same coloured regions in the hydropathy 
plot (middle). The arrangement of these regions results the structure shown (bottom left) which when in 
the membrane leads to the N terminus displaying on the exterior of the membrane with the C-terminal 
region presented on the magnetosome interior. There are additionally two intermembrane loops, one on 
the interior and one on the exterior of the magnetosome membrane, the internal loop is believed to give 
the protein its nucleation properties, (bottom). Figure created from hydropathy data provided by 
TMPred Server (Expasy). 
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The structure and sequence composition of Mms6 is key to its function.61 A high 
proportion of the Mms6 protein is thought to span the magnetosome membrane via a 
transmembrane helix. This topology means that the C-terminal region will be exposed 
to the magnetosome core, and able to make contact with the magnetite crystal (Figure 
8.2). The residue character of the C-terminal region of Mms6 is highly acidic, having a 
pI of 4. This region has the ability to bind metal ions (in particular ferric iron) and the 
magnetite crystal face.61, 205 Wang et al205 have devised a hypothesis by which Mms6 
accumulates iron ions via acidic amino carboxylic acid side chains. This is believed to 
initiate magnetite nucleation in the magnetosome.205 Again, Mms6 has been studied 
















Figure 8.2: Sequence analysis of Mms6 (top) with a transmembrane helix shown by the region highlighted 
in blue in the sequence. This corresponds to the blue region in the hydropathy plot (middle). The predicted 
structure of Mms6 is shown (bottom left) and its arrangement in the membrane in which the single 
transmembrane helix spans the magnetosome membrane in a topology so that the N-terminus is on the 
exterior of the magnetosome and the C-terminus is presented to the interior. Figure created from 
hydropathy data provided by TMPred Server (Expasy). 
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 BIOMIMETIC SCAFFOLD PROTEINS 8.3.1.3
 
The membrane associated nature of the Mms suite of proteins can cause difficulties in 
successful over expression in E. coli as well as in subsequent purification steps for in 
vitro use. To alleviate these problems, a coiled-coil peptide display scaffold was 
developed in the Staniland group based on previous work by Gurnon et al.206 A coiled-
coil is, as the name suggests, two ∝-helices which can coil around one another, forming 
a stable and soluble “coiled-coil”.207  In our case, the two helices are present within one 
protein molecule, and the region connecting these two coils forms a loop which is 
displayed as shown in figure 8.3. The loop region of the sequence (highlighted in black 
in figure 8.3) can be designed to display loop sequences of interest from other proteins. 
In this case, the coiled coil protein scaffolds have been mutated to display the active 















 Figure 8.3: Top: Schematic of the stem loop coiled-coil incorporated into vesicles a) shows the region 
of hydrophobicity (gold) and hydrophilicity (blue) b) Overlay shows areas of electron density. Bottom: 
The protein sequence of the coiled-coil used.  
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This methodology has been applied to MmsF, to display the loop region between the 
two transmembrane helices which are displayed in the magnetosome core for 
nucleation of iron ions. This is designed to act as a soluble mimic of monomeric MmsF. 
Similarly the same approach has been applied to the loop connecting helices I and II in 
the MTB biomineralisation protein Mms13. Mms13 was found to be tightly bound to 
the magnetite crystal from magnetosomes from M. magneticum AMB-1. Although it is a 
larger protein, it is thought to have a similar function to Mms6 in vivo, being able to 
exert control over magnetite crystal morphology.1a Previous studies carried out in the 
Staniland group (unpublished) have proven unsuccessful in purification of Mms13; 
therefore it proved an excellent target for incorporation into the coiled-coil scaffold 
.  
 PROTEIN PURIFICATION 8.3.1.4
 
The proteins used in the following analyses were produced in E. coli and purified by Dr 
Andrea Rawlings. 
MmsF was purified to assess its effect on the in vitro precipitation of magnetite, and for 
its incorporation into synthetic vesicles. It was hoped that the addition of MmsF into 
the artificial magnetosome would yield precipitation of particles analogous to those 
precipitated in naturally occurring magnetosomes. MmsF purification was expected to 
be challenging due to this protein’s transmembrane regions. Unexpectedly, it was 
found that MmsF was produced in a soluble form in E. coli, and could be purified 
without the aid of detergents.5 Circular dichroism was used to analyse the secondary 
structure of the protein and, as expected, it gave the characteristic peaks at 222 nm and 
208 nm, confirming the presence of alpha helical secondary structure5 (Figure 8.4 b). 
Thermal stability tests revealed that MmsF was stable up to 85 °C, at which point 50 % 
of the secondary structure was lost; this was measured by monitoring the change in 
















Purification via a Streptactin resin column using the StrepII tag on the protein resulted 
in only a small amount of protein bound to the column, evident by the large amount of 
StrepII tagged material present in the unbound fraction (Figure 8.4 a). This indicates 
that the majority of the StrepII tags on over-expressed soluble MmsF protein is not 
accessible for immobilisation onto the Streptactin column. The high aqueous solubility 
and lack of binding to the Streptactin purification resin suggested that MmsF may be 
forming larger assemblies, similar to those observed for Mms6.205 Due to this 
unexpected high solubility of MmsF it was hypothesised that self-assembly may be 
occurring to shield the transmembrane helices and hence improve the solubility of the 
protein.5 This would also explain the lack of affinity for the Streptactin column, as it is 
likely that the tag could become buried in such an assembly. 
The combination of these factors led to the decision to analyse the protein by DLS 
(section 2.7.1.3) to look for the presence of assembled structures.5 The DLS showed the 
presence of species of 100 ± 25 nm in diameter. This size meant that the assemblies 
would be visible by TEM (Section 2.7.1.1). Stained TEM micrographs revealed discrete 
and uniform vesicular-like assemblies now termed ”proteinosomes” with an average 
size of 36 nm (Figure 8.5).  
 
 
Figure 8.4: a) A Western blot of purified MmsF in which (I) is the total cell fraction (II) is the soluble 
fraction (III) is the unbound protein fraction following streptactin column purification. Arrow indicates the 
presence of the monomer in the western blot. (IV) shows a coomassie stain gel of the fully purified MmsF. 
Again arrows indicate the positions of the monomer and dimer species (as labelled). b) Circular dichroism 
spectrum of MmsF protein at 0.1 mg/ml at an absorbance of 280 nm collected using a 1-nm slit width 
cuvette and 1-s intervals, data shown is the average of three measurements with the subtraction of water 
blank. Adapted from Rawlings et al.5 
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It was difficult to determine whether these structures were dense or hollow from TEM 
due to drying and staining artefacts. Therefore cryo-TEM was employed to better 
investigate the proteinosome structures (Figure 8.5). Under cryogenic conditions, the 
















It was presumed that these assemblies were composed entirely of protein. To confirm 
this, proteinase K was added. This should exclusively degrade the protein assemblies 
leaving any lipid present intact. This experiment revealed a large increase in species 
present in DLS studies, suggesting aggregation of the protein, and a white precipitate 
was observed in the sample.  
 
Figure 8.5: (Left) room temperature TEM of MmsF proteinosomes, showing protein assemblies with an 
average diameter of 40 nm. (Right) Cryo-TEM of MmsF proteinosomes in which they appear to be hollow 
protein assemblies. Adapted from Rawlings et al. 5 
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TEM performed after the addition of the proteinase K confirmed degradation of the 
assemblies replaced by large amorphous protein aggregates.5 This goes someway to 
confirming the hypothesis that proteinosomes are composed entirely of MmsF. Further 
analysis by electrospray ionisation mass spectrometry showed no lipid present in the 
sample.5  
 
8.4 PROTEIN EFFECTS ON IN VITRO PRECIPITATION 
 
8.4.1 MMSF IN MINERALISATION REACTIONS 
 
The addition of purified MmsF has a significant effect on in vitro magnetite synthesis 
when added to a room temperature co-precipitation reaction. Much more consistent 
particle morphology was observed, with an absence of alternative iron oxide by-
products when compared to control samples containing either no protein or MmsF 
homologue proteins (Figure 8.6).5 Particles produced in the presence of MmsF were 
larger and with a more homologous morphology, much closer in appearance to the 
particles observed in MTB magnetosomes. Selected area electron diffraction revealed a 
higher degree of crystallinity in the MmsF sample with much more defined absorption 









Figure 8.6: Left: Shows TEM (top) of room temperature co-precipitated magnetite nanoparticles, and 
the electron diffraction pattern collected from the TEM (inset) also shown is the particle grainsizing 
from the TEM (bottom). Right: shows the equivalent data for the particles produced via the same 
method with the addition of MmsF. Adapted from Rawlings et al.5 
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The control sample (which was produced in the absence of protein) electron diffraction 
confirmed that particles were much more amorphous, with more diffuse diffraction 
rings. Furthermore, particle grainsizing revealed a significantly narrower size 
distribution of the resulting particle population with the addition of MmsF to the 
reaction having an average size of 56 ± 22 nm. The effects observed in the particles 
produced in the presence of MmsF indicate that, despite its assembly into a 
proteinosome-like structure in aqueous solution, it still has the ability to exert control 
over magnetite particle formation. This suggests that, in the proteinosome assembly, 
the active loops of the protein may be displayed on the outer shell of the proteinosome, 




As with MmsF, addition of Mms6 to a room temperature co-precipitation reaction 
causes a significant change in the quality of the particles produced. Converting what 
would normally be a mixed population of iron oxides (Figure 8.7 a) to a homogenous 
particle population comparable to the morphology of MTB mineralised magnetite 
(Figure 8.7 b).1a, 61-62 The particles are much larger in size, presumably becoming more 
ferrimagnetic, and appear to contain a single iron oxide species, unlike the control 
particles which contained needles and plates, indicating mixed iron oxides (Figure 8.7). 
This tight control is exerted despite relatively low concentrations of protein being used 
(5.6 µg ml-1).1a It has also been discovered that the same level of control can be 
achieved in partial oxidation routes to synthesis,1a, 62 proving that the mechanisms of 
Mms6 control are not specific to synthesis route, iron salt or control of the 
intermediate oxide phases, as these vary between the two synthesis routes.  
The mechanism by which the protein can control the magnetite precipitation is largely 
still unknown; however, as with MmsF, the presence of the hydrophobic region in 
Mms6 gives rise to the hypothesis of aggregation in aqueous solution.205 The high 
hydrophobicity at the N-terminal region of Mms6 is believed to drive this assembly.205 
 
 












Zeta potential measurements of these aggregates have proven that they are negatively 
charged at neutral pH which suggests that the negative C-terminal chain of the protein 
must be covering the surface of the assembly. This surface may then act as a nucleation 
site for in vitro magnetite precipitation.205 The aggregation of Mms6 may affect 
vesicular incorporation, in a similar way to MmsF, although incorporation into 




The functionality of coiled-coil scaffolds displaying the active regions of MmsF and 
Mms13 have been tested previously by members of the Staniland group in room 
temperature co-precipitation reactions. Coiled-coil proteins were added at a 
concentration of 50 µg ml-1. TEM micrographs of the particles precipitated in the 
presence of the MmsF and Mms13 coiled-coils are shown in figure 8.8, along with 
control particles precipitated in the absence of a coiled-coil. A huge increase in the size 
of the resulting particles was observed as confirmed by particle grainsizing (Figure 
8.8).  
 
Figure 8.7: a) A standard room temperature co-precipitation of magnetite (arrows indicate needles) b) 
the particles produced via the same reaction route with the addition of Mms6. Adapted from Arakaki et al. 
(Scale bars = 100 nm).1 
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An increase from 10 ± 2 nm (no protein) to 74 ± 12 nm with the addition of MmsF 
coiled coil and 41 ± 24 nm in the case of Mms13 coiled coil, which will have a direct 
effect on the magnetic properties of the particles, possibly improving their suitability 
for biomedical application. Particles precipitated in the presence of the coiled coils also 
had a much more defined morphology, appearing closer to the expected cubo-



















Figure 8.8: TEM micrographs of magnetic nanoparticles produced by a) standard room temperature 
precipitation conditions, with the addition of b) coiled-coil displaying the active region of MmsF and c) 
coiled-coil displaying the active region of Mms13, and their corresponding TEM particle grainsizing. Data 
provided by previous Staniland group members (TEM performed by me). 
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8.5 VESICLE INCORPORATION OF BIOMINERALISATION PROTEINS 
 
Proteins were incorporated into DPhPC liposomes or PBD-PEO polymersomes on 
rehydration of a lipid/polymer film with 10 mM NaOH. The proteins should remain 
stable and folded after vesicular incorporation at pH 12, as they have all been 
previously used in room temperature co-precipitation with basic solution at higher 
concentrations and retained their activity. These data present morphological changes 
in the vesicle core following the incorporation of biomineralisation proteins into the 
vesicle.  
 
8.5.1 LIPIDS AND PROTEINS 
 
MmsF and Mms6 were added to a DPhPC film rehydrated with 10 mM NaOH, so that 
protein incorporation can occur during liposome assembly. The vesicles were then 
electroporated (Section 2.3.3) with an applied voltage of 750 V in the presence of 
ferrous and ferric chloride solution (at the stoichiometric ratio for magnetite). The 
nature of incorporation of the proteins is currently unknown, but is likely to proceed 
via disassembly of the aggregate or incorporation of the protein aggregates as a whole. 
 
 MMSF INCORPORATION 8.5.1.1
 
It was hoped that the resulting vesicles would be filled with iron oxide as seen with 
previous vesicle samples (Chapter 6) but that the presence of MmsF would yield higher 
quality nanoparticles closer in morphology to those extracted from MTB. Due to its 
self-assembling properties it was unknown how MmsF would incorporate into the 
synthetic DPhPC liposomes. One hypothesis was that the proteinosome will remain 
assembled and sit within the liposome forming almost another leaflet. Incorporation 
via this mechanism would yield a complete nucleation surface on the inside of the 
liposome offering increased control over precipitation of the particle.  
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However incorporation of this type (which would essentially increase the bilayer 
thickness) may hinder transmembrane transport of iron. Another hypothesis is that the 
proteinosome will disassemble and incorporate into the membrane in the same way as 
monomeric membrane proteins. It is also possible that the MmsF protein may 
incorporate into the membrane not as single protein monomers, but instead form 
“islands of proteins” akin to lipid rafts observed in liposomes.208 In both cases, the 
orientation of the protein upon incorporation will be crucial to the proteins 
functionality, and it is likely that incorporation via the second proposed mechanism has 
a higher probability of positioning the protein with the desired topology. TEM 
micrographs of the liposomes following electroporation show incorporation of what is 
















Figure 8.9: TEM micrograph (main picture and inset magnification) of MmsF incorporated into DPhPC 
liposomes after electroporation (5 x 750 v) in the presence of ferrous and ferric mixed iron chloride (10 mM) 
solution, Inset: magnification of negatively stained liposomes from the same sample that have not been 
electroporated in the presence of iron.  
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It is impossible to distinguish presence of the protein/proteinosome or any obvious 
difference in the morphology of the precipitate. What can be seen is a distinct density 
difference between the core of the liposome and the bilayer, suggesting increased 
penetration of the bilayer. There is an obvious presence of electron dense material in 
the liposome bilayer (as liposomes are otherwise unstained), (figure 8.9). This could be 
as the result of miss-orientation of the protein in the bilayer causing nucleation of iron 
oxide on and in the bilayer. As yet, this hypothesis remains inconclusive and 
confirmation would first require identifying the position and orientation of the protein 
in the bilayer, either by the addition of fluorescent tags to the protein or chemical 
composition analysis.  
 
 MMS6 INCORPORATION 8.5.1.2
 
TEM micrographs of Mms6 incorporated vesicles post electroporation indicates 
encapsulation of iron oxide, by the appearance of electron dense material in the 
vesicles (see figure 8.10). Vesicles also appear much less discrete than in previously 
imaged samples. It is hard to determine whether the disrupted vesicle structure is as a 
result of Mms6 incorporation or degradation of the DPhPC lipid (Figure 8.10). 
However, as with MmsF, there is an increased density associated with the vesicle core. 
It is hoped that this is a consequence of increased nucleation of iron ions to 








Figure 8.10: TEM micrograph (and inset magnification) of Mms6 incorporated into DPhPC liposomes and 
electroporated (5 x 750V) in the presence of ferrous and ferric mixed iron chloride (10 mM) solution, Inset: 
magnification of liposomes from the same sample. 
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8.5.2  POLYMERS AND COILED-COILS 
 
As with the native biomineralisation proteins, the coiled-coil scaffold proteins were 
incorporated into PBD-PEO polymersomes during rehydration of the polymer film with 
10 mM NaOH. Polymersomes were subsequently electroporated in the presence of 
ferrous and ferric chloride solution (mixed at the stoichiometric ratio for magnetite). 
The polymersomes were cleaned up by SEC to remove externally precipitated iron 
oxide (Section 2.2.3). The polymersome sample was analysed SDS-PAGE with 
Coomassie staining for detection of the coiled-coil in the sample. The resulting gel 
confirmed that coiled-coils are associated with the PBD-PEO polymersomes by the 
presence of the bands at 15 kDa (compared to PageRuler Life Technologies molecular 















Figure 8.11: a) Western blot of polymersomes incorporating coiled coils (after clean up) confirmed the 
presence of the proteins associated with the polymersomes as shown by the bands at approximately 15 kDa. 
TEM micrographs of the same polymersome sample incorporating b) Mms13 coiled coil and c) MmsF coiled 
coil. 
P a g e  | 245 
 
 
When these same samples are observed in TEM, the polymersomes appear to be of a 
high quality and relatively monodisperse polymersomes which have a consistent highly 
spherical morphology. A bilayer is visible on many of the PBD-PEO polymersomes 
(Figure 8.11 b). All polymersomes imaged had consistently filled electron dense cores, 
predicted to be iron oxide. They are significantly different in morphology to 
electroporated polymersomes without coiled coils, (Figure 6.4). Therefore, this change 
could be attributed to the presence of the coiled coil artificial proteins within the core.  
The MmsF coiled-coil incorporated polymersomes were of a highly uniform 
morphology (Figure 8.11 c), when compared to polymersomes incorporating the 
Mms13 coiled-coil. In both polymersome samples, it is also possible to distinguish the 
presence of a bilayer. The reason for this may be the high homogeneity of the 
precipitate, more of which appears to have occurred within the core of the 
polymersome for the Mms13 coiled-coil when compared to the MmsF coiled-coil 
polymersome samples. For the MmsF sample, although the core is equally as dark, 
heterogeneity in the density of the core suggest the presence of a cluster smaller 
particles rather than a single MNP crystal. It is possible that these smaller particles 
reside in the polymersome membrane as with electroporated PBD-PEO in the absence 
of protein (Figure 6.4). It is possible that this is also why the bilayer is not as easily 
distinguished. This could be due to a difference in the position of the coiled-coil in the 
polymersomes, although this is impossible to confirm without further analysis. To 
answer this question this would first require labelling of the coiled coil proteins with a 
fluorescent tag or perhaps gold binding peptide to make its detection and analysis of its 
position possible.  
 
8.6 BIOMINERALISATION WITHIN VESICLES: DISCUSSION 
 
This chapter presents the preliminary work on the incorporation of MTB proteins into 
synthetic magnetosomes, for the control of intra-vesicular magnetite precipitation. 
This is a difficult process, involving the expression and purification of the protein, 
incorporation into synthetic vesicles, identification of position and orientation of the 
incorporated proteins and confirmation that they are functioning successfully.  
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Not all of this work has been completed as part of this project, but the proof-of-concept 
data presented now allows for further modification of the proteins to confirm the 
successful incorporation that TEM analysis suggests. The chapter focussed on 
observation of morphological changes introduced by MTB biomineralisation proteins 
and their biomimetic scaffold counterparts.  
Each of the MTB proteins in their native form (cloned from bacterial genomic DNA) are 
difficult to purify and work with due to their highly hydrophobic nature, expressing at 
low concentrations. Incorporation of both the proteins and the artificial scaffold 
proteins into synthetic vesicles will help to create an artificial magnetosome. Not only 
will this aid the formation of a fully functional synthetic magnetosome with the 
superior properties required for biomedical application, it is hoped that this would also 
contribute to understanding the function of the proteins in a  close to native 
environment.  
However confirmation of a) incorporation, b) position, c) orientation and d) 
functionality of the proteins and scaffolds is extremely difficult. It can be assumed that 
the incorporation has been successful and TEM micrographs and in some cases SDS-
PAGE supports this hypothesis. For this premise to be conclusive detection of the 
protein must be confirmed via the routes discussed (such as addition of fluorescence 
tags, or other labels). Tagging the protein should also indicate its position in the vesicle, 
conclusive evidence of the proteins orientation and functionality are much harder to 
achieve. For these, multiple characterisations are required, which when combined 
should confirm the hypotheses drawn from the preliminary data shown throughout 
this chapter. For example, confirming the orientation can be strengthened using 
protease experiments, which should degrade the outer membrane region of the protein 
which could then be detected using mass spectroscopy to work out which sites are 
exposed. This is a lengthy process requiring in-depth analysis of the sequence and 
careful selection of the protease.  
The predicted regulation of iron oxide precipitation functionality of the proteins is 
supported by the data shown, by the distinct difference between electroporated 
vesicles with and without the proteins incorporated. 
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Increased nucleation of electron dense material within the vesicles that incorporate 
proteins suggests an iron oxide nucleating function of the protein. Measurement of 
internal pH gradients is difficult, but would help confirm what appears to be 
happening. Energy dispersive X-ray could provide confirmation of the elements 
present, and selected area electron diffraction could probe the crystallinity of these 
electron dense cores to confirm whether they are iron oxide.  
There is a distinct difference between the vesicles containing MmsF and Mms6. For 
example, MmsF incorporation has yielded a much higher quality vesicle population, 
(Figure 8.8) in comparison to vesicles after Mms6 incorporation (Figure 8.10), which 
appear to be interconnected with some forming what appears to be a network of 
organic material. This could arise from the self-assembling properties of the MmsF, 
which has been proven to form highly monodisperse proteinosomes.5 If the 
proteinosomes are being incorporated as assembled, they are likely to have an effect 
on the dispersity of the resulting vesicles. The MmsF incorporated vesicles also appear 
to have increased and more homologous precipitation indicated by electron dense 
cores. This may indicate improved nucleation properties of MmsF. This is particularly 
evident when compared to Mms6 incorporated vesicles, in which the precipitate does 
not fill the vesicle core, and appears much more heterogeneous. As all other conditions 
were kept constant between the two samples, the difference in vesicle appearance and 
amount of the precipitate can be attributed to the presence of the two different 
proteins. With these preliminary data corresponding with the literature,209 which 
suggests improved nucleation and regulation of iron oxide precipitation in the case of 
MmsF.  
The apparent success of the coiled coil vesicular incorporation is again a novel process, 
and whilst these experiments need further characterisation to confirm their success, 
this is a positive advancement in the creation of an artificial magnetosome. The coiled-
coil scaffold proteins are much easier to express and purify than the native MTB 
proteins, alleviating difficulties experienced with purification and solubility, 
particularly with respect to refolding proteins such as Mms6. Due to their easy 
purification, it is possible to achieve yields which are orders of magnitude higher than 
with the full protein. This makes their incorporation into a synthetic vesicle much more 
feasible, particularly with regards to scale-up for application and possible future 
commercialisation. 








CHAPTER 9:  
 
9 BIOMEDICAL APPLICATION OF 
MAGNETO-VESICLES 
  





One ultimate aim of this project is that the artificial magnetosome developed will be 
functional for future use in biomedicine. More specifically, it is hoped that superior 
magnetic properties as a consequence of the biomimetic synthesis route will yield 
superior MRI contrast agents and/or hyperthermic materials for ablation of tumour 
tissue. With this in mind in vitro testing of magneto-nano-vesicles produced throughout 
this thesis have been tested by both myself and collaborators with expertise in these 
areas. The data presented in this chapter is as a proof-of concept, but is designed to 
give an indication of the potential of artificial magnetosomes for future biomedical 
application.  
The samples tested in this chapter for their biomedical potential were those that were 
the most successful in vesicle synthesis (as optimised throughout chapters 6, and 7) 
when examining the different transport methods for mineralisation within vesicles. 
Specifically, these include; electroporated (750 V) DSPC EHDA synthesised liposomes 
(shown in figure 7.5), PBD-PEO electroporated (2500 V) polymersomes (Figure 6.4), 
PMOXA-PDMA-PMOXA electroporated (750 V) polymersomes and PEG113-PHPMA400 
/PMPC28-PHPMA400, via all three transport routes tested (electroporation, ionophore 
and flocculated). These were chosen as they appeared to show a good amount of 
electron dense material, presumed to be iron oxide, in TEM imaging, within the vesicle 
structure. Of particular interest were the vesicles with NPs in differing position in the 
vesicle structure, particle size and amount of iron oxide present, and how these 
differences affect the magnetic properties, and therefore their potential for biomedical 
use. 
The values obtained for the samples above are compared to literature values, 
physiological conditions and commercially available nanoparticles. For MHT ILP values 
measured from these magneto-vesicle samples, these have been compared to an 
average ILP of 2.5-3 nHm2kg-1 in current literature, and an ILP of approximately 3 
nHm2kg-1 for current commercially available particles.145 Similarly, MRI relaxation 
rates obtained from measurements on magneto-vesicles were compared to the R2* 
relaxation rate of grey matter, which is 30 s-1.210  
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The particle’s relaxation rate must be greater than this value to be effective in vivo as a 
contrast agent. A T2 relaxation rates of 146 mmol-1s-1 for MTB magnetosomes and 62 
mmol-1s-1 for synthetic dextran iron oxide coated nanoparticles148 has also been used 
for comparison. 
 
9.2 IN VITRO MAGNETIC HYPERTHERMIA TESTS 
 
All initial magnetic hyperthermia tests were conducted using a Magnetherm 
(Nanotherics) system. This comprises either a 9 of 17 turn coil in the centre of which 
the sample is placed. The magnetic field strength and its alternating frequency are 
determined by a power supply (from which a current is generated) and a frequency 
generator respectively. These parameters are dependent on the coil/capacitor 
combinations which are chosen to obtain specific field frequency and field strength. 
The system is tuned to resonance using a digital oscilloscope to avoid over heating of 
the coil which in turn heats the sample. Additional measures are taken to prevent coil 
heating by attachment of the system to a water supply. There must be a minimal water 
flow rate around the coil for the system to be operational. In this case the system was 
connected to a recirculating water bath set at either 10°C or 20°C.  
 
9.2.1 CALIBRATION OF THE MAGNETHERM 
 
The collection of reliable calibration data is difficult due to the many parameters that 
can affect heating.145 These were previously outlined in the paper by Wildeboer et 
al.145, who discuss the common inaccuracies encountered during the measurement of 
the heating capabilities of materials and how this can widely affect the value obtained. 
Their work also highlights that there is not yet a universally accepted method of 
SAR/ILP measurement.145 Typical inaccuracies arise firstly from heat transfer between 
the sample and its surroundings or vice versa.  
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This means that heat from the particles in the sample can be lost, resulting in the 
SAR/ILP value being underestimated. Conversely, these values can be inflated if there 
is heating from the solution, or as the result of convection currents in the sample, 
either of which contributes to the overall temperature difference. Ideally, 
measurements would be carried out under adiabatic conditions which would ensure 
the SAR or ILP measurement is unaffected by the heat transfer discussed above. 
However, in terms of practicality of the measurements, this is unfeasible, as it is 
impossible to obtain an entirely adiabatic system. 
Therefore it was decided that measurement data presented in this chapter would be 
calibrated for the heating power of the solvent and for heat loss to the surroundings. 
This was achieved by measurement of the temperature change to the surroundings of 
the sample, as closely as possible. Of course, this cannot account for heat loss to the 
container, but any change in temperature was added to or subtracted from the final 
temperature change. Similar subtractions were made with regards to the heating 
capability of the solvent. This was done by taking repeat measurements of the 
temperature increase of the solvent when subjected to an alternating magnetic field. 
This was then subtracted from any heat increase observed in the presence of the 
particles, ensuring the same sample volume was used. It was found that changing the 
sample volume of the control PBS sample could change the temperature increase 
observed as much as 2-3 °C for a 1 ml sample, when compared to 7-8 °C when only 
100-300 µl are used. Therefore, to ensure heating power of only the magneto-vesicles 
was measured, the volume transferred to the heating chamber was kept consistent 
between samples. Also critical to the outcome of the measurement is the shape of the 
sample container, with flat-bottomed containers offering more evenly distributed 
heating and therefore more accurate measurements. Similarly the position of the 
temperature probe can affect the result; it was found that tests in which the probe was 
placed at the bottom of the sample container (particularly with tests conducted in 
Eppendorf’s) appeared to have increased heating. This is reinforced by Wildeboer et 
al.145, who recommend the use of a flat bottomed vial, with a centrally located probe. 
This should give an accurate reading of the mean temperature of the sample ±1°C.145 
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After much experimentation, a method was designed for measurement of the heating 
capability of magneto-vesicles, as accurately as practicalities would allow. This 
consisted of measurement of a defined volume of the sample solvent alone, in a glass 
bottomed vial, followed by measurement of the same volume of solvent, now with the 
addition of the vesicles. In each case, the temperature of the solution was left to 
equilibrate for 10-20 minutes before the magnetic field was applied. This is because it 
was also found that this fluctuated less when the recirculating water bath temperature 
was higher (20 °C). The temperature change was then measured for 15 minutes. Before 
plotting, both the starting temperature and the temperature of the solvent alone were 
subtracted. This is especially important as a thermocouple was used to measure the 
temperature increase (as provided by Nanotherics and it is standard equipment), but 
due to metal components, is believed to also have induced heating in an AMF. 
 
9.2.2 MAGNETO-VESICLE HEATING CAPABILITY 
 
The most promising magneto-vesicle samples from each set of experiments presented 
throughout this thesis were tested for their potential use as hyperthermia agents. This 
was done by placement of the vesicle solutions (following clean-up to remove external 
iron oxide precipitate) in an alternating magnetic field. The temperature increase when 
samples were placed in an alternating magnetic field (AMF), of H = 7.68 kA m-1, is 
shown in figure 9.1. The heating ability was recorded every second for 15 minutes 
(following equilibration of the baseline temperature), over three runs, and an average 
temperature increase was calculated and plotted (Figure 9.1). In all samples, initial 
temperature increase was observed in the first 30-60 seconds; it is from this initial 
temperature gradient that the heating capability of the sample can be obtained. All ILP 
calculations are measured using the iron concentration in the sample based on ICP-MS 
measurements. Due to the variation in the concentration of the magneto-vesicles 
between samples, comparison of and the reproducibility of the heating effects has been 
difficult. Presented here is some preliminary work that needs to be further optimised 
to ensure reproducibility of the results seen. 
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Most samples showed a discernible temperature increase, with the exception of the 
electroporated tri-block magneto-polymersomes (PMOXA-PDMA-PMOXA). In this case, 
the solution decreased in temperature over the 15 minute measurement period in the 
AMF. These polymersomes appeared to be distorted post-electroporation (Chapter 6). 
While these morphological defects may dampen the heating capability of the 
polymersomes, it is not expected that they would cause a decrease in temperature, so 













One hypothesis for why this may have occurred is that the particles in the 
polymersomes do not cause any heat dissipation in an AMF. This may be for one of two 
reasons, the first being that their position in the membrane hinders their switching. 
This would mean that the MNPs produce no heat at this applied field strength. 
Secondly, and more likely, is that the particles are not magnetic and therefore have no 
response to the alternating field. 
 
Figure 9.1: Temperature increase induced by various iron oxide filled vesicles after 10 minutes in 
alternating magnetic field at 739 kHz and field strength of 7.68 kAm-1, control PBS heating and the initial 
temperature have both been subtracted from the plots. 
PBD-PEO (500 V) 
PBD-PEO (750 V) 




PEG113-PHPMA400 / PMPC28-PHPMA400 
(Electroporated) 
PEG113-PHPMA400 / PMPC28-PHPMA400 
(Ionophore) 
PEG113-PHPMA400 / PMPC28-PHPMA400 
(Flocculated) 
PBD-PEO (250 V) 
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 In either case, the decrease in temperature yields an ILP value of -1.69 nHm2 k-1 and is 
likely to be due to be the flow around the coil from recirculating water bath cooling the 
sample. For PEG113-PHPMA400 / PMPC28-PHPMA400 the samples which were 
electroporated to initiate iron ion transport gave the greatest temperature increase, 
and continued to increase at a faster rate than the other samples. The maximum final 
temperature increase was 5.2C, which would be sufficient to damage/destroy 
cancerous cells. 
 
Sample MNP Formation method ILP (nHm2 kg-1) 
PMOXA-PDMS-PMOXA Electroporated (750 V) -1.69 
DSPC 
(EHDA synthesised) 
Electroporated (750 V) 3.65 
PEG113-PHPMA400/ 
 PMPC28-PHPMA400 
Electroporated (750 V) 
3.5 
 
Ionophore (A23187 1.8 
Flocculated (RTCP) 0.4 
PBD-PEO 
Electroporated (250 V) 1.05 
Electroporated (500 V) 1.01 
Electroporated (750 V) 0.13 
Electroporated (1500 V) 1.37 
Table 9.1: ILP values corresponding to the heating capabilities of samples plotted in figure 9.1. 
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The temperature increase produced by the same polymer in which the A23187 
ionophore was incorporated was lower at 4.0C, which would also be sufficient to have 
ablation effects on the surrounding tissue. The temperature increase achieved with the 
flocculated PEG113-PHPMA400/PMPC28-PHPMA400 polymer was lower still at 2.8C. A 
temperature increase of this kind can have a detrimental effect in vivo, as the gentle 
warming (2-3 °C) of cancer cells can actually accelerate division of the tumour cells, 
with the consequence of helping to spread the tumour tissue. 
These results are not surprising with respect to electroporation and transport via the 
ionophore, as it known that electroporation reliably porates the vesicle membrane 
multiple times per pulse.160, 164 This means that a much higher uptake of soluble iron is 
likely, which can be further increased by multiple pulses in some cases (Figure 6.14). 
This is in contrast to transport using the A23187 ionophore, in which it takes two 
ionophore molecules to transport a single ferrous ion across the membrane, therefore 
the mass of iron transported across the vesicle membrane is likely much lower. 
Furthermore, the A23187 is divalent cation specific; therefore the precipitation of 
magnetite within the core requires a significant proportion of the transported ferrous 
ions to be oxidised to ferric iron and successfully mineralise magnetite. On this basis, it 
is unlikely that the same amount of magnetic iron oxide is being precipitated within the 
ionophore porated vesicles as is achieved by electroporation. More surprising is the 
heating capability of the flocculated sample, which is significantly lower than with the 
other transport methods used for this polymer. Incubation in a room temperature co-
precipitation before flocculation to isolate the polymersomes (section 2.3.4) should 
have the highest probability of successfully precipitating magnetite. This is because the 
polymersomes are incubated in a controlled magnetite precipitation reaction. 
However, the low heating capability raises concerns that reagents are not penetrating 
the polymersome membrane effectively. This means that the electron dense material 
observed in the TEM is unlikely to be magnetite, as magnetite would have a direct 
effect on the heating ability of the magneto-polymersomes.  
Electroporated DSPC vesicles which had been synthesised using EHDA show similarly 
high heating capabilities to commercially available iron oxide nanoparticles. These 
produce an ILP of 3.65 nHm2 k-1 over a 15 minute heating period.  
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This heightened heating is likely to be the result of an iron oxide filled vesicle core, the 
composition of which was confirmed to be magnetic iron oxide; either magnetite or 
maghemite (see section 7.4.4). The filled vesicle core will also give a high iron ion 
concentration in ICP-MS measurements on which the ILP calculation is based. This 
increase compared to other samples with much lower ILPs (Table 9.1) suggests that 
other polymersomes perhaps contain another less magnetic iron oxide, causing the 
vast difference in calculated ILP.  
The most interesting results are in the ILP measurements of PBD-PEO electroporated 
polymersomes. The ILP’s of the samples measured on the Magnetherm show no 
correlation to increasing the applied voltage, with the sample at 750 V showing the 
lowest heating capability. This is a voltage which yields an ILP of 3.65 nHm2 k-1 in DSPC 
liposomes. All other PBD-PEO samples measured give values of approximately 1 nHm2 
k-1. Control readings are taken of the blank solution and thermocouple heating, this is 
then subtracted and the reading set to zero before measuring the magneto-
polymersome sample. It’s possible that despite subtracting control data, coupling is 
occurring between the magneto-polymersome solution and the thermocouple. This 
would lead to the magneto-polymersome solution heating, this heats the thermocouple, 
this in turn further heats the solution which then becomes cyclic. This requires further 
investigation using an alternative probe, such as a fibre optic probe (which has been 
recently purchased by the Staniland group). Therefore, all experiments will be 
repeated as part of further work with the fibre optic probe. 
These polymersomes (electroporated at 2500 V) were tested on a different system to 
test the hypothesis that heating from the probe is introducing inaccuracies into 
hyperthermia reading from the Magnetherm (Nanotherics). These experiments were 
repeated under different parameters (1 MHz, 1.32 kAm-1) using alternative equipment 
(MACH (Magnetic Alternating Current Hyperthermia) system, Resonant Circuits 
Limited, UK) by experts in the field (UCL, Nanomagnetics Lab), an observed 
temperature change of 6°C was achieved, with an ILP of 9.3, (Figure 9.2) a value which 
is triple the ILP of commercially available nanoparticles. The ILP was calculated from a 
more accurate iron oxide concentration (as measured by SQUID).  
Furthermore, the temperature increase was measured using a fibre optic probe as 
opposed to a thermocouple, which does not heat in an AMF and therefore should 
provide more accurate readings.  















A hypothesis for the increased heating capability of this sample is the precipitation of 
the iron oxide nanoparticles in the polymer membrane. It is possible that in situ 
formation of MNPs, as opposed to encapsulation of pre-formed MNPs, may lead to 
tighter association with the vesicles membrane. Due to the particle size (2-3 nm) they 
are superparamagnetic, and therefore will undergo Brownian rotation. If particles are 
tightly associated with a membrane, this is likely to cause friction between the 
membrane and the MNP rather than free in fluid, as the particle flips. This friction will 
generate heat, therefore heightening the heating ability of the particles beyond what is 
expected for their size.  
Figure 9.3 shows repeated measurements of a second PBD-PEO polymersome sample 
electroporated at two different voltages (750 V and 1500 V, a repeat of the data shown 
in figure 9.1). This repeat was again performed at UCL using the MACH (Magnetic 
Alternating Current Hyperthermia) system, (Resonant Circuits Limited, UK) and again, 
the results are highly inconsistent with the data collected using the Magnetherm.  
Figure 9.2: Temperature increase induced by PBD-PEO magneto-polymersomes after 30 minutes in an 
alternating magnetic field at 1 MHz and field strength of 13.2 kAm-1, yielding an ILP of 9.3 for an 
estimated iron oxide concentration of 22 µg ml-1. 






The data shown in figure 9.3 of PBD-PEO polymersomes were electroporated at 750 V 
and 1500 V and were subsequently tested at the UCL Nanomagetics Lab (as in the case 
of data shown in figure 9.2) to rule out inaccuracies from thermocouple heating. 
Although there is a large amount of noise in the traces (due to the small sample size), 
the heating capability of the samples still show a trend closer to that expected (i.e. 
increasing ILP as function of applied voltage). This time an increase of 2°C was 
observed in the sample electroporated at 1500 V when compared to only 0.5°C from 
the sample electroporated at 750 V.  
Calulation of the ILPs from this sample are shown in figure 9.4. Figure 9.4 a) shows 
comparison of the three different PBD-PEO magneto-polymersome samples, 
synthesised at the three different electroporation voltages. Relative ILP values for 
these three samples are based on the total iron concetration in the sample (measured 
by ICP-MS) and are shown in figure 9.4 b). These have the predicted trend of increasing 
ILP as a function of increasing applied electroporation voltage (relative to Fe 
concentration).  
Figure 9.3: Temperature increase induced by PBD-PEO magneto-polymersomes electroporated at 750 V and 
1500 V after 30 minutes in an alternating magnetic field at 944 kHz and field strength of 9.9 kAm-1, heating of 
a blank water sample has been subtracted from these plots to normalise for contributions from the buffer 
and container. 
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However, a much greater ILP is obtained from figure 9.2, where the ILP is caluculated 
from the concentration of magnetic iron oxide present in the sample (as measured by 






9.3 MAGNETO-VESICLES AS MRI CONTRAST AGENTS 
 
All MRI measurements were performed by Dr Aneurin Kennerley (Magnetic Resonance 
Physicist for fMRI facility, Department of Psychology, University of Sheffield) 
 
9.3.1 CALIBRATION OF MEASUREMENTS 
 
Magneto-vesicles were tested for their potential as MRI contrast agents. All tests were 
carried out on a 7 Tesla Bruker MRI, with samples of equal volume in glass vials, or in 
capillary tubing suspended in Agar (to avoid distortion of the magnetic field due to the 
surrounding/vessel; known as shimming) in a capillary model system.  
 
Figure 9.4: Temperature increase induced by PBD-PEO magneto-polymersomes electroporated at 750 V , 
1500 V, 2500 V after 30 minutes in an alternating magnetic field at 944 kHz and field strength of 9.9 kAm-1. 
b) Relative ILP values (relative to total iron concentration in the sample) for the temperature increase 
induced by the magneto-polymersomes electroporated at the three different voltages.  
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In each case, the vesicles were compared to a control saline solution to ensure that any 
contrast seen was due to the vesicles in the sample. Initial tests confirmed that PBD-
PEO magneto-polymersomes had increased contrast at both high (approximately 60 
mg ml-1) and low concentration (approximately 1 mg ml-1) when compared to saline 
(Figure 9.5). Conversely the contrast was much lower than commercially available 












The same concentration effect can be seen in the relaxation rates of the magneto-
polymersome samples, where serial dilutions of the samples have a proportional 
decrease in the R2 relaxation rate (Figure 9.6). This effect is also observed as the iron 
oxide concentration in the sample increases from 10 mg ml-1 (Figure 9.6 a) to 60 mg ml-
1 (Figure 9.6 b) and c) gives rise to an increase in R2 relaxation from 1.65 to 7.52 and 




Figure 9.5: MRI images of contrast provided by two different magneto-polymersome concentrations 
compared to a blank saline sample and a control sample of magnetic iron oxide nanoparticle (MION) 
solution. 












The same effect was observed in measurement of R2* relaxation rates as a function of 
sample concentration. Again there was a general trend of increasing relaxation rate as 
a function of concentration, but without the same linearity due to the presence of a 
number of anomalies (Figure 9.7). It is believed that these anomalies are as a result of 











Figure 9.6: R2 relaxation rates of serially diluted PBD-PEO magneto-polymersomes of increasing 
concentration a) 10 mg ml-1 to b)/c) 60 mg ml-1. Arrows on the each graph indicates increasing dilution of 
each sample. Blue trace on each graph is a saline control. 
Figure 9.7: R2* relaxation rates of serially diluted PBD-PEO magneto-polymersomes. Arrow indicates 
increasing dilution of the sample. Blue trace represents a saline control. 
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9.3.2 MAGNETO-VESICLE MRI MEASUREMENTS 
 
Both DSPC magneto-vesicles synthesised by EHDA and electroporated PBD-PEO 
magneto-polymersomes were imaged in a saline phantom (control sample to reflect 
physiological conditions) to assess their contrast capabilities (Figure 9.8). Images taken 
at several echo times suggested that the DSPC samples were experiencing a degree of 
sedimentation, with contrast decreasing as the time increased. This trend shows higher 
concentrations at the bottom of the vial (probably due to sedimentation), with contrast 
being lost completely over time. Therefore, the measurements need to be repeated 
with more optimised sample preparation, such as suspension in more viscous solution 
to prevent sedimentation. The opposite was true in the case of PBD-PEO, in which 
there was a dramatic increase in the contrast of the image (when compared to the 





Therefore a more in-depth analysis of the MRI properties of the polymersome sample 
was performed (Figure 9.9). Relaxometry results (at 7 Tesla) for the R2 and R2* rates 
of the magneto-polymersome sample in PBS were 22.7 s−1 and 148.8 s−1 respectively 
(Figure 9.9). The R2 relaxivity was normalised for sample iron concentration (as 
measured by ICP-MS) was 9.1 [Fe mM]−1 s−1.  
Figure 9.8: MRI contrast images of DSPC EHDA synthesised iron oxide liposomes (top) and PBD-PEO 
magneto-polymersomes (bottom), vesicle samples (inner circle), are sat in a saline phantom control 
sample (white circle), darker vesicle sample is equal to better contrast agent. 
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Similarly, R2* data shows enhanced decay with the presence of MNPs, although it was 
not possible to extract a clear relationship between MNP concentration and decay due 
to the very rapid relaxation. It is clear from comparison to the saline relaxation rate 
(Figure 9.9), that the precipitation of small superparamagnetic particles within the 
magneto-polymersome membrane has positive effects on the contrast in MRI. Firstly, 
the 2.5 ± 0.5 nm MNPs precipitated within the magneto-polymersome membrane have 
a much greater surface area than conventional MNPs used as MRI contrast agents 
(these are usually about 20 nm in diameter). Secondly, diffusion effects are often 
observed when measuring R2 decay data, if more diffusion occurs MNPs will come into 
closer contact with water, more often, which will affect the overall contrast agent 









Figure 9.9: 7 T Magnetic resonance R2 relaxometry data (16 echoes, 9 slices, image shows the 5th slice) and 7 
T Magnetic resonance R2* relaxometry data (12 echoes, 9 slices, image shows the 5th slice). Both R2 and R2* 
relaxometry rates show significant difference between saline (dashes) and electroporated PBD PEO magneto-
polymersomes (solid). 
 
This is particularly of note due to the position of MNPs within the membrane. MNPs are 
immobilised in close proximity to the permeable water molecules, essentially creating 
more random magnetisation dephasing interactions that cannot be refocused with 
conventional spin-echo (MR). This enhances the contrast to a higher degree than 
expected. Peters et al210 measured the R2* relaxation rate of brain tissue to be 30 s-1.  
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This is significantly different to the R2* relaxation rate measured for the magneto-
polymersomes (148.8 s-1). This large difference suggests that, with optimisation, 
magneto-polymersomes have potential as future in vivo biomedical MRI contrast 
agents. However, this requires further dose and toxicity related investigation, in 
particularly with respect to measurements from an in vivo environment, such as within 
cultured tissues or a mouse model. 
 
9.3.3 ALTERING THE IRON CONCENTRATION: EFFECTS IN MRI 
 
Control tests (Figure 9.10) conducted on magneto-polymersomes, unelectroporated 
polymersomes and saline samples show a difference in R2 relaxometry upon addition 
of MNPs in the polymer membrane. Electroporated polymersomes display a 
significantly faster decay than saline and unelectroporated controls. It also evident that 
the rate of decay is dependent on magneto-polymersome concentration, with the rate 
decreasing as the concentration of magnetopolymersomes decreases (Figure 9.10). The 
decay of the control unelectroporated polymersomes is comparable to that of the saline 
sample. This confirms that little or none of the contrast shown in figure 9.9 is the result 
of signal coming from the polymersome membrane. R2* control data shows faster 
decay with the presence of magnetopolymersome MNPs, although it was not possible 
to extract a clear relationship between magnetopolymersome MNP concentration and 
decay. This is due to the decay being faster than the time window needed to collect 
sufficient data points to form a suitable exponential decay curve. Therefore, the control 











Figure 9.10: R2 relaxation rate of saline, control polymersomes (with no iron present) and electroporated 
magneto-polymersomes which were serially diluted. Starting iron concentration 28 mg L-1 (as measured 
by ICP-MS), each dilution was a 2 x dilution.  
 
Precipitation of MNPs using electroporation has the potential to be tuned to give 
magneto-polymersomes with differing numbers and sizes of MNPs. This would be done 
by varying a number of parameters as shown in chapter 6. Figure 9.11 a) shows that, in 
general, relaxivity per mM Fe concentration increases as the applied voltage increases 
during electroporation. However, there seems to be two distinct mechanisms of 
electroporation, with lower and higher voltages displaying differing trends. At lower 
voltages, relaxivity per mM Fe concentration increases as a function of iron 
concentration in the vesicles, which was increased by applying an increasing voltage 
from 250 V to 750 V, yielding increased iron ion uptake (in ppm).  
Similarly, an increase in relaxivity per mM Fe concentration as a function of measured 
iron content (ppm) in the vesicles is observed for the magneto-polymersomes 
electroporated at between 1500 and 2500 V. However, there is a crossover in 
behaviour when magneto-polymersomes are electroporated at 1000 V. At this point, 
the magneto-polymersomes contain smaller particles in increased numbers (as shown 
by grainsizing from TEM in figure 6.15) compared to polymersome electroporated at 
low voltage. This appears to be responsible for the increased relaxivity per mM Fe 
concentration. This suggests that increased contrast is achieved by increasing the MNP 
particle number rather than increased particle size within the magneto-polymersome 
membranes.  
Control Polymersome 
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This supports the hypothesis discussed in section 9.3.2 that diffusion in and around the 
membrane plays a key role in the enhanced relaxation properties of the vesicle 
membrane, as more particles would result in increased diffusion effects. 
 
 
Figure 9.11: a) Average MNP particle size of MNPs in magneto-polymersomes that were electroporated at 
200, 1000, and 2500 V. Red circles indicate high voltage and low voltage electroporation mechanisms the 
results of which are shown in the schematic associated to each mechanism (indicated by the arrows), as 
established in figure 6.15 b) Plot shows relaxation rate per mole of iron as a function of the voltage applied 
during electroporation. 
 
This effect is also observed in figure 9.11 b), with increased R2 relaxivity per mM Fe 
concentration seen from 1.3 [Fe mM]-1s-1 to 9.1 [Fe mM]-1s-1. This effect is not solely 
dependent on the iron concentration or the electroporation voltage applied during 
mineralisation, the size of the particles also has an effect. This is because, as water 
diffuses in and around the vesicle membrane, a greater number of protons will come 
into contact with MNPs. This contact increases if there are a larger number of smaller 
sized particles sat in the membrane as opposed to smaller numbers of large particles. 
This explains why the relaxivity per mM Fe concentration can vary significantly 
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9.4 DISCUSSION OF BIOMEDICAL APPLICATIONS OF MAGNETO-
VESICLES 
 
While the data presented in this chapter is far from conclusive, it is a good indicator of 
the future potential the magneto-vesicles (particularly the polymersomes) in 
biomedical theranostic applications. The proof-of-concept data presented shows 
promising magnetic hyperthermia heating ranging from a heat increase of between 1 
and 6°C, depending on the sample analysed. ILP values varied greatly depending on the 
sample, measurement method and equipment used. This highlights the reproducibility 
issues that can occur with this new and experimental technique. Although it would be 
unwise to quote these values as accurate ILP values at this stage, it can be accepted that 
the magneto-vesicle samples have potential for development for use in magnetic 
hyperthermia.  
It should be noted that the acquisition of these data can be improved, paticularly with 
respect to optimising the type and position of the temperature probe. During 
calibration of the system, siginficant heating was observed from the thermocouple 
provided with the system. Data collection could be vastly improved with use of a fibre 
optic probe, which would avoid unwanted heating from the probe and improve the 
accuracy of obtaining a more realistic heat increase measurement. This is evident 
across the current literature in the field, with SAR and ILP values sometimes conflicting 
between measurements for similar samples.145 With clinical trials beginning in humans, 
the call for standardisation of hyperthermia data acquisition is becoming evermore 
prominent. This should make published data values more comparable, and the ILP 
values presented in this chapter more meaningful to the field in the future. 
MRI contrast properties of the magneto-vesicles were tested for DSPC and PBD-PEO. 
Although, in the case of the DSPC liposomes, they appear to show good contrast initially 
(figure 9.8 top row), there are obvious issues with the sample sedimenting as contrast 
is lost over time. Therefore, MRI contrast with DSPC magneto-liposomes requires 
optimisation of the sample preparation, as it is likely that re-suspension in more 
viscous (agar) solution will result in more reliable measurements. 
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This optimisation of the sample sedimentation will need to be characterised using a 
different technique (possibly fluorescence or DLS measurements) due to the expensive 
nature of MRI measurements. 
The relaxation rates obtained for the electroporated PBD-PEO magneto-polymersomes 
were extremely high, especially when the low concentration of iron oxide in the 
polymersomes sample (1-1.4 %) is taken into account. The relaxation rate for the iron 
oxide was confirmed by comparison of the relaxation rate of the magneto-
polymersomes to the relaxation rate of unelectroporated polymersomes. This was 
done to rule out  the possibility that this effect was due to the polymer membrane or 
buffer alone. This relaxation rate also increases as a function of both polymersome and 
iron concentration. It is believed that the relaxation rate can be altered by tuning of the 
electroporation parameters used to mineralise the magneto-polymersomes. Initial data 
suggests that these two parameters are inherently linked, that as applied 
electroporation voltage increases, so does the MRI relaxation rate. However, there is a 
clear anomaly when the magneto-polymersomes were electroporated at 1000 V, in 
which a change in the particle size and number are also observed within the magneto-
polymersomes. At this point, the MRI contrast increases, and these preliminary data 
suggests that this is due to the increase in particle size and number. It appears that 
even higher electroporation voltages (1500 V and 2500 V) yields a greater number of 
small MNPs, whereas lower voltages (250 V and 750 V) result in fewer particles which 
are bigger in size. Despite having equivalent iron oxide content, the MRI relaxivities are 
significantly different. This is essentially because, at the higher electroporation 
voltages, there are more particles for protons from water to come into contact with. 
Before this hypothesis can be proven and fully explained, so that magneto-
polymersomes can be exploited for biomedical applications, more needs to be 
understood regarding how electroporation controls the mechanism of mineralisation. 
This should yield a more consistent and reproducible response in MRI and magnetic 
hyperthermia response activity. Further work and optimisation of both sample 
preparation (with respect to electroporation) and data collection (particularly 
magnetic hyperthermia) is required before the biomedical potential of the magneto-
vesicles can be realised, with in vivo tests of magneto-polymersomes on the horizon. 
 
 











CHAPTER 10:  
 
10 FUTURE WORK AND 
CONCLUSIONS 
  





This work overall has demonstrated that it is possible to design and create an artificial 
magnetosome. This has been done by the development of a vesicular nanoreactor for 
compartmentalisation of a magnetite precipitation reaction. These magneto-vesicles 
have then been tested to determine their magnetic and materials properties, using both 
classical characterisation techniques (e.g. SQUID and EDX) and testing for biomedically 
useful properties (MHT and MRI). 
 
10.1.1 VESICLE OPTIMISATION FOR MINERALISATION 
 
To develop magnetite mineralisation nanoreactors has required optimisation of both 
lipid and polymer vesicle properties. It has been determined that overall PBD-PEO and 
DPhPC, offered the best vesicle composition of appropriate size, permeability and 
stability. Although DSPC and PEG113-PHPMA400 /PMPC28-PHPMA400 were also 
largely successful, depending on the synthesis route and iron ion transport method 
employed. With each vesicle forming material, room temperature co-precipitation of 
magnetite using NaOH (10 mM), and iron chloride salts in the stoichiometric ratio for 
magnetite precipitation (Fe3+ 2:1 Fe2+) was carried out. Conditions were established 
that are the most appropriate for effective precipitation of electron dense, iron oxide 
material, using environmentally friendly conditions. Due to this benign mineralisation 
method, these magneto-vesicles are also likely to have relatively low toxicity, which 
bodes well for future use in biomedical application. Electroporation of the both lipid 
and polymer vesicle membranes was discovered to be the most effective method for 
iron oxide mineralisation of the vesicles across the board. 
The use of electroporation allows for the remote triggering of MNP precipitation by 
application of an electric field. This is hugely advantageous, from a practical point of 
view, in that MNPs can be highly sensitive to oxidation which can incur long-term 
stability problems. 
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Electroporation at the point of use would deliver the freshest MNPs to ensure the 
timely delivery of high quality, stable MNPs for application, removing shelf-life issues. 
Additionally, remotely triggering polymersomes to form magneto-polymersomes via 
electroporation can present a host of opportunities in further applications. For 
example, in cases were a magnetic response would be valuable during application both 
in vivo and in vitro, such as in the case of iron sensing assays. Furthermore, the 
structure of the PBD-PEO and PMOXA-PDMA-PMOXA magneto-polymersomes, in 
which MNPs are localised to the membrane, leaves the vesicle core free for 
encapsulation of e.g. hydrophilic drugs. This shows their great potential as therapeutic 
agents, and opens up extensive engineering opportunities with respect to MNP 
/polymersome properties for various applications. This approach permits the creation 
of a simple biocompatible nanoreactor, activated by the application of an electric field 
for the engineering of precise magneto-polymersomes. 
Attempts to spectroscopically quantify both iron ion transport and eventual iron oxide 
concentration were unsuccessful. Each assay developed was unable to quantify iron ion 
transport effectively once incorporated into the vesicles. For this reason, most samples 
were characterised only qualitatively (via TEM), with more in-depth analysis only able 
to be applied to samples that looked promising for future development. Successful 
development of a transport assay would allow quantitative analysis of all samples, and 
give a better picture of iron ion transport to inform further optimisation. This thesis 
presents the first cloning, expression and purification of MTB transporter MamMB and 
the use of MTB proteins and artificial MTB coiled coil proteins into synthetic vesicles. 
However, a similar problem was encountered with quantifying the incorporation of 
purified MTB proteins and biomimetic MTB protein. Again analysis was limited to 
qualitative characterisation via detection of the proteins using electrophoresis and 
observing morphological changes by TEM imaging. Although all of this points to 
successful incorporation, mutation of each of the proteins/scaffolds is required to 
allow for the detection and conclusively confirm their incorporation. Once this has 




P a g e  | 272 
 
 
A novel and high yield method of artificial magnetosome synthesis (i.e. a vesicle of 
appropriate size of which the core is entirely filled with a single magnetite crystal) has 
been developed. This was optimised using EHDA synthesised DSPC lipid vesicles, with 
electroporation used to induce mineralisation. 
 It was also discovered that particles could preferentially be formed in the core of the 
vesicle or within the membrane (leaving the core free for future drug encapsulation) 
depending on the material and electroporation voltage used. For example, it has been 
found that electroporation of EHDA synthesised DSPC lipid at 750 V yields a single 
particle in the core, whereas electroporating PBD-PEO polymer at 2500 V causes in situ 
precipitation of MNPs in the membrane. These data essentially demonstrate proof of 
concept data for the future development of a “toolbox” of MNP decorated vesicles, the 
design of which can be tailored to suit the application depending on the size and 
position of the particles required. This would require a large amount of further 
optimisation. However, this thesis has demonstrated that, by informed selection of 
materials and the tuning of applied electroporation voltage, it is possible to design 
control of the size and location of the nanoparticles mineralised. 
However, as eluded to throughout this thesis, the benefits of this system are that it can 
be engineered to suit a desired application. Therefore, although not currently showing 
the type of coercivity usually observed in hard ferrimagnetic nanoparticles, 
incorporation of hardening elements such as cobalt is entirely feasible by adjustment of 
the electroporation solution composition. This will then harden the magnet by doping, 
thus giving the artificial magnetosomes increased coercivity. This should make it more 
difficult to switch the magnetisation by applying an alternating field and generate more 
heat for hyperthermia applications. A change of material, like in the case of DOPC, leads 
to bigger vesicles and hence bigger particles, which would be presumed to display 
more ferrimagnetic behaviour. 211 
The magneto-vesicles are designed to mimic the production of magnetosomes within 
MTB. This has a number of important advantages. Firstly, it provides a simplified 
abiotic model of the biomineralisation process, observed in MTB. This model system 
could be used to probe the biomineralisation process itself, by sequentially inserting 
biomineralisation proteins; as discussed throughout chapters 5 and 8, to better 
understand their function.  
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Secondly, and crucially, the system enables the development of a commercially viable 
route of creating monodispersed populations of lipid encapsulated, precise single-
domain MNPs. These artificial magnetosomes offer enormous potential for 
modification that is simply not possible for natural magnetosomes, facilitating the high-
yield production of a wealth of new nanomaterials for biomedical and 
nanotechnological applications. 
This has been a broad, multi-disciplinary project, which has involved high-throughput 
trialling of a wide range of materials and synthesis routes for the creation of a synthetic 
magnetosome. Three modes of transmembrane transport have been explored starting 
entirely biological, then exploring biomimetic and bioinspired transmembrane 
transport, before finally entirely synthetic transport modes. An artificial magnetosome 
has been designed and developed, which shows potential for biomedical application. 
Further to this unexpected results with regards to the electroporation of 
polymersomes. These have yielded a versatility which wasn’t expected, and has 
revealed potential for a highly adaptable nanoreactor system in which the particles can 
be preferentially precipitated in the membrane or vesicle core, of a material to suit a 
specific application. These results are summarised in table 10.1: 
 Synthetic Biomimetic Biological 

















Table 10.1: Summary of various methods used throughout the project 
 
With future applications of this “toolbox” (various material and transport method 
combinations to yield specific results) in mind it has also been shown that the 
bioinspired synthesis routes presented have huge potential for use as MRI contrast 
agents and therapeutic nanocarriers for use in magnetic hyperthermia treatment. 
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10.1.2 CHARACTERISATION OF MAGNETO-VESICLES FOR USE IN BIOMEDICAL 
APPLICATIONS 
 
Despite further optimisation being required, the initial studies presented in chapter 9 
demonstrate the extremely fast relaxation rates and exceptional heating ability of 
magneto-polymersomes. This is despite the relatively small concentrations of iron 
oxide present when compared to unsupported MNPs currently used for such 
applications. However, this does need further work and optimisation with respect to 
better quantification of both iron oxide content and sample concentrations. This is 
difficult at this stage due to the nature of the small sample size at these initial stages 
before scale up. For example, traditional characterisation methods are currently 
impractical, as techniques like X-ray powder diffraction or SQUID require too large a 
quantity for reliable, accurate analysis, access to single area electron diffraction would 
also help to confirm mineral composition. The small sample size may also contribute to 
some of the reproducibility issues, as was demonstrated by variability in 
measurements e.g. using DLS and gas chromatography. 
 
10.2 FUTURE WORK 
 
There are a number of other potential routes to magneto-vesicle synthesis which could 
be explored to improve upon the work presented here. Co-functionalising them with 
fluorophores (e.g. on the lipids or polymers used to construct the magneto-vesicles) 
would allow easy tracking for both in vitro and in vivo applications. It would also be 
prudent to examine whether magneto-vesicles can be selectively functionalised on 
both the internal and external surfaces.  
Controlled external functionalisation of the magneto-vesicles would allow the 
demonstration of the potential targeting capabilities of these assemblies. The external 
decoration of magneto-vesicles with targeting moieties may allow them to localise at a 
designed target (e.g. a cell line displaying a particular cancer marker).  
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This may also encourage differential uptake of magneto-vesicles at the target site, 
selectively concentrating them, and thus their cargo, within the diseased tissues. 
Internal functionalisation of magneto-vesicles could be used to add drugs or other 
desired molecules to their lumen in a controllable manner. 
It would also be of interest to explore whether the magneto-polymersomes presented 
in chapter 9 are magneto-responsive, i.e. can be ruptured and release cargo by 
continued application of an alternating magnetic field. A previous study in the 
literature have shown that vesicle decorated with MNPs can be engineered to be 
magneto-responsive in an alternating magnetic field, thus releasing a fluorescent cargo 
upon irradiation by the field.212 If this possible with the magneto-polymersomes, which 
appear to be responsive in the alternating magnetic field applied in chapter 9, then 
encapsulation of both hydrophilic and/or hydrophobic drugs (perhaps simultaneously) 
could be explored without further vesicle functionalisation. This would involve further 
tests to determine if a) magneto-vesicles can incorporate drugs and/or drug proxies, 
and b) magneto-vesicles can be triggered to rupture/leak upon the application of an 
alternating field. 
For example, the Kros lab makes use of coiled-coil proteins to induce membrane fusion 
of two separate vesicles, with the aim of fusing vesicle carriers to cells. This is done by 
incorporation of complementary heterodimer coiled-coil peptides in to two separate 
liposomes.213 Assembly of these two complementary halves of the heterodimer forces 
fusion of the two liposomes, and more importantly, mixing of the two encapsulates.213 
It would be interesting to investigate whether such coiled-coil heterodimers could be 
used in this manner for our own system. Not only would this ensure the vesicular 
integration of the scaffold, but also precipitation of magnetite upon membrane fusion if 
vesicles were designed so as to encapsulate NaOH and iron chloride solutions in 
separate vesicles. It could also be possible to design hetero-trimer systems that are 
able to assemble vesicles incorporating three different components in a controlled 
manner. This could include a co-precipitation system (Fe2+, Fe3+ and base) or a partial 
oxidation (Fe2+, oxidiser and base) or reduction reactions (Fe3+, reducing agent and 
base) for the production of magnetite within vesicles.  
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It would be interesting to see if the nanoreactor system developed in this project can 
be applied to the biomineralisation of other materials such as calcite, hydroxyapatite, 
silica to form similar capsules for drug delivery, or mineralisation of titania for use in 
photovoltaics214 or quantum dot for fluorescence functionality215 and gold nanoparticle 
for surface plasmon imaging.127a, 127b, 216 The next natural step would be to combine 
these functionalities in to a single carrier vesicle, (e.g. magnets and quantum dots) 
together in one to create e.g. magneto-optical vesicles.94b, 128, 132a 
There is still a large amount of work to be done before a fully functional artificial 
magnetosome and its application in biomedicine is realised. This work shows that it is 
not only possible, but also has the potential to be fully tuneable with respect to the 
properties of the final product. This would allow for fully tuneable electroporation and 
biological transport, yielding a functional biomimetic magnetosome, and the “toolbox” 
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NMR analysis of block co-polymer. A nuclear magnetic resonance spectrum of block 
copolymer PBD-PEO used for polyermersome formation was taken before the polymer 
was utilised in film rehydration synthesis. NMR spectrum confirms expected structure 
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To determine the dilution effect of the polymersome clean-up, gas chromatography 
was used to estimate the final concentration of the samples this was by relation of the 
polymer peak area in the chromatograph the polymer concentration by integration of 
the areas under the peak an comparison to a sample of a known concentration  
 
 
Gas chromatography calibration for determination of polymersome concentration. Carried out 
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Estimation of magnetic material: 
 
Magnetopolymer film mass = 0.7 𝑚𝑔  
 
Gas chromotography polymer concentration =  0.2 𝑚𝑔/𝑚𝑙 
 
 Polymersome area = 4𝜋 𝑥 2.5 𝑥 10−7 = 1.57 𝑥 10−65𝑐𝑚3 
 





N x Area = 𝑥 1.8 𝑥 10−4   






= 1.146 𝑥 1061  
 
Therefore volume occupied = 𝑛 𝑥 100 𝑛𝑚3 
 
Magnetic film total mass = 0.7 𝑚𝑔/𝑚𝑙 
Polymer mass =  0.2 𝑚𝑔/𝑚𝑙 
 
 
Therefore theoretical internal volume = 0.7 − 0.2 = 0.5 𝑚𝑔/𝑚𝑙 




4 𝑥 𝜋 𝑥 502 𝑥 5   ∶    
3
4
 𝑥 𝜋 𝑥 552   
157080  ∶     392012 
  1    ∶   2.5 
0.2   ∶    0.5 
 
Elemental analysis  
2000 ∶ 22.3 𝑝𝑝𝑚 
2000 ∶ 28.46 𝑝𝑝𝑚 (𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑚𝑎𝑔𝑛𝑒𝑡𝑖𝑡𝑒 𝑀𝑤) 
2000 ∶ 28.99 𝑝𝑝𝑚 (𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑚𝑎𝑔ℎ𝑒𝑚𝑖𝑡𝑒 𝑀𝑤) 
 
% Magnetite  =
𝑀𝑎𝑔𝑛𝑒𝑡𝑖𝑡𝑒 𝑝𝑝𝑚 
𝑃𝑜𝑙𝑦𝑚𝑒𝑟+𝑀𝑎𝑔𝑛𝑒𝑡𝑖𝑡𝑒 𝑝𝑝𝑚
𝑥 100 =  
28.46
2028.46
 𝑥 100 = 1.40 % 






𝑥 100 =  
28.99
2028.99
 𝑥 100 = 1.42 % 
 
Magnetic saturation (from SQUID measurement) =  3.76 𝑥 10−5 𝑒𝑚𝑢 𝑔−1  
 
If magnetite  =  
𝑒𝑚𝑢
𝑔
=  91  therefore 𝑔 =  
3.76 𝑥 10−5
91
=  4.13 𝑥 10−7 
 % Magnetite material   =  
4.13 𝑥10−4
0.200413
 𝑥 100 = 0.20 %  
If magnetite  =  
𝑒𝑚𝑢
𝑔
=  80 therefore 𝑔 =  
3.76 𝑥 10−5
80
=  4.7 𝑥 10−7 
% Magnetite material =  
4.7 𝑥10−4
0.20047
















MTB iron Transporter sequences 











































































































































     
 
 
 
 
 
